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Abstract
The granulosa cells of the ovarian follicle surround the oocyte and support it 
during follicle development. Once exposed to the LH surge, the granulosa cells 
are characterised by the induction of genes necessary for cellular 
differentiation. The extensive morphological and functional changes which 
characterise lutéinisation involve the regulation of gene and protein expression 
responsible for the cessation of proliferation and the induction of 
differentiation in the individual granulosa cells. The differentiating granulosa 
cell also functions in both an endocrine and paracrine manner mediating 
follicle and oocyte maturation and subsequent corpus luteum remodelling. The 
formation of the functional corpus luteum and secretion of progesterone is 
essential for the establishment of pregnancy following ovulation. A lthou^ 
much is known about the molecular mechanisms responsible for follicular 
development comparatively little study has been carried out to analyse the 
control of, and events which occur during, lutéinisation. It is therefore 
pertinent to study gene expression changes to try to clarify and understand 
mechanisms which regulate and underpin ovarian granulosa cell lutéinisation.
In order to investigate the mechanisms underlying these processes we 
embarked on a time- and cell-specific analysis of gene expression in the 
granulosa cell during late follicle development and early lutéinisation. Changes 
in gene expression during granulosa cell lutéinisation were measured using 
serial analysis of gene expression (SAGE). Immature nonnal mice were treated 
with gonadotrophin to induce formation and lutéinisation of ovarian follicles. 
SAGE libraries were generated from mRNA isolated from granulosa cells 
collected before and after induction of lutéinisation. The combined libraries 
contained 105,224 tags representing 40,248 unique transcripts. Overall, 715 
transcripts showed a significant difference in abundance between the two 
libraries of which 216 were significantly down-regulated by lutéinisation and 
499 were significantly up-regulated. Among transcripts differentially 
regulated, there were clear and expected changes in genes involved in 
modelling of the extracellular matrix, regulation of the cytoskeleton and intra 
and intercellular signalling. Also identified were transcripts relating to genes 
and cellular signalling pathways novel to the granulosa cell, including 
members of the E2F family of cell cycle regulators and the Notch signalling 
pathway as well as genes implicated in angiogenesis and cellular metabolism 
not previously associated with the granulosa cell.
Further studies into an unmatched SAGE tag which was highly differentially 
expressed revealed that it represented a variable length non-coding transcript 
which showed a tissue- and temporal-specific expression pattern within 
granulosa tissue. This transcript is highly conserved across species and lies 
distal to the 3’ end of the inhibin pA subunit. Highest levels of expression were 
found within the gonadotrophin-stimulated, mature antral follicle prior to the 
LH surge where it was the 6th most highly expressed transcript. After 
lutéinisation there was a rapid downregulation of expression. It is suggested 
that this transcript may have involvement in regulating the transcription and/or
IV
translation of the inhibin pA subunit during follicle development and 
lutéinisation.
In conclusion, this thesis provides insight into some of the important 
mechanisms involved in the regulation of lutéinisation, namely angiogenesis, 
differentiation, cell cycle control and the metabolic machinery within the 
granulosa cell. We have isolated a large number of candidate genes related to 
the cellular differentiation processes occurring within the granulosa cell during 
lutéinisation. The data generated and presented here constitutes a new base for 
the testing of hypotheses in the field of follicle development and lutéinisation.
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Introduction
Mammalian folliculogenesis and 
lutéinisation
1. The Mammalian ovary
The major functions of the female gonad are endocrine support of sexual 
development and reproductive function, prenatal multiplication of the germ cell 
line and germ cell storage and release during the postnatal reproductive lifespan.
1.1 Historical perspective
The recognition of a role for
the ovary as the major organ for reproductive function began in the century 
BC with the hypothesis put forward by Herophilus that the ovary was the source 
of female semen. It took until the work of Galen, in the second century AD, to 
recognise the transmission of this ‘semen’ through the fallopian tubes to the 
uterus. Fifteen hundred years later came the first proposition of the role of the 
oocyte was made by William Harvey with his treatise, Exercitationes de 
Generatione Animalium (1651) proposing the concept ex ovo omnia, that all 
living things come from eggs, a deduction inspired largely by his work in the 
avian field. The first recording of the ovarian follicle by van Home, and further 
identification and investigation of the tertiary follicle by Regnier de Graaf in the 
late 17* century led to the proposition that the follicle itself was the mammalian 
egg, although this was never reconciled with the problem of transmission of this 
egg through the much narrower fallopian tube to the utems. The corpus luteum 
was first accurately depicted in de Graaf s publication “De Mulierum Organis 
Generationi Inservientibus Tractatus Novus” of 1672 in which he proposed that 
the corpora lutea are transient and provide an estimation of the number of 
embryos. The discovery of the oocyte within the fallopian tube was made in 
1797 by William Cruickshank, and in 1827 the origin of the oocyte was 
identified by von Baer. This can be regarded as the start of the accurate 
elucidation of the cellular structure of the Graafian follicle.
Although the follicular lineage of luteal tissue was not conclusively determined 
until the latter half the 20^ ^^  century its function was unravelled much earlier. In 
1897 John Beard proposed that the corpus luteum inhibits ovulation during
gestation and degenerates before parturition (as cited by Amoroso 1968). 
Although corpora lutea were referred to as glands by Malpighi, de Graaf, and 
Fabricius, Prenant (1898) was the first to suggest that the corpus luteum was an 
endocrine gland. He wrote “As for the physiological role of the corpus luteum 
there can be no doubt from a study of its histological appearance that it acts as a 
gland of internal secretion, releasing one or more products into the bloodstream” 
(as cited by Short, 1977). In 1903 Frankel found that removing the ovaries of 
pregnant rabbits terminated pregnancy and thus provided evidence for Gustav 
Bom’s hypothesis that corpora lutea are required for implantation (as cited by 
Amoroso, 1968). Further investigation into the intemal secretion of the corpus 
luteum culminated in the purification of progesterone by several research groups 
(Allen and Wintersteiner, 1934; Butenandt and Westphal,1934; Hartman and 
Wettstien, 1934; Slotta et al, 1934).
1.2 Development, anatomy and physiology of the ovary
1.2.1 Gonadal development and sexual differentiation
The undifferentiated gonad develops during early foetal life on the cranioventral 
mesonephros. This early gonad has the ability to differentiate into either testes or 
ovary as determined by the genetic sex of the individual. By embryonic day 10 
in mice it is recognisable as the gonadal ridge on the ventral mesonepliros. 
Sexual differentiation is initiated by embryonic day 11.5 (Viger et al 2005).
The germ cells themselves arise extra-gonadally and migrate to the developing 
gonad. Different origins have been suggested for the primordial germ cells but a 
recent study suggests the posterior primitive streak as the likely source 
(Aiderson et al 2000). In mice, germ cell migration is complete by embryonic 
day 10.5 (McLaren, 2003).
The developing gonad is covered by coelomic epithelium. The granulosa cells of 
the ovary arise from cell populations within the region of the developing gonad, 
which in the male, become the Sertoli cells of the seminiferous tubules. In both 
sexes the cellular function is homologous: to nurture and aid maturation of the
____
germ cells and to mechanically discharge them into the genital duct system. The 
precise origin of the somatic cells is controversial, the coelomic epithelium, local 
mesenchymal cells and mesonephros have all been proposed as potential 
sources. It has been suggested, on the basis of immunohistochemical detection of 
steroidogenic factor 1, SF-1 (Hatano et al., 1996) and ultrastructural stereological 
studies of calf embryos (Wrobel and Slip, 1999) that the steroid producing cells 
of the gonads and adrenal gland develop from the same cell population, an 
adreno-genital primordium that originates in the mesonephros. This is supported 
by the observation that when sexually undifferentiated female gonads were 
inoculated into nude mice, only those with attached mesonephros developed 
normal follicles, indicating the importance of the mesonephros in follicle 
development (Byskov,1974; Byskov et al., 1977). Various cellular markers have 
been used to trace the origin of granulosa cells including the ligand receptor pair 
SCF-c-kit and cytokeratin (Tisdall et al 1999, Loftier et al 2000). Both these 
studies support the notion that the first generation of granulosa cells develop 
from the mesonephros, but do not exclude the possibility of an origin in the 
surface epithelium, which is supported by the work of Sawyer et al (2002). In 
the male, the Sertoli cell is known to develop from the coelomic epithelium (Karl 
and Capel 1998) but an analogous situation in the female has yet to be proven. 
The importance of the origin of the granulosa cell is debatable since it has been 
shown that somatic cells from newborn rat ovaries mixed with oocytes from 
newborn mouse ovaries and implanted underneath the kidney capsule develop 
into hybrid follicles of rat granulosa cells and mouse oocytes (Eppig and 
Wigglesworth 2000) which suggests that the oocyte may have the ability to exert 
influence on sufficiently undifferentiated somatic cells to develop into granulosa 
cells.
Sexual differentiation of the gonad becomes evident in male mice around 
embryonic day 12.5 with the development of testicular cords (Upadhyay et al., 
1981), initiated by sex determining region Y (^^y) expression on the Y 
chromosome (Gubbay et al 1990; Sinclair et al 1990; Koopman et al 1991). 
Ovarian differentiation follows slightly later and was for a time considered the 
default pathway of development in the absence of expression of testis
determining genes. Ovary determining genes are however now being identified, 
among them Wnt-4 (Vainio et al 1999) and Dax-1 (Swain et al 1998) which 
lends weight to the argument for a specific gene pathway that drives ovarian 
development rather than passive differentiation in the absence of testes.
Following gonadal differentiation the proliferating germ cells become 
concentrated in the cortex and undergo mitosis to give rise to oogonia, which 
continue to proliferate. Shortly thereafter meiosis is initiated in the oogonia and 
they become oocytes, surrounded by granulosa cells and stroma, and as such are 
regarded as primordial follicles. These primordial follicles were thought to be the 
source of all developing follicles during the reproductive lifespan. However 
recent evidence has shown that mammalian ovaries possess persistant large 
germline stem cells and gives rise to the possibility of follicular renewal in adult 
females (Johnson et al 2004).
1.2.2 Histological structure of the ovary
The mammalian ovary consists of three distinct regions, the hilum, which 
contains the entry point for the blood vessels, the medulla, containing a 
heterogeneous group of cells, and the cortex, the dominant zone, lined by 
germinal epithelium and containing the oocytes. In the mature cycling, fertile, 
female follicle development is ongoing and a variety of stages of developing and 
atretic follicles may be present at any one time. In addition, depending on the 
species and stage of the ovarian cycle, active or regressing copora lutea may be 
present, (figure 1.1)
The outennost layer covering the ovary consists of germinal epithelium, directly 
underneath this there is a dense layer of connective tissue known as the tunica 
albuginea. The ovarian follicles, in conjunction with surrounding fibroblasts, 
collagen and elastic fibres, form the ovarian cortex located under the tunica 
albuginea. The ovarian medulla contains the blood vessels, lymphatic vessels 
and nerve terminals.
The ovary is an organ of constantly fluctuating populations of cells due to 
continual growth and regression of follicles and corpora lutea. These
___
developmental processes within the ovary involve cell proliferation (Reynolds 
and Redmer 1998) and differentiation (Chang et al 1977, Anderson and Little
1985), angiogenesis (McClellan et al 1975) and cell death (Ingram 1962). 
Normal ovarian function in mammalian species requires that during every 
oestrus cycle only a limited number of follicles reach the stage of Graafian 
follicles and ovulate. This is essential for the prevention of excess embryos 
during pregnancy. In each stage of the cycle about 50% of the large preantral and 
antral follicles will be in the process of apoptotic death (Almog et al 2001), the 
stimuli for apoptosis or survival can be autocrine, paracrine or
Secondary follicle
Primordial follicles
Mature antral follicle
G ranulosa ce lls  
Antrum
Mature CL
O ocyte
Figure 1.1 Schematic of an ovary depicting the life cycle of a follicle destined 
to ovulate. The ovum of a mature follicle is situated within the fluid filled 
antrum on a pedicle of granulosa cells. At ovarian rupture the follicular antrum 
is filled with blood forming the corpus haemorrhagicum (CH), the clot is 
resorbed and replaced by lutein cells forming the corpus luteum (CL)
endocrine (Amsterdam et al 1999). The ultimate goal of the successful follicle is 
a release of the female germ cell, termed ovulation (Hartman 1932, Hisaw 1947, 
Comer 1963).
1.2.3 Endocrine control of ovarian function
Reproductive function is controlled by a variety of physiological and hormonal 
factors. The mouse has oestrus cycles of 4-6 days duration (Schwartz 1973), 
although considerable variation in cycle length has been recorded (Whitten 1958, 
1959). Ovulation is spontaneous but in absence of copulation corpora lutea fail 
to develop (Schwartz 1973, Greenwald and Rothchild 1968).
Inhibii
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♦
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■
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Figure 1.2 Summary of the hypothalamic-adenohypophyseal-ovarian axis. The 
gonadal steroids exert negative or positive (depending on the stage of the 
ovarian cycle) feedback at the pituitary level by blocking GnRH action and at 
the hypothalamic level by inhibiting GnRH release. Separate gonadal products 
either suppress (inhibin and follisatin) or stimulate (activin) FSH release, (red 
arrow represents negative effect, black arrow positive effect).
The physiological and behavioural changes associated with the oestrus cycle 
depend on a complex interaction of endocrine and local factors under the 
integrative control of the hypothalamus. This hypothalamic-adenohypophyseal- 
ovarian axis is the system under which normal ovarian function is driven by the 
pituitary hormones, whose secretions are in turn controlled via the hypothalamic- 
hypophysiotrophic hormones, and a feedback mechanism of steroid and peptide 
hormones (figure 1.2). Therefore hypothalamic hormones stimulate the 
production of hormones from the anterior pituitary that ultimately stimulate
follicle development and ovulation in the ovary. Steroid hormones from the 
ovary provide a feedback loop at both the hypothalamic and adenohypophyseal 
level to control hormone secretion.
The oestrus cycle is divided into luteal and follicular phases. The luteal phase in 
mice starts after ovulation and copulation when the corpus luteum is formed 
from the wall of the collapsed follicle. Progesterone is the dominant hormone of 
the luteal phase. The follicular phase starts after regression of the CL, Oestrogen 
levels increase gradually in the follicular phase in association with follicle 
growth. The preovulatory follicle produces high levels of oestradiol leading to 
behavioural changes during oestrus and stimulating gonadotrophin release to 
induce ovulation.
The main hormones regulating reproductive function that are released from the 
anterior pituitary are follicle stimulating hormone (FSH) and luteinising 
hormone (LH), they regulate ovarian function and steroid hormone secretion. 
FSH is the key regulatory hormone involved in follicle growth and development, 
LH is the key hormone involved in terminal preovulatory follicle maturation for 
ovulation and then lutéinisation.
Control of gonadotrophin secretion is through release of gonadotrophin releasing 
hormone (GnRH) from neurones in the hypothalamus. They represent the final 
output component of the neuronal network that regulates reproductive hormone 
secretion. The episodic release of GnRH into the hypophyseal portal system 
creates a pulsatile pattern of LH secretion (Knobil 1980, Levine et al 1991). 
Fluctuations in this pattern generate the marked changes in the LH secretion 
profile observed over the course of the ovarian cycle (Freeman 1994, Goodman 
1994). The midcycle LH surge, responsible for initiation of ovulation, results 
from an abrupt and massive increase in hypophyseal GnRH secretion in a 
number of species (Sarkar et al 1976, Ching 1982, Caraty et al 1989, Moenter et 
al 1990, Pau et al 1993, Karsch et al 1997). Oestrogen is one of the principle 
determinants of GnRH neurone function and is critical in enabling these cells to 
exhibit fluctuating patterns of biosynthetic and secretory activity. For most of the 
ovarian cycle oestrogen serves to restrain LH secretion partly by inhibition of 
GnRH secretion (Caraty et al 1989, Sarkar and Kink 1980, Chongthammakun
. ,
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and Terasawa 1993, Evans et al 1994) and also by direct action on the pituitary
gland (Freeman 1994, Goodman 1994, Shupnik 1996). Oestrogen also exhibits
.positive feedback influence on GnRH neurones and pituitary gonadotrophs to 
generate the LH surge. The rising follicular concentrations of circulating 
oestradiol can on their own, or in combination with circadian input, trigger an 
LH surge (Moenter et al 1990, Karsch et al 1997, Sarkar and Fink 1980, Xia et 
al 1992, Everett and Sawyer 1950, Legan et al 1975).
The gonadal peptide hormones, inhibins and activins, produced by the granulosa 
cells in the female and sertoli cells in the male, comprise an endocrine feedback 
loop to the pituitary. Inhibins and activins are named for their effects which 
inhibit and activate respectively pituitary production of FSH. Their importance 
in regulating reproductive function is demonstrated by mice null for the inhibin a 
subunit, and thus deficient in inhibins, developing mixed granulosa/sertoli cell 
tumours in the ovaries and testes (Matzuk et al 1992).
The pattern of events that occur during ovulation is initiated in a responsive 
preovulatory follicle by a surge of LH, which induces both theca cells and 
granulosa cells to stimulate cAMP production and activate selected protein 
kinase signalling cascades (Richards 1994, 2001, Richards et al 2000). These 
pathways induce the transient transcription of specific genes prior to follicle 
rupture that induce ovulation and promote follicular remodelling to form a 
corpus luteum. Although the principal effects of the hormones LH, FSH, 
oestrogen and progesterone on the ovary are known, their precise functions and 
interplay are still not clear. Moreover, it is becoming increasingly apparent that 
other hormones, growth factors and cytokines are involved in the fine-tuning of 
ovarian function. A complete intraovarian paracrine system is implied in 
follicular growth and maturation (Findlay 1994, Chabbert-Buffet et al 1998). 
Local regulation of ovulation and lutéinisation involves the interaction of LH 
and intrafollicular factors including steroids, prostaglandins and peptides derived 
firom endothelial cells, leukocytes, fibroblasts, and steroidogenic cells.
___
1.3 The Gonadotrophic hormones and receptors
Follicle stimulating hormone (FSH) and luteinising hormone (LH) are 
glycoproteins whose release from the gonadotroph cells of the anterior pituitary 
is stimulated by gonadotrophin releasing hormone (GnRH) from the 
hypothalamus. The pleiotrophic effects of gonadotrophins are manifest in 
various cells of the reproductive system including LH and FSH in ovarian 
granulosa cells, LH in theca interna cells, FSH in testicular Sertoli cells, and LH 
in Leydig cells (Sprengel et al 1990, Amsterdam et al 1992, Segaloff and Ascoli
1993). Both hormones are heterodimers that contain a common a subunit and 
dissimilar p subunits that confer biological specificity on the individual 
hormones. The two subunits are linked by non covalent interactions stabilised by 
a p cysteine loop (Lapthom et al 1994, Wu et al 1994). Structurally these 
hormones are members of the superfamily of cysteine-knot growth factors which 
also include transforming growth factor p (TGF P). The gonadotrophic receptors 
bind only the intact heterodimeric hormone, the individual subunits having no 
binding activity (Catt et al 1973)
Follicle stimulating hormone plays a central role in the regulation of follicle 
growth and survival (Hillier 2001), it is essential for normal folliculogenesis and 
fertility (Kumar et al 1997 and 1998). The hormone interacts with receptors 
expressed exclusively on granulosa cells in the ovary and it initiates 
cytodifferentiation and proliferation which ultimately results in the development 
of the preovulatory follicle (Camp et al 1991, Erickson 1983, Hirshfield 1991). 
The physiological importance of this can be demonstrated by the death of 
follicles by apoptosis when FSH action is restricted (Hseuh et al 1994, Tilly 
1996). Follicle growth from the secondary to late antral stage is dependant on 
FSH. In the ovary, FSH induces LH receptor expression in small and medium 
follicles, the LH surge promotes the maturation of follicular cells and enhances 
the subsequent stages of follicular development and steroidogenesis in granulosa 
and luteal cells (Richards and Hedin 1988), acting to induce ovulation and 
lutéinisation of the mature antral follicle.
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The ability of FSH to modulate ovarian function depends not only on the 
circulating levels of hormone, but also on the expression of appropriate receptor 
proteins by the granulosa cells of the ovary. Both FSHR and LHR are 
structurally related members of the seven transmembrane domain G-protein 
associated receptor super family (Sprengel et al 1990, MacFarland et al 1989) 
The gene encoding the FSHR protein is encoded by the first 9 exons of the 
FSHR gene giving rise to a highly specific FSH binding protein (Huhteniemi
1994). Gonad specific expression of FSHR mRNA (Camp et al 1991, Zeleznik et 
al 1974, Nimrod et al 1976) and in situ hybridisation has shown FSHR mRNA 
localised exclusively within the granulosa cells of healthy follicles, persisting 
throughout preovulatory folliculogenesis.
The gene encoding the LHR protein contains 11 exons and variable transcription 
leads to multiple gene splice variants (Segaloff et al 1990 and 1993). The LHR is 
expressed primarily in gonadal tissues and has been studied extensively in 
Leydig and ovarian cells and in cell membrane preparations from several 
species, including rat, mouse and pig (Richards and Hedin 1988, Dufau 1988, 
Saez 1994). The presence of LHR on thecal/interstitial cells has been 
demonstrated as has their induction in granulosa cells by FSH (Zeleznik et al 
1974, Magoffin et al 1982). In-situ hybridisation has shown LHR mRNA to be 
located in the thecal cells of immature follicles but in both thecal and granulosa 
cells of mature antral follicles (Camp et al 1991). The receptor is composed of 
two functional units, the extracellular hormone binding domain (Tsai-Morris et 
al 1990, Xie et al 1990) and the seven membrane/transmembrane cytoplasmic 
module, which is the anchoring unit that transduces the signal initiated in the 
extracellular domain and couples to G proteins (Tsai-Morris et al 1993, Wang et 
al 1993).
The connections between the gonadtrophin receptors and specific signal 
transduction pathways within the granulosa cell will be discussed later (section 
1.5.2.2).
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1.4 Endocrine feedback from the granulosa cell.
1.4.1 Oestrogen
The endocrine actions of oestrogen are wide ranging and are manifest in a 
number of tissues outwith the reproductive system including bone, liver, and 
brain. The influence of oestrogen is known to be important for processes such as 
bone metabolism, cardiac and vascular function, neuroprotection, and the 
modulation of immunity (Srivastava et al 2001, Mendelsohn and Karas 1999, 
Migliaccio et al 1996, Simoncini et al 2000, Wilder 1998, Manolagas 2000, 
Mathews et al 2000, Wise et al 2001).
Its influence on the reproductive process is profound, via direct actions on the 
hypothalamic neurones and pituitary cells (McEwan and Alves 1999) it can 
control the rate of synthesis and secretion of nearly all pituitary hormones, 
including FSH and LH (Fink 1988, Gharib et al 1990). As already mentioned 
positive oestrogen feedback, which drives the ovulatory process, occurs at the 
time of the preovulatory surge of LH, while negative feedback is shown in the 
luteal and early follicular phases of the reproductive cycle. Other reproductive 
functions include its actions on mammary tissue, both directly (Migliaccio et al 
1996, Razandi et al 2000) and via prolactin to promote mammary development 
and lactation (Maurer et al 1990), and on the female reproductive tract where it 
acts to stimulate cell proliferation and progesterone receptor synthesis (Horowitz 
et la 1978).
1.4.2 Inhibin/Activin/Follistatin
Inhibin and activin are members of the transforming growth factor p family and 
have a considerable role in the regulation of FSH production. The inhibin oc, pA, 
and Pb subunits dimerise to give rise to the inhibin and activin isoforms (Ying 
1988, Knight and Glister 2001). Inhibins suppress FSH and activins stimulate 
FSH (Ying 1988). A role for inhibins in regulating FSH release is supported by 
evidence that shows, in cattle, immunoneutralisation of inhibin is associated with 
elevated circulating FSH and increases in follicular development and ovulation
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(Kaneko et al 1995, Kaneko et al 1997, Glencross et al 1994, Bleach et al 1996, 
Morris et al 1995). Activin secretion in known to increase as follicles increase in 
size (Newton et al 2002) and has been shown to stimulate GnRH-induced LH 
secretion from rodent pituitary cells (Weiss et al 1993). Follistatins are the 
binding proteins of activins and inhibins, binding to activin negates the activity 
of that ligand (De Winter et al 1996, Phillips and De Krester 1998) while 
inhibins, bound or unbound, retain their biological activity. Inhibins have the 
ability to antagonise activin by binding both activin receptors and inhibin 
binding proteins (Martens et al 1997, Lebrun and Vale 1997, Pangas and 
Woodruff 2000, Chong et al 2000) and then interfering with activin signalling.
In addition to the gonad, these proteins are also produced at the pituitary level 
and act in a paracrine manner to regulate gonadotrophin secretion (DePaolo et al 
1991, Bilezikjian et al 1994, Mather et al 1992, Padmanabhan 2001)
1.4.3 Gonadotrophin surge attenuating factor (GnSAF)
As early as the 1980s several research groups had identified a product with the 
ability to alter responsiveness of pituitary cells to GnRH (Ferraretti et al 1983, 
Littman and Hodgen 1984, Spoelak and Hodgen 1984, Messinis and Templeton
1986). It is now clear that this is a gonadotrophin-stimulated ovarian product 
emanating specifically firom the granulosa cell (Fowler et al 2002). In rodents 
GnSAF production is FSH-dependant and at its highest levels in early antral 
follicles. LH has no apparent effect on GnSAF production (Fowler and Spears 
2004). In rodents, the wave of atresia due to follicle dominance appears to occur 
around the mid antral stage of development (Baker et al 2001). The fall in 
GnSAF production in the antral follicle occurs immediately after that (Fowler 
and Spears 2004), alongside a rise in the production of oestrogen as follicles 
mature towards the preovulatory stage (Spears et al 1998). It has been proposed 
that the role of GnSAF is to regulate LH pulsatility (Fowler et al 2003).
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1.5 The Antral Follicle: development, structure and physiology.
1.5.1 Follicular development: primordial to antral follicle
The first primordial follicles are formed in mice around the day of birth, these 
are the non-renewable dormant follicle stock from which follicle recruitment 
occurs and, consequently, is depleted throughout the reproductive lifespan. There 
are between 5750 and 8250 resting follicles per ovary in the mouse (Hirshfield
1991). There is little information about the mechanisms controlling primordial 
follicle development but it has been established that the transcription factor, the 
factor in the germ line alpha (FIGa), is required for follicular formation in mice 
(Soyal et al 2000). From birth to menopause follicles will continually exit the 
primordial follicle pool and enter the growth phase. A variety of growth and 
paracrine factors have been indentified during early follicular growth and shown 
to be expressed in a cell- and stage-specific manner (McNatty et al 2000), 
although their precise roles are not clear. The transition from follicular 
quiescence to follicular growth does not appear to be dependant upon 
gonadotrophins (Peters et al 1973) although hypogonadal mice with a deletion of 
the gonadotrophin releasing hormone (GnRH) gene have a reduced number of 
early growing follicles, an abnormality which can be reversed by FSH 
administration (Haplin and Charlton 1988) and, equally, chronically elevated LH 
levels cause accelerated depletion of the ovarian reserve (Flaws et al 1997). This 
implicates some gonadotrophic involvement in follicular recruitment despite the 
evidence for continued early follicle development in absence of FSHR mRNA 
(Dierich et al 1998). Local paracrine factors, by contrast, are heavily involved in 
follicular recruitment. Kit ligand (KL) from granulosa cells, acts on receptors 
produced by both the oocyte and thecal cells and has been shown to enhance in 
vitro initiation of follicular growth (Parrott and Skinner 1999) while keratinocyte 
and hepatocyte growth factor produced by thecal cells can stimulate granulosa 
cell proliferation (Parrott and Skinner 1998). Basic fibroblast growth factor 
(bFGF) has been localised to the oocyte of primordial and primary follicles (Van 
Wezel et al 1995) with miminal levels of receptors in the granulosa cells of
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primordial follicles rising to maximal levels in the granulosa cells of primary 
follicles before declining thereafter as the follicles increased in size (Wandji et al
1992), consistent with the idea that secretion of bFGF firom the oocyte could 
activate receptors on adjacent granulosa cells. Follicular development from the 
primordial follicle stage is a process that involves oocyte enlargement, granulosa 
cell proliferation and basement membrane synthesis, processes which bFGF has |
been shown capable of stimulating in vitro (Nuttnick et al 1993, Lavranos et al 
1994, Rodgers et al 1995). Another potential mechanism regulating follicle 
development involves neurotrophic molecules such as nerve growth factor 
(NGF) and brain-derived neurotophic factor (BDNF) the absence of which has 
been shown to impair folliculogenesis and delay puberty (Lara et al 1990, Ojeda 
et al 2000). Equally as important as the production of activating substances is the 
removal of potential inhibitors of early folliculogenesis. Transforming gi'owth 
factor (32 is expressed in quiescent but not early growing follicles in primates and 
has been suggested as an inhibitor of the kit ligand system and, subsequently, of 
follicular recruitment (Gougeon and Busso 2000, Heinrich et al 1995).
Antimullerian hormone (AMH) is highly expressed in the granulosa cells of non- 
atretic preantral and small antral follicles and has been shown to exert an 
inhibitory effect on recruitment of primordial follicles into the pool of growing 
follicles with AMH-null females showing rapid depletion of their primordial 
follicle stock (Durlinger et al 1999).
When a follicle does begin to grow it will continue to grow and either succeed to 
ovulation or degeneration (Peters and McNatty 1980). It takes three weeks to 
grow firom the primordial stage to maturity in the mouse (Pedersen 1970).
During this time the oocyte enlarges and the surrounding layer of granulosa cells 
become cuboidal and proliferate to develop into an intermediary and then 
primary follicle (Fortune and Eppig, 1979). The secondary follicle is 
characterised by the appearance of a second layer of granulosa cells. Primary and 
secondary follicular development can take place in the absence of 
gonadotrophins but the follicles are responsive to, and optimal follicular growth 
may require, the presence of these hormones (Fortune and Eppig, 1979). Mice 
lacking growth differentiation factor 9 or bone moiphogenic protein 15 form
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primordial follicles but do not progress past the primary follicle stage and 
females are sterile (Dong 1996, Galloway 2000). Somewhat later in 
folliculogenesis, induced mutations in connexins that are involved in somatic 
cell interactions and somatic-germ cell interactions arrest development at the 
primary and early antral stages (Simon et al 1997, Juneja et al 1999)
Histological architecture of a Graffian Follicle
Mural granulosa Theca interna
/A M P Antrum
Cumulus oophorus ÿjB&k 8  ÆFf 
Basem ent membrane-    ____
Theca externa
Figure 1.3 The follicular wall consists of three distinct layers, mural granulosa, 
theca interna and theca externa. The follicular basement membrane separates 
the granulosa and theca layers.
During the preantral stage, follicles undergo progressive differentiation in 
addition to substantial growth. The oocyte completes growth and the zona 
pellucida becomes prominent, whereas theca cells condense and become 
vascularised outside the developing basement membrane. Granulosa cells 
proliferate and begin to differentiate relative to their proximity to the basement 
membrane or the zona pellucida. FIGa has been implicated in the coordinated 
expression of the three genes (Zpl, Zp2, Zp3) that encode the mouse egg coat 
(Liang et al 1997) since FIGa null females do not express these genes and the 
persistence of FIGa expression through folliculogenesis suggest it may play a 
regulatory role in the expression of multiple oocyte specific genes and regulate 
additional pathways critical for ovarian development (Soyal et al 2000).
Paracrine signalling within the follicle, which is crucial to emergence of the 
dominant follicle in species such as humans, brings about the sensitisation of 
follicles to FSH and LH. Sex steroids, IGF’s, and TGF-p are important
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components of the follicular paracrine system. Development beyond the antral 
stage is dependant on gonadotrophins (Halpin et al 1986); in their absence 
follicles become atretic and disappear.
Differentiation of granulosa cells first occurs when the primordial follicle is 
recruited to initiate growth. Profound alterations in granulosa cells occur 
concurrent with morphological transformation. The once flattened epitheloid 
granulosa cell assumes a cuboidal shape and the cells are shifted into prominent 
mitoses. At the secondary or tertiary follicular stage, differentiation of granulosa 
cells becomes FSH dependant, in contrast to the pituitary independent 
differentiation of earlier stages. Recent studies have demonstrated the expression 
of another type of FSH receptor other than the widely accepted Gg coupled 
entity, and its upregulation under hormonal (PMSG) influence during follicular 
growth (Babu et al 2001). It has been proposed that the receptor may be coupled 
to a signalling pathway that induces rapid calcium mobilisation and extracellular 
regulated kinase (ERK) 1 / 2  activation without elevating cAMP (Babu et al 
2001). This receptor may serve to stimulate the rapid cell proliferation required 
for follicular expansion
Some of the physiologically important genes that are induced by FSH signalling 
in the granulosa cell include cytochrome P450 aromatase (cypl9) luteinising 
hormone receptor (LHR), steroidogenic acute regulatory protein (StAR), P450 
side chain cleavage enzyme (cypllal), 3p hydroxysteroid dehydrogenase 
(3pHSD) and inhibin subunits. (Steel and Leung 1993, Richards et al 1995). This 
physiological importance is underlined by the fact that when FSH action is 
restricted the developing follicles die by undergoing apoptosis and there are no 
ovulations (Hseuh et al 1994, Tilly 1996).
Gonadotrophin stimulation of the granulosa cells in larger follicles is responsible 
for the secretion of the angiogenic factor VEGF that regulates the development 
of the blood vessel network within the thecal compartment. Those follicles, 
which activate VEGF synthesis early, increase their blood vessel extension and 
activate steroidogenesis, thus pointing to VEGF production as a crucial event in 
the control of follicular dynamics (Mattoli et al 2001).
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The critical role of FSH in follicular development is well established but the 
effect of the hormone itself is subject to numerous growth factors produced by 
the follicle that modulate FSH action through autocrine, paracrine and endocrine 
mechanisms. Increasing evidenee supports a role for various systemic growth 
factors, intraovarian growth factors, or both, including insulin-like growth 
factors I and II (IGF-I and IGF-II) and their binding proteins (IGF-BPs), 
epidermal growth factor (EGF) family members (including transforming growth 
factor alpha; TGFa), and TGFp superfamily members (including inhibins and 
activins) as co-regulators of follicle development and will be discussed at length 
later (section 1.5.2.3). There is increasing evidence that FSH also plays a role in 
the resumption of meiosis (Dekel and Beers 1978, Downs et al 1998, Singh et al
1997). In the antral follicle, FSH alters the enviroment of the maturing oocyte by 
stimulating granulosa cell divison and differentiation (Themmen and Huhtaniemi 
2000), modulating steroidogenesis (Zhang and Armstrong 1989, Moor et al 
1985, Szoltys et al 1994), granulosa cell metabolism (Downs and Utecht 1999, 
Downs et al 2002) protein synthesis (Singh et al 1997, Moor et al 1985) and 
inducing cumulus expansion (Eppig 1979). At this time the oocyte undergoes 
critical cellular events that enable the egg to resume meiosis and complete 
cytoplasmic maturation.
During late FSH-induced granulosa cell development LH has a stronger effect on 
cAMP than FSH (Richards 1994, Yong et al 1992b), which would suggest 
increased LHR density or more effective coupling to cAMP generation. The LH 
surge triggers the expression of ‘high-tone’ cAMP response genes leading to 
terminal granulosa cell differentiation and ovulation (Hillier 2001). The genes 
activated by LH include interleukin Ip, interleukin IpR (Adashi 1998a), 
prostaglandin endoperoxidase synthetase 2 (COX-2) (Morris and Richards
1995), VEGF (Ravindranath et al 1992), proteases (Liu et al 1998), neurotrophin 
receptors (Mayerhofer et al 1996), StAR (Ronen-Fuhrmann et al 1999), and 
progesterone receptors (Natraj and Richards 1993, Duffy et al 1996, Clemens et 
al 1998). LH also suppresses granulosa cell division (Yang et al 1992a) and 
follicle growth; the genes activated by LH create the conditions for follicle 
rupture, lutéinisation and progesterone secretion. Many in vivo models have
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linked the failure of these LH-activated processes to different degrees of female 
infertility (Matzuk and Lamb 2002).
In the maturing follicle, granulosa cells are not a homogenous tissue but rather a 
specialised subpopulation that consists of corona radiata, cumulus, mural and
. iantral granulosa cells. The two populations of granulosa cells, those around the |
oocyte, the cumulus oophorus, and those lining the follicle wall, the mural 
granulosa cells, influence each other through paracrine effects. In the pre-antral ?follicles with a single layer of cuboidal granulosa cells, these cells contact both 
the growing oocyte and the basal lamina. By the antral follicular stage the 
granulosa cell population has become more heterogeneous with distinct separate 
mural and cumulus cell phenotypes. The subpopulation of cumulus cells that 
surrounds the oocyte, in direct contact with the oocyte through cytoplasmic 
extensions across the zona pellucida are known as the corona radiata (De Loos et 
al 1991). During folliculogenesis, differentiation of these cell types becomes 
more marked. Prior to ovulation, cumulus cells, under gonadotrophin stimulus 
secrete hyaluronic acid in a process called mucification (Eppig 1979), mural 
cells however, under the same stimulus undergo lutéinisation. The 
subpopulations of granulosa cells differ in the distribution of receptors and 
steroidogenic characteristics (Rouillier et al 1994, 1996, and 1998). This 
variation has been demonstrated to involve differences in LH receptor 
distribution, steroidogenic capability, and mRNA encoding cholesterol side 
chain cleavage cytochrome P450, cytochrome P450 aromatase, IGF-1, Mullerian 
inhibiting substance, lectin binding, and other uncharacterised molecules 
(Latham et al 1999). Using high resolution 2D-PAGE analysis Latham et al 1999 
showed that protein synthesis patterns of mural and cumulus cells differ at a 
level of about 10.5% of the proteins having a 2 fold or greater difference. The 
result of this is that in antral follicles the mural granulosa cells closest to the 
basal lamina are highly differentiated, as demonstrated by their high 
steroidogenic potential and LH receptor content (Amsterdam et al 1975,
Lawerance et al 1980, Peng et al 1991, Whitelaw et al 1992). In contrast, the 
cumulus cells surrounding the oocyte are less differentiated, showing lower 
steroid production and LH receptor levels. The undifferentiated status of the
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cumulus cells is necessary for optimal oocyte development (Eppig et al 1998), 
whereas the highly differentiated mural cells are essential for steroidogenesis as 
well as follicle rupture induced by the preovulatory LH surge (Nekola et al 
1982),
Much of the variation between mural and cumulus cells is thought to be as a 
result of oocyte-cumulus interactions already described. A concentration 
gradient of paracrine factors established by the oocyte within the follicle could 
explain the stratification of granulosa cells in antral and preovulatory follicles, 
with the oocyte itself responsible for the development of two distinct 
subpopulations of granulosa cells. The Gdf-9 inhibition of FSH induced 
differentiation (Vitt et al 2000) of granulosa cells is a striking example of this 
(discussed in section 1.5.2.3).
The basement membrane is an acellular layer between the thecal and gianulosa 
cells containing several forms of collagen as well as fibronectin, laminin and 
proteoglycans (Rodgers et al 1999). The follicular antrum contains the follicular 
fluid made up from blood exudates modified by local secretions and metabolism 
(Gordon and Lu 1990). Although meiotically competent at the antral stage, 
oocytes are held in arrest by their interactions with granulosa cells until the 
preovulatory follicle stage, at which time they progress to metaphase II in 
anticipation of ovulation and subsequent fertilization (Pincus and Enzmann 
1935).
The preovulatory gonadotrophin surge is responsible for the resumption of 
meiosis in oocytes and induces marked changes in the mural granulosa and 
cumulus cells. Cumulus expansion occurs via the secretion, from the granulosa 
cells, of hyaluronic acid (a non-sulphated glycosaminoglycan bound to the cells 
by linker proteins) which when hydrated embeds the cells in a mucified matrix 
(Epigg 1979, Salustri et al 1999). Suppression of this process greatly reduces 
ovulation rate. The mural granulosa cells undergo further differentiation and 
lutéinisation under the same influence.
In addition to granulosa cell development, folliculogenesis is characterised by 
recruitment and growth of the thecal cell layers. Theca cells are derived from the 
mesenchymal tissue surrounding the follicles (Hirshfield 1991), and although a
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clear thecal cell layer cannot be distinguished in early follicle stages, the 
secondary follicle is surrounded by theca cells, which proliferate during follicle 
progression.
It has been shown that it is the oocyte that coordinates and orchestrates the rate 
of follicular development (Eppig et al 2002). The rate of follicular development 
can be doubled by the transfer of mid growth stage oocytes to primordial 
follicles.
In primates and rodents dominant follicles develop only during the follicular 
phase and are thus destined for ovulation (Fortune 1994). In contrast the bovine, 
ovine and equine species show the development of dominant follicles outwith 
this phase. Dominant follicles influence the development of other follicles 
(Ginther 1996). Since dominant follicles are more vascular it has been proposed 
that greater vascularity may play a part in the acquistion of dominance (Reynolds 
and Redmer 1998). Dominant follicles have a more vascular theca than other 
antral follicles, and as a result display increase uptake of serum gonadotrophins 
(McNatty et al 1981). Equally it has been reported that decreased proliferation of 
thecal capillary endothelial cells leads to reduced thecal vasculature, one of the 
earliest events in follicular atresia. Atresia of primordial follicles may be due to 
reduced blood supply (Greenwald 1989, Jablonka-Shariff et al 1994). During 
follicular development, the majority of ovarian follicles are destined to undergo 
atresia (Tilly et al 1991, Kaipai and Hseuh 1997). Apoptosis of follicular cells 
occurs at all stages of follicle development, and is regulated by several 
intraovarian factors, including tumour necrosis factor (TNF)-a, interleukin (IL)- 
6, and gonadotrophin releasing hormone (Gorospe 1992, Billig et al 1993, 
Santana et al 1995, Kaipai et al 1996). In addition, overexpression of Bcl-2 in 
follicular cells inhibits cell apoptosis and increases the frequency of germ cell 
tumours in ageing animals (Hsu et al 1996). Therefore, follicular cell apoptosis is 
also important for normal ovarian development.
Development of the ovarian follicles is accompanied by qualitative and 
quantative changes in the microvascular bed. Primordial follicles are surrounded 
by single capillary loops and growth of these follicles can be initiated by locally 
sprouting microvessels (Banks 1992). At a later stage of development the thecal
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layers differentiates into two, the theca externa, an outer layer of connective 
tissue cells and the theca interna, which is an inner vascular layer with cuboidal 
secretory cells (banks 1992). Entering the theca interna the arterioles break up 
into a rich network of capillaries that builds a basket like network around the 
avascular stratum granulosm (Koing et al 1988). The mature Graffian follicle 
itself is avascular, nourished by diffusion, and its growth gradually leads to inner 
hypoxia (Neeman et al 1997). After the surge in LH prior to ovulation, 
vasodilation of capillaries is prominent and the cross-sectional areas of 
vasculature lumina increase. There is evidence of increased vascular 
permeability, tissue oedema and ischaemia. Capillaries develop perforations 
through which blood cells and platelets escape when ovulation occurs. Shortly 
before ovulation, blood flow stops in a small area of the ovarian surface 
overlying the bulging follicle, this area then ruptures (Findlay 1986, Russe et al 
1987).
1.5.2 Follicular signalling mechanisms.
Paracrine and autocrine factors produced within the ovary have the ability to 
regulate folliculogenesis. Some of these factors are synthesised and secreted by 
the oocyte (Eppig et al 1997), and act as morphogens to control follicular growth 
as well as differentiation (Erickson and Shimasaki 2000). Others are produced by 
the granulosa cells and can have varied effects on follicle growth and 
development. Communication between the granulosa cells and the oocyte is bi­
directional, involves paracrine factors and gap junction mediated signals (Eppig 
et al 1994 and 1997) and is governed by a complex interplay of regulatory 
factors. The gonadotrophins are likely to affect the function of this loop by 
driving the pathways of granulosa cell differentiation, although it is thought that 
the oocyte controls the direction of differentiation (Eppig 2001) with the mural 
cell phenotype and ultimate lutéinisation the default pathway. The oocyte has the 
ability to promote the development of the cumulus cell phenotype, although in 
vitro this has been shown to require the presence of FSH (Eppig 1991).
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1.5.2.1 Communication pathways
To efficiently allow the paracrine interactions described above the oocyte and 
companion cumulus and mural granulosa cells have developed into a functional 
syncytium connected via gap junctions, and have established adherence junctions 
that are specialised zones of cell-cell contact (Eppig 1991, Eppig et al 1996, 
Amsterdam et al 1976, 1981, 1989a, 1989b, Amsterdam and Rotmensch 1987, 
Sommersberg et al 2000). This coupling starts at the formation of primordial 
follicles in the foetus or neonate and expands during later folliculogenesis 
(Mitchell and Burghardt 1986). As well as paracrine signals, metabolites, amino 
acids and nucleotides are passed to the developing oocyte. Multiple connexins 
are involved in these pathways; Cx32, Cx37, Cx43, Cx45 and Cx57 have been 
identified in rodents (Acket et al 2001). Gap junctions consist of two hemi- 
channels present in the opposing plasma membranes of adjacent cells formed 
from the oligomerisation of six gap junction proteins. Granulosa cell 
proliferation beyond the unilaminar stage has been shown to be blocked in Cx43 
deficient mice and it has been hypothesised that the ability of granulosa cells to 
maintain their response to certain paracrine stimulants depends on intercoupling 
via Cx43 channels. Cx43 null mice also show impaired oocyte development 
(Acket et al 2001). Cx32 null female mice are both viable and fertile (Nelles et al 
1996), Cx37 null mice are viable but follicle development cannot proceed 
beyond the antral stage and ovulation does not occur. Instead the granulosa cells 
appear to undergo premature lutéinisation (Simon et al 1997). Cx45 knockouts 
suffer early foetal death (Kumar et al 2000). This variation in phenotype 
indicates specificity in the gap junction coupling, possibly involving different 
permeant molecules, and it is therefore incorrect to assume a free passage of 
paracrine signals throughout the granulosa-oocyte syncytium.
It seems that the integrity of gap junctions plays an important role in the survival 
of granulosa cells. This conclusion is drawn from the fact that gap junctions 
become larger and appear in higher incidence subsequent to culturing of the cells 
on native ECM and/or in the presence of LH, FSH or glucocorticoids (Sasson 
and Amsterdam 2002, Amsterdam et al 1989). Following stimuli for apoptosis,
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integrity of the junctions is interrupted (Sasson and Amsterdam 2002), but it is 
not yet clear whether apoptotic signals cause the breakdown of gap junctions or 
whether breakdown of gap junctions initiates and accelerates the apoptotic 
process. Cx43 is a major component of gap junctions, and its expression is 
clearly elevated both by gonadotrophins/cAMP (Sommersberg et al 2000) and 
glucocorticoids (Sasson and Amsterdam 2002). Adherence type, junction size 
and frequency were also found to be elevated by glucocorticiods, concomitantly 
with the elevation of cadherin expression (Amsterdam et al 2003). Therefore, 
integrity of adherence and gap junctions may also play a role in the resistance of 
granulosa cells to apoptotic signals.
1.5.2.2 Intracellular receptor mediated signalling pathways
Gonadotrophins exert their stimulatory activity via interaction with their specific 
transmembrane receptors. Upon binding of the ligands both receptors stimulate 
the Gs-protein via contact sites on the intracellular loops with the specificity of 
the receptor/G protein interaction depending on the appropriate configuration of 
the intracellular surface of the receptor (Bimbaumer 1995, Schwartz 1996, 
Strader et al 1994). This, in turn, activates membrane associated adenylyl 
cyclase, causing an elevation of intracellular cAMP (Cooke 1999, Hunzicker- 
Dunn and Bimbaumer 1976, Zeleznik et al 1977). Activation of alternative 
signalling pathways by gonadotrophin receptors include calcium ion 
mobilisation (Flores et al 1992), the MAPK pathway (Das et al 1996), the PKA 
and PKB pathways (Gonzalez-Robayna et al 2000), Sgk signalling (Richards et 
al 2002) and stimulation of chloride ion influx (Amsterdam et al 1999). FSH is 
known to regulate glucose uptake via the PI3-kinase pathway (Roberts et al 
2004) and signalling via this same pathway has been demonstrated in rat 
granulosa cells by increased phosphorylation of protein kinase B (PKB/Akt) in 
the presence of FSH (Gonzalez Robayna et al 2000, Shimada et al 2003). Further 
FSH stimulated responses can be inhibited by PI3-kinase inhibitors (Sun et al 
2003, Shimada et al 2003).
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In the ovary, FSH and LH stimulate the A-kinase pathway and thereby control 
the growth and differentiation of the ovarian follicle (Walsh et al 1968). Tonic 
FSH stimulation of immature granulosa cell induces low levels of intracellular 
cAMP formation and activation of genes required for proliferation and 
differentiation. (Hillier 2001). Genes such as serum- and glucocorticoid-induced 
kinase (Sgk) (Alliston et al 1997, Webster et al 1993) and serum-induced kinase 
(Snk) (Walsh et al 1968), as well as the cell cycle regulatory molecule, cyclin D2 
(Sicinski et al 1996, Robker and Richards 1998), are induced in these cells in an 
immediate early expression pattern. In contrast, other genes exhibit a more 
delayed response to hormone stimulation and do not peak until 24-48 hrs after 
exposure to FSH when granulosa cell function has reached the preovulatory 
stage. Genes induced at this time include aromatase (Hickey et al 1990, 
Fitzpatrick and Richards 1991), inhibin a (Pei et al 1991), LH receptor (Segaloff 
et al 1990, Richards 1994), and the secondary rise of Sgk (Natraj and Richards
1993). hi response to the LH surge granulosa cells generate high levels of cAMP 
and rapidly initiate a program of terminal differentiation in which proliferation 
ceases (Richards 1994, Robker and Richards 1998). LH dramatically down- 
regulates genes associated with follicular function such as aromatase (Richards 
1994, Fitzpatrick and Richards 1991) and cyclin D2 (Robker and Richards 1998) 
and rapidly, but transiently, induces genes required for ovulation such as 
progesterone receptor (Natraj and Richards 1993, Park and Mayo 1991, Richards 
et al 1998, Clemens et al 1998, Lydon et al 1995), prostaglandin synthetase-2 
(Wong and Richards 1991, Sirois and Richards 1993, Dinchuk et al 1995, 
Morham et al 1995) and CAAT enhancer binding protein (Sirois and Richards 
1993, Stemeck et al 1997). During the process of lutéinisation granulosa cells 
appear to become refractory to further cAMP stimulation. Genes such as 
P450scc (Richards et al 1986, Oonk et al 1989) are constitutively expressed at 
elevated levels. Neither cAMP stimulation, nor A-kinase inhibition, alters 
expression of P450scc in luteinised cells (Oonk et al 1989).
In the testis and ovary agonist activation of LHR via G protein coupling leads to 
stimulation of adenylate cyclase and phosphorylation of intracellular proteins via 
activation of protein kinase A (Catt and Dufau 1991, Dufau 1988), as discussed
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below. The high surge concentrations of LH up-regulate PKA signalling and 
alter the expression of other genes that coordinate the final stages of follicular 
development and ovulation (Hillier 2001). In the ovary the receptor also 
promotes PI hydrolysis and calcium signalling (Davis et al 1984, Kosugi et al
1996). PI hydrolysis probably results firom stimulation of phospholipase C 
(Herrlich et al 1995, Rajagopalan-Gupta et al 1997). There is a wide difference 
in gonadotrophin concentrations ( E D 5 0  50-100pM versus 2500 pM hCG 
respectively) needed for stimulation of adenylate cyclase and PI hydrolysis in 
Leydig cells expressing LHR (Guderman et al 1992) confirming the 
predominace of the adenylate cyclase pathway in this cell type. In the ovary, 
however, the increased hormonal stimulation at certain stages of the ovarian 
cycle brings the PI pathway into operation (Dufau 1998). The diverse pathways 
of gene expression that are regulated by FSH in granulosa cells are dramatically 
altered by the LH surge-induced transition to luteal cells. LH also regulates the 
expression of PRL receptors (Richards and Williams 1976, Ormandy et al 1997, 
Gibori 1992) which, in response to cytokine, activates the Jak/Stat signalling 
pathway in rat luteal cells (Dajee et al 1996 and 1998, Russell et al 1996).
Protein Kinase A
Gonadotrophin signalling via PKA/adenylyl cyclase is one of the most 
extensively documented granulosa cell signalling pathways. Activation of the 
gonadotrophin receptors activates adenylyl cyclase, and in turn leads to the 
induction of PKA. A-kinase not only regulates its own pathway by controlling 
levels of its regulatory subunits (Richards et al 1987), LH receptors (Segaloff et 
al 1990), and the phosphorylation of transcription factors such as cAMP 
response element binding protein (Carlone and Richards 1997, Mukherjee et al
1996) but it is also known to regulate other cellular signalling pathways that 
control cell proliferation and differentiation. These include the cyclin-dependant 
kinases controlling mitosis (Sherr 1996, Elledge 1996, Hunter and Pines 1994), 
MAPK (Das et al 1996, Maizels et al 1998), PRL receptors (Richards and 
Williams 1976, Ormandy et al 1997, Gibori 1992) and several members of the 
serine/threonine kinase family including Sgk and Snk (Webster et al 1993,
26
Simmons et al 1992). Apoptosis is rapidly induced in cultured granulosa cells 
from hen preovulatory follicles when treated with the pharmacologic PKA 
inhibitor, H-89 (Chun et al 1994 and 1996).
Thus the A-kinase pathway controls the expression of numerous genes in 
granulosa cells at distinct stages of differentiation and by specific molecular 
events.
Protein Kinase B
The PKB pathway consists of three isoforms that are activated following 
phosphorylation. It is well established that several growth factors such as insulin­
like growth factor -I (IGF-I) and transforming growth factor a (TGFa) initiate 
PKB activation and promote granulosa cell survival (Westfall et al 2000, 
Johnson et al 2001). FSH can activate PKB signalling in a PKA independent 
manner (Gonzalez-Robayna et al 2000) mediated by PI3 kinase (Zeleznik et al
2003), with inhibition of this activation by a PI3 kinase inhibitor actively 
promoting apoptotic cell death (Asselin et al 2001) and blocking the survival 
promoting effects of IGF-1 and TGFa treatment (Westfall et al 2000, Johnson et 
al 2001). Significantly, this apoptosis is reversed when cells are co-cultured in 
the presence of cAMP or LH (Johnson et al 2001). PKB is obligatory to FSH- 
stimulated granulosa cell differentiation since it is required for the expression of 
aromatase and LH receptor mRNA (Zeleznik et al 2003).
Protein Kinase C
In primary rat granulosa cell culture the effect of ovulatory concentrations of LH 
can be mimicked by subovulatory concentrations of LH/hCG used in conjunction 
with a PKC activator, suggesting that the PKC pathway serves to mediate the 
actions of LH (Morris and Richards 1993 and 1995). However Salvador et al 
2002 demonstrated that activation of PKC is not a direct consequence of LH 
receptor activation and its precise role as a mediator of gonadotrophic signals has 
yet to be determined.
Serum and glucocorticoid-induced kinase (Sgk)
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Up-regulation of Sgk signalling is promoted by FSH and LH in granulosa cells 
from preovulatory follicles, and upon activation Sgk is known to translocate to 
the nucleus where it can modulate the activity of transcription factors (Richards 
et al 2002). However there is a distinct transition of Sgk protein from the nucleus 
in immature, proliferative granulosa cells to punctate sites within the cytoplasm 
of differentiated, non proliferative, luteinising granulosa cells (Gonzalez- 
Robayna et al 1999). Its expression in both proliferating granulosa cells, 
tenninally differentiated luteal cells as well as resting oocytes suggests Sgk may 
have multiple functions in controlling cell cycle progression and differentiation 
(Alliston et al 2000).
Mitogen activated protein kinase (MAPK)
The mitogen-activated protein kinase cascade consists of multiple pathways, 
including those that signal through c-Jun N-terminal kinases (JNKs), p38 MAP 
kinases (p38 MAPK) and extracellular signal related kinases (ERKs). Whilst 
JNK and p38MAPK pathways are linked to promoting cell apoptosis (Gebauer et 
al 1999), the ERK pathway is indirectly linked to promoting cell survival 
(Gebauer et al 1999, Johnson et al 2001) and has a firmly established role in the 
modulation of gonadotrophin induced differentiation (Seger et al 2001). FSH has 
been shown to regulate the mitogen activated protein kinases (Das et al 1996, 
Maizels et al 1998). It has also been demonstrated that ovarian granulosa cell 
ERK is activated (2-5 fold) in response to LH and FSH (Cameron et al 1996, Das 
et al 1996) and that this activation is generated via the PKA pathway in 
gonadotrophin-induced granulosa cells (Seger et al 2001). The ERK cascade can 
activate G-protein-coupled receptor kinase 2 which, in turn, induces down 
regulation of the gonadotrophin receptors (Pitcher et al 1999).
1.5.2.3 Intrafollicular paracrine and autocrine signalling factors
Over the last few years a number of growth factors have been identified as being 
involved in folliculogenesis. Those secreted by the oocyte and acting on 
granulosa cells: GDF-9, BMP-15, BMP-6, TGFp-2, FGF-8. Other factors
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produced by the gi'anulosa cells include components of the IGF system, PAPP- 
A, inhibin, activin, fbllistatin and kit ligand. Thecal cells produce IGF, EGF, 
KGF, TGFa, BMP-4 and BMP-7, which also target the granulosa cell (for 
reviews see Knight and Glister 2001 and 2003).
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GDF-9
Evidence is available to indicate that oocyte-secreted factors can influence FSH 
action (Eppig et al 1997, Matzuk 2000, Erickson and Shimasaki 2000). In vitro 
experiments have shown that oocyte-derived factors can act to inhibit FSH- 
induced expression of P450scc, progesterone (P4) production (Goldschmit et al
1989), urokinase plasminogen activator (Canipari et al 1995), and LH-R mRNA 
(Eppig 1997), while acting to stimulate mitosis (Vanderhyden et al 1992), 
hyaluronic acid (Buccione et al 1990, Salustri et al 1990, Vanderhyden et al
1990), and oestradiol production (Vanderhyden 1995). GDF-9, which is 
exclusively expressed in the oocyte (Dong et al 1996), is one oocyte factor 
involved in the regulation of these proliferative and differentiation responses 
(Hayashi et al 1999, Elvin et al 1999, Elvin et al 2000, Vitt et al 2000 ). Gdf-9 
production starts in mice at the primary follicle stage but in other species can be 
expressed by primordial oocytes. In Gdf-9 null mice, follicle development ceases 
at the primary pre antral stage, despite continued oocyte growth and zona 
pellucida formation (Dong et al 1996/ The oocyte growth in this case being 
correlated with increased expression of another paracrine signalling molecule,
3r-':MGF (mast cell growth factor), by the granulosa cells (Elvin et al 1999b). Study a
of Gdf-9 deficient mice has shown that it has an important role in the stimulation 
of granulosa cell proliferation during pre antral and primary follicle development 
and stimulates DNA synthesis in preantral and dominant secondary follicles. It 
also reduces FSH-induced differentiation in granulosa cells as reflected by the 
suppression of steroidogenesis and LH receptor expression (Vitt et al 2000).
Kit Ligand
Granulosa cells produce kit ligand (KL), which induces oocyte growth or 
development and theca cell proliferation (Parrott and Skinner 1997 and 2000).
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Expression of the KL gene encoding KL mRNA, important for initiation of 
follicular growth, antrum formation and oocyte maturation (Driancourt et al
2000), is increased in granulosa cells of Gdf-9 null mice (Elvin et al 1999). This 
indicates that Gdf-9 suppresses KL in granulosa cells. Gdf-9 null animals also 
fail to express c-kit receptors on the theca cells (as well as 17-alpha-hydroxylase 
and LH receptors) (Haung et al 1993). Immature oocytes in vitro have been 
shown to reduce kit ligand expression by granulosa cells (Joyce et al 1999), 
therefore, early follicle progression could be coordinated through combined 
actions of oocyte derived Gdf-9 and granulosa cell derived kit ligand.
The importance of c-kit receptor and KL interaction was initially found in mouse 
strains with a homozygous mutation in either c-kit or KL encoding genes which 
were fertile. There are two membrane bound forms, KL-1 and KL-2, which can 
be cleaved to produce soluble forms of KL (Williams et al 1992). In the ovary c- 
kit is expressed in oocytes (Horie et al 1991, Manova et al 1991) and KL 
produced by granulosa cells affects oocyte growth in a paracrine manner (Clark 
et al 1996, Motro and Bernstein 1993, Tisdall et al 1997). Expression of c-kit is 
found in oocytes at as early as the primordial follicle stage in newborn mice 
(Manova et al 1993) and in the mouse inliibition of the interaction between KL 
and c-kit by specific antibody prevents transition from primordial follicles to 
primary follicles without blocking the formation of primordial follicles (Haung 
et al 1993, Yoshida et al 1997). Administration of anti- c-kit antibody to mice 
has even stopped the proliferation of granulosa cells (Yoshida et al 1997). 
Therefore KL/c-kit interactions appear to be essential for the growth initiation of 
mouse oocytes. It has also been shown that KL promotes the growth of oocytes 
in vitro (Packer et al 1994) and induces significant development of primordial 
follicles (Parrott and Skinner 1999), as well as having a promotional effect on 
antrum formation (Reynaud et al 2000).
Bone morphogenic proteins
Another member of the same transforming growth factor-^ superfamily, BMP- 
15 (or GDF-9B) has been implicated in modifying FSH action by suppressing 
FSH receptor expression (Otsuka et al 2001) without affecting adenylate cyclase
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activity, as well as stimulating granulosa cell proliferation and selectively 
inhibiting FSH induced P4, but not E2, production (Otsuka et al 2000), BMP 15 
achieves this by lowering the steady state levels of FSH-induced mRNA 
including StAR, P450scc, 3p-HSD, LH-R, inhibin/activin subunits and FSH-R 
(Otsuka 2001). It is considered to be a negative regulator of the major actions of 
FSH in the ovary and consequently the oocyte can play an important role in 
determining granulosa cell proliferation and FSH sensitivity in developing 
follicles. BMP 15 has an essential role in folliculogenesis and fertility by 
promoting early folliculogenesis while preventing the later stages of follicular 
maturation. A recent genetic study with a naturally occurring BMP 15 defect 
homozygous mutant in sheep shows follicular development which has arrested 
at the primary stage resulting in infertility. In contrast heterozygotes exhibit 
increased ovulation rate and multiple pregnancies (Galloway et al 2000), an 
effect which may possibly be related to the inhibitory action of BMP 15 on FSHR 
expression.
BMP 6 unlike Gdf-9 and BMP 15 lacks mitogenic activity on granulosa cells and 
has a selective modulation of FSH action on steroidogenesis, suppressing FSH 
induced progesterone P4 production but not oestradiol production. It also has 
similar actions to BMP 15 as it attenuates steady state mRNA levels of FSH- 
induced StAR and P450scc, without an affect on P450 aromatase mRNA level. It 
is thought to work by down-regulating adenyl cyclase activity without altering 
FSH-R mRNA levels (Otsuka et al 2000). This factor does not appear to have an 
essential role in fertility since BMP6 null mice are fertile with normal sized 
litters (Tilly et al 1992). The highly prolific Booroola strain of Merino ewes have 
a point mutation in a gene encoding the bone morphogenic protein receptor IB 
(Mulsant et al 2001, Wilson et al 2001, Souza et al 2001) which confers 
increased fertility through higher ovulation rates and litter sizes in both 
heterozygotes and homozygotes. It has been suggested that this phenotype may 
be caused by the inability of the granulosa cell to elicit BMP 6 signalling. 
(Otsuka 2001). This would prevent inhibition of cAMP synthesis causing an 
increased sensitivity to FSH.
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other members of the BMP system are known to be active within the follicle, 
BMP3 is expressed in human granulosa-lutein cells (Jaatinen et al 1996) and 
BMP receptors are expressed in both oocytes and granulosa cells throughout 
follicle development (Shimasaki et al 1999). BMP4 and BMP7 are produced by 
the thecal cell and exert a paracrine influence on granulosa function (Glister et al
2004).
Inhibin, acitivin and follistatin
Granulosa cells are a major site of inhibin, activin and follistatin (FS) expression. 
FSHR activation is required for granulosa cells to transcribe the inhibin |3A, pB 
and alpha subunits above basal levels (Hirst et al 2004). While increased levels 
of FSH increase production of inhibin B in granulosa cells it is suggested that 
LH stimulation may be responsible for the late follicular rise in inhibin pA 
subunit expression (Woodruff et al 1996, Hirst et al 2004). The endocrine role 
played by inhibins in the negative feedback regulation of pituitary FSH secretion 
has already been mentioned, however activins, FS, and inhibins are also firmly 
implicated as intraovarian autocrine/paracrine regulators of follicle function. For 
instance, activin A has been shown to promote granulosa cell proliferation, up 
regulate FSH receptor expression and enhance granulosa cell steroidogenesis and 
inhibin production. Tlirough its role as an activin binding protein, FS can 
neutralise these actions of activins. Follistatin is highly expressed by granulosa 
cells of developing follicles (Shimasaki et al 1988 and 1989, Nakatani et al
1991) and binds activin A, AB, and B with high affinities (Roberts et al 1993, 
Nakamura et al 1990, Shimonaka et al 1991, Kogaua et al 1991, Schneyer et al
1994) blocking the biological action of those molecules including stimulation of 
FSH receptor expression and inhibin secretion (DePaolo et al 1991, Xiao and 
Findley 1991, Nakamura et al 1992, Xiao et al 1992, Cataldo et al 1994, Eramaa 
et al 1995). It also binds to BMP-15 to form an inactive complex inhibiting its 
bioactivity (Otsuka et al 2001).
It is debatable whether inhibins exert autocrine actions to modulate granulosa 
cell function, although they have a potent paracrine effect on thecal cells to 
enhance LH-induced androgen production, while activin acts to inhibit thecal
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androgen synthesis (Hseuh et al 1987, Hillier 1991, Hillier et al 1991b). Activin 
predominates in immature follicles where it promotes FSH-induced mitosis and 
FSH-induced steroidogenic differentiation (Miro and Hillier 1996). Inhibin and 
follistatin are produced in progressively greater amounts relative to activin by 
granulosa cells as follicles mature (Nakatani et al 1991). Thereby the stimulatory 
action of inhibin on thecal androgen synthesis gains sway during late 
preovulatory follicular development, when androgen is required in increasing 
amounts as a substrate for oestrogen synthesis (Hillier 1991).
Insulin-like Growth Factors
Of the many growth factors which have varied effects on follicle growth and 
development the IGF system is among the most extensively studied. Granulosa 
cells express type 1 IGF receptors (Perks et al 1995, Spicer et al 1994,
Armstrong et al 2000) and it has a proven link to FSH action via IGFBP-4, 
which is a potent inhibitor of FSH-induced oestradiol production in granulosa 
cells. Gene expression of IGFBP-4 has been demonstrated in atretic follicles in 
vivo and is thought to be involved (tlirough its FSH antagonistic activities) in the 
regulatory pathways that lead to follicle atresia. The production of an IGFBP-4 
protease in granulosa cells has been reported to be stimulated by FSH.
Pregnancy associated plasma protein-A (PAPP-A) has been identified as an 
IGFBP-4ase and demonstrated to be present in follicular fluid. Recent evidence 
suggests that expression of the PAPP-A gene is restricted to granulosa cells of 
healthy Graafian follicles and luteal cells of healthy CL’s (Erickson and 
Shimasaki 2001).
Although physiological concentrations of insulin, IGF-I and IGF-II can stimulate 
thecal androgen production, inhibin greatly enhances the action of all three 
factors in vitro (Nahum et al 1995). Thus, regardless of the contributions made 
by insulin or IGF’s to the control of follicular androgen production, paracrine 
regulation by inhibin could be of overriding importance during preovulatory 
follicular development. Antral follicles, too immature to secrete oestrogen, do 
not need androgen as an aromatase precursor (Hillier et al 1994). At such early 
stages of development, androgen synthesis may be suppressed due to a '
preponderance of activin relative to inhibin, possibly aided by granulosa cell 
derived IGF-BPs that sequester and inliibit the actions of IGFs (Ling et al 1993). 
Granulosa cells express type 1 IGF receptors and it is well established in a range 
of species, that IGF can act both alone, and in synergy with FSH, to modulate 
granulosa cell proliferation, differentiation, and steroidogenesis. IGF-1 has been 
found to induce mitosis and enhance steroidogenesis of bovine granulosa and 
thecal cells (Schams et al 1988, Spicer et al 1996). Deletion of the IGF-I gene 
leads to a failure of ovulation although follicle development occurs to the 
preantral stage (Baker et al 1996). It is thought that the role of IGF-I is to 
amplify FSH action. Transcripts of IGF-II, -IR, and IGFBP-2 to -5  have also 
been shown to be expressed in the mouse ovary (Wandji et al 1998), with only 
the expression of IGF-I and IGFBP-4 and -5 changing during the course of 
follicular development. IGF-I levels increase within the follicle as it progresses 
to the antral stage and it is known to regulate antral development and FSH action 
(increased aromatase activity) (Baker et al 1996, Zhou et al 1997). Early 
follicular development with low growth rate is associated with low IGF-I levels, 
whereas high IGF-I levels are found in rapidly growing large preantral and early 
antral follicles and it has been suggested that IGF-I may be rate limiting for 
preantral follicle development (Wandji et al 1998). Expression of IGFBP-4 
transcripts in granulosa cells have been found to precede the moiphological 
appearance of atresia, and it has been hypothesised that IGFBP-4 promotes 
follicular atresia by sequestrating IGF-1, thereby reducing its ability to interact 
with IGF-IR in granulosa cells (Baker et al 1996). In the rat ovary, FSH can 
stimulate the production of IGF-I by granulosa cells, this suggests a paracrine 
role for granulosa cell derived IGF-I in the regulation of thecal androgen 
synthesis (Hernandez et al 1992, Adashi 1998b). Thecal cells have been shown 
to possess receptors for insulin and IGFs, (Poretsky et al 1985) and both insulin 
and IGF stimulate thecal/stromal androgen synthesis in vitro.
Connective tissue growth factor
Connective tissue growth factor (CTGF) is expressed during the 
predifferentiated stage of granulosa cell development in the rat ovary. FSH
34
stimulus on granulosa cells induces down regulation of granulosa cell CTGF 
mRNA although it remains expressed in the most antrally located granulosa cells 
up to and after ovulation. It is suggested that it may have a role in establishing or 
maintaining the early follicular cell phenotype and also as a thecal cell mitogen 
or luteotrophic factor (Harlow and Hillier 2002).
1.5.2.4 Intraovariai! role of the steroid hormones
The paracrine activities of ovarian steroid hormones have important roles in the 
regulation of local ovarian function as well as their feedback regulation of 
pituitary ftinction.
Oestrogen
FSH-induced expression of the enzyme cytochrome P450arom leads to increased 
conversion of androgen to oestrogen in preovulatory granulosa cells (Richards 
1980, Hillier et al 1994). Granulosa cells also express oestrogen receptors, which 
may mediate autocrine action within the granulosa cell layer (Richards 1975a 
and 1975b). The effect of oestrogen on the granulosa cell is to amplify the 
overall actions of FSH (Richards 1994). Oestradiol has been shown to be 
obligatory for synthesis of specific proteins in rat granulosa cells in response to 
FSH and LH (Richards 1980, Hseuh et al 1984)
Oestrogen synthesis by the granulosa cell can exert diverse local and systemic 
physiological effects. Oestrogens stimulate the proliferation of granulosa cells 
and facilitate the LH- and FSH-induced differentiation of these cells by 
increasing LH receptor level and enhancing gap junction formation (Rosenfield 
et al 2001). The autocrine actions of oestradiol 17p (E2), the principle bioactive 
oestrogen, are mediated via two nuclear factors, oestrogen receptor (ER)-a and - 
P, in the granulosa cell. Effects are principally via ER-p, although both receptors 
are present (Couse et al 1997).
Oestrogens increase follicular expression of both FSH and LH receptors and in 
bovine follicles acts on thecal cells to provide positive feedback on androgen 
synthesis (Fortune 1986, Roberts and Skinner 1990). It can influence gap
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junction formation (Burghardt and Anderson 1981) via regulation of connexin 43 
(Yu et al 1994) and inhibit granulosa cell apoptosis (Lund et al 1999). Oestrogen 
is known to increase the CYP17 expression in theca cells (Johnson and Crane
1998), an essential enzyme foe catalysis of the 14-demethylation of sterol 
precursors, and the consequent increase in progesterone production which is 
thought to promote corpus luteum formation and maintenance through luteal 
progesterone receptors (Duffy and Stouffer 1995).
Oestrogens are pro-angiogenic in vivo. They are known to moduate 
angiogenesis, and have been demonstrated to augment angiogenesis induced by 
FGF. Equally however, the endogenous oestrogen metabolite 2-methoxyestradiol 
is known to be a potent anti-angiogenic factor. It induces apoptosis in endothelial 
cells and inhibits angiogenesis (Yue et al 1997).
Glucocorticoids
Glucocorticoids are not true ovarian paracrine factors since the ovarian cells do 
not express the enzymes necessary for glucocorticoid synthesis. They do 
however express l ip  hydroxysteroid dehydrogenase (llpHSD), a microsomal 
short chain alcohol dehydrogenase (Krozowski 1992), that interconverts 
cortisone and cortisol and thereby control the access of cortisol to ovarian 
corticosteroid receptors (Micheal et al 1997). Evidence for glucocorticoids 
having a physiological role in the regulation of ovarian folliculogenesis has been 
strengthened with the knowledge that granulosa cell expression of 11 pHSD is 
developmentally regulated. High affinity glucocorticoid receptors are present in 
rodent granulosa cells (Schreiber et al 1982) and glucocorticoids have been 
shown to modify gonadotrophin action on these cells in vitro. Gonadotrophic 
regulation of 11PHSD genes in the ovary has been demonstrated-LH induces 
11 PHSD 1 and down regulates llpHSD2-both enzymes catalysing cortisol- 
cortisone conversions (Tetsuka et al 1997, 1999a, 1999b). This favours local 
accumulation of anti-inflammatory cortisol to aid rapid postovulatory healing 
and quickly restore normal ovulatory function (Hillier and Tetsuka 1998). 
Glucocorticoids have been shown to stimulate FSH-induced progesterone 
production and tissue-type plasminogen activator (Tetsuka et al 1999). The
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physiological importance of this is that the follicle is likely to operate a cortisol-
cortisone (corticosterone-11-dehydrocorticosterone in the rat and mouse) shuttle |
'ibased on differential expression of llpHSD, the follicle can alternate between 
inactivation via lipHSD2 catalysed oxidation to activation via 11 PHSD 1 
catalysed reduction. This allows ovulatory follicles to gain exposure to 
glucocorticoids at levels required for involvement in oogenesis, or the process of 
follicular rupture, possibly as an anti-inflammatory modulator.
"Glucocorticoids such as dexamethasone and hydrocortisone enhance 
steroidogenesis in granulosa cells while co-stimulation with 
gonadotrophin/cAMP enhances formation of progesterone (Hosokawa et al
1998, Sasson et al 2002, Barkan et al 1999). Glucocorticoids have been found to 
exert protective effects on apoptosis induced by serum deprivation, cAMP, p53 
and TNF-a (Hosokawa et al 1998, Sasson et al 2001 and 2002, Barkan et al
1999,). The protective effects are exerted by upregulation of BCL2 and/or 
attenuation of its degradation (Barkan et al 1999, Sasson and Amsterdam 2002). 
Glucocorticoids, therefore, may play an important role in vivo by accelerating 
the healing process of the ruptured follicle subsequent to ovulation and during 
formation of the corpus luteum (Sasson and Amsterdam 2002, Amsterdam et al 
2002)
Progesterone
Progesterone is produced in increasing amounts in differentiated granulosa cells 
tlirough FSH induction of cytochrome P450scc, which catalyses the rate limiting 
conversion of cholesterol to pregnenolone (Richards et al 1998). Progesterone is 
one of the major steroids synthesised and secreted by the ovary (Monniaux et al
1997). It is synthesised by preantral follicles with just two to four layers of 
granulosa cells (Roy and Greenwald 1987), with the rate of progesterone 
secretion increasing as follicle development proceeds (Roy and Greenwald 1987, 
Fujii et al 1983). Although the concentration of progesterone fluctuates 
tliroughout the oestrus cycle, the concentration of progesterone within antral 
follicles is always within the micromolar range (Fujii et al 1983). The 
importance of these high progesterone levels in regulating ovulation has been
emphasised by several studies (Curry and Nothnick 1996, Robker et al 2000).
These investigations have shown that the nuclear PR does not appear in 
granulosa cells until the onset of the LH surge. It is then transiently expressed 
before ovulation and reappears later in the corpus luteum (Natraj and Richards
:1993). Further treatment with PR antagonists or genetic ablation of the nuclear 
PR interferes with gonadotrophin-induced ovulation (Curry and Nothnick 1996,
Robker et al 2000, Pall et al 2000, Conneely et al 2002, Lydon et al 1996) 
demonstrating the progesterone receptor gene to be essential for ovulation.
Based on the expression pattern of the PR it is predictable that progesterone 
inhibits apoptosis of granulosa cells isolated during the periovulatory period 
(Svensson et al 2000). Progesterone also prevents apoptosis of granulosa cells 
isolated from immature rats prior to the gonadotrophin surge (Peluso and 
Pappalardo 1998, Peluso et al 2001) and inhibits apoptosis of spontaneously 
immortalised granulosa cells (Peluso et al 2001). This is suprising considering 
that granulosa cells isolated prior to the LH surge do not express the classic 
nuclear PR (Natraj and Richards 1993, Park and Mayo 1991). Recent work has 
suggested that this anti-apoptotic action is mediated via a 60kDa progesterone 
binding protein which serves to regulate calcium homeostasis and ultimately 
granulosa cell viability (Peluso 2003).
Progesterone synthesis during the oestrus cycle can play an important role in the 
fertilisation of the oocyte following ovulation. It has been suggested that early 
progesterone production in the preovulatory follicle impairs the quality of the 
mature egg during fertilisation (Lindheim et al 1998, Fanchin et al 1997, Urman 
et al 1999). In contrast, proper timing of progesterone production and the 
duration of its secretion seems to be critical for maintaining functional 
granulosa-lutein cells, subsequent to the LH surge and maintenance of the corpus 
luteum during early pregnancy. Progesterone interaction with its cytosolic 
receptor may play a part in the survival activity of the granulosa-lutein cells 
(Svensson 2001)
Androgens
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Synthesis of androgens occurs in thecal cells under LH control (Smyth et al
1993). Granulosa cells express androgen receptors (AR) throughout antral 
development, permitting paracrine androgenic stimulation (Tetsuka et al 1995 
and 1996). The main effect of this is the up-regulation of cAMP formation, 
possibly through inhibition of cAMP metabolism (Hillier and de Zwart 1982). 
Amplification of FSH induced PKA signalling by androgen appears to be a 
means of sensitising granulosa cells to tonic stimulation by FSH. During late 
preovulatory development, transcription of the granulosa AR gene and AR 
protein levels decline which may serve to diminish granulosa cell responsiveness 
to gonadotrophins and delay tenninal differentiation (lutéinisation) until 
exposure to the LH surge (Hillier and Tetsuka 1997, Tetsuka et al 1995).
The role of androgens in influencing the process of folliculogenesis has been 
examined. They have two roles, firstly as metabolic precursors for androgen 
synthesis, and secondly as ligands for androgen receptors. Androgens are the 
predominant steroids produced in early follicular development and are present at 
high concentrations in follicular fluid at all stages of follicular growth, although 
the ratio of androgens to oestrogens changes as the follicle advances and 
dominant follicles engage in aromatase activity (McNatty et al 1979). Studies 
using 5 a-dihydrotestosterone (DHT) have shown that androgens have a direct 
effect on ovarian function (Louvet et al 1975, Nandedkar et al 1981, Rao 1975, 
Armstrong and Dorrington 1976, Daniel and Armstrong 1980, Hillier and De 
Zwart 1981), an effect thought to be mediated by the androgen receptor (AR) 
which has been detected in ovarian cells from all vertebrate species studied to 
date (Ito et al 1985, Hild-Petito et al 1991, Horie et al 1992, Yoshimura et al 
1993, Hirai et al 1994, Sperry and Thomas 1999, Touhata et al 1999, 
Slomczynska et al 2001, Lutz et al 2001, Vermeirsch et al 2001), suggesting a 
conserved receptor mediated role for androgens in folliculogenesis. Granulosa 
cells display the strongest AR immunoreactivity and are exposed to both 
testosterone and DHT sourced from thecal cells and internal production from 
conversion of androgen precursors (McNatty et al 1979). Both testosterone and 
DHT promote in vitro follicle growth in mice (Murray et al 1998, Wang et al
2001) and many of the differentiative actions of FSH on granulosa cells are
augmented by AR agonists including, cholesterol mechanism, progesterone 
secretion, expression of steroidogenic enzymes, and induction of aromatase 
activity (for review see Hillier and Tetsuka 1997)
Other steroid metabolites
One product of lanosterol 14a-demethylase (CYP51) mediated lanosterol 14 
déméthylation has been identified as a meiosis activating steroid (MAS). 
Ovarian CYP51 is expressed in mature ovarian follicles and corpa lutea, and is 
suppressed in hypophysectomised animals. Induction of CYP51 activity with 
PMSG is due to synergism of marked growth of follicles and elevation of 
CYP51 levels in each follicle. The expression of CYP51 is dependant on 
pituitary gonadotrophins and its expression in follicles, triggered by FSH, has 
been shown to be higher in cumulus cells than in mural granulosa cells 
supporting a local elevation of MAS required for resumption of meiosis 
(Yamashita 2001, Rozman et al 2002).
Ovarian steroid hormones may also play an important role in controlling ovarian 
cell death. Oestradiol acts as a survival factor in both corpus luteum and 
granulosa cells (Goodman et al 1998). Progesterone was suggested to maintain 
genomic viability through non genomic mechanisms (Peluso 1997). 
Glucocorticoids, such as hydrocortisone and dexamethasone, were also found to 
protect against apoptosis and it has been reported that both oestradiol and 
dexamethasone can increase the synthesis of Bcl-2, which serves as an ovarian 
survival factor (Goodman et al 1998, Sasson et al 1999). Androgens are reported 
to antagonise the protective effect of diethylstilbestrol (DES), which has 
oestrogenic activity in granulosa cells (Billig et al 1993). In contrast testosterone 
was found to reduce spontaneous follicular apoptosis in immature rats, leading to 
the development of polycystic ovaries (Gold et al 1999).
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1.5.3 Thecal role in follicular function.
Communication between the granulosa cells and the oocyte is necessary for 
follicle development (Tsafriri 1997), but interaction between granulosa and theca 
cells is also critical. Factors secreted by preantral granulosa cells enhance Idifferentiation of theca cells before expression of LH receptors (Gelety et al i
1997), and co culture of theca and granulosa cells increases the proliferation and 
steroidogenesis of both cell types (Kotsuji et al 1994). Thus paracrine factors 
secreted between theca and granulosa cells are likely to play a crucial role in 
follicle development. In vitro studies suggest that these two somatic cell types 
modulate each other’s responsiveness to gonadotrophins in a reciprocal manner 
(Kotsuji et al 1994). Signalling of c-kit receptors on theca cells is modulated by 
granulosa cell derived kit ligand, and theca cells produce keratinocyte and 
hepatocyte growth factor, which influence granulosa cell physiology (Parrott and 
Skinner 1998, McGee et al 1999). Furthermore, following stimulation by LH, 
theca cells secrete androgens to serve as substrates for the oestrogen producing 
granulosa cells.
EOF, and its closely related homologue TGFa, are expressed by various cell 
types; they both interact with the same cell surface receptor (EGF receptor), 
which is expressed by numerous cell types including granulosa and thecal cells.
Exposure of granulosa cells to EGF/TGFa promotes cell proliferation and this is 
associated with a loss of differentiated function, exemplified by a marked 
reduction in E2 production in vitro and in vivo. Theca cells have been identified 
as a key site of TGFa expression in the bovine ovary and evidence suggests that 
TGFa of thecal origin exerts a local paracrine action on neighbouring granulosa 
cells to modulate their proliferation and responsiveness to gonadotrophins and 
other regulatory factors.
Keratinocyte growth factor derived from the thecal cell may play a role in early 
folliculogenesis by promoting gianulosa cell survival, increasing the rate of 
follicle growth, and enhancing early granulosa cell differentiation (McGee et al
1999).
BMP-7 is expressed in the thecal cell, and the BMP-7 receptor is expressed by 
the granulosa cell (Shimasaki et al 1999). BMP-7 has been shown in vitro to 
reduce FSH-induced progesterone production while enhancing FSH induced 
oestradiol production by granulosa cells, this has been shown to be mediated 
through decreasing levels of StAR mRNA and increasing P450arom resulting in 
an enhanced conversion of androstenedione to oestradiol and inhibition of 
cholesterol transport from the outer to inner mitochondrial membrane. BMP-7 
has also been found to stimulate folliculogenesis while inhibiting ovulation and 
lutéinisation (Lee et al 2001). BMP-7 null mice die shortly after birth with severe 
bilateral renal dysplasia (Dudley et al 1995) and conditioned knockouts have not 
yet been produced which are targeted at thecal cells.
Stanniocalcin (STC) is a glycoprotein hormone first discovered in bony fish. In 
rodents STC 1 is widely expressed in a range of tissues with the ovary showing 
the highest level (Chang et al 1995, Chang et al 1996, Varghese et al 1998). 
Treatment of granulosa cells with STCl decreases gonadotrophin stimulation of 
progesterone production, C yplla mRNA expression and LH receptor formation 
without affecting gonadotrophin-induced oestradiol secretion (Luo et al 2004). In 
addition, gonadotrophin treatment suppresses STCl transcripts in thecal cells 
(Luo et al 2004), suggesting the induction of granulosa cell differentiation by 
gonadotrophins may involve the suppression of the biosynthesis of theca cell- 
derived STCl. Transgenic mice overexpressing STCl are sub-fertile as reflected 
by reduced litter sizes, and a possible defect in the ovulatory mechanism has 
been suggested (Varghese et al 2002). STCl may, therefore, be a potential 
lutéinisation inhibitor sourced from thecal cells in the developing follicle.
1.5.5 Ooctye growth and development
The observation that no follicle can be formed in the absence of oocytes had 
been made as long as 50 years ago (Coulombre et al 1954), while 
pharmacological ablation of oocytes in rats is known to result in defective 
folliculogenesis (Merchant 1975, Hirshfiled 1994). It has also been known for 
several decades that oocytes prevent the spontaneous lutéinisation of granulosa
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cells (El-Fouly et al 1970, Nekola and Nalbandov 1971). More recently, 
however, the level of influence that the oocyte has over normal development of 
its own follicle is much better understood. It has been shown that it is the oocyte 
that coordinates and orchestrates the rate of follicular development (Eppig et al
2002). The rate of follicular development can be doubled by the transfer of mid 
growth stage oocytes to primordial follicles. Oocytes participate in the 
modulation of steroidogenesis by maintaining oestradiol production and 
inhibiting progesterone production (Vanderhyden and Tonary 1995). In the 
presence of oocytes, proliferation of granulosa cells is accelerated (Vanderhyden 
et al 1992), and expression of LH receptor mRNA is inhibited (Eppig et al 1997 
and 1998).
Although the zona matrix physically separates the oocyte and somatic cells, 
close associations are maintained throughout follicular development via 
paracrine factors and cellular processes that fonn gap junctions with the oocyte 
membrane (Eppig 1991). These interactions provide the two-way 
communications required for oocyte growth and maintain the oocyte in meiotic 
arrest. Oocytes unable to form interactions with surrounding granulosa cells, 
either because of ectopic displacement (Zamboni and Upadhyay 1983), or 
genetic mutation (Soyal et al 2000) do not survive.
The growth of the oocyte has been shown to be positively correlated with the 
number of adherent granulosa cells and extent of metabolic cooperation between 
these two cell types (Brower and Schultz 1982, Herlands and Schultz 1984). The 
establishment of gap junctions allows the accumulation of materials essential for 
fertilization and pre-implantation development and increased protein content is 
known to be related to growth in oocyte size (Schultz and Wassarman 1977). 
Granulosa cells actively transfer low molecular weight substances such as 
nutrients and metabolic precursors (Heller et al 1981, Colonna and Mangia 1983, 
Eppig 1977) to the oocyte which also appears to incorporate externally produced 
macromolecules (Glass 1961). Granulosa cells convert cystines to cysteines 
which are then made available for oocyte utilisation (De Matos 1997). 
Gonadotrophins are known to stimulate glucose consumption by cumulus cells 
via the P13-kinase pathway leading to pyruvate production (Roberts et al 2004,
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Hillier et al 1985, Zuelke and Brackett 1992). Pyruvate as an energy source is 
obligatory for resumption of meiosis (Biggers et al 1967, Eppig 1976) and is 
supplied by surrounding cumulus cells tlirough the glycolysis of glucose (Leese 
and Barton 1985, Donahue and Stem 1968). Levels of these energy substrates 
can have a profound effect on oocyte maturation (Downs and Mastropolo 1994) 
and adequate levels of pyruvate and glucose are important for progression to 
metaphase II. (Downs and Hudson 2000, Rose-Hellekant et al 1998). This serves 
to demonstrate the supportive role played by the granulosa cell in maintaining 
oocyte viability and growth.
Cumulus-enclosed oocytes can be prevented from undergoing spontaneous 
maturation using inhibitory agents such as cyclic AMP and purines (Dekel and 
Beers 1978, Downs et al 1988). FSH overcomes this inhibition, resulting in 
ligand-induced maturation (Downs et al 1988). FSH has been shown to 
significantly increase the proportion of oocytes reaching metaphase II after 15- 
16 hours of in vitro culture, suggesting that FSH has the ability to accelerate 
maturation (Roberts et al 2004). FSH also increases hexokinase activity in the 
cumulus oophoms (Downs et al 1996), facilitating glucose uptake and its 
conversion to glucose-6-phosphate. It is the pentose phosphate pathway that is 
the metabolic route that mediates ligand-induced resumption of meiosis (Downs 
and Utecht 1999, Downs et al 1996) and which provides precursors for the de 
novo purine pathway. This in turn is involved in meiotic induction (Downs et al
1998). Additionally, ATP is known to induce Ca^ "*" release from intracellular 
stores in cumulus cells, which is then transmitted via gap junctions to the oocyte 
(Webb et al 2002) and it has been suggested that FSH-induced glucose uptake 
may result in increased glycotically produced ATP, leading to Ca^”^ release and 
stimulation of maturation (Roberts et al 2004).
The correct hormonal support is fundamental to achieving adequate development 
competence by increasing the number and penneability of gap junctions between 
oocyte and cumulus cells, thus leading to a better interaction between the 
germinal and somatic components of the follicle (Mattioli et al 1990 and 1991). 
Both cytoplasmic and nuclear maturation are important when determining the 
developmental competence of the germ cell (Lucidi et al 2003). Properly
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matured oocytes no longer affect progesterone production but acquire the ability 
to inhibit oestrogen production (Lucidi et al 2003, Glister et al 2003). Thus, 
properly matured oocytes not only control the activity of cumulus cells but also 
modify their messengers in order to favour the functional lutéinisation of 
granulosa cells after the gonadotrophin surge.
1.5.5 Steroidogenic activity
Steroid hormone secretion by ovarian tissues is episodic, tightly regulated, and 
crucial to the coordination of reproductive cyclicity. Biochemically, steroid 
honnone biosynthesis is modulated by cholesterol availability and expression of 
specific steroidogenic enzymes. In the developing follicle, oestradiol is the main 
steroid product synthesised by granulosa cells and has major endocrine and 
intraovarian roles to regulate the oestrus cycle, follicle development and 
ensuring granulosa cell survival
In order that steroids, including oestradiol, can be synthesised by steroidogenic 
cells, they must first acquire cholesterol either via de novo synthesis or by the 
uptake of lipoprotein-carried cholesterol (Brown and Goldstein 1997, Gwynne 
and Strauss 1982, Strauss et al 1981). The actual biosynthesis of oestradiol 
incorporates both the theca and granulosa cell layers. These 2 layers must 
integrate fully to facilitate the conversion of cholesterol to oestradiol. The 
conversion of the various precursors depend entirely upon many enzymes, in 
particular several members of the large cytochrome P450 family of heme- 
containing enzymes, and hydroxysteroid dehydrogenases (HSD) (Strauss et al 
1981) (figure 1.4).
The first rate-limiting step in steroid synthesis is the conversion of cholesterol to 
pregnenolone, and cyplla catalyses this conversion. Cyplla is localised to both 
granulosa and theca layers in the follicle (Huet et al 1997). However, the next 2 
steps take place almost exclusively in thecal cells. Firstly, cypl7 catalyses the 
conversion of pregnenolone and progesterone to dehydroepiandrosterone and 
androstenedione. Secondly, 3(3-HSD catalyses the conversion of pregnenolone 
into progesterone, 17a-hydroxypregnenolone into 17a-hydroxyprogesterone, and
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dehydroepiandrosterone into androstenedione (Fortune and Quirk 1988; Strauss 
and Penning 1999). 17p-HSD catalyses the conversion of the weak androgen, 
androstenedione, to the stronger androgen, testosterone (Strauss and Penning
1999). Finally, testosterone and/or androstenedione are aromatised into 
oestradiol in the granulosa cells by Cypl9 (Strauss and Penning 1999, Huet e al 
1997). Therefore, the whole process of oestradiol synthesis in the follicle is a 
two-cell two-gonadotrophin system (Fortune and Quirk 1988) whereby, under 
the direction of FSH and LH, theca cells essentially produce androgens that can 
be used as a substrate for oestradiol synthesis in the granulosa cells. In addition, 
there is evidence that the increase in oestradiol secretion positively feeds back to 
stimulate more androgen secretion from the theca cells(Bao et al 1998, Fortune 
1986, Fortune and Quirk 1988, Roberts and Skinner 1990).
During the follicular phase of the cycle, FSH promotes the differentiation of 
granulosa cells of the growing follicles and consequently renders them 
competent to produce copious amounts of oestradiol, but nearly no progesterone 
(Smith et al 1975, Richards 1994). In contrast when granulosa cells from early 
antral follicles are cultured in vitro in the presence of FSH they secrete both 
oestradiol and progesterone (Shimasai et al 1999, Otsuka et al 2000). Although 
the stimulation of steroidogenesis by FSH has been studied extensively, at 
present little is known about the regulation of the divergent steroidogenic 
properties of granulosa cells. Bone morphogenic proteins (BMP-7 and BMP-4) 
have been identified as factors that act on granulosa cells to augment FSH 
induced P450 aromatase expression and subsequent oestradiol secretion and to 
attenuate FSH-induced StAR expression and subsequent progesterone secretion 
(Shimasaki et al 1999, Lee et al 2001). Mitogen activates protein kinase 
molecules (MAPK), particularly extracellular signal related kinases 1 and 2 
(ERK 1 and 2) have been directly implicated in the modulation of steroid 
biosynthesis by granulosa cells (Moore et al 2001).
The periovulatory period is accompanied by dramatic changes in ovarian 
follicular steroidogenesis as the LH surge triggers follicular lutéinisation, a 
process during which the predominant steroid produced switches from 17(3- 
oestradiol to progesterone.
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Figure 1.4 Pathways of synthesis of steroid hormones in ovarian somatic cells. 
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1.5.6 Extracellular matrix.
Dynamic remodelling of the ovarian extracellular matrix is characteristic of 
follicle growth and atresia, ovulation, and corpus luteum development and 
regression. Adhesion to the extracellular matrix regulates the survival, 
proliferation and differentiation of numerous cell types in many tissues 
(Rusolahti 1990, Adams and Watt 1993, Lelievre e al 1996 ,Streuli 1999). In 
vivo, ovarian follicles are surrounded by a typical basement membrane 
containing components such as laminin, type IV collagen, heparin sulphate 
proteoglycans and fibronectin, whose composition has been shown to change 
during follicular growth and atresia (Rodgers et al 1999 and 2003 ). Individual 
ECM components such as type I collagen, fibronectin, laminin and heparin are 
able to alter granulosa cell function, even in the absence of exogenous growth 
factors. Moreover these components regulate granulosa cell shape, survival,
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proliferation and steroidogenesis in a specific and controlled manner (Huet et al
2001).
It would appear therefore that the ovarian ECM does more than just provide a 
framework to support ovarian structure, it serves to provide a specialised 
microenviroment for specific ovarian cells. Changes in this microenviroment can 
influence gene expression and cell migration, proliferation, differentiation and 
atresia (Smith et al 1999).
One of the means by which components of the ECM are able to regulate cell 
function is through interaction with integrins (specific receptors for ECM 
components on the cell surface). Culture of rat granulosa cells on fibronectin or 
laminin, but not type 1 collagen, promotes differentiation into a luteal phenotype 
whereas an antibody to the integrin (31 subunit blocks granulosa cell 
differentiation (Aten et al 1995). In addition, many gi'owth factors are 
constitutively secreted and sequestered in an inactive form in the ECM or in 
association with specific binding proteins where they can subsequently be 
liberated by proteolysis. Examples include fibroblast growth factor, transforming 
growth factor (3, platelet derived growth factor, hepatocyte growth factor and 
IGFBP 3 (Smith et al 1999). The follicular basal lamina also has a function in 
controlling the selective filtration of molecules in and out of the follicular fluid 
both by means of electrical potential (Hess et al 1998), and physical size (Shalgi 
et al 1973), allowing it to determine, in part, the milieu of factors to which 
granulosa cells and the oocyte are exposed.
Remodelling of the ECM is carried out by two main groups of enzymes, the 
matrix metalloproteinases (MMP) and the plasminogen activator/plasmin family. 
In the bovine it has been shown that specific MMP and plasminogen activator 
system components are regulated in a temporally unique and cell specific fashion 
in the preovulatory follicle in response to a ovulatory stimulus (Bakke et al 1999, 
2000, Dow et al 1999, 2000a, 2000b). Throughout follicular growth the 
composition of the basal lamina changes. Collagen type IV declines (Frojdman 
et al 1998) during development while laminin (31 is transiently expressed at the 
preantral stage, and a l, (32, and yl appear to be more highly expressed in 
preantral and antral follicles (Van Wezel et al 1998). Nidogen 1 and perlecan are
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not detectable in primordial follicles but are expressed later in follicle 
development (MacArthur et al 2000). The significance of the decreased collagen 
and increased laminin content of the basal membrane is not known, but the 
upregulation of perlecan may be significant since it has the ability to bind a
number of growth factors.
;The follicular fluid of antral follicles contains proteins and soluble ECM 
molecules, including proteoglycans. Among those proteglycans identified are 
versican, decorin (MacArthur et al 2000, Eriksen et al 1999) and hyaluronan 
(Salustri et al 1992, Schoenfelder and Einspanier 2003). Their roles in follicular 
fluid are as yet poorly understood, although the role of hyaluronan in the 
expansion of the cumulus oophoms complex in ovulating follicles has been well 
studied (Richards 2005).
____
1.6 Ovulation and Lutéinisation
1.6.1 Morphological changes associated with lutéinisation
Ovulation is the unique process by which mature ovarian follicles respond to the 
surge of luteinising hormone and rupture to release fertilisable oocytes. The LH 
induced transition of a preovulatory follicle to one that can ovulate is a complex 
multi-step, multi-gene process. The gonadotrophin surge is the physiological 
trigger that stimulates ovulation of preovulatory follicles, LH activates adenylyl 
cyclase via its receptor and stimulates the A kinase pathway, inducing in 
granulosa cells of preovulatory follicles the rapid and transient expression of 
specific genes that have been shown to be critical for ovulation (Natraj and 
Richards 1993). During ovulation functional changes occur in multiple ovarian 
cell types within the follicle (granulosa and thecal cells) and the stroma 
(fibroblasts and endothelial cells), as well as the ovarian surface epithelium 
(Espey and Lipner 1994). In addition ovulation is characterised by the 
recruitment and invasion of inflammatory cells, such as leukocytes (neutrophils) 
and macrophages (Norman and Brannstrom 1994), and can be regulated by 
cytokines that are secreted by, and act on, immune cells and ovarian cells 
(Norman and Brannstrom 1994).
Expansion of the cumulus oocyte complex is a prelude to ovulation which has 
been examined in many species (Dekel et al 1978, Dekel and Phillips 1979, 
Flechon et al 1986). Although an extracellular matrix appears to accumulate 
gradually during the preovulatory interval, complete coverage of the cumulus 
cells with hyaluronan is achieved only a few hours before ovulation. Expansion 
of the cumulus oophorus is associated with the interruption of gap junctions and 
a reduction in the physical integrity of the cumulus oocyte complex (Anderson 
and Albertini 1976). These modifications of the cumulus oocyte complex alter 
the cellular mechanisms of the granulosa-oocyte interface affecting the bi­
directional exchange of paracrine signals to and fi-om the oocyte (Buccione et al 
1990). These signals are primarily transferred by means of granulosa cell 
transzonal projections (TZPs) that transverse the zona pellucida and terminate on
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the oocyte cell surface (Motta et al 1994). Cumulus cell uncoupling from the 
oocyte involves TZP retraction and remodelling during maturation of cumulus 
oocyte cell complexes (Suzuki et al 2000, Albertini and Rider 1994).
Prior to ovulation, but after the preovulatory LH surge, follicular diameter 
increases and the follicular wall becomes slightly folded (Priedkalns et al 1968, 
McClellan et al 1975). In addition gap junctions among granulosa cells decrease, 
the cells disperse, and the cumulus oocyte complex becomes free floating 
(Murdoch 1985, Murdoch and Cavender 1987, LeMarie 1989). After ovulation 
in sheep there is no evidence of mitotic figures among luteinised granulosa cells; 
however, evidence of mitosis has been observed in theca interna cells, 
endothelial cells and fibroblasts (McClellan et al 1975). The majority of cells 
undergoing mitosis include endothelial cells and fibroblasts, which are reported 
to migrate into the developing corpus luteum (Pedersen 1951). The granulosa 
cells undergo ultrastructural changes associated within increased steroidogenic 
activity. The cells hypertrophy and differentiate into the large granulosa lutein- 
cells, as discussed previously (Fawcett et al 1969). Cytostructural changes 
include expansion of the smooth endoplasmi reticulum, increased size of the 
golgi apparatus and an increased number and complexity of mitochondria 
(Priedkalns et al 1968, Cavazos et al 1969, Fawcett et al 1969, Enders 1973, 
McClellan et al 1975).
The remodelling process of ovulation also requires structural changes within the 
extracellular matrix, where regulated dissolution of matrix proteins occurs. At 
the time of ovulation a precise area of the ovarian surface adjacent to the apical 
region of the ovulatory follicle disintegrates to allow release of the oocyte. 
Subsequent structural reorganisation and remodelling of the follicle occurs as the 
granulosa and thecal cells luteinise. The basement membrane between the 
granulosa and thecal layers undergoes dissolution and rupture and collapse of the 
follicular wall results in the mural granulosa forming folds which protrude into 
the residual follicular lumen (O’Shea et al 1980). Thecal capillaries expand by 
sprouting into the avascular granulosa compartment to form a dense network of 
sinusoidal capillaries surrounding the luteinised granulosa cells. The majority of 
dividing cells in the developing CL are endothelial with the proliferation rate
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being even more intense than that found in malignant neoplasms (Stouffer et al 
2001, Machelon and Emilie 1997). The folding of the follicular wall allows 
migration of cells into the more central areas of the developing corpus luteum. 
Connective tissue and endothelial cells from the theca interna rapidly migrate 
into the fibrin rich ovulation site to form a primitive network of neovasculature 
(Goede et al 1998). Interstital (type 1) collagen constitutes the primary fabric of 
the follicular theca and tunic albuginea. Basement membranes that circumscribe 
thecal capillary beds and support mural granulosa and ovarian surface cells are 
comprised of type IV collagen (Eyre et al 1984). Type IV collagen forms a 
flexible mesh like scaffold to which matrix consitituents attach (Murdoch 2000). 
Collagen breakdown and cellular death (apoptosis and inflammatory necrosis) 
within the apex of the preovulatory follicle are the hallmarks of the impending 
ovulation (Andreasen et al 2000). After ovulation, growth within the corpus 
luteum can exceed the growth rate of most rapidly growing tumours (Reynolds 
and Redmer 1998). The degeneration of the follicular basement membrane over 
the periovulatory period allows theca cells and vascular elements, as well as 
connective tissue cells, to invade the previously avascular membrana granulosa 
(Van Blerkholm and Motta 1978, Mori et al 1983, Murphy 2000). The 
subsequent consolidation of these cells results in a functional corpus luteum. In a 
mature CL the capillary network pervades the organ, such that each luteal cell is 
in direct contact with two to four capillaries (Goede et al 1998). These 
anatomical observations show that CL formation requires the development of an 
extensive blood vessel network and suggests that mediators of angiogenesis must 
play an important role in its formation.
1.6.2 Granulosa cell differentiation: follicular lineage of luteal cells
Corpora lutea are a continuation of follicular maturation and form from the 
remaining follicular cells after ovulation. It has been known for decades that the 
preparation of luteal cells for the synthesis of progesterone begins before 
ovulation (McNatty and Sawers 1975, McNatty 1979), therefore the mechanisms
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associated with lutéinisation are not dependant on follicular rupture, and neither 
does successftil ovulation guarantee normal luteal development and function.
The corpus luteum is made up of a heterogenous population of cells with distinct 
morphological appearances. These cell types include endothelial cells, 
fibroblasts and pericytes, but the steroidogenically active cells are the small and 
large luteal cells, responsible for luteal steroidogenesis. It is generally accepted 
that in mammals granulosa cells differentiate into large luteal cells and theca 
cells into small luteal cells (O’Shea 1987). The fate of granulosa cells has been 
investigated in studies utilising both morphological and immunological 
approaches. In sheep, the number of granulosa cells within preovulatory follicles 
(O’Shea et al 1985) approximates the number of large luteal cells (Rodgers et al 
1984, O’Shea et al 1986). Because ovine granulosa cells undergo very little or no 
mitosis after ovulation (McClellan et al 1975) this suggests the differentiation of 
granulosa cells into large luteal cells. In addition theca and granulosa cells 
incubated in the presence of forskolin plus insulin exhibit the morphological and 
function characteristics of small and large luteal cells isolated from the corpus |
luteum (Meidan et al 1990). In the case of the granulosa cells this includes the 
high basal secretion of progesterone, reduced LH-induced progesterone 
secretion, and secretion of oxytocin, similar to large luteal cell function. Finally 
monoclonal antibodies against surface antigens of bovine granulosa cells have 
been shown to bind primarily to large luteal cells (Alila and Hansel 1984)
1.6.3 Molecular and genetic response to lutéinisation hormone
The LH surge rapidly initiates the terminal differentiation of granulosa cells to 
luteal cells. Beginning within 4 h and complete by 12 hrs of exposure to LH, 
granulosa cells cease to divide (Robker and Richards 1998). During this time 
granulosa cells are completely programmed to become luteal cells. They acquire 
and maintain a stable luteal cell phenotype, as characterised by the constitutively 
elevated expression of genes such as P450scc (Richards et al 1986, Oonk et al
1989).
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Although the LH surge simultaneously initiates the processes of ovulation and 
lutéinisation, these events are functionally dissociated. In fact, it is critical that 
the events associated with and controlling ovulation proceed those that dictate 
and finalise the genetic program for lutéinisation. If the events of lutéinisation 
occur too rapidly, as in PDE4D (a cAMP specific phosphodiesterase involved in 
feedback regulation of cAMP levels) null mice (Jin et al 1999), or if the events 
associated with ovulation are impaired or delayed, as in PR null mice (Lydon et 
al 1995), oocytes can be trapped within a functional corpus luteum. To this end it 
has been noted that in species with differing ovulatory time spans following the 
LH surge, expression of COX-2 occurs at a similar time prior to follicle rupture 
(Liu et al 1997, Boerboom and Sirois 1998).
It has been well documented that the effect of the LH surge is evident only in 
preovulatory follicles while the remaining pool is apparently unaffected. The 
acquisition of the correct receptor is involved in this selective effect of LH (Peng 
et al 1991), but differential distribution of the gonadotrophin due to increased 
follicular blood vessel development and permeability is also involved (Zeleznik 
et al 1981), a condition strictly dependant on the ability of the follicle to sustain a 
local production of VBGF.
1.6.3.1 Follicular dissemination of the LH signal
It is perhaps surprising that there is an absence of LH receptors on the cumulus 
oocyte complex (Mattioli et al 1994), consequently alternative means of 
signalling have to be generated by LH within this region. A series of signals 
appear within the COC with a precise time schedule following the LH surge. The 
first of these appears to be an immediate rise in intracellular Ca levels within 
follicular somatic cells (Davis et al 1987), followed within minutes by a Ca rise 
within the oocyte (Mattioli et al 1998).
Following this another second messenger, cAMP, rapidly shows increased levels 
within the COC (Moor et al 1981, Yoshimura et al 1992, Mattioli et al 1994). 
This messenger has a complex regulatory role. Levels of cAMP within cumulus 
cells and oocytes, determine the transcriptional response to this messenger 
(Mattioli et al 1996). Activation of oocyte PKA mediates the suppressive effect
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on germinal vesicle breakdown (GVBD), while the activation of PKA that 
results within cumulus cells, resulting from gonadotrophin stimulation, is 
responsible for the induction of maturation (Mattioli and Barboni 1998).
The next event to occur is the depolarisation of the cumulus-oocyte complex, 
happening a few hours after exposure to LH (Mattioli et al 1996). The LH- 
induced activation of PKA/PKC results in cumulus-corona cells undergoing 
progressive depolarisation of membrane potential (Barboni and Mattioli 1996), a 
response peculiar to cumulus cells (Mattioli et al 1991). The coupling of 
cumulus cells and the oocyte by gap junctions ensures that depolarisation 
originating in the somatic compartment is rapidly extended to the oocyte 
(Mattioli et al 1990). This depolarisation can act througli a number of methods to 
influence oocyte maturation. Firstly it can induce the translocation of PKC from 
the plasma membrane to the nuclear membrane where it could contribute to the 
process of GVBD (Kong et al 1991). Secondly its effect on voltage gated ion 
channels may provide a mechanism for producing a sustained rise in intracellular 
calcium. The presence of Ca channels on the oolemma (Mattioli et al 1998a) and 
their requirement for gonadotrophin-induced maturation has been demonstrated 
by the ability of Ca channel blockers to reversibly arrest meiotic progression of 
the oocyte (Mattioli et al 1998a, Mattioli and Barboni 2000). Finally, the 
depolarisation also serves to influence the permeability of the junctional network 
between the follicular cells. Prior to the LH surge there is a permanent electrical 
gradient of positive ions from the oocyte to the cumulus cells (Mattioli et al
1990). Depolarisation eliminates this transjunctional potential leading to a 
transient increase in both metabolic and electrical coupling (Mattioli and Barboni 
2000).
One of the more puzzling aspects of LHR expression is its restriction to the 
mural granulosa cells (Mattioli 1994); cumulus cells and oocytes expressed few 
or no LHRs and are insensitive to direct LH stimulation. The connection 
between mural and cumulus granulosa cells and the oocyte via gap junctions 
may allow the flow of intracellular mediators from the periphery to the core of 
the follicle (Tasfriri and Dekel 1994). Alternatively factors released by mural 
granulosa cells may convey the LH stimulus to cumulus cells and the oocyte.
'
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The epidermal growth factor (EGF)-related proteins amphiregulin (AR), 
epiregulin (EPI), and betacellulin (BTC) are three growth factors which have 
been shown to mediate LH activity with the follicle via EGF receptor (Park et al 
2004). They have functions as short range mediators in tissue remodelling and 
cell growth and are potential intermediates in G protein-coupled receptor 
signalling (Prenzel 1999). They show rapid and transient expression within 1-3 
hours following an ovulatory dose of hCG, with EPI mRNA remaining elevated 
for up to 12 hours (Park et al 2004). Although their expression is limited to the 
mural granulosa cells they have been shown in vitro to be potent stimulators of 
oocyte maturation and cumulus expansion in cumulus oocyte complexes (COCs) 
which have been denuded of mural granulosa cells and shown to be insensitive 
to LH (Park et al 2004). This confirms their role as paracrine mediators of LH 
signals during ovulation.
The junctional area between mural and cumulus cells is rapidly lost after LH 
stimulation while heterologous junctions between the corona radiata and the 
oocyte remain unaltered during most of the maturation period (Larsen et al 
1987). This indicates that the persistence of cell support provided by the corona 
cells represents an essential prerequisite for the maturation of the oocyte 
(Mattioli et al 1988)
1.6.3.2 Genomic response to the LH signal
LH acts on mature follicles to terminate the program of gene expression 
associated with folliculogenesis. The transcription of genes that control 
granulosa cell proliferation, IGF-1 (Zhou et al 1997), FSHR (Richards 1979), 
oestrogen receptor p (Sharma et al 1999), cyclin D2 (Robker and Richards 1998a 
and 1998b), and others (Richards 2001) is rapidly turned off. Expression of 
genes encoding steroidogenic enzymes for oestrogen synthesis is also rapidly 
terminated (Richards 1994). Not surprisingly the targeted disruption of genes 
obligatory for follicle maturation precludes ovulation or lutéinisation. 
Specifically in mice null for FSHR, FSHp, LHR, LH, IGF-1, IGF-IR, leptin, c- 
fos, cyclin D2, Erp, Era, ai'omatase, or the corepressor RIP 140, either follicular 
growth is arrested at a developmentally immature stage or further growth results
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in the formation of cystic follicles (Richards 2001,Elvin and Matzuk 1998, Orly 
2000, Couse and Korach 1999, Hasegawa et al 2000, White et al 2000, Johnson 
et al 1992). In conjunction with the termination of specific gene expression in 
mature follicles, LH induces genes involved in ovulation. These include the 
genes for progesterone receptor (Park and Mayo 1991, Natraj and Richards 
1993), cycloxygenase-2 (Sirois and Richards 1993), CAAT enhancer binding 
protein p (C/EBPP) (Sirois and Richards 1993), early growth regulatory factor 
(Egr-1) (Espey et al 2000), and pituitary adenylyl cyclase activating peptide 
(PACAP) (Park J. et al 2000, Park H. et al 2000). Genes involved in lutéinisation 
are then also induced by the LH surge. Some of these include the cell cycle 
inhibitors p21 CIP and p27KIP, steroidogenic enzymes StAR and P450scc, 
specific transcription factors Fra2/JunD, protein kinases, and other factors 
(Richards 2001, Sharma and Richards 2000).
Egr-1, C/EBPp, and progesterone receptor (Espey et al 2000, Sirois and Richards
1993, Park and Mayo 1991, Natraj and Richards 1993) are induced rapidly but 
expressed only transiently, with peak levels of message and protein occurring 
approximately 4 hours after the LH surge. Other transcription factors, such as the 
activator protein-1 family members (eg. C-fos, c-jun, Fra2, and JunD), are 
induced rapidly and remain elevated during the postovulatory luteal phase 
(Sharma and Richards 2000). Each of these mediators appears to be involved in 
the functional activity of the granulosa cells of ovulating follicles.
The LH-induced induction of progesterone receptor (PR) (Park and Mayo 1991, 
Natraj and Richards 1993) and prostaglandin endoperoxide synthase-2 (PGS-2) 
or cyclooxygenase-2 (COX2) (Richards 1994, Sirois and Richards 1992, Wong 
and Richards 1991) has led to them being implicated in ovulation. This was 
initially based on the timing of their synthesis following the LH surge (Richards
1994, Espey and Lipner 1994, Espey 1980) and by the effects of specific 
inhibitors and antagonists on their synthesis or action (Espey and Lipner 1980, 
Espey 1980). More recently inhibitors of prostaglandin synthesis and 
progesterone action have been used to block the rupture of follicles in vitro 
(Mikuni et al 1998, Rose et al 1999). It has also been observed that the 
expression of PR (Park and Mayo 1991, Natraj and Richards 1993) and PGS-2
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(Sirois and Richards 1992, Wong and Richards 1991) is selectively induced by 
LH in preovulatory follicles. The fate of the oocytes in both PR and PGS-2 null 
mice is to remain within morphologically and functionally normal corpora lutea 
which have failed to ovulate due to the absence of the proteolytic cascade 
(Robker et al 2000). Mice null for PR fail to ovulate even when stimulated by 
exogenous hormones, findings which support other studies implicating 
progesterone as a key player in the ovulatory process (Lydon et al 1995, Rose et 
al 1999, Pall et al 2000). Despite this failure of ovulation, the expression of 
COX-2, cumulus expansion, and lutéinisation proceed normally (Robker et al 
2000). Thus the molecular targets of PR appear to be those controlling mpture of 
the follicle, rather than those of lutéinisation.
The expression of several molecules including ECM components such as 
fibronectin and collagen have been reported to change in luteinising granulosa 
cells during corpus luteum formation (Amsterdam et al 1989, Honda et al 1997, 
Yamada et al 1999). The expression of these molecules is regulated by 
gonadotrophin and/or cytokines. For example, the expression of low density 
lipoprotein receptor, integrin 5 a and collagen type IV is enhanced by hCG in 
luteinising cell cultures (Honda et al 1997, Yamada et al 1999, Golos et al 1986, 
Golos and Strauss 1987) whereas dipeptidyl peptidase IV and leukocyte 
functional antigen-3 are induced, not by hCG, but by inflammatory cytokines 
such as interleukin (IE)-la and tumour necrosis factor a (Fujiwara et al 1994, 
Hattori et al 1995). On the other hand the expression of endothelin converting 
enzyme-1, which is a cell surface endopeptidase and activates proendothelin 
peptide, is promoted by hCG, IL-la and TNF-a.
1.6.3.3. Transcription factors implicated in lutéinisation
Early growth response l(Egrl)
As discussed above the genomic response usually includes the induction of 
immediate-early transcription factor genes such as early growth response 
protein-1 and/or the c-fos and c-jun genes (Gashler and Sukhatme 1995, 
McMahon and Monroe 1996). Egr-1 is a zinc finger transcription factor. It often
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binds overlapping sequences with Spl, an important transcription factor for 
several ovarian expressed genes, such as Sgk, P450scc, MMP 14 and p21CIP 
(Pardali et al 2000, Alliston et al 1997, Prowse et al 1997, Haas et al 1999). Egr- 
1 can exert positive transcriptional events or negative regulation of Spl 
(Richards et al 2002). Mice null for Egr-1 have impaired synthesis of LH and fail 
to ovulate or form corpora luteal, although whether this is due to a lack of 
pituitary LH or ovarian defects is not known (Lee et al 1996). Ovarian 
expression of Egr-1 mRNA and its protein product appears to peak after 
approximately 4 hours following the ovulatory gonadotrophic surge and does not 
return to basal level until 12-24 hours later (Espey et al 2000). This 
transcriptional factor has the unique ability to regulate the transcription of some 
genes positively while affecting other genes negatively (Gashler and Sukhatme 
1995, Beckmann and Wilce 1997). Among the genes induced by Egr-1 is the 
slightly delayed induction of NGFI-A-binding proteins, a family of co-repressors 
that bind directly to Egr-1 and repress Egr-1 mediated transcription (Qu et al 
1998, Swimoff et al 1998, Silverman et al 1999), thus ensuring that the Egr-1 
mediated cascade is a transient effect. Some of the physiologically relevant 
genes that are now recognised as targets for Egr-1 include fibroblast growth 
factor, tumour necrosis factor, platelet derived growth factor, the interleukin 
genes, cell surface adhesion proteins and matrix metalloproteinases (Gashler and 
Sukhatme 1995, McMahon and Monroe 1996, Dom et al 1999, Fitzgerald and 
O’Neill 1999, Haas et al 1999, Bourguignon et al 1998, Takahashi et al 1999, Yu 
and Stamenkovic 1999), This has led to Egr-1 being proposed as a mediator of 
the transient events that cause degradation and rupture of a follicle.
Nerve growth factor induced B (NGFI-B)
NGFI-B (also called Nur77), an orphan nuclear receptor of transcription factor, 
is rapidly and transiently induced by the LH surge in granulosa cells in the rat 
(Park et al 2001). The induction of NGFI-B is mediated through both ERK 1/2 
(Stocco et al 2002) and PKC (Park et al 2003). It is an immediate early response 
gene whose expression is regulated by a variety of extracellular stimuli and it 
encodes transcription factors regulating the expression of other genes, ultimately
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culminating in phenotypic changes (Herschman 1991). It has been implicated in 
the regulation of expression of steroidogenic enzymes (Wilson et al 1993, 
Havelock et al 2005) and mediation of apoptosis (Liu et al 1994). In the ovary, 
expression has been reported in corpora lutea (Richards 1994) and in granulosa 
cells following the LH surge (Stocco et al 2000). It has also been shown to 
induce 20a-HSD expression during prostaglandin mediated luteolysis (Stocco et 
al 2000) and to regulate the expression of 3pHSD2 (Havelock et al 2005). 
Because the spatial pattern of NGFI-B matches with the expression patterns of 
P450SCC (Zlotkin et al 1986) and StAR (Ronen-Fuhnnann et al 1998) in cells 
engaged in steroidogenic activity, it has been suggested that NGFI-B may be 
correlated with terminal commitment of cells for steroidogenic differentiation 
(Park et al 2003).
Two other members of the NGFI-B subfamily, Nurrl and Norl are also induced 
by LH in the granulosa cells of preovulatory follieles, although, unlike NGFI-B, 
they are not induced in the theca cells at the same stage (Park et al 2003). 
Whether they perform a similar function as NGFI-B is unknown.
CAAT enhancer binding protein beta (C/EPBp)
C/EPBp is another transcription factor known to be induced by LH (Sirois and 
Richards 1993). All of the C/EPB family members are expressed in the ovary 
(Piontkewitz et al 1993, Sirois and Richards 1993). Mice null for C/EPBP 
exhibit impaired ovulation and lutéinisation (Stemeck et al 1997, Pall et al 1997) 
with the ovaries displaying abnormal vascular morphology and haemorrhagic 
follicles as well as entrapped oocytes. Null mice also lack corpora lutea (Dekel et 
al 1988, Stemeck et al 1997). A possible target gene for C/EBPp is prostaglandin 
synthase-2 (PGS-2) (Sirois and Richards 1993).
Wnt and Frizzled family
Wnt-4, a member of the Wnt family of extracellular signalling proteins, has 
already been mentioned as having an important role in the regulation of foetal 
gonad development. Several members of the Wnt and Frizzled (Fz) families and 
downstream components of the Wnt-Fz signalling pathway are known to be
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expressed within the mature rodent ovary (Hsieh et al 2002, Ricken et al 2002). 
Wnt-4, Fz-4 and Fz-1 have been found to be regulated by gonadotrophins and 
steroids with Fz-1 specifically induced by the LH surge, as indeed is the Fz-1 
receptor, both appearing at high level in granulosa cells 8-12 hours after 
exposure to LH/hCG. Wnt-4 and Fz-4 are present in terminally differentiated 
luteal cells. These signalling factors are involved in processes such as cell fate 
specification, proliferation, differentiation and tissue patterning (Cadigen and 
Nusse 1997, Miller et al 1999, Richards et al 2002). Secreted frizzled related 
protein 4 (sFRP-4) expression is also induced in granulosa cells under the 
influence of LH and maintained in luteinised cells by stimulation from 
progesterone receptor ligand (PRL) (Hsieh et al 2003). Interestingly, the 
expression pattern for sFRP-4 in cultured luteinised granulosa cells is similar to 
the expression pattern of P450scc (Hsieh et al 2003). A potential role for Wnt/Fz 
regulation of steroidogenesis is indicated because Wnt-4 and Fz-4 are expressed 
in luteal cells. In addition gonads of female mice null for Wnt-4 misexpress the 
steroidogenic enzymes 3p HSD and 17a-hydroxylase (Vainio et al 1999). The 
Wnt/Frizzled pathways and the BMP pathways have been shown to impact and 
antagonise each other in many aspects of development (Schneider and Mercola 
2001, Marvin et al 2000) and, thus, may act to modify the actions of various 
BMP like molecules (GDF-9, TGF-p, BMP 15) or FGF molecules (Kawakami et 
al 2001) in the ovary.
1,6.3.4. Cytokines, role and regulation
After ovulation, the basement membrane is destroyed and immune cells and 
endothelial cells rapidly invade the luteinising gianulosa cell layer in a process 
resembling tissue inflammation (Espey 1980). Indeed ovulation has many 
features in common with an inflammatory reaction, including the central 
participation of leukocytes and classical inflammatory mediators such as 
eicosanoid, histamine and bradykinin (Espey 1980). Detection of leukocytes in 
ovarian tissue has revealed accumulation of some specific subsets of these cells 
in the preovulatory follicle at the time of ovulation (Brannstrom and Norman
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1993). It has been reported that peripheral blood leukocytes increase the number 
of LH-induced ovulations in rat ovaries in vitro (Hellberg et al 1991). A function 
for these cells at ovulation is likely because depletion of circulating neutrophils 
in rat ovaries decreases the ovulation rate (Brannstrom et al 1995). In addition, 
the cellular content of human follicular fluid has been shown to consist of 5-15% 
macrophages (Loukides et al 1990) which are involved in the production of 
interleukin 1(3 (Machelon et al 1995). There is evidence that cytokines are 
involved in the inhibition and stimulation of follicular responsiveness to 
gonadotrophins (Gougeon 1994). Cytokines, therefore, seem to play a pivotal 
role in the regulation of the development and atresia of follicles in the ovary 
(Jasper et al 1996, Kaipai and Hsueh 1997).
Tumour necrosis factor cc
One of the most frequently studied cytokines in the ovary is tumour necrosis 
factor a  (TNFa), which has the capacity to elicit inflammatory responses 
(Kondo and Sander 1997). Because ovulation has similarities to the 
inflammatory process (Espey 1994), and TNFa is produced in the ovary (Zolti et 
al 1990), its function there is usually discussed with respect to ovulation 
(Murdoch et al 1999). However it also has roles in steroidogenesis, proliferation, 
apoptosis, and luteolysis in several species (Terranova and Rice 1997), and its 
effects on follicular development and differentiation are due to a receptor- 
mediated pathway (Balchak and Marcinkiewicz 1999, Veldhuis et al 1991, Roby 
et al 1999). In several species TNFa has been shown to decrease gonadotrophin- 
upregulated progesterone production (Terranova and Rice 1997) and suggests 
that it has an inhibitory effect on lutéinisation. It also has the ability to induce 
apoptosis in mouse granulosa cells (Quirk e al 1998) through a pathway that 
involves modulation of Bcl-2 (Sasson et al 2002), and yet can also increase 
human granulosa-lutein cell number (Yan et al 1993). The coexistance of the 
effects of TNFa on proliferation and apoptosis has been suggested to be due to 
the differential expression of TNFa receptors I and II (Prange-Kiel et al 2001, 
Tartaglia et al 1993). It has recently been suggested that the luteolytic effect of 
TNFa may be mediated by inhibition of StAR, the key regulatory protein in
62
progesterone production (Lin et al 1996) or by indirectly decreasing LHR -Ï:expression in addition to stimulation of PGF2a production (Lin et al 1996, Chen 
et al 1999)
In human and rat granulosa-lutein cells, glucocorticoids can attenuate the 
apoptotic action of TNFa (Sasson et al 2002) and may therefore play a part in 
the healing process of the ovarian follicular tissue during follicular rupture and 
corpus luteum formation.
Interleukins
Interleukins are best known for their immune and inflammatory functions but a 
growing body of evidence has implicated their involvement in the periovulatory 
follicle. Interleukin la  and interleukin 1(3 mRNA have been localised to the 
theca, cumulus and oocyte of the murine follicle. In the mouse, ovarian synthesis 
of IL-la and IL-lp is first observed in the theca interna of growing follicle and 
the oocyte (Simon et al 1994, Terranova and Rice 1997). At the time of 
preovulatory maturation, after the LH surge, high levels of IL-la and IL-1(3 are 
observed in cumulus cells (Simon et a 1994). Type I interleukin receptor (IL- 
IR l) is synthesised by thecal cells from growing follicles. Before ovulation it is 
expressed by cumulus and granulosa cells, and is abundantly expressed in the 
mouse oocyte throughout follicular development (Simon et al 1994). The 
potential functions of interleukins in the ovary are wide ranging, IL-lp in the rat 
has been shown to induce ovulation and potentiate the inductive ovulatory effect 
of LH (Brannstrom et al 1993), they are also involved in the production and 
activation of proteolytic enzymes, prostaglandin production, nitric oxide 
production, cellular metabolism, and steroidogenesis (for review Gerard et al 
2004), frequently in a species-specific manner.
Ovarian granulosa luteal and stromal cells also express interleukin (IL)-8 mRNA I
and produce IL-8 protein with the protein level being increased by hCG 
administration (Ariel et al 1996). Its importance in follicular growth and 
ovulation has been shown by the inhibition of hCG induced ovulation following 
administration of anti-IL-8 antiserum (Ujioka et al 1998). IL-8 is a chemotatic 
cytokine secreted by a variety of cells in response to inflammatory stimuli such
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as IL-1, TNFa, or lipopolysaccharide and acts in the recruitment and activation 
of neutrophils as well as in angiogenesis (Herbert et al 1991, Clark-Lewis et al 
1993, Strieter et al 1995). It has been shown to induce ovarian vasodilation, 
follicle development (Goto et al 1997) and to increase the density of capillary 
vessels around developing follicles (Goto et al 2002) this suggests a role as a 
potent angiogenie factor in neovascularisation of the developing/luteinising 
follicle. Interleukin 6, whose production is induced by both TNFa and IL-1, has 
also been detected in follicular fluid (Büscher et al 1999)
An interleukin 1 receptor antagonist (IL-l-ra) has also been found in follicular 
fluid in concentrations comparable to serum concentrations or higher (Büscher et 
al 1999). This could serve to suppress the IL -la  and IL-lp mediated reactions of 
the immune system against further ovulatory tissue damage, and may represent 
an attempt to limit the reaction cascade.
Melanoma cell adhesion molecule
Human luteinising granulosa cells express melanoma cell adhesion molecule 
(MCAM), which is upregulated by LH/hCG and cytokines during lutéinisation 
(Yoshioka et al 2003). MCAM has been shown to mediate cell-endothelial cell 
interaction (Xie et al 1997) and may play a role in neovascularisation during 
corpus luteum formation in the human ovary. Its expression can be induced by 
TNFa (Yoshioka et la 2003) which is known to be an angiogenic and 
inflammatory cytokine (Ferrara 2000, Kim et al 2002), and by IL-la (Yoshioka 
et al 2003). These cytokines have also been reported to stimulate other 
angiogenic factors such as VEGF and angiopoietin (Jung et al 2001, Scott et al
2002). The production of inflammatory cytokines by luteinising gianulosa cells 
plays a role in promoting the production of soluble angiogenic factors during 
luteal development.
Granulocyte colony stimulating factor
Granulocyte colony-stimulating factor (G-CSF) is known to have specific effects 
on the proliferation, differentiation and activation of haematopoietic cells 
(Mielcarek et al 1996, Visani and Manffoi 1995). It exerts these biological
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effects through binding to specific, high affinity receptors (Nagata and Fukunaga
1993, Fukunaga et al 1990, Demetri and Griffin 1991, Shimoda et al 1993, 
Nicholson et al 1994, Nagata and Fukunaga 1991) that have been reported on 
cells of the granulocytic lineage, platelets (Shimoda et al 1993), monocytes and 
lymphocytes (Nicholson et al 1994, Nagata and Fukunaga 1991, Avalos 1996). 
Its expression in human luteinised follicular granulosa cells has also been 
demonstrated, indeed both G-CSF and G-CSF receptor (G-CSFR) are expressed 
(Salmassi 2004). Granulosa cells therefore seem to represent one of the sources 
and targets of G-CSF around the periovulatory peroid, acting via autocrine or 
paracrine mechanisms.
Ovulation, therefore, appears to be a LH-induced, cytokine-regulated 
inflammatory process, followed by an anti-inflammatory response mediated by 
interleukin receptor antagonists and glucocorticoids.
1.6.3.5. Steroidogenesis
Tenninal granulosa cell differentiation, like differentiation in other cells, is 
accompanied by cessation of proliferation, altered gene expression, and 
morphological changes (Nanbu-Wakao 2000). A hallmark of terminal granulosa 
differentiation after ovulation is the rapid loss of cytochrome P450 aromatase, 
the rate-limiting enzyme that converts testosterone to oestradiol (Fitzpatrick et al 
1997, Hickey et al 1998). The process of follicular lutéinisation is also associated 
with marked changes in the expression patterns of other steroidogenic enzymes, 
most notably an increase in StAR and P450scc which promote enhanced 
progesterone synthesis (O’Shaughnessy et al 1990, Fortune 1994, Richards
1994, Sandhoff and Maclean 1996, Ronen-Fuhnnann et al 1998). Progesterone 
biosynthesis requires only two enzymatic steps; the conversion of cholesterol to 
pregnenolone, catalysed by P450 side chain cleavage enzyme (P450scc) located 
on the inner mitochondrial membrane, and its subsequent conversion to 
progesterone, catalysed by 3P-hydroxysteroid dehydrogenase (3(3-HSD) present 
in the smooth endoplasmic reticulum. Both these organelles show increased size
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and/or number and complexity in periovulatory granulosa cells (Priedkalns et al 
1968, Cavazos et al 1969, Fawcett et al 1969, Enders 1973, McClellan 1975).
The loss in 17p oestradiol biosynthetic capacity after the LH surge has been 
explained by this marked decrease in the expression of the key steroidogenic 
enzymes involved in the follicular production of active oestrogen. However, it is
-Ialso now known that members of the 17pHSD family, in particular 17(3HSD4, 
which are key regulators of the biologieal potency of androgens and oestrogens 
in mammals, show an increase in expression that accompanies hCG induction of ;
ovulation in preovulatory follicles (Brown 2004). This upregulation occurs both 
in theca and granulosa but is clearly more pronounced in the granulosa cell 
compartment (Brown 2004). The 17|3HSD family reversibly catalyse the 
interconversion of less active 17-ketosteroids such as androstenedione and 
oestrone into the more active 17p-hydroxysteroids such as testosterone and 17^- |
oestradiol (Penning 1997, Peltoketo et al 1999). The induction of an 17p- 
oestradiol inactivating enzyme such as 17pHSD4 may represent a novel and 
complementary mechanism that can contribute to the reduction in active 
oestrogens within the follicle during lutéinisation.
The steroidogenic process first requires the coordinated regulation of cellular 
uptake, transport and utilisation of cholesterol (Miller 1988). Blood home low I
density lipoprotein (LDL) taken up by low density lipoprotein-receptor (LDL-R) 
is the primary souree of intracellular sterol substrate in some mammals such as 
primates and pigs (Chaffin et al 2000, Grummer and Carroll 1988, LaVoie et al 
1997, Soumano and Price 1997). LDL-R expression increases in preovulatory 
granulosa-luteal cells and remains elevated in the corpus luteum (Chaffin et al 
2000, Yamada et al 1998, Garmey et al 2000). In vitro FSH, LH, insulin and 
IGF-1 all drive the LDL-R gene and protein expression and concomitant 
progesterone production (Golos and Strauss 1987, Grummer and Carroll 1988,
LaVoie et al 1999, Sekar et al 2000, Veldhuis 1988, Veldhuis et al 1986).
In cattle and rodents high density lipoprotein (HDL) is regarded as the more 
important for maintaining luteal steroidogenesis (Bao et al 1995, O’Shaughnessy 
and Wathes 1985, Temel et al 1997) with the selective uptake of HDL being 
particularly active in rats and mice (Glass et al 1985, Stein et al 1983) mediated
through specific binding to scavenger receptor class B, typel (SR-Bl) (Temel et 
al 1997). Mice null for SR-Bl show a significant increase in plasma cholesterol 
levels and decreased adrenal gland cholesterol content (Rigotti et al 1997). Li et 
al (1998) demonstrated that SR-Bl expression within the ovary increases 
dramatically during PMSG induced follicle maturation but is localised primarily 
to the thecal cells. As lutéinisation progresses there is a shift in the cellular 
localisation of SR-Bl with an increased intensity of the hybridisation signal in 
the corpus luteum, demonstrating its inducibility in the granulosa cell by hCG. 
The StAR protein is known to regulate acute transport of cholesterol fi*om the 
outer to the inner mitochondrial membrane for conversion to pregnenolone by 
P450SC C  (Stocco and Clark 1996). Prior to the LH surge StAR is virtually absent 
from granulosa cells which are unable to metabolise and synthesise progesterone 
from cholesterol precursors (Chaffin et al 2000, Kiriakidou et al 1996, Pescador 
et al 1996). Regulation of StAR gene transcription is the primary mechanism for 
regulating StAR activity in granulosa cells (Kiriakidou et al 1996) and thereby 
controlling progesterone production.
Peroxisome proliferator-activated receptors (PPARs) are key regulators of lipid 
metabolism and cell differentiation (Maloney and Waxman 1999). All known 
isoforms of PPAR are expressed in the ovary (Braissant et al 1996) but their 
functions in this tissue remain unclear. While PPARy is highly expressed in 
preovulatory granulosa cells, it is down regulated after ovulation, suggesting it 
may be involved in the differentiation of oestrogen producing granulosa cells, to 
progesterone producing luteal cells (Komar et al 2001, Lohrke et al 1998). 
Targeted loss of PPARy in oocytes and granulosa cells decreases progesterone 
levels and impairs fertility, consistent with a role for PPARy in normal ovarian 
function (Cui et al 2002). PPARy ligands also stimulate progesterone secretion in 
luteal cells, evidence for a role of PPARy in developing and maintaining a 
differentiated phenotype in luteal cells (Lohrke et al 1998).
A link between activation of PPARy and suppression of aromatase has been 
established. The PPARy ligand troglitazone inhibits aromatase activity and 
mRNA levels in human ovarian granulosa cells (Mu et al 2000). Recent studies 
show that activation of both PPARa and PPARy suppresses aromatase mRNA
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and oestradiol levels, but has no effect on P450scc mRNA, (Lovekamp-Swan et 
al 2003). Both pathways upregulate fatty acid binding protein (FABP) 
(Lovekamp-Swan et al 2003), a protein associated with the differentiation of 
oestrogen-producing granulosa cells into progesterone producing granulosa cells 
(Iseki et al 1995). Levels of FABP have been shown to be differentially altered 
after hCG induction of ovulation (Leo et al 2001). Only PPARa activation 
induces 17p-HSD IV, aryl hydrocarbon receptor (AhR), cytochrome P450 IBl 
(CYPIBI), and epoxide hydrolase (Lovekamp-Swan et al 2003) all of which 
have involvement in regulation of oestrogen synthesis (Gorton et al 1996,
Murray et al 2001, Hattori et al 2000) and are generally thought of as being finvoloved in xenobiotic activation and metabolism (Murray 2001). Induction of 
these enzymes likely contributes to decreased oestradiol levels and increased 
estrone levels produced by granulosa cells in vitro and in vivo (Davis et al 1994a 
and 1994b). AhR is upregulated after the ovulatory gonadotrophin stimulus in 
primate granulosa cells, and may be involved in terminal differentiation (Chaffin 
et al 1999). These observations suggest that PPARa and y function as regulators 
of metabolism and differentiation in the granulosa cell demonstrating specific 
effects on steroidogenesis.
1.6.3.6 Angiogenesis
Apart from during tumour growth and wound healing the adult vascular 
endothelial epithelium is generally quiescent. The exception to this occurs within 
the female reproductive system which undergoes cyclical tightly controlled 
angiogenesis and angiogenic regression regulated by endogenous stimulatory 
and inhibitory factors (Pepper 1997, Risau 1997, Plendl and Sinowatz 1999). It 
is mediated by the same proangiogenic factors as tumour angiogenesis but is 
highly controlled (Smith et al 1993, Nicosia and Villaschi 1999). The 
development of new ovarian blood vessels is essential to guarantee the necessary 
supply of nutrients and hormones to promote follicular growth and corpus 
luteum formation. During follicle formation the granulosa compartment is 
avascular but the theca layer acquires a vascular sheath that consists of capillary
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networks in the theca interna and externa (Stouffer et al 2001). The acquisition 
of a vascular supply is probably a rate limiting step in the selection and 
maturation of dominant follicles (Stouffer et al 2001).
As follicles mature angiogenesis becomes accompanied by vasodilation, a 
functional adaptation to impending ovulation and to the developing thecal 
endocrine function (Jiang et al 2003). Although angiogenesis prior to ovulation 
occurs in the thecal layer, granulosa cells exert an important role in this process 
in that they produce several angiogenic factors that act in the theca. Granulosa 
cells from pig follicles, when co-cultured with aortic endothelial cells have been 
shown to significantly enhance endothelial sprouting and capillary elongation 
(Grasselli et al 2003). The maturation of preovulatory follicles, as a prelude to 
ovulation and CL formation, require sufficiently well developed 
microvasculature to deliver adequate levels of hormones and lipoprotein bound 
cholesterol (Davis et al 2003). During corpus luteum formation, endothelial cells 
migrate into regions containing luteinising granulosa cells and then form 
vascular networks among luteal cells. When labelling cells with 3H-thymidine, 
no less than 30% of the endothelial cells in the forming CL show active DNA 
synthesis (Gaede et al 1985). An increasing body of evidence suggests that 
endothelial migration among luteinising granulosa cells is promoted by secretion 
of soluble angiogenic factors such as bFGF and VEGF (Phillips et al 1990, Yan 
et al 1993, Reynolds and Redmer 1998). Several works have demonstrated that 
the production of some angiogenic factors is regulated by oxygen concentration 
with the induction of VEGF and angiogenin being induced by hypoxic stress in 
cultures of human luteinising granulosa cells (Friedman et al 1997, Koga et al
2000). The initial growth of the follicle after gonadotrophin stimulation results in 
inner hypoxia that triggers elevated expression of VEGF in the cumulus and 
inner granulosa cells. In response to VEGF, vessel permeability increases along 
with neovascularisation of the follicular periphery, thereby supplying a larger 
effective dose of LH to that particular follicle (Neeman et al 1997).
Among the angiogenic factors produced by the ovary are basic fibroblast growth 
factor (Gospodarowicz et al 1985), angiopoietins (Stouffer et al 2001) and VEGF 
(Robker and Richards 1998).
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Basic fibroblast growth factor (bFGF) stimulates endothelial cell proliferation 
(Bikfalvi et al 1998) and its expression in granulosa and thecal cells of the pig 
ovary has been shown to be enhanced by eCG administration (Shimizu et al
2003). In the bovine ovary, thecal expression of bFGF has been shown to 
increase during final follicular maturation, while remaining weak in granulosa 
cells (Shimizu et al 2003).
In the mouse three angiopoietins have been identified and serve to destabilise 
existing vessels, loosening the supporting cell matrix and allowing angiogenic 
factors such as VEGF to stimulate endothelial cell proliferation and migration. 
They also recruit peri-endothelial support cells to promote vessel maturation and 
maintain vessel integrity (Stouffer 2001, Tamanini and DeAmbrogu 2004). In 
the mouse, angiopoietin 1 is expressed in the thecal layer of the preovulatory 
follicle and then in the granulosa derived luteal cells, angiopoietin 2 expression 
precedes invading blood vessels, firstly in the theca and then in the granulosa 
layer (Stouffer 2001).
Vascular endothelial growth factor (VEGF) is a critical regulator of angiogenesis 
in CL formation (Fen'ara and Davis-Smyth 1997). With multiple isoforms 
(Tamanini and DeAmbrogu 2004) it is expressed during the angiogenic growth 
phase of CL formation (Ferrara et al 1998, Shweiki et al 1993). VEGF has been 
localised in the preovulatory follicle and early CL and shown to be stimulated by 
both LH and IGF-1 in bovine granulosa cells (Schains et al 2001). The VEGF 
protein in this species is found within granulosa, theca, and some endothelial 
cells in the preovulatory follicle and early CL (about 24hrs after ovulation) 
(Schams et al 2001). VEGF mRNA and protein in the primate are not present in 
granulosa cells of primordial and pre-antral follicles but become evident in the 
theca layer of antral follicles and in the cumulus granulosa of preovulatory 
follicles (Stouffer et al 2001). The ovine preovulatory follicle only shows VEGF 
mRNA expression in the theca interna and theca derived areas of the CL 
(Redmer et al 2001). In the marmoset VEGF expression starts at the end of the 
development of secondary follicles and is maximal in tertiary follicles, especially 
in granulosa cells (Wulff et al 2001), VEGF-A null mice die during early 
embryonic development, whereas VEGF-B null mice develop with cardiac
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abnonnalities but are fertile (Argraves and Drake 2005) suggesting isoform 
specific roles during vasculogenesis.
In the pig and bovine hypoxia will increase granulosa VEGF expression (Bianco 
et al 2003, Berisha et al 2000), but not in the primate (Martinez-Chequer 2003). 
LH administration upregulates bovine and primate granulosa VEGF mRNA 
(Berisha et al 2000, Martinez-Chequer 2003), an effect mimicked by eCG in pigs 
(Shimizu et al 2002) and hCG in humans (Laitinen et al 1997). In the pig, 
however, although eCG induced follicular maturation causes granulosa cells to 
actively secrete VEGF into follicular fluid, this activity is rapidly switched off 
by an ovulatory dose of hCG (Barboni et al 2000). In this species the 
organisation for VEGF production is completely reprogrammed after hCG 
administration when theca cells remain the only source of this angiogenic factor 
in preovulatory follicles. There is, therefore, considerable variation between 
species in the localisation and regulation of VEGF expression in the ovary.
Other angiogenic factors expressed within the ovary include nitric oxide (for 
review Tamanini et al 2003) and epidermal growth factor (Shimizu et al 2002) 
but many potential angiogenic factors can also be found among the numerous 
cytokines known to be produced within the ovary (Gaetje et al 1994). As 
previously stated there is evidence that ovulation shares many features of an 
acute inflammatory reaction, and pro-inflammatory cytokines contribute to the 
rupture of the follicle at ovulation and amplify the ovulation rate. Just before the 
time of ovulation the number of neutrophils increases markedly in the thecal 
layer. Interleukin-8 (IL-8), a neutrophil-activating factor and potent angiogenic 
agent which is modulated by steroid and trophic hormones, has been proposed to 
have a role in periovulatory physiology, particularly in the neovascularisation of 
the CL (Arici et al 1996). TNF-a is an angiogenic molecule suggested to regulate 
CL function (Okuda et al 1999, Sakumoto et al 2000). Other factors which are 
known to have effects on endothelial cell function include interferons, platelet 
derived growth factor, TGF alpha and beta, nerve growth factor and angiogenin 
(Pepper 1997).
In order to ensure control, anti-angiogenic factors have been suggested as a 
potential mechanism of balancing of angiogenic proliferation (Hanahan and
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Folkman 1996, Plendl 2000). One potential anti-angiogenic factor may be 
metalloproteinase inhibitor. The principal step in angiogenesis is degradation of 
the basement membrane, consequently protease inhibitors are anti-angiogenic 
because they prevent the breakdown of matrix proteins and thus maintain the 
integrity of the endothelium (Auerbach and Auerbach 1994). Tissue inhibitors of 
metalloproteinases (TIMPs) have been indentified as being secreted by granulosa 
cells of preovulatory follicles under gonadotrophic stimulation (Smith and Moor 
1991, Smith et al 1993).
1.6.3.7. Final oocyte maturation; meiotic resumption
The oocyte resumes meiosis in response to the preovulatory LH surge (Callesen 
et al 1986, Charming et al 1978, Dieleman et al 1983, Ireland and Roche 1982, 
Masui an Clarke 1979, Peng et al 1991). The question of how the preovulatory 
gonadotrophin surge acts to trigger resumption of meiosis has yet to be properly 
answered. The general opinion is that it acts to overcome a molecular inhibitor 
maintaining meiotic arrest, or alternatively generates local trophic signals within 
the follicle, or a combination of both. During the meiotic process the nuclear 
membrane starts to fold, the nuclear pores disappear and then nuclear membrane 
fragments before disappearing (Kubelka et al 1988, Szollosi et al 1972). These 
events are known as genninal vesicle breakdown (GVBD) and are the first 
visible sign of meiotic resumption. Oocyte maturation also involves 
transformations at the cytoplasmic level that prepare the cell to support 
fertilisation and early embryonic development. The completion of nuclear 
maturation alone does not guarantee subsequent embryo development (Sirard et 
al 1989, Yang et al 1998). Resumption of meiosis in vitro can be instigated 
spontaneously by separation of the oocyte from its surrounding follicle cells and 
is associated with a drop in intraoocyte concentrations of cAMP (Dekel 1996). 
However this ability to resume meiosis is not shared by all ovarian oocytes, and 
is progressively acquired during oocyte growth (Sorensen and Wasserman 1976, 
Jelinkova et al 1994).
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The mitogen-activated protein kinases are known to have a role in regulating 
meiosis. In oocytes a MAKP pathway has been implicated as a cell cytostatic 
factor responsible for the second metaphase arrest in conjunction with a germ 
cell exclusive kinase, Mos (Masui and Market 1971, Sagata et al 1989). MAKP 
interacts during the meiotic cell cycle with another regulatory enzyme, 
maturation promoting factor (MPF). MPF was originally identified as a factor 
that triggers reinitiation of meiosis in frog oocytes (Masui and Market 1971) and 
has subsequently been observed in a number of meiotically and mitotically 
dividing cells. In mammalian oocytes an MPF-dependant regulatory step of 
MAKP activation at reinitiation of meiosis involving the expression of Mos has 
been identified, and it has been suggested that the upstream regulator of this 
cascade is cAMP (Josefsberg et al 2003). The expression of Mos is subject to 
negative regulation by a protein kinase A mediated cAMP action (Lazar et al
2002)
The role of cAMP in the initiation of meiosis only becomes active after 
maturation of the oocyte. Goren et al (1994) have demonstrated that meiotic 
arrest in incompetent oocytes is independent of intra-oocyte cAMP 
concentrations suggesting that other factors responsible for the meiotic 
incompetence of immature oocytes must be involved.
Another paracrine system influencing meiotic activity in the oocyte involves 
Leydig insulin-like 3 (Insl3). Female INSL3-null mice exhibit impaired fertility 
associated with increases in follicular atresia and premature luteolysis (Nef and 
Parada 1999, Spanel-Borowski 2001). Recent studies indicate that testis Insl3 
acts as an endocrine factor to activate a G-protein coupled receptor LGR8 
(leucine-rich repeat-containing G protein-coupled receptor 8) with consequent 
increases in cAMP production (Kumagai et al 2002), LGR8 is expressed by the 
germ cells of both sexes and Insl3 has been shown to have a paracrine role in 
initiating oocyte maturation (Kawamura et al 2004). Insl3 is expressed in the 
thecal cells of the ovary (Bathgate et al 1996) with transient stimulation of this 
expression being induced by LH/hCG (Kawamura et al 2004). Although LH 
stimulates cAMP production in follicular somatic cells, a decrease in intraoocyte 
cAMP is required for meiotic resumption (Tsafriri and Pomerantz 1986), this
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being an evolutionary conserved mechanism for regulating meiotic progression 
(Mailer 1985). Insl3 has been shown to suppress intraoocyte Ca levels and to 
induce oocyte maturation as early as 1 hour after administration (Kawamura et al 
2004), indicating that the Insl3-LGR8 pathway may be important for germ cell 
meiotic progression.
In cultured, intact follicles both LH and FSH have been observed to induce 
oocyte maturation (Hillensjo 1976, Tsafriri et al 1972, 1998, and 2002, Dekel et 
al 1988, Tomell et al 1995). LH has the ability to induce meiosis in oocytes from 
large antral follicles from eCG primed rats, but FSH can induce meiosis in large 
and small follicles from unprimed rats (Dekel et al 1995). It had been proposed 
that cumulus cells secrete a substance after stimulation by FSH which influences 
meiotic resumption, and this has led to the identification of meiosis-activating 
sterols (MAS) (Byskov et al 1995 and 1997). Since then several studies have 
revealed that MAS play a role in the mouse oocyte meiotic resumption (Lu et al 
2000, Grondhal et al 1998 and 2000). Recent studies have shown that MAS 
levels increase rapidly in response to LH in the rabbit ovary in vivo (Grondhal et 
al 2003) and that MAS binding sites can be detected at the surface of the mouse 
oocyte membrane (Faerge et al 2001). Further work using a serum-free culture 
model for intact mouse follicles has also concluded that gonadotrophins employ 
MAS as a downstream signal transduction molecule for the initiation of oocyte 
maturation (Xie et al 2004).
During the phase when resumption of meiosis is becoming apparent there is also 
a decrease in the availability of granulosa cell aromatase as the shift to 
progesterone dominance progresses. Progesterone titres can become particularly 
high in follicular fluid with levels of 6400ng/ml being recorded in domestic farm 
animals (Hunter et al 1976). Progesterone has been shown to influence oocyte 
quality and maturation independent of the gonadotrophin surge (Borman et al 
2004). It has also been shown to be able to prevent oocyte atresia and promote 
oocyte nuclear maturation in primate follicles.
1.6.3.8. Cell survival
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During follicular growth and development the majority of the follicles 
selectively degenerate. This atresia is characterised primarily by granulosa cell 
apoptosis. In cultured, fully differentiated preovulatory follicles (following FSH- 
induced LH receptor expression) LH is proposed to provide continued support 
for follicle survival until the time of ovulation (Chun et al 1994) and an 
increased resistance to apoptosis has been observed in granulosa cells of 
preovulatory follicles following the LH surge in cattle (Porter et al 2001) and in 
rats (Svensson et al 2000). If preovulatory gonadotrophin surges are blocked or 
serum gonadotropins are decreased following hypophysectomy, follicles undergo 
atresia (Braw and Tsafriri 1980, Braw et al 1981). However, studies using 
cultured rat granulosa cells have shown that treatments with FSH, LH/hCG or 
insulin growth factor (IGF-I) are ineffective in the prevention of apoptosis, 
despite their apoptosis-suppressing action in cultured rat follicles (Billig et al 
1996). This indicates the importanee of neighbouring theca cells and local 
factors produced in the ovary for regulation of follicle growth and atresia. Other 
follicle survival factors, e.g. epidermal growth factor/transforming growth factor, 
basic fibroblast growth factor (Tilly et al 1992), interleukin-Ip (Chun et al 1995) 
and growth hormone (Eisenhauer et al 1995) as well as pro-apoptotic factors, 
e.g. tumour necrosis factor-a (Kaipai et al 1996), Fas ligand (Quirk et al 1995) 
and GnRH (Billig et al 1994) have been characterized
One of the most extensively documented granulosa cell survival pathways 
involves PKA/adenylyl cyclase signalling (Johnson et al 2003). Mechanisms 
implicated in this gonadotrophin-mediated survival pathway include the 
suppressed expression of proapoptotic factors such as Bax (Tilly et al 1995), 
Apaf-1 (Robles et al 1999), and caspase 3 (Boone and Tsang 1998). 
Progesterone, acting through its nuclear receptor, is also reported to exert 
antiapoptotic effects on isolated granulosa cells collected from periovulatory 
follicles (Svensson et al 2000). In addition peptide hormones such as vasoactive 
intestinal peptide (VIP) and pituitary cyclase-activating polypeptide (PACAP) 
also act via PKA to support survival. Progesterone has the ability to upregulate 
PACAP and the PACAP receptor in granulosa cells during the periovulatory 
period.
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Serum glucocorticoid regulated kinase (Sgk) expression is rapidly reduced by the 
LH surge but this decrease is transient. The expressions of Sgk mRNA and 
protein are increased as the cells begin to luteinise (Gonzalez-Robayna 1999, 
Alliston 2000). Upon activation Sgk is known to translocate to the nucleus where 
it can modulate the activity of transcription factors, including at least one 
member of the Forkhead family (Richards et al 2002) which has been shown to 
induce cell cycle arrest and apoptosis (Brunet et al 2001). Sgk is known to 
prevent apoptosis in mammary epithelial cell lines (Mikosz et al 2001) and in a 
human embryonic kidney cell line (Brunet et al 2001).
A number of cellular anti-apoptotic proteins are also involved. Many of the 
members of the Bcl-2 family have been isolated in the ovary. The antiapoptotic 
Boo (Bcl-2 homologue of ovary) expression is highly restricted to the ovary and 
the epididymis (Song et al 1999) and Bok (Bcl-2 related ovarian killer) is highly 
expressed in the ovary, testis and uterus (Hsu et al 1997). Members of the Bcl-2 
family have been shown to be upregulated by gonadotrophins via PKA 
signalling (Tilly et al 1995) and it has been suggested that the production of 
excess levels of these proteins enables efficient binding and neutralisation of 
other pro-apoptotic proteins such as Bad, Bax, and Apaf-1 (Tilly et al 1995, Hsu 
and Hsueh 2000). Bcl-2 has been shown to funetion as a survival factor in 
primary human granulosa cells (Sasson and Amsterdam 2002). Sasson et al 
(2004) identified a number of genes related to cell death and/or survival 
expressed in luteinised human granulosa cells in response to gonadotrophic 
stimulation. Among them is BAX inhibitor 1, Bcl-2 antagonist of cell death 
(BAD), Bcl-2 associated athanogene (BAGl). Bax null mice have been shown to 
have reduced ovarian apoptosis (Perez et al 1997). Another protein, apoptotic 
repressor (ARC), thought to be unique to heart muscle, is now known to be 
expressed in granulosa cells (Neuss et al 2001) and to be induced by 
gonadotrophin stimulation (Sasson et al 2004). ARC contains caspase 
recruitment domains which interact with and inactivate caspase activités thus 
helping to preserve mitochondrial integrity and function (Neuss et al 2001, 
Shelke and Leeuwenburgh 2003).
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1The Myc/Max/Mad family of transcription factors is linked closely to 
proliferation, differentiation and apoptosis (Grandori et al 2000). The 
protooncogene c-myc, which typically facilitates movement of cells into DNA 
synthesis (Nasi et al 2001), is antagonised by Mad proteins which compete for 
access to promoter sites and are thus associated with cell cycle arrest and 
differentiation (McArthur et al 1998). Granulosa cells from rodents and primates 
express c-myc transiently after a gonadotrophic ovulatory stimulus and it has 
been suggested that that this gene may act as a switch mechanism between 
proliferating and luteinising follicles (Agarwal et al 1996, Piontkewitz et al 
1997, Fraser et al 1995). C-Myc is also a potent inducer of apoptosis 
(Piontkewitz et al 1997) with both reduction and inappropriate overexpression
granulosa cells following an hCG stimulus (Piontkewitz et al 1997), suggesting 
an increased proliferation of cells during the very initial steps of CL formation. 
This matches well with data from primates showing that the acquisition of the 
luteal phenotype by granulosa cells is proceeded by a proliferative burst driven in 
part by a transient increase in the ratio of c-myc to Mad (Chaffin et al 2003). Yet 
in the mouse within 4 h and complete by 12 hrs of exposure to LH, granulosa 
cells cease to divide (Robker and Richards 1998). The cessation of cell division 
is associated with the rapid loss of cyclin D2 and the increased expression of the 
cell cycle inhibitors, P21^^ ^^  and p27^^^* (Robker and Richards 1998). Cyclin D2 
regulates cell cycle kinase cascades that are obligatory for entry of cells into the 
G1 phase of the cell cycle. In the ovary, cyclin D2 is expressed selectively in 
proliferating granulosa cells of the growing follicle (Robker and Richards 1998). 
Mice null for cyclin D2 fail to ovulate; however, the granulosa cells within the 
small follicles can be stimulated to differentiate and to express genes associated 
with ovulation (PR, COX-2) and lutéinisation (P450scc) (Sicinski et al 1996). It 
could be hypothesised that this final proliferative activity is a necessary 
component of the terminal differentiation of granulosa cells, which is brought to 
an effective stop by the increasing concentrations of the cell cycle inhibitors 
andp27“ ’’' .
associated with apoptosis. C-Myc is rapidly indueed (within 1 hour) in rat
I
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1.6.3.9 Follicular remodelling
The mature ovarian follicle contains granulosa cells with a number of luteinising 
hormone receptors (Espey and Lipner 1994, Richards 1994). The signal 
transduction processes that are initiated by these receptors at the time of the 
ovulatory surge of LH induce several dynamic changes in follicular cell function. 
Along with resumption of meiotic activity in the oocyte, there is induction of 
granulosa cell differentiation into progesterone secreting lutein cells. The 
fibroblasts in the thecal layers around the periphery of a follicle undergo a 
transfonnation from quiescence to motility, as they proliferate through the 
membrana propria towards the interior of the follicle, where they lay down a 
connective tissue framework to support the developing luteal tissue (Espey and 
Lipner 1994). Thus acute hormonal stimulation of a mature ovarian follicle leads 
to substantial cellular changes that convert a cavernous ovulatory follicle into a 
solid mass of luteal cells within 24-48 hours. This transfonnation of an ovarian 
follicle into a corpus luteum involves distinct ovarian cell types, diverse 
signalling pathways and temporally controlled expression of specific genes 
(Richards et al 1998).
The characteristics of both the theca and granulosa cells change markedly during 
lutéinisation. The cells increase in size, acquire a polyhedral shape, accumulate 
lipids and produce increased amounts of progesterone (Van Blerkholm and 
Motta 1978, Mori et al 1983). In some species the theca- and granulosa-lutein 
cells are separated in layers and can be distinguished from one another (Mori et 
al 1983, Greenwald and Rothchild 1968), but in rodents the two types of luteal 
cells become intermingled (Greenwald and Rothchild 1968, Pedersen 1951).
78
Integrity of cell-cell adherence and gap junction communication also has a role 
in increasing the resistance of granulosa cells to apoptotic stimuli. The |
expression of connexin 43 is clearly elevated by gonadotrophins (Sommersberg 
et al 2000). Following stimuli for apoptosis, integrity of the gap junctions is ■;interrupted (Sasson and Amsterdam 2002), although whether this is a cause or 
effect of an apoptotic process is not known.
Cell-cell adhesion
Clearly changes in cell adhesion molecules (CAMs) must occur during this 
remodelling process to permit the migration of theca cells and to facilitate the 
association of luteinising theca and granulosa cells into a functional corpus 
luteum.
The cadherins are a family of calcium dependant CAMs that have been studied 
extensively and shown to be important regulators of reproductive tissue 
structure, function and viability (Peluso 1997, Makrigiannakis et al 2000, Peluso 
2000, Rowlands et al 2000) and to have a role in maintaining the viability of 
granulosa cells (Trolice et al 1997). Cell adhesion affects the ability of granulosa 
cells to acquire LH receptors (Farookhi and Desjardins 1986) and also influences 
their responsiveness to gonadotrophin signals. Both E- and N-cadherin 
expression have been reported in preovulatory follicles and during formation of 
the corpus luteum, and E-cadherin is expressed during the functional luteinisaton 
of isolated rat granulosa cells in vitro (Machell and Farookhi 2003),
The neural cell adhesion molecule (NCAM) has been localised to granulosa cells 
and luteal cells of ovaries from both the rat and mouse. Granulosa cells from 
preovulatory follicles of the human ovary and cultured GCs that underwent 
lutéinisation in vitro, both expressed NCAM mRNA and protein (Mayerhofer et 
al 1991), suggesting it may be involved in corpus luteum formation. NCAM has 
been reported to downregulate the expression of matrix metalloproteinases 
(MMPl and MMP9) (Edvardsen et al 1993).
Integrins build up cell matrix connections and act as receptors for ECM proteins. 
Several groups have been found, in particular integrin a6, but also a2, a3, and 
p i, that are expressed during follicular development and corpus luteum 
formation in time and cell specific manners, suggesting specific roles during 
these processes (Aten et al 1995, Honda et al 1995, Giebel et al 1996, Nakamura 
et al 1997, Fujiwara et al 1998).
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Proteolytic mechanisms 
Two principle families of enzymes, plasminogen activators/plasmin and matrix 
metalloproteinases (MMPs), govern tissue dissolution and remodelling during 
ovulation and lutéinisation. In response to the LH surge plasminogen activator
?expression is increased differentially at the apices of preovulatory follicles 
within the ovarian surface epithelial cells (Carmeliet et al 1994). Both urokinase 
and tissue plasminogen activators contribute to ovarian plasmin production and 
ovulatory efficiency in rodents (Hagglund et al 1996, Curry and Osteen 2001,
Murdoch et al 1986). That ovarian/follicular MMPs are increased and collagens 
are degraded during ovulation has been established (Murdoch and McCormick 
1992). In preovulatory ovine follicles, there is a direct association of apical I
plasmin accumulation with the onset of collagenolysis (Fukumoto et al 1981,
Bjersing and Cajander 1975). Morphological observations indicate that 
preovulatory connective tissue disruption begins at the ovarian surface and 
advances inward to encompass the ovarian follicular wall (Reich et al 1991,
Tadakuma et al 1993). Tunica/thecal fibroblasts and follicular steroidogenic 
(theca, granulosa) cells are sources of procollagenase (Ichikawa et al 1983,
Reich et al 1985).
Tumour necrosis factor (TNF) a is known to be expressed by preovulatory 
follicles (Black et al 1997, Johnson et al 1999, Murdoch 1994 and 1995) and is 
secreted, within a limited diffusion radius, into the progenitor site of follicular 
rupture (DeMola et al 1998). TNFa induces collagenase production in the 
follicle (Murdoch et al 1999, Brannstrom et al 1995) and it therefore appears that 
it potentiates ovulatory collagenolysis by assuring that sufficient quantities of 
(pro) MMPs are synthesized. Secretion into the follicular fluid of low levels of 
TNFa by the oocyte cumulus complex evidently facilitates collagen breakdown 
throughout the follicular wall (Murdoch et al 1999).
MMP 2 production during the follicular transition to the luteal phase is 
upregulated under the transcriptional control of TNFa (Murdoch and Gottsch 
2003) and its localisation within the connective tissue strands that extend into the 
substance of the corpus luteum (Brannstrom et al 1995) is consistent with the 
concept that follicular type IV collagen is remodelled into an anchoring
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infrastructure for blood vessel development and cellular migration (Sato and 
Seiki 1996, Stack et al 1998, Nelson et al 2000, Woessner 1991). MMP 2 is 
essential for ovulatory rupture and remodelling and normal angiogenesis witbin 
the developing corpus luteum (Baibin et al 1996).
In addition, other proteolytic enzymes have been found to be involved in 
periovulatory connective tissue dynamics; MMP-9 is elevated in the luteinising 
granulosa cells of rodents (Boujrad et al 1995), MMP-13 is elevated in 
preovulatory follicles (Baibin et al 1996, Komar et al 2001) as are cathespin L 
and ADM ATS-1 (Robker et al 2000).
Net proteolysis during ovulation is controlled by the relative balance of enzymes 
to inhibitors. Increased expression of TIMP-1 and a2-macroglobulin by 
granulosa cells of periovulatory follicles apparently serves to confine the extent 
of ovulatory tissue destruction and assure that a viable corpus luteum is formed 
(Liu et al 1998 and 1999).
There is also evidence that MMPs and TIMPs influence luteal emergence 
independent of ramifications on the extracellular matrix. Matrix 
metalloproteinases, by liberating growth factors from inhibitory binding proteins, 
can trigger cellular expansion (Liu et al 1999). Progesterone production by rat 
granulosa cells is stimulated by TIMP-1 when complexed with cathespin L 
(Boujrad et al 1995).
Two proteases that are induced in granulosa cells of preovulatory follicles by the 
LH surge and whose expression is impaired in PR null mice are cathespin L and 
ADAMTS-1. Cathespin L is a lysosomal cysteine protease which degrades types 
I and IV collagen, fibronectin and laminin (Kirschke et al 1998). It has been 
associated in vivo with metastatic potential of transformed cells (Ishidoh and 
Kominami 1998), suggesting that it is important for tissue remodelling and cell 
migration/invasion. ADAMTS-1 is a member of the AD AMs family of 
proteases (Kuno et al 1997) characterised by a multifunctional structure and zinc 
binding domains (Black and White 1998). The peak in ADAMTS-1 
transcripition occurs 8-12hrs after exposure of the ovaries to an ovulatory dose 
of hCG (Robker et al 2000, Espey et al 2000), after the peak of PR expression 
but before ovulation (usually observed at 14-16 hrs). It has several possible
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functions in the ovary, firstly it is a potent active proteases which may serve to 
initiate one or more proteolytic cascades (Kuno e al 1999). Secondly as a 
protease it may serve to control the amount and cellular location of various 
proteoglycans. It has been shown to degrade aggrecan and brevican both of 
which are present in follicular fluid (MacArthur et al 2000, Nakamura et al 2000, 
Tortorella et al 2000, Kuno et al 2000) and to proteolyze the cell surface 
ectodomain of the syndecans, which may release potent biological peptides into 
the follicular matrix (Park et al 2000). Proteoglycans appear to play a critical role 
in the physical composition of follicular fluid and are important for cell 
migration and for other cell functions (Salustri et al 1999). A lack of ADM ATS- 
1 might prevent the activation of one or more potent bioactive factors in the 
follicular fluid by preventing their release from proteoglycans. Finally, its ability 
to interact with specific cellular signalling molecules suggest its third putative 
function as a cell signal regulator (Kuno et al 1999, Bigler et al 2000). At least 
one class of G protein coupled receptors are activated by proteolytic cleavage of 
their extracellular domain (Nakanishi-Matsui et al 2000).
In addition at least two other AD AMs family member are expressed in the rodent 
ovary, ADAMTS-4 and ADAMTS-9, but the specific source cell type has not 
been identified (Abbaszade et al 1999).
1.7 Rationale and aims for the present study.
Although much is known about the molecular mechanisms responsible for 
follicular development comparatively little study has been carried out to analyse 
the control of, and genetic response to, lutéinisation. The extensive 
morphological and functional changes described above during luteinsiation 
involve the regulation of gene and protein expression responsible for the 
cessation of proliferation and differentiation of the individual granulosa cells. 
The formation of the fiinctional corpus luteum and secretion of progesterone is 
essential for the establisment of pregnancy following ovulation. However, as 
already described, the differentiating granulosa cell also functions in an 
endocrine manner, as a paracine mediator of thecal function and oocyte
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maturation, as the driving force behind follicle fonnation and subsequent corpus 
luteum remodelling, and as a provider of nutritional and metabolic support for 
the oocyte. The control of such an array of functions depends on the tight 
regulation of protein expression within the cell. Initiation of gene transcription 
depends on the activity and cooperation of transcription factors and other 
controlling elements binding to a gene specific promoter region on the 
chromosome and activating synthesis of the mRNA. Following this, transcript 
processing, transport, translation and post translation modification/activation or 
inactivation will all impact on the eventual role of the transcribed gene.
In order to investigate the mechanisms underlying these processes we embarked 
on a time- and cell-specific analysis of gene expression in the granulosa cell 
during late follicle development and early lutéinisation. Our aims were to 
provide a comprehensive record of gene expression within the cell during this 
fundamental transformation and in so doing identify some of the core regulatoiy 
systems controlling lutéinisation.
The advantages of the experimental approach chosen to perform this analysis 
will be discussed in Chapter 3.
1.8 Tissue generation and mouse model
The mouse is an excellent animal for the study of follicle development and 
lutéinisation. The first follicles are formed in mice around the day of birth 
(Peters 1970) so that the newborn mouse ovary contains only primordial 
follicles. At 2-3 weeks after birth the follicles have developed to antral follicle 
stage. Neonatal mouse ovaries therefore contain unifonn follicle populations of 
similar sizes as determined by the number of days after birth (Sorensen et al 
1976; Epigg 1991).
To attain a more complete knowledge of the mechanism of cell function, it is 
necessary to investigate the fijll range of molecules involved. Analysis of mixed 
cell populations may miss significant transcripts expressed in a cell type that has 
a low fi-equency in the population, or over emphasise the importance of a 
transcript expressed in multiple cell types compared to those with more limited
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expression. By isolating follicular somatic cells from thecal and interstitial tissue 
this problem is largely overcome and results in a significant improvement over 
those gene expression studies (Leo et al 2001; Espey and Richards 2002) based 
on the whole ovary without regard for variation between specific cellular 
compartments. The value of this approach is illustrated by the work of Virion et 
al 1999 who microdissected kidney tubules and identified transcripts 
dramatically enriched in specific histological regions. The fact that several of the 
most highly expressed transcript tags in this study had no matches to cDNA 
databases suggests that existing cDNA libraries made from entire kidneys did 
not contain important genes expressed in small subpopulations.
The gonadotrophin-induced mouse model using PMSG (pregnant mare serum 
gonadotrophin; mainly FSH activity) and hCG (human chorionic gonadotrophin; 
mainly LH activity) at 20 days old, before the animal has entered its own oestrus 
cycle, simplifies the staging and collection of uniform populations of cells. It is 
also a considerable advantage that the timing of ovarian events are well known 
in this model, which allows tissue sampling and pharmacological treatments at 
defined time points during follicular development and ovulation. The PMSG 
treatment stimulates follicular growth and development and the subsequent hCG 
administration induces ovulation between 12 and 14 hours later (Wilson and 
Zarrow 1962; Zarrow and Wilson 1961).
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Chapter 2
Introduction to basic laboratory 
methods, mouse model and tissue
collection.
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Chapter 2. Overview of Basic Laboratory Procedures
The main objective of this project were the identification of genes with altered 
expression during lutéinisation. This was largely achieved using serial analysis 
of gene expression (SAGE) but a number of molecular biology techniques such 
as RNA extraction, DNAse treatment of RNA, reverse transcription, normal and 
‘hot start’ PCR, gel electrophoresis, cDNA cloning and sequencing were also 
used and require a brief explanation. Unless specifically stated later in the text 
these are the protocols followed.
2.1. RNA extraction
Messenger RNA within the cell is the inteimediate coding stage between the 
gene and the protein. The initial stage in RNA formation is the production of 
heteronuclear RNA, a direct copy of a sequence of genomic DNA, containing 
both introns and exons. The noncoding exons are removed by splicing, leaving 
the coding exon sequence mRNA as the template for protein synthesis.
RNA extraction was carried out by addition of the tissue sample to the 
appropriate volume of Trizol (Invitrogen, UK), usually 400pl. When dealing 
with aspirated granulosa cells firom ruptured follicles no homogenisation was 
used other than vortexing the sample for 15 seconds. In the case of samples with 
significant structural organisation homogenisation was carried out using the 
Ribolyser (Hybaid, UK) for a 20 second period or as required for complete 
disruption of tissue structure. A one fifth volume of chloroform (usually 80pl) 
was added and the contents mixed by vortexing. The tube was left on ice for 3 
minutes then centriftiged for 7 minutes at 14,000 rpm (18,000g). The top 
aqueous layer was removed and transferred to another tube. An equal volume of 
isopropanol was added along with Ipl of RNAase fi-ee glycogen (Invitrogen, 
UK) and the tube left at room temperature for 20 minutes before centrifiigation 
for 20 mills at 18,000g. The centrifugation formed an RNA pellet. The 
supernatant was decanted and the pellet washed in 750pl 75% ethanol, vortexed 
for a few seconds and then recentrifugated for 15 minutes. The ethanol was
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removed and the pellet allowed to air dry before resuspension in 20-50pl rtHzO 
(UV treated) and storage at -70°C or in liquid nitrogen.
2.2 DNAse Treatment of RNA samples
Contamination of RNA samples with genomic DNA can produce a false positive 
signal, particularly in highly sensitive real time PCR processes. This will occur if 
the amplicon does not span an intron/exon boundary. While false positives can 
be detected using a control which has undergone the reverse transcription 
protocol without active enzyme, removal of contaminating DNA aids detection 
and quantification of RNA species. This can be carried out efficiently by using a 
DNAse treatment such as DNA-^ae (Ambion Inc UK) which breaks down DNA 
into short oligo and mononucleotides but leaves RNA unaffected.
To DNAse treat one sample Ipl of lOx DNAse buffer (lOOmM Tris, pH 7.5; 25 
mM MgCb; 5 mM CaCL) and 0.5pi DNAse (Ambion Inc) was added to 5 pi of 
the RNA sample along with 3.5pl rtH^O (total volume of reaction lOpl) and 
incubated at 37°C for 30 minutes and then placed on ice. DNase inactivation 
reagent (4pi) was added to each sample and left to stand at room temperature for 
2 minutes. Centrifugation at 18,000g for 2 minutes pelleted the inactivation 
reagent and DNAse and allowed removal of the supernatant containing DNA- 
fi-ee RNA. This was stored at -70‘’C or in liquid nitrogen.
If real time PCR showed DNA contamination still present then a second cycle of 
DNAse treatment was performed.
2.3 Reverse Transcription
The conversion of unstable RNA to the more easily manipulable cDNA by RNA 
dependant DNA polymerases is the starting point for many molecular biology 
techniques. Recent evidence has shown that some types of reverse transcriptase 
such as RnaseH RT (Superscript II, Invitrogen, Paisley UK) may generate up to 
four time more cDNA from an identical amount of starting material (Virion et al 
1999) when compared to some of the more traditionally used enzymes such as
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the Moloney murine leukaemia virus reverse transcriptase, making it the obvious 
choice for use.
These enzymes act by extending an oligo dT or random hexamer primer in the 3’ 
direction by the incorporation of deoxynucleotides (dNTPs)
Reverse transcription reactions were usually performed in a lOpl total volume 
containing 2pi 5x RT buffer, Ipl lOmM DTT, 0.25pl dNTPs (20pmol/L), 0.25pi 
random hexamers (20pmol/L) or oligodT primer (20pmol/L), 0.15pl of RNAse 
inhibitor (RNasin, Promega, UK), 0.15pl of Superscript II RT (Invitrogen, UK),
5.2 pi of water and Ipl of RNA template. The mixture was incubated at 42^C in a 
water bath for 1 hour then cooled and stored at -20‘’C.
2.4 Polymerase Chain Reaction
The polymerase chain reaction allows amplification of specific target sequences 
of DNA using oligonucleotide primers each complimentary to one end of the 
DNA target sequence. These primers are extended in a 3 ’ direction by a thermo 
stable DNA polymerase in a three-step reaction involving a high temperature 
dénaturation step (95”C), a low temperature annealing step (54-65°C) and an 
extension step (72°C).
The primers are usually 17-28 bases long, with 45-60% GC content and minimal 
self complementarity. The specific primers used in various reactions will be 
listed in the text.
Each PCR reaction usually contained lOx buffer (750mM Tris-HCl pH8.8, 
200mM (NH4)2S0 4 , 0.1% (v/v) Tween 20®.) , 0.1 pi taq polymerase (5iu/pl), 
MgCh (2mM) (All from Abgene, UK), dNTPs (0.2mM), Ipl of cDNA template, 
primers (200mn each) and rtïÎ20 to an appropriate volume (usually 25pl or 50pl). 
The appropriate cycling program was performed using a PCR express machine 
(Thermo Hybaid). Cycling programs consisted of an initial dénaturation step of 
95°C for 2 minutes, then 25-35 cycles of 95°C dénaturation, a primer-specific 
annealing temperature and then 2 minutes of 72°C extension. A terminal 
extension step of 5 minutes at 72°C was used in most protocols. Non template 
controls were included in all reactions.
88
In a variation of the normal PCR protocol some enzymes require a 95“C 
dénaturation step to activate the polymerase enzyme. When setting up a PCR 
reaction at low temperatures, non-specific amiealing can lead to the generation of 
non-specific constructs which will be reamplified throughout the remainder of 
the PCR reaction. A system requiring hot start activation of the polymerase 
allows premixing of the reagents at room temperature without extension of non­
specific annealed primers. This increases reaction fidelity and reduces the 
incidence of mis-primed PCR products and primer oligomers, particularly 
valuable when performing real time PCR quantification of low level expression 
transcripts.
The Ampiltaq Gold (Applied Biosystems) hot start PCR system was used for all 
real time PCR reactions performed in this study. The reaction was performed in 
Ix GeneAmp PCR Gold Buffer and 6.25mM magnesium chloride solution (both 
Applied Biosystems) with 0.15 units Amplitaq Gold polymerase per reaction. 
Also included were 200pmol/L dNTP’s, 300nmol/L of each primer, 200nmol/L 
of probe and the reference dye rox (60pmol/L). The thermal profile consisted of 
an initial 10 minute 95°C dénaturation then 40 cycles of 95°C for 15 seconds 
dénaturation with a 60°C extension step. Thermal cycling and fiouresence 
detection was performed by a GeneAmp 5700 system (Applied Biosystems, 
Cheshire, UK). A further description of real time PCR is given in Chapter 3.
2.5 Gel electrophoresis
This involves the separation of DNA or RNA products on the basis of size and 
electric charge. The DNA molecule is negatively charged and will migrate 
through the gel matrix towards a positive electrode. Product size was 
electrophoretically resolved by comparison with DNA size standards. The 
loading buffer added to the DNA sample contains both glycerol to retain the 
DNA within the wells and bromophenol blue to allow estimation of sample 
migration. Two types of gel matrix are used in this study, agarose and 
polyacrylamide.
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Agarose gels were 1% unless otherwise stated, prepared in 0.5x TBE buffer, 
heated to induce dissolution of the agarose, as being cooled, ethidium bromide 
was added (Ipl ethidium to lOOmls agarose gel) to permit visualisation of the 
DNA product under uv light. A voltage difference of lOV/cm was applied to the 
gel and run for as long as required to induce separation of the DNA fragments. 
Polyacrylamide gels (PAGE) are efficient at separating lower molecular weight 
products with better resolution than can be achieved with agarose gels. 12% 
PAGE gels were routinely used for separation of the PCR and restriction enzyme 
digest products involved in SAGE. To generate a 12% gel, 10.5ml 40% 
Acrylamide/Bis Solution, 19:1 (Bio-Rad Laboratories, CA) was combined with 
23.5ml water, 700|il of 50x TAE, 350)0,1 ammonium persulphate (Sigma 
Chemicals, UK) and 30|Li1 TEMED (Sigma Chemicals, UK), mixed and allowed 
to set as a 1mm thick gel.
Following electrophoresis the gel was removed from the mould and washed in 
lOOmIs IxTAE buffer containing 6|li1 ethidium bromide for 1 5  minutes followed 
by rinsing in 1 OOmls clean IxTAE for another 15 minutes and then visualised 
under UV-A light.
2.6 cDNA Cloning using TOPO vector
The TOPO (Invitrogen, UK) range of cloning vectors utilise a bound 
topoisomerase enzyme attached to each end of the open vector to ligate the 
desired insert. Selection of cloned insert over empty vector is performed by 
means of a suicide gene. The pCR 4-TOPO vector (Invitrogen, UK) is supplied 
open with an A base overhang to permit cloning of PCR products. This system 
was used repeatedly to elone cDNA for sequencing analysis.
The cloning reactions were set up using 4|il PCR product, Ipl salt solution (1.2M 
NaCl, 0.06M MgCE) and Ipl TOPO vector. The mixture was gently mixed by 
pipetting and incubated at room temperature for 5 minutes then placed on ice. 
Ethanol precipitation was used prior to electroporation to reduce salt 
concentration and prevent arcing. For precipitation 3 pi glycogen was added to 
the supernatant followed by 50pl sodium acetate 3M, pH5.2, and 1300pl 100%
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ethanol and the mix was stored at -70‘’C for 2 hours followed by centrifugation at 
18,000g for 15 minutes. The supernatant was removed and discarded, the pellet 
washed in 500pl 70% ethanol and centrifuged for 5 minutes at 18,000g. Again 
the supernatant was removed and discarded and the pellet washed in 500pl 70% 
ethanol before centrifugation for 5 minutes at 18,000g. The supernatant was 
discarded and the pellet dried before resuspension in lOpl LoTE.
Amplification of the insert in recombinant plasmids was carried out using the 
vector based primers M13R (5’-TCACACAGGAAACAGCTCTGA-3’) and 
M13F (5’-TGT AAA ACG ACG GCC AGT-3’), sequencing was performed 
using Ml 3R primer.
2.7 Electroporation of E.coli
The DHIOB E.coli strain (Invitrogen, Paisley, UK) was used as the host cell for 
transformation with plasmid DNA. Ipl of a lOpl ligation reaction was added to 
an aliquot of 40pl of cells which had been stored at -70^3 and then defrosted on 
ice. This mix was transferred to a chilled 0.1cm cuvette (Bio-Rad) and 
electroporation at 150kV and 2000 using a Bio-Rad Gene Puiser carried out. 
Cuvettes where maintained on ice for 2-3 minutes following electroporation then 
cells resuspended in 1ml SOC (Invitrogen, Paisley, UK) at room temperature and 
incubated for 1 hour at 3TC  shaking at 220 rpm. This suspension was aliquoted 
onto normal or low salt LB agar plates with the appropriate selective antibiotic 
and incubated at 3TC  overnight. Analysis of growing colonies was carried out 
by PCR utilising plasmid based primers.
2.8 DNA Sequencing
Sequencing of PCR products or plasmid purified DNA was carried out with the 
ABI PRISM Big Dye Terminator Cycle Sequencing Kit (Applied Biosystems). 
Amplification reactions were performed in a lOpl reaction volume containing 
3pi Big Dye buffer, Ipl Big Dye (both Applied Biosystems), 0.5pi sequence
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specific primer (3.2pmor^ concentration, sourced fi-om MWG Biotech) and 2pl 
of PCR product as template. Thermal cycling was performed at 96°C for 30 
seconds, 50®C for 15 seconds and then 55”C for 4 minutes for 25 cycles.
The amplified product was purified by ethanol precipitation. To the lOpl 
reaction volume was added 8pl water and 32pl 95% ethanol and this was left to 
stand at room temperature for 15-30 minutes then centrifuged for 30 minutes at 
4000g at 4°C. The supernatant was removed and the pellet washed in 150pl 70% 
ethanol. Following further centrifugation at 4000g at 4°C for 10 minutes, the 
supernatant was removed, the pellet dried and then reuspended in 15pl 
formamide.
Sequencing was performed on the ABI Prism 3100 Genetic Analyser (ABI 
Biosystems). The sequences were viewed and text files created using Chromas
2.3 (Technelysium Pty Ltd, AUS).
2.9 Collection of experimental tissue for SAGE libraries
The experimental tissue for this study was obtained by treating 30 normal d20 
female mice, bred on the C3H/Hehxl01h strain, with 5IU PMSG 
intraperitoneally (i/p). Isolation of granulosa cells from mature antral follicles 
was carried out by puncturing follicles of ovaries collected 48 hours following 
injection. Further granulosa tissue was collected by the same method from 
preovulatory follicles 12 hours after the sequential administration of 5IU PMSG 
and 15IU hCG intraperitoneally to 30 female mice 48 hours apart. Cells were 
collected by follicle puncture and aspiration in Dulbecco’s ME medium 
(Invitrogen, Paisley, UK) and stored at -70°C until use.
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Chapter 3
Serial analysis of gene expression 
Introduction, protocol, some 
methodological considerations and results.
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Chapter 3; Serial Analysis of Gene Expression 
3.1 Overview of Gene expression analysis
Changes in gene expression can have a major effect on ovarian function. Small 
shifts in the expression levels of hormones, their transporters and receptors can 
have wide implications for cell function. The description of gene expression 
patterns provides clues about the regulatory mechanisms, biochemical pathways, 
and broader cellular functions. Therefore identification of physiological variation 
in expression patterns will add to the understanding of the pathways affected. 
Messenger RNA expression studies are complementary to these goals. The 
advantage of mRNA analysis is that it is generally less difficult and more 
sensitive than protein based methods. The differences found in mRNA levels are 
often, but not always, correlated with differences in protein levels. For example, 
study of the C.cresentus bacterium cell cycle using two dimensional gel method 
for proteins and DNA microarrays for RNA showed similar expression profiles 
between protein and RNA (Grunenfelder et al 2001). The main disadvantages of 
measuring mRNA are associated with these molecules not being the final 
expression product and an inability to account for protein modification, 
interactions with other proteins, and to identify the location of the final product. 
The extent of the genomic DNA that encodes genes varies greatly between 
organisms, the yeast genome, for example, is approximately 70% coding, while 
the human genome contains only about 3% coding sequence, equating to a 
surprisingly low number of genes (Lander et al 2001). It is estimated that around 
10000 genes are active at a given time in a mammalian cell (Yanamoto et al
2001) and of these a proportion can be useful in identifying differences between 
cell types by representing cell specific functions. Gene expression studies aim to 
identify and measure the relative copy number of each transcript, creating an 
expression profile that can be used to look specifically at or for genes with 
altered expression levels in response to certain stimuli. It is, however, important 
to bear in mind that transcript and protein profiles do not always agree (Griffin et 
al 2002). It is also important to note that a large proportion of transcribed
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sequences represent non-coding RNA. This may include ribosomal RNA, 
transfer RNA and other small RNA’s (Mattick 2001, Eddy 2001). The separation 
of mRNA from other RNA species is aided by the transcriptional modification of 
coding RNA by the addition of a 3’ polyadenylated tail, although some 
noncoding RNA strands also have poly A tails. Hybridisation of this tail to a 
complementary polyT oligonucleotide anchored on a solid support is the feature 
on which a variety of global expression techniques are based. By reverse 
transcription of the RNA into complementary DNA (cDNA) and cloning of this 
cDNA, a library is created with the same sequence distribution as the original 
mRNA.
3.1.1 Gene profiling techniques
Several approaches are possible in studying the differential expression of genes 
within tissue samples. The hypothesis driven selective study of specific genes 
and proteins can be expanded by techniques which allow the open-ended study 
of all genes expressed within a tissue or cell type in the hope that knowledge of 
complete gene expression patterns will provide insight into the physiological 
control of function of that tissue or cell. All techniques require the extraction of 
mRNA and subsequent reverse transcription to cDNA. Large-scale arrays using 
cDNA or oligonucleotides and tagging techniques such as serial analysis of gene 
expression (SAGE) and GeneCalling rely on databases of EST and gene 
sequences to identify expressed genes.
Older techniques frequently relied on the use of cDNA libraries in the form of a 
bacterial population each harbouring cDNA clones synthesized from a single 
mRNA molecule. These libraries may be non-normalised, preserving the relative 
abundance of mRNAs in the starting tissue and allowing assessment of the gene 
expression levels within the study sample, or normalised with relative similar 
levels of abundant and rare genes in the final product. These normalised libaraies 
are consequently useful for identification of genes with low level expression. 
The various methods of gene expression analysis are briefly outlined below.
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EST sequencing and electronic databases
The use of cDNA technology to generate EST libraries allows sequencing of 
most of the expressed genes from any particular tissue. Comparison of ESTs 
from libraries constructed from different tissues allows identification of tissue
'h:specific gene expression patterns. Most EST libraries are constructed using 
directional cloning of cDNAs and then sequencing from the 5’ or 3’ end of the 
transcript. The 5’ sequencing strategy is useful for identifying coding regions 
within genes, primarily because the majority of cloned cDNAs are truncated 
(Williamson 1999). In contrast 3’ sequences span the 3’ untranslated region 
(UTR), which is more transcript specific due to less evolutionary conservation in 
such non-coding regions. These databases allow for selection of genes associated 
with a particular function or cell type. The ESTs representing these genes can 
also be used as a starting point for synthesis of PCR primers or hybridisation 
probes for further investigation.
Initially EST sequencing was one of the most important methods for discovery 
of novel genes, currently this data is useful in predicting gene coding regions and 
splice variants from genomic data and for showing tissue expression profiles for 
particular genes. The drawback is that in order to represent all transcripts within 
a cell, many thousands of clones must be sequenced. EST sequencing is 
therefore an expensive and laborious procedure and, in the genomic era, has been 
superseded to an extent by more efficient methods.
Differential hybridisation and subtractive cloning
Probing a single cDNA library with two or more radioactive cDNA samples can 
allow the identification of variation in gene expression in different physiological 
settings. Comparison of the hybridisation patterns allows clones with different 
signal intensities to be identified. This comparative hybridisation method 
requires a good cDNA library and tends to be biased towards abundantly 
expressed transcripts. As a technique it foreshadows the later development of 
identifying differentially expressed genes tlirough the use of cDNA arrays.
Subtractive hybridisation takes a different approach by hybridising single 
stranded cDNA from one sample (tester sample) to an excess of RNA from
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another sample (driver sample) followed by the isolation of the unhybridised 
tester strands. These strands, following purification and amplification, could then 
be used to identify cDNAs that were more abundant in the tester than in the 
driver.
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Differential Display
This technique involves two basic steps; reverse transcription of a subset of total 
cellular mRNA using a set of 3’ anchored primers; and then PCR amplification 
using the same 3’ primers and an arbitrary set of 5’ primers. Approximately 30 
upstream randomly selected 5’ primers are thought to be sufficient to amplify all 
of the mRNA species in any one tissue. Multiple samples can then be amplified 
in parallel, resolved by electrophoresis and visualised. Differences in the pattern 
of PCR products will reflect differences in the gene expression profile of the 
samples.
GeneCalling
This is a modification of the differential display technique requiring cDNA 
generation from ploy A (+) mRNA of the tissue samples, digestion with 
restriction enzymes, PCR amplification with specific linkers, and identification 
of differentially expressed fragments by polyacrylamide gel electrophoresis. 
Fragments can be tentatively identified by comparison against sequence 
databases.
DNA Arrays and microarrays
DNA arrays and microarrays simply consist of thousands of cDNA clones or 
oligonucleotides, usually of known identity, attached to filters or slides which 
can be hybridised with flourescently labelled cDNA reverse transcribed from the 
tissue of interest. The fluorescent signal intensity represents the abundance of 
mRNA molecules in the tissue, which are hybridised to the array as cDNA. 
Unlike SAGE, differential display, or subtractive hybridisation, hybridisation to 
a specific spot on the array is immediately interpretable if the identity of the 
sequence was known when the array was constructed. If the clone was an EST,
bio informatics and sequence extension software can often identify the gene of 
interest without further cloning or sequencing. Wliile the chief limitation of this 
method is that it is only able to identify those genes present on the array, it holds 
the advantage of being less technically challenging, and less expensive, and can 
thus be used to analyse more samples in less time than SAGE (as discussed 
below).
The use of microarrays as genome wide tools to elucidate the expression profiles 
of genes is increasing (for example Chuaqui et al 2002, Yengi 2005, Liew 2005). 
However technical difficulties involve the requirement for highly concentrated 
RNA samples with 50-200pg or 2-5pg polyA+ RNA required (Duggan et al 
1999). Additional problems are cross hybridisation (Chuaqui et al 2002), the 
reproducibility of assays, and the development of efficient procedures to handle 
the multitude of data points produced in each individual experiment (Yang et al 
2002).
The comparibility of SAGE and microarray data has been assessed (Evans et al
2002) and results showed that detectability on arrays improved with increasing 
tag abundance (as discussed below a SAGE tag is effectively the same as an EST 
clone) with 90% of those genes in the most abundant range in a rat hippocampal 
SAGE library being detected efficiently by array. Wlien the data was extended to 
cover the full complement of over 28,000 unique SAGE tags present within that 
library, this figure dropped to less than 30%, as many of the genes expressed 
were of low abundance. This emphasises the value of using SAGE to identify 
transcripts present in low abundance. SAGE does not depend on a knowledge of 
gene sequence and will detect all genes expressed in a tissue, including many 
genes which are not currently characterised and not present on microarrays. The 
value of SAGE is immeasurable in its use to generate an initial picture of the cell 
transcriptome in a particular tissue or phenotypic state, with the subsequent use 
of microarray technology utilising this data to design tissue- or state-specific 
arrays for more efficient evaluation of large numbers of samples being perhaps 
the most efficient approach, and one that has already been utilised in the analysis 
of the expression of 516 genes in malignant ovarian cancer (Sawiris et al 2002)
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3,1.2 Serial Analysis of Gene Expression
Developed by Velculescu et al 1995 this technique differed from others in its 
ability to quantatively and simultaneously provide analysis of the transcriptome 
of a particular cell type at any given time without restriction to known genes. 
The application of this technique has provided valuable information about the 
normal and or diseased physiological state in many tissues or organisms 
including yeast (Velculescu et al 1997), pancreas, colon (Zhang et al 1997), lung 
(Hibi et al 1998), monocytes, macrophages (Hasimoto et al 1999b), kidney 
(Virion et al 1999), oocyte (Neilson et al 2000), liver (Yamashita et al 2000), 
thyroid (Pauws et al 2000) and testes (O’Shaughnessy et al 2003).
SAGE strategy involves the collection of short 10-14bp tags of mRNA 
transcripts, which have undergone reverse transcription and serial analysis 
(figure 3.1). Each tag contains sufficient information to identify a unique 
transcript provided it has been isolated from a defined position within the 
transcript. Each SAGE tag is prefixed by the anchoring enzyme restriction site 
and corresponds to a 10-11 bp extension of the 3’most site in the cognate 
transcript. This technique has the potential to both identify (by comparison with 
cDNA databases) and quantify expressed genes. Tags can be matched to 
characterised cDNA sequences and EST sequences, or they may have no match 
as in the case of novel genes. In theory the variety provided by the 4^  ^possible 
combinations of these lObp sequences is sufficient to identify all expected 
transcripts from the mouse genome. The major advantage offered by this method 
is the collection of tags from unknown as well as characterised sequences and its 
ability to detect unknown genes meaning there is no restriction to knowledge- 
driven analysis. The technique also provides quantitative information about the 
relative expression of such genes and permits comparison of gene expression 
under different conditions
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Figure 3.1 Schematic representation of Serial Analysis of Gene Expression 
(SAGE). Messenger RNA is extracted, reverse transcribed with a biotinylated d(T) 
primer, converted to double stranded cDNA then digested using Nlalll. 3’ 
fragments of this digestion are recovered using strepavidin beads, linkers annealed 
to cut ends, then tags released by BSM FI digestion. Tags are ligated to from 
ditags flanked by linkers and amplified using PCR. Tags are then excised by Nlalll 
digestion, gel purified, concatenated and cloned into plasmid vector (Pzreo) for 
later insert selection and sequencing.
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The initial step in SAGE analysis is the extraction of mRNA and synthesis using :
biotinylated oligo (dt) primer of double stranded cDNA. The cDNA is then 
cleaved using a restriction endonuclease, in this case NIa III with a 4 bp 
recognition site -CATG- cleaving on average every 256bp. Binding to |
streptavidin beads then isolates the cleaved cDNA (figure 3.1). This isolates a 
unique site on the transcript corresponding to the closest NIa III restriction site to 
the polyadenylate tail. The cDNA sample is then split and each sample bound to 
one of two linkers containing a restriction enzyme site, which allows cleavage at
' -t:a defined distance away from the recognition site. Cleavage with this tagging 
enzyme releases linkers with short attached pieces of cDNA (figure 3.1). These 
two pools of released tags can then be ligated to each other and then serve as 
templates for PCR amplification using linker-specific primers. The PCR 
products are ditags flanked by sites for the anchoring enzyme. Cleavage with this 
enzyme (NIa III) releases ditags, which can then be concatenated by ligation, 
cloned and sequenced (figure 3.1).
Several authors have developed variations on SAGE to resolve some of the 
technical problems of the procedure. The requirement for a relatively high 
amount of starting mRNA has been bypassed by MicroSAGE (Datson et al 
1999), a simplified one tube procedure allowing analysis of microdissected 
samples, and SAGE-Lite, ( Peters et al 1999, Virion et al 1999). Minimising the 
contamination of linkers by use of biotinylated PCR primers and their 
subsequent removal with streptavidin beads (Powell 1998) and increasing the 
efficiency of the final concatamerisation by the introduction of a heating step 
(Kenzelmann and Muhlemann 1999) have both improved the tag yield. The 
newer LongSAGE method (Saha et al 2002) can distinguish 4^  ^different tags, a 
number sufficient to be virtually unique even within the whole genome.
There are now 209 mouse SAGE libraries containing over 16 million 
(corresponding to 1536012 million unique transcripts) SAGE tags of mouse 
origin in the SAGE database
('http://www.ncbi.nlm.nih.gov/SAGE/index.cgi7cmd -printstatsf.
Among the negative aspects of the SAGE technique are the limitations due to the 
short tag length generated and a failure of a tag to match and uniquely identify
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sequences in SAGE reference databases especially if it is situated in a conserved 
region (Ishii et al 2000, Kannbley et al 2003). Further analysis of unknown tags 
can be carried out using an RT-PCR method utilising the identified tag 
sequences and oligo-dT as PCR primers, the main disadvantage of this is the 
shortness of the 5’ tag-derived specific primer and the common nature of the 3’ 
primer to all mRNAs.
The identification of novel transcripts and genes from unknown SAGE tags has 
been elegantly demonstrated by Chen et al (2002), who showed that 67% of the 
umnatched SAGE tags examined in their study originated from novel transcripts 
that did not match existing ESTs. The extension of 17 of these tags to full-length 
cDNAs confirmed that these tags were derived from authentic transcripts and not 
genomic contamination or sequencing error. Importantly the majority of these 
sequences did not match any existing ESTs or predicted exons suggesting they 
may be indicative of novel genes.
1
3.1.3 Using Gene Expression Data.
The above techniques do little more than associate specific genes with specific 
cell types or physiological situations. They cannot suggest functional roles for 
the encoded proteins, and neither do they address the multiple levels of 
regulation that lie downstream of transcription. For the identification of genes of 
known function in another tissue extrapolation from previous work can be useful 
in determining function, while for novel genes the only basis for analysis is often 
the degree of homology to known genes. The sequence and number of tags can 
be archived electronically, and matched against several available databases to 
determine the significance of the genes expressed therein. Because SAGE data 
represents absolute expression levels of a gene, where each transcript is 
individually counted, cumulative data can be generated and comparisons 
between libraries remain valid over time. In this way SAGE data is sometimes 
described as ‘digital’ data.
The archive of SAGE data is maintained by the National Centre for 
Bioinformatics (NCBI) who have assigned unigene clusters to SAGE tags and
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have numerous SAGE libraries available for study at 
http:www.ncbi.nih.gov/SAGE. The libraries reported in this thesis are available 
as GSM 30721 and GSM 30722. Libraries can be compared and significant 
differences between them re-evaluated and confirmed experimentally, allowing 
determination of those genes which have tissue-specific and, therefore, function- 
specific expression patterns.
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3.2 Current detailed SAGE protocol
All work required during construction and analysis of the SAGE libraries 
described here was performed by myself with the exception of the generation to 
ditag stage of the first (PMSG-treated) SAGE library (carried out by Prof. P. 
O’Shaughnessy). The concatention, cloning and sequencing of the PMSG library 
was performed by myself as was all work relating to the hCG library. In addition 
to the 2 SAGE libraries reported here I have subsequently generated 3 other 
libraries to sequencing stage.
Extraction of mRNA and generation of cDNA (Figure 3.1, Stage 1)
Tissue collection
Granulosa cells were collected from stimulated follicles (PMSG or PMSG/hCG) 
by follicle puncture in Dulbecco’s MEM (Invitrogen, UK), as previously 
described (Chapter 2). Cells were spun at 350g for 2minutes, the supernatant 
removed and the cell pellet stored at -70°C until use.
RNA Extraction
The cell pellet was resuspended in 400pl Trizol (Invitrogen, UK) and incubated 
at room temperature for 5 minutes. 80pl chloroform was added to the sample, 
which was then vortexed for 15 seconds and incubated at room temperature for a 
further 3 minutes. This was centrifuged at 12,000g for 5 minutes at 4°C. The 
aqueous supernatant was removed and retained. Ipl 2% glycogen and 250pl 
isopropanol was added to the aqueous phase and then this mixture incubated for 
20 minutes at room temperature. Centrifugation for 10 minutes at 12,000g at 4®C 
was subsequently performed. The supernatant was discarded and the pellet 
washed in 600pl 75% ethanol, vortexed and recentrifuged at 14,000g for 15 
minutes at 4°C. The supernatant was again discarded and the pellet dried and 
resuspended in 50pl rtH20.
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mRNA Isolation
This technique was performed using the Oligotex mRNA Spin-Columns 
(Qiagen, UK). The 50pl sample prepared above was made up to 250pl in rtHzO |
and 250pl buffer QQB (20mM Tris-Cl pH 7.5, IM NaCl, 2mM EDTA, 0.2%
: ' r
SDS) and 15pl Oligotex suspension (10% suspension Oligotex particles, lOmM 
Tris-Cl pH 7.5, 500mM NaCl, ImM EDTA, 0.1% SDS, 0.1% NaNz) and 
incubated at 70°C for 3 minutes to disrupt the secondary structure of the RNA.
This was then allowed to cool at room temperature for 10 minutes, permitting 
hybridisation of the oligo dT30 of the Oligotex particle and the poly-A tail of the 
mRNA. Centrifugation for 2minutes at 14,000g was performed and the 
supernatant removed and discarded. The pellet was resuspended in 400pl buffer 
OW2 (lOmM Tris-Cl pH 7.5, 150mM NaCl, ImM EDTA) by pipetting, added to 
a spin column and centrifuged at 14,000g for 1 minute. The flow-through was 
discarded, the spin column transfered to a new tube and 400pl buffer OW2 
added before centrifugation for 1 minute at 14,000g and then discarding the 
flow-through. The spin column was transferred to a new tube and lOOpl buffer 
OEB (5mM Tris-Cl, pH 7.5), prewarmed to 70°C, added and pipetted to 
resuspend the resin before centrifugation for 1 minute at 14,000g. Another lOOpl 
of prewarmed buffer OEB was added to the spin column and the procedure 
repeated.
The 200pl volume of mRNA was precipitated in 1ml 100% ice-cold ethanol by 
addition of 50pl 5M ammonium acetate and 3 pi RNAase free glycogen 
(Invitrogen, UK) and incubation overnight at -IQPc.
This was centrifuged at 18,000g for 15 minutes at 4^C. The aqueous supernatant 
was removed and discarded and the pellet washed in 500pl 70% ethanol, 
vortexed and recentrifuged at 14,000g for 5 minutes at 4°C. The pellet was again 
washed in 500pl 70% ethanol, vortexed and recentrifuged at 14,000g for 5 
minutes at 4“C. The supernatant was then discarded and the pellet dried and 
resuspended in 25pi rtH2 0 .
105 ::
106
Reverse transcription and double stranded cDNA synthesis.
This was performed using the Superscript Double Stranded cDNA Synthesis Kit 
(Invitrogen, UK) according to the following protocol.
5pl Oligo dT primer (biotin [dTJig) was added to the 25pi mRNA sample 
prepared above and heated to 70®C for 10 minutes. lOpl 5x First strand buffer 
(200 mM Tris-HCl, pH 8.4, 500 mM KCl), 5pl O.IM DTT and 2.5pl lOmM 
dNTPs were then added to the reaction mix, this was vortexed and pulse 
centrifuged before heating to 45”C for 2 minutes. 2.5pl of Superscript II reverse 
transcriptase was added and then the reaction vessel placed in a 45°C waterbath 
for 30 minutes. Another 2.5pl of Superscript II reverse transcriptase was added 
and reaction temperature maintained at 45”C for a further 30 minutes before |
placing on ice.
For second strand synthesis 227.5pi DEPC water was added straight to the 
reaction followed by 75pl 5x second strand buffer (250 mM Tris-HCl (pH 8.3),
375 mM KCl; 15 mM MgCh), 7.5pl lOinM dNTPs, 2.5pl E.coli DNA ligase 
(lOiu/pl), lOpl E.coli DNA polymerase I (lOiu/pl) and 2.5pl E.coli Rnase H 
(2iu/pl) to produce a total volume of 375pi. This was vortexed gently and 
incubated for 2 hours at 16°C. Following this 5 pi (5iu/pl) T4 DNA polymerase 
was added and the incubation continued at 16®C for a further 15 minutes. The 
reaction tube was placed on ice and lOpl of EDTA 0.5M added to the reaction 
mix. Phenol:chloroform:isoamyl alcohol (25:24:1) (375pi) (Invitrogen, UK)was 
added to the reaction which was then vortexed and centrifuged at 18,000g for 20 
minutes and the supernatant then removed and retained. lOOpl LoTE was added 
to the reaction which was again vortexed and centrifuged at 18,000g for 5 
minutes. The supernatant was collected and combined with the previous batch.
To the combined supernatant 3pi 2% glycogen, lOOpl 5M ammonium acetate, 
and 1ml 100% ethanol was added and the reaction stored at -70^C for 24 hours to 
precipitate the cDNA. This was centrifuged at 18,000g for 15 minutes at 4*^ C.
The aqueous supernatant was removed and discarded and the pellet washed in 
500pl 70% ethanol, vortexed and recentrifuged at 14,000g for 5 minutes at 4“C.
The pellet was again washed in 500pl 70% ethanol, vortexed and recentrifuged
at 14,000g for 5 minutes at 4°C. The supernatant was then discarded and the 
pellet dried and resuspended in 173 pi LoTE.
NIa III digestion
The 173pi sample prepared above was combined with 20pl lOx buffer IV 
(20 mM Tris-acetate, 50 mM potassium acetate, 10 mM magnesium acetate, 
1 mM dithiothreitol, pH 7.9), 2pi lOOx bovine serum albumin (BSA lOmg/ml), 
and 5pi NIa III restriction enzyme (all New England Biolabs) and incubated for 
1 hour at 37°C. 200pl of phenol:chloroform:isoamyl alcohol (25:24:1) 
(Invitrogen, UK) was then added and the mixture vortexed and centrifuged at 
18,000g for 20 minutes. The supernatant was removed and retained. lOOpl LoTE 
was added to the phenol:chlorofonn:isoamyl alcohol which was again vortexed 
and centrifuged at 18,000g for 5 minutes. The supernatant was collected and 
combined with the previous batch.
Approximately 280pl of supernatant was recovered and precipitated with 3 pi 
glycogen, 75pl sodium acetate 3M, pH5.2, and 360pl isopropanol. The mixture 
was left on ice for 15 minutes then centrifuged at 18,000g for 15 minutes. The 
aqueous supernatant was removed and discarded and the pellet washed in 500pl 
70% ethanol, vortexed and recentrifuged at 14,000g for 5 minutes at 4°C. The 
pellet was again washed in 500pl 70% ethanol, vortexed and recentrifuged at 
14,000g for 5 minutes at 4°C. The supernatant was then discarded and the pellet 
dried and resuspended in 20pl LoTE.
Binding to magnetic beads
lOOpl of magnetic beads (Dynabeads, Dynal) was added to 2 separate tubes, the 
beads were washed with 200pl Ix binding and washing (B+W) buffer (5mM 
Tris-Hcl pH 7.5, 0.5mM EDTA, ImM NaCl), and the tubes then placed in 
magnetic holders to retain the beads while removing and discarding the buffer. 
lOOpl 2x B+W buffer, 90pi rtH^O, and lOpl of the cDNA sample prepared above 
were added to each tube, the beads resuspended and the reaction kept at room 
temperature for 30 minutes with intermittent mixing. The beads were then 
washed 3 times with 200pl Ix B+W buffer and once with 200pl LoTE.
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Linker Sequences 
Linker A
TTTGGATTTGCTGGTGCAGTACAACTAGGCAATATAGGGACATG 
CCTAAACGACCACGTCATGTTGATCCGTTATATCCCT
Linker B
TTTCTGCTCGAATTCAAGCTTCTAACGATGATCGGGGACATG 
GACGAGCTTAAGTTCGAAGATTGCTACTAGCCCCT
The beads were washed with Ix B+W buffer eight times, and twice with Ix 
buffer IV (New England Biolabs).
Release o f cDNA using tagging enzyme (BSM FI)
The beads were resuspended in 97pl Ix buffer IV, Ipl lOOx BSA and 2pi BSM 
FI (all from New England Biolabs) added and incubated at 65“C for 1 hour and 
both reactions mixed regularly. The magnetic holders were used to retain the 
beads to allow the removal and retention of the supernatant. 
lOOpl of phenolxhloroform.'isoamyl alcohol (25:24:1) (Invitrogen, UK) was 
added to the superantant which was then vortexed and centrifuged at 18,000g for 
10 minutes. The supernatant was removed and retained. lOOpl LoTE was added 
to the phenol : chloroform :isoamyl alcohol which was again vortexed and 
centrifuged at 18,000g for 5 minutes. The supernatant was collected and
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Ditag Generation (Figure 3.1 Stage 2)
Ligation o f linkers to cDNA
29pl of LoTE was added to each tube to resuspend the beads and then 1 pi of 
linker A was added to tube A and Ipl of linker B to tube B (linkers at 
200pmol/pl concentration). 8pi 5x ligase HC buffer(250 mM Tris-HCl (pH 7.6), 
50 mM MgCU, 5 mM ATP, 5 mM DTT, 25% (w/v) polyethylene glycol-8000; 
Invitrogen, UK) was then added to each tube. The tubes were warmed to 50‘’C 
for 2 minutes and then placed at room temperature for 15 minutes. 2pi of T4 
Ligase HC (Invitrogen, UK) was added to each tube and both tubes incubated for 
2 hours at 16”C while mixing the reaction solution and beads intermittently.
i ï i î a :
combined with the previous batch and precipitated using 3pi glycogen, lOOpl 
sodium acetate 3M, pH5.2, and 900pl cold 100% ethanol at -70”C for 3 hours 
and then centrifugation at 18,000g for 15 minutes. The aqueous supernatant was 
removed and discarded and the pellet washed in 500pl 70% ethanol, vortexed 
and recentrifuged at 14,000g for 5 minutes at 4°C. The pellet was again washed 
in 500pl 70% ethanol, vortexed and recentrifuged at 14,000g for 5 minutes at 
4®C. The supernatant was then discarded and the pellet dried and resuspended in 
8pi LoTE.
Blunt ending and ligation
This was carried out using the Takara blunt ending and ligation kit (Takara 
Minis Bio, Madison, USA) according to following protocol.
To the 8pi sample Ipl lOx blunt ending buffer was added and the mix warmed to 
37°C for 5 minutes before cooling at room temperature for a further 5 minutes. 
Ipl T4 DNA polymerase was added to the solution which was left at room 
temperature for 10 minutes before being placed on ice. 40pl of ligase solution A 
and lOpl of ligase solution B were added and the reaction incubated overnight at 
16°C. Following this the total reaction volume was increased to lOOpl using 
LoTE.
:
Ditag Amplificaiton (Figure 3.1, Stage 3)
Polymerase chain reaction o f SAGE template
pi Cycling parameters
MgCl2 [25mM] 1.5
1 Ox buffer* 3 95°C for 1 minute
dUTP [20pmol] 0.3 Then 24 cycles of :
Primer A [lOOpmol] 1 95T for 20 seconds
Primer B [lOOpmol] 1 60“C for 20 seconds
Taq (5iu/pl)* 0.3 72T for 2 minutes
H2O 21.9
Template 1 Then 4 T  hold
( *  Abgene, UK. lOx buffer com position 750m M  Tris-HCl pH 8 .8 ,200m M  (NH4)2SO4 0.1% (v/v) TW EEN 20)
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This lOOjxl sample was used as a PCR template to bulk up the dltags. Samples 
were prepared at dilutions of 1/10, 1/50 and 1/200 and used as templates for the 
above PCR protocol, one non template control was included with each reaction
pi Cycling parameters
MgClz [25mM] 2.5
lOx buffer* 5 95°C for 1 minute
dUTP [20pmol] 0.5 Then 24 cycles of :
Primer A [lOOpmol] 0.6 95°C for 20 seconds
Primer B [lOOpmol] 0.6 60°C for 20 seconds
Taq (5iu/|Lll)* 0.5 72°C for 2 minutes
H2O 40.1
Template 0.2 Then 4*"C hold
(* A b g en e , UK. lOx buffer com position 750inM  Tris-HCl pH 8 .8 ,200m M  (NH4)2SO4 0.1% (v/v) TW EEN 20)
The PCR product was run on a 12% PAGE gel alongside lOObp ladder at 120V 
for 3 hours, stained by washing in ethidium bromide solution (6pl ethidium in 
250pl Ix TAB) for 15 mins and then rinsed in Ix TAB for 15mins, The lOObp 
band was visualised cDNA under uv light and excised from the gel and the 
eluted using the electrolavage protocol (discussed later).
70bp Bulk amplification
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Primer A 5 ’-TTTGCTGGTGCAGTACAACTAGGCAAT-3 ’
Primer B 5’-GCTCGAATTCAAGCTTCTAACGATGAT-3’
After completion of the PCR reaction the products were run on a 12% PAGE gel 
which was stained by washing in ethidium bromide solution (6pl ethidium in 
250pl Ix TAB) for 15 mins and then rinsing in Ix TAB for 15mins. The cDNA 
could then be visualised under uv light. The sample with the most well 
demarcated lOObp band was selected for bulk amplification.
lOObp Bulk amplification
Using the protocol below 95 PCR amplifications and 1 non template control 
were prepared
Using the protocol below 95 PCR amplifications and 1 non template control 
were prepared
pi Cycling parameters
MgCli [25mM] 2.5
lOx buffer* 5 95T for 1 minute
dNTP [20pmol] 0.5 Then 13 cycles of :
Primer 1 [lOOpmol] 0.875 95'^ C for 20 seconds
Primer 2 [lOOpmol] 0.875 53°C for 20 seconds
Taq (5iu/pl)* 0.3 72°C for 2 minutes
H2O 39.45
Template 0.5 Then 4°C hold
(* A b g e n e , UK. lOx buffer com position 750m M  Tris-HCI pH 8 .8 ,200mM  (NH4)2SO4 0 .1% (v/v) TW EEN 20)
Primer 1 5’-AACTAGGCAATATAGGGA-3’
Primer 2 5’-TCTAACGATGATCGGGGA-3 ’
The PCR product was run on a 12% PAGE gel alongside lOObp ladder at 120V 
for 3 hours, stained by washing in ethidium bromide solution (6 pi ethidium in 
250pl Ix TAB) for 15 mins and then rinsed in Ix TAB for 15mins, The 70bp 
band was visualised cDNA under uv light and excised firom the gel and then 
eluted using the electrolavage protocol (discussed later).
Nla III digestion o f 70bp product.
To lOOpl sample in LoTB 13pl lOx Buffer IV, 2pi lOOx BSA, and 13pl Nlalll 
(New England Biolabs) were added and the reaction incubated at 2>TC for 3 
hours. 30pl of loading buffer was combined with the reaction mixture and the 
sample run on a 12% PAGE gel alongside lOObp ladder at 120V for 3 hours. The 
gel was stained by washing in ethidium bromide solution (6pl ethidium in 250pl 
Ix TAB) for 15 mins and then rinsed in Ix TAB for 15mins, The 26bp cDNA 
band was visualised under uv light and excised from the gel and then eluted 
using the electrolavage protocol (discussed later).
Removal o f residual linker with streptavidin beads
The linker sequence can erroneously contribute to the SAGE library by 
contributing tags based on linker cDNA rather than sample mRNA. Althougli
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knowledge of the linker sequence means these tags can be easily recognised they 
may mask genuine SAGE tags which coincidentally possess the same or similar 
sequence. They may also reduce the efficiency of library sequencing since large 
proportions of linker based tags will be sequenced alongside genuine SAGE tags. 
Removal can be performed by using strepavidin coated magnetic beads with 
poly A oligonucleotides to adhere to the short poly T tail present on the linkers.
In order to carry this out lOOpl of magnetic beads (Dynabeads, Dynal) were 
placed in a 1.5ml eppendorf tube, washed with 200pi Ix binding and washing 
(B+W) buffer, and then the tube placed in a magnetic holder to retain the beads 
and allow buffer to be removed and discarded. The cDNA sample was added to 
the tube and left at room temperature for 15 minutes while mixing intermittently. 
Using the magnetic holder the suspension was removed and retained, and the 
beads washed with a further lOOpl LoTE. The wash was removed and combined 
with the suspension, made up to 450pl and precipitated in 1400pl 100% cold 
ethanol, 75pl sodium acetate 3M, pH 5.2, and 5pl glycogen at -70°C for 2 hours. 
The sample was centrifuged at 18,000g for 15 minutes. The aqueous supernatant 
was removed and discarded and the pellet washed in 500pl 70% ethanol, 
vortexed and recentrifuged at 14,000g for 5 minutes at 4^ *0. The pellet was again 
washed in 500pl 70% ethanol, vortexed and recentrifuged at 14,000g for 5 
minutes at 4°C. The supernatant was then discarded and the pellet dried and 
resuspended in 7pi rtH2 0 .
Concatamerisation, cloning and sequencing (Figure 3.1 Stage 4)
Concatamerisation
To the ditag suspension 2pi 5x ligase buffer was added along with 1 pi of DNA 
ligase HC (Invitrogen, UK). This was incubated at 16‘’C for 1 hour, a further Ipl 
of DNA ligase HC was added and the reaction incubated for 1 hour, a further Ipl 
of DNA ligase HC was again added and the reaction incubated for a final hour. 
The sample volume was increased to 25pl with LoTE, and warmed to 65°C for 
15 minutes and then cooled on ice for 10 minutes. 5pi loading buffer was added 
and the sample run on a 1% agarose gel at 150V for 35-40 minutes alongside
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lOObp ladder. The gel was visualised under uv light and the concatamer cDNA 
excised in two sections, from 200-800bp and above 800bp. Extraction was 
performed by electrolavage elution (described later) and the sample resuspended 
in 6pl rtH2Û.
Preparation o f pZERO vector
7pi rtH20 was added to Ipl lOx reaction buffer 6 (50 mM Tris-HCl (pH 7.4), 6 
mM MgCli, 50 mM NaCl, 50 mM KCl), Ipl pZERO vector (Ipg/pl) and Ipl 
SpH 1 (lOU/pl) restriction enzyme (All Invitrogen, UK). The sample was 
incubated at 37“C for 30 minutes, 20pl LoTE added and then warmed to 70”C for 
a further 20 minutes. Samples of cut and uncut vector were run on a 1% agarose 
gel to ensure complete cutting.
Ligation o f concatamers into vector
The 6pl concatenation product was combined with 2pi 5x ligase buffer, Ipl 
DNA ligase HC and Ipl opened pZERO vector. This was incubated at 16®C for 3 
hours then its volume raised to 200pl with LoTE and 200pl of 
phenol : chlorofbnn nsoamyl alcohol (25:24:1) (Invitrogen, UK) added. This was 
then vortexed and centrifuged at 18,000g for 10 minutes. The supernatant was 
removed and retained. Another 200pl of LoTE was added to the 
phenol:chloroform:isoamyl alcohol which was again vortexed and centrifuged at 
18,000g for 5 minutes. The supernatant was collected and combined with the 
previous batch and precipitated using 3pi glycogen, 50pl sodium acetate 3M, 
pH5.2, and 1300pl cold 100% ethanol at -70°C for 2 hours and then centrifuged 
at 18,000g for 15 minutes. The aqueous supernatant was removed and discarded 
and the pellet washed in 500pl 70% ethanol, vortexed and recentrifuged at 
14,000g for 5 minutes at 4^C. The pellet was again washed in 500pl 70% 
ethanol, vortexed and recentrifiiged at 14,000g for 5 minutes at 4*^ C. The 
supernatant was then discarded and the pellet dried and resuspended in lOpl 
LoTE.
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Transformation o f cells
The vector was inserted into DHIOB E.co/z cells (Invitrogen, UK) by 
electroporation at 2.5V in a electroporation cuvette (Invitrogen, UK). Ipl DNA 
was added to 40pl cells defrosted on ice, electroporated, and cells transferred to l/
1ml SOC medium (Invitrogen, UK). The SOC/cell suspension was incubated at 
37”C for 1 hour, shaking at 220rpm. Cells were then plated out on low salt agar 
plates (lOg/L tryptone, 5g/L NaCl, 5g/L yeast extract, 5g/L agar; all Sigma- 
aldrich, UK) containing Zeocin (Invitrogen, UK) at 50pg/ml and cultured 
overnight at 37°C.
Colony PCR and insert selection
PCR was performed using the M13R (5’-GAATTGTAATACGACTCACT-3’) 
and pZERO (5 ' -TC AC AC AGGAAAC AGCTATGA-3 ' ) primers as described 
previously. PCR product was run on a 1 % agarose gel and PCR products greater 
than 400 bp selected for sequencing. Empty vector was 217 bp in size meaning &
that insert sizes of approximately 200 bp and above were chosen to maximise 
sequencing efficiency.
Sequencing o f concatamers
This was performed using the P zero primer as previously described.
I
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3.3 Methodological alterations required for successful SAGE
During work on this project four main problem areas developed with the original 
protocol and required consideration to improve efficient production of the SAGE 
libraries. Firstly, linker release by Nla III cutting of the genuine 70bp PCR 
product was inefficient and unreliable. Secondly, during production of the 
second library we experienced a problem with preferential amplification of a 
spurious 70bp product without the CATG cutting sites. Thirdly, extraction of any 
of the DNA products fi-om PAGE gels, but especially the 26bp band, using 
standard techniques proved problematic and inefficient. Finally, 
concatamerisation and cloning was subject to an element of chance, with a 
fi*equent occurrence of high background levels of empty vector. The approaches 
used to address these issues shall now be described.
3.3.1 Failure of restriction enzyme digestion
Inefficient Nla III digestion of amplified PCR product (figure 3.1, stage 3) 
created a substantial loss of amplified ditags due to complete or partial failure of 
linker release and subsequent discarding of poorly digested product during gel 
purification. This problem arose due to two factors, the first was solved with the 
use of PAGE gel purification of the cDNA substrate, the second by PCR 
selection, through specific primer design, of sequences containing the Nla III 
recognition site
3.3.1.1 PAGE gel purification
Inefficient Nla III digestion was encountered during construction of the first 
SAGE library (figure 3.1, stage 3). This is a problem previously reported by 
others (Angelastro et al 2000). The ditag yield from this reaction was frequently 
so poor as to preclude successful attempts at concatmerisation. The original 
protocol (Velculescu et al 1995, Angelastro et al 2000) required the Nlalll 
digestion of PAGE gel purified 102bp ditag and linker cDNAs. Angelastro et al 
(2000) suggested that the inhibition of Nla III action was the result of soluble
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contaminants carried over from the PAGE gel purification of the 102 bp cDNA, 
and developed two protocols which solved this problem. Firstly by binding the 
cDNA to a fused silica membrane, followed by washing and subsequent elution 
(Qiaquick Kit, Qiagen), secondly by removal of contaminants with
centrifugation gel filtration (Clontech spelO spin gel filtration columns) in both 
cases using commercially available apparatus.
Interestingly this was at odds with our own experience. No PAGE gel separation 
or purification was initially required in our technique since we utilised a nested 
70bp PCR reaction to further amplify the ditag pool prior to Nla III digestion. 
Our own protocol incorporating this nested PCR reaction required 
phenol/chloroform/isoamyl alcohol purification of the PCR reaction, followed by 
ethanol precipitation and resuspension in Ix buffer IV prior to Nlalll cutting. 
Consequently PAGE gel interference with restriction enzyme function should 
not have arisen. Despite this we also encountered unreliable Nlalll digestion. 
Similarity, our attempts to improve Nlalll performance by using commercial 
purification kits were equally unsuccessful. The Nucleotrap Gel Extraction Kit 
(BD Biosciences, UK) allows extraction of DNA molecules greater than 20bp in 
size from gels and aqueous solutions via reversible matrix binding allowing 
elution of nucleic acid in low volumes of low salt buffer. This kit was used 
according to manufacturers instructions to attempt purification of the 70 bp PCR 
product to improve subsequent restriction enzyme activity. No consistently 
improved results were noted. Typical Nla III performance after using these 
methods is demonstrated by the PAGE gels in figure 3.3
We eventually found that, in complete contrast to Angelastro et al, purification 
of the 70bp band by running in and extracting from a 12% PAGE gel 
consistently resulted in successful cleavage of the band in question. This step 
was therefore adopted as an additional stage routinely performed on the PCR 
product prior to attempting Nla III cleavage. To date near complete Nla III 
digestions have been successfully performed on all sequences containing the 
CATG recognition site using this method.
Figure 3.4 demonstrates Nla III digestion products from PAGE gel purified PCR 
products.
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3.1.1.2 Spurious 70bp sequence.
The PMSG/hCG treated SAGE library also experienced problems with Nla III 
digestion (figure 3.1, stage 3) due to the preferential amplification of a spurious 
70bp band containing linker sequence at either end but no CATG recognition 
sites. This band was cloned into TOPO TA vector (Invitrogen, UK) and 
sequenced, all clones yielding the same sequence.
The sequence contained between the linker sequences (underlined) does not 
contain the CATG cutting site and does not match any of the tag sequences 
produced in the SAGE libraries. Elimination of this sequence was achieved by 
extending the PCR primers to incorporate the first C base of the CATG 
sequence. The failure of the last base to hybridise prevents primer extension by 
the polymerase and thereby stopped replication of this particular sequence and 
allowed unhindered amplification of the ditag containing sequences.
Interestingly others (Du et al 2003) have proposed using primers containing the 
full CATG recognition sequence for ditag amplification. While this undoubtedly 
improves the efficiency of subsequent Nlalll digestion by eliminating 
polymerase errors within the recognition site, it does mean that any spurious 
sequence carried through into the PCR reaction will have recognition sites 
artificially inserted and can thus contribute erroneous tag sequence to the final 
analysis.
Figure 3.2 Spurious 70bp band sequence, primer sequences are underlined
AACTAGGCAATATAGGGATTGGATTTGCTGGTGCAGTACAACTAA
GGTCCCGATCATAGTTAGA
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10bp
ladder
10bp
ladder
100bp 
70 bp 
50 bp
30 bp 
20bp
Uncut 70bp band
Low level 
of Nla III 
digestion 
products
Nla III digested 
product
Digestion of 
phenol/chloroform 
purified 
PCR product
Digestion of 
Nucleotrap 
purified PCR 
product
Figure 3.3 Efficiency of Nla III digestion following differing substrate purification 
methods, namely Nucleotrap (BD Biosciences, UK) and phenol:chloroform extraction.
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10bp
ladder
10bp
ladder
Uncut 70bp band
Partially cut. single 
linker removed
Released ditag 
Released linker
Figure 3.4 Nla III digestion following purification and extraction of 70bp cDNA 
substrate in PAGE gel
10bp
ladder
Uncut 70bp band
No Nla III 
digestion 
products 
present
Figure 3.5 Unsuccessful Nla III 
digestion of spurious 70bp 
sequence.
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3.3.2 PAGE gel extraction
Our SAGE protocol requires 4 PAGE gel extraction steps. The first to purify the 
lOObp band from the initial PCR reaction, the second to purify the 70bp band 
prior to Nlalll digestion, the third to purify the ditags following Nla III digestion, 
and the fourth to allow size selection following the concatamerisation reaction. 
Three of these steps occur after the final PCR amplification. Our experience is 
that the relative recovery rates from acrylamide gels using the maceration and 
incubation steps as described in the original SAGE protocol are 40% for 
incubations carried out at 65oC and less than 25% for incubations carried out at 
around room temperature (room temperature incubations being required to 
prevent dissociation of small double stranded cDNA products). The consequence 
of this is that following the final 70bp PCR amplification only 40% recovery can 
be expected from the 70bp 12% PAGE gel, only 25% retrieval of this can be 
expected from the 26bp ditag purification (12% PAGE gel), and only 40% of this 
will survive the size separation of the concatamers (8% PAGE gel). If we are to 
optimistically assume 100% efficiency of the Nla III cut, and at least 50% of the 
ditags being incorporated into suitably sized concatamers, with no loss 
whatsoever in the various intervening phenol/chloroform/isoamyl alcohol 
extractions and ethanol precipitations, this still means that only 2% of the ditags 
produced by the final 70bp PCR amplification will survive to the cloning stage. 
This is clearly grossly inefficient and a major flaw in the SAGE procedure. Other 
separation and extraction methods were tried in order to improve this situation.
3.3.2.1 Agarose gel separation
Use of agarose gel as an alternative to PAGE to try to separate and purify the 
70bp and 26bp band from the PCR reaction and Nla III digestion respectively 
was, perhaps predictably, unsuccessful. Extraction can be easily performed using 
several commercially available kits but poor band separation and cross 
contamination of sequences between bands lead to the carry over of linker 
sequence into the subsequent stages, the importance of avoiding this carryover
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has already been explained. Use of 1% agarose was however adopted for the 
separation of concatamers due to the ease of DNA extraction using either the 
Nucleotrap (Clontech) or electroelution and lavage methods (as discussed 
below).
3.3.2.2 Electroelution extraction
The extraction of DNA from all gel types by electroelution is a well known 
method which has previously been employed in the SAGE protocol with success 
(Hayday laboratory, personal communication). Our own attempts at 
electroelution met with reasonable success with extraction of the 70bp PCR 
product, but very little success with the extraction of the 26 bp ditags. Two 
methods were employed, the first as recommended by the Hayday laboratory 
(personal communication) using dialysis tubing, the second using GeBA flex 
tubes (GeBA Ltd, USA).
The Hayday laboratory used the apparatus shown below to elute ditags firom 
polyacrylamide gel. Electrophoresis was performed at lOOV for 30 minutes in 
300pl Ix TAE buffer. The buffer was then removed and replaced before twice 
repeating the procedure. The 900pl of buffer was collected and precipitated.
Direction of 
electrophoresis
Clip Clip
Dialysis tubing
Gel slice
Figure 3.6 Hayday apparatus for ditag elution
Our own attempts with this model were moderately successful for elution of the 
102 bp and 70 bp band from acrylamide gel but failed completed to elute the 26 
bp ditags with total loss of ditags from the gel and the buffer, presumably due to 
penetration of the tags through, or into, the dialysis membrane.
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Dialysis_
window
GeBA flex 
tube
electrophoresis 
r
Gel slice
V Ix  TAE buffer
Figure 3.7 GeBA flex apparatus for eluting nucleic acids
3.3.2.3 Extraction by electroelution and lavage.
This method which I developed was based on the principle that the smaller 26bp 
DNA fragments are managing to penetrate or become embedded into the dialysis 
membrane during the electroelution. If these fragments could be continuously 
washed off the membrane surface by fluid currents within the elution buffer they 
should be retained within the buffer rather than lost through or into the tubing. 
The continuous drawing off and replacement of buffer would result in an 
excessive elution volume and so necessitated the constant recirculation of the 
elution buffer by means of a syringe attached to the dialysis tubing. The rather 
simple apparatus shown below was employed to this end.
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The GeBA flex system relied on the same electroelution principle. Using the 
apparatus shown (figure 3.7) the gel slice was exposed to lOOV for 15-30 >|
minutes. The polarity of the current was reversed for the last 60 seconds to 
release any nucleic acid that may have become embedded in the dialysis 
membrane.
Again this system was reasonably successful for the elution of 102 bp and 70 bp 
sized products but it failed to recover any of the 26 bp ditags.
Direction of
Ix  TAE buffer
Syringe 
^ n..T.7"T'T'T T T rr Gel slice
Dialysis tubing
C lip
Direction of 
e lect roptioresis
Figure 3.8 Apparatus for elution of nucleic acids from polyacrylamide gels.
The comparative yields of a control cDNA sample 217bp in size achieved by 
using the above methods is demonstrated visually by the PAGE gel shown in 
figure 3.9. A typical example of Nla III digestion of the 70 bp PCR product 
following electroelution and lavage is shown in Figure 3.10. This improvement 
in our ability to elute cDNA from PAGE gels was the principle factor in 
improving the ease and efficiency with which we were able to perform SAGE.
O  CO
Figure 3.9 Comparative yields of a 217 bp cDNA recovered from PAGE gel 
using incubation or electroelution methods.
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lObp
ladder
10bp
ladder
Uncut 70bp band
Partially cut. single 
linker removed
30 bp
20bp
Released ditag
Released linker
Figure 3.10 Typical Nla III digestion after using the electroelution and 
lavage technique for extraction of substrate from PAGE gels.
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3.3.3 Formation and selection of concatamers
The successful production of concatamers by ligating ditags end to end (figure
3.1 stage 4) is more complex than might be expected. The reaction set up is
straight forward but judging the correct reaction time to ensure the majority of 
concatamers are in the correct size range is difficult. The obvious solution of 
removing samples from the reaction mixture to check concatamer formation on 
an agarose gel substantially reduces the final volume of concatamers available 
for cloning. Equally the fonnation of secondary structure by the DNA molecules 
means the gels often run as smears rather than clear bands making size 
determination awkward. The possibility of capping of concatamers by ditags or 
short sequences (such as carried over linkers) with only one correct CATG 
binding site is also a real problem. The likelihood of this happening is increased 
by the intrinsic exonuclease activity of cDNA ligases. A final possibility is the 
circularisation of concatamers formed by the ligation of complementary CATG 
sites at either end of the ditag chain, in this event the product will not size 
correctly on gels and neither is it possible to clone it into vector. In order to 
minimise the occurrence of either truncated cDNA ends or circularisation the 
reaction time was kept to a maximum of 3-4 hours.
One possible solution to the problem is to set up a cloning reaction with the 
vector and ditags without a separate concatamerisation step. This was the 
solution adopted for the first PMSG stimulated SAGE library which on that 
occasion provided an acceptable result with approximately 50% of vector inserts 
being large enough to countenance sequencing. Unfortunately this method 
proved unreliable with the majority of the inserts usually being low size and after 
repeated attempts we reverted to performing concatamerisation for the second 
library.
3.3.3.1 Size selection for cloning
In order to maximise the efficiency of the final sequencing stage of SAGE, 
important since this is the most labour intensive and expensive part of the
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protocol, it is desirable that the final cloned insert should be within a suitable 
size region, ideally 400bp or greater. Our own efforts to separate concatamers 
where not as successful as we would have liked. Several commercially available
'■ rkits claim the ability to efficiently separate and purify DNA on the basis on |
molecular weight such as Nucleotrap (BD Biosciences) and CHROMA SPIN f
(BD Biosciences). The use of such apparatus to size select concatamers should in 1
theory improve the cloning and sequencing efficiency of SAGE. We attempted 
this with CHROMA SPIN-400 columns (BD Biosciences) which claim to purify 
and size select nucleic acids >600bp with a recovery rate of up to 90%. The 
columns were used according to the manufacturers protocol which involved 
prespinning at 700g for 5 minutes to remove buffer, loading the sample into the 
column and then centrifugation at 700g for 5 mins and collecting the eluted size 
selected cDNA. Smaller molecules should be retained within the matrix pores.
Subsequent cloning into pZERO (Invitrogen, UK) vector yielded an average 
insert length of 550bp, equivalent to 40 SAGE tags per insert. This is an 
excellent ratio but had to he offset against a disappointingly low yield of 
concatamers leading to only 23% of colonies containing inserts. Consequently 
although a viable method of size selection low insert yield from the subsequent 
cloning reaction rendered this an inefficient method.
Gel electrophoresis separation has been shown to yield an average concatamer 
size of only 137bp within the 700-1000bp fraction of the gel and the average 
concatamer size within a 700-2500bp fraction being only 287 bp (Kenzelmann 
and Muhlemann 1999). This anomaly can be explained by the aggregation of 
smaller fragments by hydrogen bonding leading to a communal migration as a 
larger unit. Equally the presence of inactivated enzyme molecules binding to 
cDNA fragments may cause slower migration. Although some of this effect can 
be alleviated by heating the concatamer sample prior to electrophoresis to disrupt 
secondary structure (Kenzelmann and Muhlemann 1999) it still remains a source 
of disruption of size selection. Gel separation does however have the 
considerable advantage that it at least retains the entire product within the gel 
and consequently a high proportion of the concatamers can be recovered
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following electrophoresis. It remains the preferred method for concatamer 
selection.
3.3.3.2 Cloning concatamers
Cloning inserts into vector presented a problem with a high incidence of 
apparently empty vector despite the use of suicide gene or hlue/white selection. 
Different vectors and cloning/selection methods were investigated to attempt to 
minimise this problem.
Suicide Selection
pZERO (Invitrogen UK) is the vector of choice due to ease of cloning, presence 
of a SpH 1 restriction endonuclease site allowing insertion of sequence 
containing a CATG overlap and the suicide selection method for eliminating 
empty vector. On numerous occasions using this vector we obtained a high 
proportion of empty vector containing colonies, indicating a high background of 
nonrecomhinant plasmids and a failure of suicide gene activation. Attempts to 
reduce this background by using calf intestinal alkaline phosphatase (Promega, 
USA) to dephosphorylate cut vector ends (carried out according to 
manufacturers instructions) did not produce any improvement in background 
levels of empty vector. Equally the length of the cloning reaction was varied 
from 2 hours to 24 hours without marked difference in the level of recombinant 
product. The occurrence of high levels of nonrecomhinant vector did appear to 
he associated with both individual hatches of vector and the increasing age of the 
vector batch. Examples of PCR amplification of vector inserts using the SAGE 
vector based primers on colonies produced from successful and unsuccessful 
cloning reactions are shown in figure 3.11.
Optimisation of the cloning reaction with regard to vector insert ratio is not 
easily achievable due to the highly variable sizes of the concatamers being 
cloned. Attempts were made to increase this ratio by carrying out a short 30 
second digestion of the concatamers with the SpH 1 restriction enzyme (8pi 
concatamers added to Ipl lOx reaction buffer 6 and Ipl SpH 1 restriction
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enzyme (All Invitrogen, UK). The reaction mix was incubated at 37°C for 30 
seconds, and then 20pl LoTE was added and the mix heated to 70®C for a further 
20 minutes.) This enzyme has the 6 base recognition site GCATGC which 
should digest 1 in every 16 CATG sites, thus shortening the concatmers and 
increasing the number of cDNA ends available to ligate into vector. No 
appreciable difference was produced in relation to reducing the number of 
nonrecombinant colonies using this method.
We did however investigate other cloning methods in an attempt to improve 
cloning efficiency.
100bp
ladder pZERO successful cloning reaction
100bp
ladder
eOObp
pZERO cloning reaction with high nonrecombinant level
600bp
Figure 3.11 Successful and unsuccessful pZERO cloning attempts under 
identical reaction conditions
Blue/white Selection
The apparent failure of the pZERO selection strategy to eliminate empty vector 
led us to attempt another method of selection, namely hlue/white selection. 
Increased efficiency with this method has been reported by Angelastro et al 
(2002). pGEM vector (Promega, USA) makes use of the lacZ blue/white 
selection to determine the presence of inserts. Unfortunately this proved no more 
successful than the pZERO system, with equal levels of empty and recombinant
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vector in both blue and white colonies, with the largest proportion of colonies 
containing nonrecomhinant vector.
TOPO TA Cloning System
The TOPO (Invitrogen, UK) range of cloning vectors utilise the bound 
topoisomerase attached to each end of the open vector to ligate the desired insert. 
Selection of cloned insert over empty vector is performed hy means of a suicide 
gene.
The pCR 4-TOPO vector (Invitrogen, UK) is supplied open with an A base 
overhang to permit cloning of PCR product. In order to use this vector the 
concatamers were added to a 30pl reaction volume containing taq polymerase 
(0.5U) and dNTPs (0.2mmol) (both Abgene, UK) before incubation at 72°C to 
fill the CATG site and leave only an adenosine base overhang. Cloning was then 
performed as per manufacturers instructions. This method was successful in 
eliminating the carryover of empty vector but unfortunately was not sufficiently 
productive for SAGE. Each cloning reaction yielded only 350-400 colonies, far 
short of the 5000 or more colonies required (based on an average yield of 10 
tags/insert) to produce a SAGE library of around 50,000 tags.
In conclusion successful pZERO concatamer cloning reactions are considerably 
more efficient than alternative vectors, yielding a far greater number of 
recombinants than TOPO and having a higher selection efficiency of 
recombinants than blue/white screening. The absence of the high number of non 
recombinants occurring with the pGEM and on occasions with the pZERO 
vectors when using the TOPO cloning system suggests that the incidence of 
failure of suicide gene selection may be related to the use of either SpH 1 to 
cleave the plasmid prior to cloning, or the subsequent use of DNA ligase to 
religate the plasmid.
The improvements to Nla III digestion and polyacrylamide gel extraction meant 
that it became easier to generate larger volumes of concatamers in a consistently 
repeatable manner. This means that generating concatamers for repeated cloning 
attempts on those occasions when pZERO cloning produced high levels of
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recombinant vector in the end proved not to be a significant problem. 
Consequently pZERO cloning was retained as the method of choice for the 
SAGE protocol, although this is not a particularly satisfactory resolution and 
refinement is still required.
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3.4 SAGE Results
The total number of tags sequenced in the PMSG library (treatment with PMSG 
alone) was 51,528 while the total number sequenced in the PMSG/hCG library 
(treatment with PMSG followed by hCG) was 53,696. The combined total of 
105,224 tags corresponded to 40,248 unique transcripts of which 9,877 were 
represented by 2 or more tags. Of the transcripts represented by more than one 
tag, 5689 were shared between both libraries, 1806 were unique to the PMSG 
library and 2382 were unique to the PMSG/hCG library (figure 3.12a). Using the 
chi-squared test to detect significant differences in tag abundance between those 
tags with greater than 5 transcripts present in the combined libraries, 499 tags 
were significantly up-regulated by hCG treatment while 216 tags were 
significantly down-regulated.
PMSG hCG
1,806 
t r a n s c r i p t s 2,383transcripts5,689
transcripts
Figure 3.12a. Venn diagram illustrating the distribution of the 9,877 
transcripts sequenced at least twice between both libraries
Comparison of the SAGE libraries was carried out using Microsoft Access and 
statistical calculations performed with Microsoft Excel. Statistical analysis using 
the Chi Squared test enabled identification of tags over-expressed within one 
particular library. In cases where tags matched to multiple sequences the identity 
of the l l ‘^  base was used where possible to differentiate between real and 
spurious matches.
Tables of abundant and differentially expressed tags were generated and tables 
of granulosa cell specific tags created by comparison with other available murine 
SAGE libraries (http://www.ncbi.nlm.nih.gov/projects/SAGE/). Tag
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identification was achieved using the SAGEmap ftp site 
(ftp://ftp.ncbi.nlm.nih.gov/pub/sage/) and tags of interest manually curated.
Matches were checked manually to ensure reliability.
Matched transcripts have been categorised, and are presented here, either based 
on abundance of expression in either or both libraries (table 3.1), significant 
differential expression (table 3.2), current knowledge of transcript function (table 
3.3), and uniqueness of expression to this cell type (tables 3.4 and 3.5).
7,'3.4.1 Abundant Tags
The 30 most abundant tags in the combined libraries are shown in Table 3.1, 
Three of this list are from the mitochondrial genome, 4 encode ribosomal 
proteins and a further 4 match to more than a single gene. Two tags have no 
match to known genes within the NCBI database and both of these tags show 
significant differential expression between the two libraries. This list contains a 
number of genes known to be highly expressed in granulosa cells or induced by 
gonadotrophic stimulation including 3|3 hydroxysteroid dehydrogenase, 
scavenger receptor IB (Ghersevich et al 1994, Rajapaksha et al 1997), connexin 
43 (Itahana et al 1996) and hyaluronidase 1 (Eppig 1979). If absolute abundance 
is to be taken as a measure of transcript importance for cellular function those 
genes identified will necessarily include a number of housekeeping genes such 
as those encoding metabolic enzymes and the protein synthesis apparatus, i.e. 
ribosomal components. In addition since this is a remodelling tissue we would 
expect transcripts responsible for products such as extracellular matrix 
components and for the maintenance of cytoskeletal structure. This is indeed the 
case although we also find within this group genes not previously associated 
with this cell type such as secreted phosphoprotein 1, and translationally 
controlled tumor protein 1.
Table 3.1 Top 30 most abundantly expressed transcripts present in the combined
libraries
Tag Sequence PM SG hCG Total U nigene Gene
GTGGCTCACA 878 564 1442 M ultiple matches
GCTGCCCTCC 566 409 975 104368 Ribosom al protein L32
A TACTG ACAT 321 391 712 Mitochondrial
T AATG TAG AC 405 116 521 4504 Gap junction membrane chamiel protein alpha 
1
10305 Hyaluronidase 1CCTTTAATCC 397 61 458
TTGCTGCCTT 39 410 449 M ultiple matches
TCGCTGCTTT 13 418 431 28327 RIKEN cD N A  2510049119 gene
TGGGTTGTCT 156 253 409 254  Tumor protein, translationally-controlled 1
TTGTTGCTAC 8 387 395 268000  Vim entin
A TA A T A C A TA 154 231 385 200362  Cytochrome b-245, beta polypeptide
TTGCTACTTT 6 367 373 M ultiple matches
AACTG AG GG G 49 306 355 233010  Prosaposin
A TG AC TG A TA 105 215 320 Mitochondrial
C AA ACACCG T 2 278 280 285918 Secreted phosphoprotein 1
G G TTAAATGT 56 206 262 930 Cathepsin L
A G C A A G A A TT 28 226 254 1061 Ferredoxin 1
CAG TCAATAC 212 30 242 Unknown
CAGGACTCCG 105 136 241 193096 Stearoyl-Coenzym e A  desaturase 2
A G G C A G A CA G 94 131 225 335315 Eukaryotic translation elongation factor 1 
alpha 1
TGGTTGCTGG 149 70 219 M ultiple matches
GCTCTGGGAG 152 56 208 140811 Hydroxysteroid dehydrogenase-1, delta<5>-3- 
beta
AGCAGTCCCC 94 101 195 Mitochondrial
A C TG A A G C A A 46 146 192 4603 Scavenger receptor class B , mem ber 1
TGACCCCGGG 112 72 184 43005 Ubiquitin A -52 residue ribosom al protein  
fusion product 1
GGCTTTGGTC 119 60 179 3158 Ribosom al protein, large, P 1
TGG TG TAG GA 83 93 176 918 RIKEN C D N A D 730039F16 gene
A AC AG G G CC A 13 159 172 324864 M us musculus transcribed sequences
CTAGTCTTTG 94 68 162 154915 R ibosom al protein S29
G A A A A TG A G A 133 28 161 315259 M us musculus transcribed sequences
GGATTTGGCT 107 51 158 14245 R ibosom al protein, large P2
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3.4.2 Abundant, differentially expressed SAGE tags
A total of 715 tags showed a significant difference in abundance between the 
two libraries of which 216 were significantly down-regulated by hCG and 499 
were significantly up-regulated. Table 3.2 lists the 35 most abundant tags which 
were shown to be differentially expressed between SAGE libraries by the Chi- 
squared test. Most of these tags match unambiguously to known genes and the 
majority of them are known to be expressed in granulosa cells during 
development such as the peptide hormones inhibin Bb and follistatin 
(O’Shaughnessy and Gray 1995, Jorgez et al 2004), or to show a change in 
expression after luteinization for example the steroidogenic components P450 
H a l, 17B-hydroxysteroid dehydrogenase type 1 and scavenger receptor class B 
type 1 (Oonk et al 1989, Ghersevich et al 1994, Rajapaksha et al 1997). This list 
also contains 13 tags which have no match, are linked to sequence of unknown 
function or have multiple assignments. In addition there are also a number of 
transcripts whose expression patterns have not been described previously during 
lutéinisation.
Among those highly upregulated by hCG are vimentin, an intermediate filament 
protein, developmentally regulated and found in cells of mesenchymal origin, it 
has been implicated in steroid synthesis via its function as a storage and transport 
network for lipid droplets containing cholesterol. (Runembert et al 2002, Evans 
1998). Leprecan, a basement membrane associated proteoglycan shown to have 
growth suppressor activity (Raul et al 2000). Secreted acidic cysteine rich 
glycoprotein (SPARC) is an upregulated transcript known to inhibit cell cycle 
progression, influence extracellular matrix interactions and to be strongly 
angiogenic (Sweetwyne et al 2004). Secreted phosphoprotein 1 can act as a 
cytokine and has multiple functions associated with cell growth, survival, 
proliferation and repair (Standal et al 2004). Prosaposin is involved in the 
lysosomal degradation of sphingolipids (Vaccaro et al 1999) and ferredoxin in 
electron transfers firom NADPH to cytochrome P450 in mitochondria (Liu and 
Chen 2002). Vanin 1 is a cell surface molecule thought to be involved in the 
migration of mesenchymal cells, particularly during thymic and gonadal
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development, and may be involved in follicular remodelling during and after 
ovulation (Bowles et al 2000, Aurrand-Lions et al 1996).
The functional distribution of the abundantly upregulated tags reflects accurately 
what is already known with regard to the changing functions of the 
differentiating granulosa cell with metabolic, steroidogenic, endocrine and 
paracine signalling, cytoskeletal and extracelluar matrix proteins all represented é
within this group.
The complete list of significantly differentially expressed tags that can be 
unambiguously matched to a single gene can be found in Appendix 1 with 
annotations describing gene function (functions described on the basis of 
infonnation contained in either the EMBL Harvester website 
thttp://harvester.embl.de/f or the Information Hyperlinked Over Proteins (IHOP) 
website thttp://www.pdg.cnb.uam.es/UniPub/iHOP/k Of the 715 differentially 
expressed tags 18% are unmatched, 11.6% match to uncharacterised transcripts, 
and a further 8.5% match to multiple genes (figure 3.12). The remainder match 
to characterised named sequences. The functional distribution of these 
significantly differentially expressed tags is shown in figure 3.13. Many genes 
have previously been described as having multiple or uncertain functions and 
consequently may appear in more than one category.
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Table 3.2 Top 35 significantly differentially expressed tags present in the combined
libraries.
Tag Sequence PM SG hCG U nigene Gene P V alue
TCGCTGCTTT 13 418 28327 RIKEN cD N A 4.04x10'®^
TTGTTGCTAC 8 387 268000 Vim entin 1.29x10'^^
TTGCTACTTT 6 367 M ultiple match 1.22x10"’^
TTGCTGCCTT 39 410 M ultiple match 2.71x10'^^
CCTTTAATCC 397 61 10305 Hyaluronidase 1 1.49x10'^®
CAA ACACCG T 2 278 285918 Sppl secreted phosphoprotein 1 2.01x10'^®
AACTG AG GG G 49 306 233010 Prosaposm 6.37x10’'*°
TAATGTAG AC 405 116 4504 Gap junction membrane channel protein  
alpha 1 (Comiexin 43)
2.42x10'®°
A G C A A G A A TT 28 226 1061 Ferredoxin 1 1.94x10’®®
CAG TCAATAC 212 30 Unmatched 4 .9 8 x 1 0 ’®®
A G G C A A T A A A 3 143 27154 V anin 1 1.95x10 ’^ °
A A A G C A C A C A 0 128 Unmatched 3.76x10 '^
A AC AG G G CC A 13 159 324864 M us musculus transcribed sequences 3 .55x10 ’^ ^
T A A C T G A C A A 11 140 147226 M etallothionein 2 2 .62x10 ’^ '*
CCTCCCCTTG 1 98 U nknown 3.39x10’ *^
TTGCTGCTTT 0 89 250254 RIKEN cD N A 6.27x10 ’^ °
A G A ATG TTAT 3 97 M ultiple match 9 .01x10 ’^
GTGGCTCACA 878 564 M ultiple match 9 .96x10 ’^ °
GG TTAAATGT 56 206 930 Cathepsin L 6 .40x10’*°
ATA CTA AC G T 6 99 34102 Ornithine decarboxylase, structural 1 .73x10’*®
TA C A G T A T A A 98 9 3092 Inhibin beta-B 2.62x10’*®
GGGCATTTGA 11 108 108678 Cytochrome P450, fam ily 11, subfam ily  
a, polypeptide 1
9.30x10’*®
G A A A A TG A G A 133 28 315259 M us M usculus transcribed sequences 2 .53x10 ’*'*
CAA AC TC TCA 16 116 35439 Secreted acidic cysteine rich 
glycoprotein
4 .97x10 ’*^
GATACTTG GA 3 73 297 A ctin, beta, cytoplasm ic 9 .96x10’*®
TGTCATCTAG 1 67 4071 Laminin receptor 1 (ribosomal protein 1.19x10’*^
SA)
7 .90x10’*'*G C G AAG CTCA 5 74 265 Ribosom al protein S25
A A A A C A G TG G 91 16 21529 Ribosom al protein L37a 1.67x10’*®
ACA G TTAA TT 0 55 Unmatched 9 .89x10’*®
TAC TAC ATAG 0 54 Unmatched 1.61x10’*^
GCTCTGGGAG 152 56 140811 Hydroxysteroid dehydrogenase-1, 
delta<5>-3-beta
5 .48x10’*®
A C T G A A G C A A 46 146 4603 Scavenger receptor class B , mem ber 1 6 .55x10’*®
GACTCAGGGC 0 47 2580 Syndecan 1 4 .98x10’**
G A A A A G TG G A 9 69 15295 Epoxide hydrolase 2, cytoplasm ic 7.91x10'**
GGATGGGGAG 3 54 204705 Pending type I transmembrane receptor 
(seizure-related protein)
9 .78x10 ’**
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Figure 3.12b Distribution of significantly differentially expressed transcripts.
Total number of significantly differentially expressed transcripts 715
Transeripts with known functions 416
Characterised transcripts of unknown function 26
Uncharacterised but sequenced cDNAs 77
Tags matching clusters containing only ESTs 6
No true match in Unigene database 129
Multiple match in Uni gene databse 61
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Figure 3.13 Functional distribution of the 416 identifiable significantly differentially 
expressed transcripts present in the combined SAGE libraries
□ other 8 .75%
Unknown 
7%
I Transcription factors 
5%
□ Cell metabolism 
13%
1 Membrane proteins 
10%
Cytoskeletal 7%
Extracellular Matrix 
5%
□  DNA replication/ cell cycle 
7%
□ Protein metabolism 
19%
Steroidogenesis and lipid
B Cell signalling 13.5% metabolism
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3.4.3 Functional Groups
i
■Î
Table 3.3 shows the expression of a number of tags in the libraries that represent 
genes linked with established functional groups. These tables include all 
identifiable significantly differentially expressed genes and the top 100 most Iabundant tags in the combined libraries which can be assigned, or hypothesised Ito have, a specific function within the granulosa cell. Many of these are genes 
which have previously been shown to be associated with follicular growth such 
as extracellular matrix components (Smith et al 1999), genes involved in 
cytoskeletal remodelling (Grieshaber et al 2003) and the rearrangement of f
steroidogenic machinery reflecting the shift from oestradiol to progesterone 
dominance (Rodgers et al 1987). This is demonstrated by the decline in 
expression of aromatase, a change mirrored by the rise in P450scc, StAR, 
ferredoxin, scavenger receptor B1 and LDLR during the same phase. Cellular 
filaments such as actin, profilin, cofilin, tropomysoin and tubulin show 
expression within one or both libraries with significant differential expression of |
different actin and tropomyosin isoforms. A number of signalling and receptor 
molecules are expressed in one or both libraries including FSH receptor, LH 
receptor, 1GFBP4, inhibin, follistatin, and kit ligand, again reinforcing 
expression patterns established by earlier observations. Gap junction membrane 
channel proteins (connexins) show fluctuations in expression level around the 
ovulatory period. We now report the expression of connexins 26, 29, 30.3 and 43 
within the pre-ovulatory follicle. Cx29 has not previously been identified as 
having involvement in folliculogenesis while Cx 26 and Cx 30.3 have not 
previously been recorded as having a role in folliculogenesis in the mouse.
Many of the identified genes also have diverse functions of a ‘housekeeping’ 
nature including metabolic enzymes, genes involved in protein synthesis and 
degradation, metabolite/ion transporters and energy metabolism These genes 
only indirectly relate to granulosa cell function by maintaining cell health and 
providing the fi-amework and metabolites for more ‘granulosa specific’ 
processes.
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Within all these groupings are genes with multiple functions and, consequently, 
some have been placed in more than one category. Also present are a large 
number of transcripts not previously associated with granulosa differentiation, 
particularly with relation to genes influencing cell cycle control and apoptosis, 
cellular differentiation and a number of transcription factors. Clearly it is not 
feasible to discuss changes in every gene listed in this table, although general 
trends can be established in many cases. For example, there is an increase in the 
majority of angiogenesis related genes, and in a large proportion of the 
cytoskeletal transcripts. These changes will be discussed at more length later in 
this thesis.
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Table 3.3 Functional distribution of SAGE transcriots
T'rify Sftfiiienre Tag number ■ U nigene Genei (tg ■PMSG hCG
Angiogenesis
TACTTTATAA 0 39 1421 A DAM TS 1
TCCATATATT 7 21 259667 RNA binding motif, single stmnded interacting protein 1
G GAATTTAGA 0 12 332793 B lood vessel epicaidial substance
GTGCTGTTGT 4 26 196189 Angiopoietin like 4
CTTGCTCTGT 6 35 263396 Integrin 1 beta
G AAAGCCTCT i 24 8245 TIM ? I
CCCTTCTTCT 44 10 196110 Hemoglobin alpha adult chain 1
TGCTGTGCAT 14 60 289662 FGF inducible 14
TCTCACCTCA 0 2 15607 Vascular endothelial growth factor B
Apoptosis
TTAGAAGTGA 1 40 373563 Salvador hom olog 1 (Drosphilia)
TGAATGAGCG 0 6 1401 Chem okine (C-X-C motif) receptor 4
CTCTCCAGAA 0 6 274810 HRAS like suppressor 3
TATCTATACA 0 7 258475 Zinc finger and BTB domain containing 24
TATGCAGATG 9 1 2662 Glutathione S-transferase, alpha 4
GTGCTATTCA 2 12 1639 M yeloid cell leukemia sequence 1
C A A A ATACAT 21 8 27578 M agedl Melanoma antigen, family D, 1
CTGTAGAGTG 0 9 196508 Mortality factor 4 like 1
TTAGAACGTG 0 11 27218 Mortality factor 4 like 2
AGGAAGATCA 14 1 4078 Antigen identified by monoclonal antibody Ki 67
GGTTATAATA 5 34 28405 Seruin/glucocoiticoid regulated kinase
TCTCGTAATG 1 29 42095 Secreted frizzled related sequence protein 4
TGCTGTGCAT 14 60 289662 FGF inducible 14
Cell Cycle
TACTGCTGAT 9 11 250419 Cyclin 1
TCCCCCCCCT 0 33 51116 M astennind like 1 (Drosophila)
TTTAATACAA 4 10 13725 Cyclin L2
TCGCTGCTGC 3 20 27921 C yclin G associated kinase
A A TG ACACAA 2 10 219645 Cyclin dependant kinase 8
TAGTTGCAAA 5 9 2823 B cell tm nslocation gene 3
TTAGAAGTGA 1 40 373563 Salvador hom olog 1 (Drosophilia)
TGCTGTGCAT 14 60 289662 FGF inducible 14
GGGAGCGAAA 2 28 34871 Inhibitor o f  D N A  binding 2
TCTTTAATCC 23 2 196638 CDC 23 (Cell division cycle 23, yeast hom olog)
TGCACCACCT 5 30 182470 Ribonuclease H2 large subunit.
AGGAATCCAC 0 14 22701 Growth an est specific 1
ATGAGAACAG 0 13 236123 Splicing factor 3b, subunit 3
GAAACTGAAC 12 0 42196 Ubiquitin-like, containing PHD and RING finger dom ains, 1
CTTAAATCTT 0 12 239605 B -cell translocation gene 2, anti-proliferative
AAGCAGAAGG 4 16 1 S I 00 calcium  binding protein AlO (calpactin)
TGCAGGAGCT 0 12 333388 Chiom odomain helicase D NA binding protein 4
AAAATGTACT 11 0 3752 RAN binding protein 1
G GAGTAAGAA 18 4 371563 H3 histone, fainily 3B
TCCATATATT 7 21 259667 RN A  binding motif, single stranded interacting protein 1
CCCTCTGGAT 0 8 100144 SlOO calcium  binding protein A6 (calcyclin)
AATGCTTGAT 7 24 270186 Retinoblastoma binding protein 7
AACTTTTAAA 7 0 354643 Heterochromatin protein 1, binding protein 3
AATGTTTCTG 10 2 7141 Proliferating cell nuclear antigen
AAG AG AAAAG 6 0 240066 Proteasome (prosome, macropain) activator subunit 4
GAGTCTCTTC 0 6 184021 Protein tyrosine phosphatase, receptor type, D
TACTATAGTC 0 6 123211 Polymerase (D N A  directed), beta
TGGAGCGTTG 0 6 6839 Cyclin-dependent kinase 4
TATTGTGGCT 0 9 195663 Cyclin-dependent kinase inliibitor 1A  (P21)
.1
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Tag Sequence Tag number U nigene GenePMSG hCG
TTCATTATAA 17 6 19187 Prothymosin alpha
CAGACCTCAA 2
Cell Differentiation
11 250605 S ell (suppressor o f  lin -12) 1 hom olog (C. elegans)
GGATGGGGAG 3 54 283926 Seizure related 6 hom olog (inouse)-like 2
TATCCCACGC 8 23 280038 S 100 calcium  binding protein A 1 1
TCTTCATCAA 3 12 229151 SW l/SN F related, matrix associated, actin dependent regulator o f  
chromatin, subfamily a, member 1
AG CCAAACAA 0 7 172897 M itogen activated protein kinase kinase kinase 12
CCCTGATTTT 13 3 185453 Eukaiyotic translation initiation factor 4 , gamma 2
TCCCGATATC 2 13 263414 Polioviius receptor-related 4
TAAG TGG AAT 12 26 3360 Tyrosine 3-monooxygenase/tryptophan 5-m onooxygenase activation 
protein, epsilon polypeptide
TGTTGGTTGA 1 12 246990 Reticulon 3
CCTCTAGCTG 1 10 29346 Guanosine monophosphate reductase 2
GTCTGCTTGT 10 0 4375 Fatso
TAAATTCAGG 0 11 275909 Sema domain, iimnunoglobulin domain (Ig), transmembrane domain 
(TM ) and short cytoplasmic domain, (semaphorin) 4B
TCCCCCCCCT 0 33 51116 M astennind like 1 (Drosophila)
Cytoskeletal Related Transcripts
GATACTTGGA 73 3 297 Actin, beta, cytoplasmic
TTGTTGCTAC 8 387 395 Vimentin
TGGCTCGGTC 4 53 196173 Actin, gaimna, cytoplasmic
AA G ATCAAG A 6 44 214950 Actin, alpha 1, skeletal m uscle
GGCTGGGGGC 18 18 2647 Profilin
GGATGGGGAG 3 54 4024 Cofilin 1 non m uscle
CCCTCACCCA 4 22 246377 Tubulin beta 2
GCAGGCACTC 21 24 1703 Tubulin beta 5
ATGTCTCAAA 48 30 231463 Tubulin alpha 2
A A G G AAG AG A 2 5 7 Vimentin
TTCAGGTGGT 6 9 240839 Tropomyosin 3, gamma
CCCGTAGCCC 1 9 121878 Tropomyosin 1, alpha
GACTGTGCCA 8 6 256858 Dynein, cytoplasmic, light chain 1
TCCCCAATCA 2 9 21109 Gelsolin
TCTCGGGGGC 7 1 219663 Fibulin 1
ATCAGTGTGA 0 6 275555 Calponin 3 acidic
ATTTGACTGG 1 30 29677 M yosin heavy chain IX
AGGATCAATG 6 28 205601 Cortactin
TTTCATTGCC 5 25 308452 Transfbnning, acidic coiled-coil containing protein 1
CCCTCACCCA 4 24 371591 Tubulin, alpha 1
ACTCCTTAGT 0 11 336400 Syntrophin, gamma 1
ATAGTAAGCT 11 1 289707 Fascin hom olog 1, actin bundling protein
GTGCTGCCTT 0 9 295565 Echinodenn microtubule associated protein like 4
GTGTCTGATA 0 9 738 Procollagen, type IV, alpha 1
TAACCGAGAC 0 9 277812 V illin 2
TGTTCATCTT 2 13 249555 Procollagen, type 111, alpha 1
TCATTTGGTG 1 10 172 Lysyl oxidase
AGATGTACTG 0 7 21767 Cadherin 5
AACTGCTTCA 3 13 30010 Actin related protein 2/3 complex, subunit 1B
CTCTGGGGTT 3 13 271711 Transgelin 2
ACCACTGATA 1 9 50424 T axi (human T-cell leukemia v im s type 1) binding protein 1
ATCAAAGTTC 1 9 10299 Procollagen, type V , alpha 2
ATTTCCCGAG 1 9 288974 Actin related protein 2/3 complex, subunit 5
GGGAACAACT 2 11 8687 CAP, adenylate cyclase-associated protein 1 (yeast)
CAGAACTTTG 0 6 4352 Procollagen, type X V llI, alpha 1
GTAATCACGT 0 6 2654 W D repeat domain 1
GGAAATGACT 0 9 46497 Ras hom olog gene family, member E
GCTCCCCCAC 7 6 2509 Procollagen type IV
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Tag Sequence ■ Tag number • U nigene GenePMSG hCG
TGTGCCAAGT 36 30 190641 Collagen type X X V  alpha 1
GCTCTAGCCA 6 10 181021 Procollagen type IV alpha 2
TGTTCATCTT 2 13 234850 Procollagen type III alpha 2
Extracellular Matrix Related Transcripts
CCTTTAATCC 397 61 10305 Hyaluronidase 1
GTGGCGCACG 54 10 214645 Hyaluronidase 3
TTGCTACTTT 6 367 27961 Leprecan 1
CCAACGCTTT 2 10 193099 Fibronectin 1
A A G ATCAAG A 6 44 44176 Epidennal GF, containing fibulin, like ECM protein 1
GGTTAAATGT 56 206 930 Cathepsin L
CCTCAGCCTG 24 20 231395 Cathepsin D
GTTTGCTGTG 12 9 22753 Cathepsin B
GGAGGGGGGA 10 7 156919 Cathepsin Z
GACCACCTCT 2 7 7386 M icrofibrillar associated protein 2
GAAAGCCTCT 1 24 8245 T issue inhibitor o f  metalloproteinase 1
GTGGCTCACG 11 9 217116 Matrix metalloproteinase 15
TGTGGTACGC 4 8 29373 Matrix metalloproteinase 23
CTTGCTCTGT 6 35 4712 Integrin beta 1
GGAGGGATCA 14 20 8131 Integrin linked kinase
CAAACACCGT 2 278 288474 Secreted phosphoprotein 1
CAAACTCTCA 16 116 291442 Secreted acidic cysteine rich glycoprotein (SPARC)
GACTCAGGGC 0 47 2580 Syndecan 1
TTGGCTGGAT 0 7 3815 Syndecan 4
TACTTTATAA 0 39 1421 ADAM TS 1
TGCCAATAAT 0 7 23156 ADAM TS 4
TATGAATGCT 7 48 158700 Chondroitin sulphate proteglycan 2
TA CA A A A TTA 8 1 355306 ADAM  17
TGQAACAATG 1 18 338790 Proteoglycan secretoiy granule
GTTTGTACAA 4 24 182396 Latent TGF beta binding protein
CGTGGTGGCC 8 0 45071 Cartilage oligom eric matrix protein
CTGAGGAAGT 3 14 29027 SPARC-like 1
AAATGCACTA 0 7 57734 LIM and senescent cell antigen-like domains 1
TTTACTGTGT 8 1 28897 Pyrophosphatase
Membrane Proteins
G AAG AG AG CA 12 9 243 Laminin alpha 1
TAATGTAGAC 415 116 4504 Gap junction membrane channel protein alpha 1
TCCCTATCCT 3 4 102422 Gap junction membrane chamiel protein epsilon 1
AACTGGGGAT 2 3 56906 Gap junction membrane channel protein beta 4
GTGTGTAACC 2 3 34118 Gap junction membrane channel protein beta 2
TCTCCAGGCG 55 31 200608 Clusterin
AGACACTTCC 48 6 584 Annexin A 2
TTGTTACTGC 1 11 20794 Annexin A7
AAGGGTGCTG 1 10 1620 Amiexin A5
CAAG AATTAA 0 6 294083 Annexin A 1 1
AAGGGTGCTG 1 10 265347 Aim exin A6
GTGTTTTGTC 44 25 201455 Secretoiy canier membrane protein 1
GGTGGGACAC 6 16 276326 TM P 21 transmembrane trafficking protein
CCTTTTCCTT 5 7 182912 Growth hormone inducible transmembrane protein
TGTGTCCCGC 0 6 287810 Importin 13
A G G CAATAAA 3 143 27154 Vanin 1
GATATGGTCT 1 23 2863 Integral membrane protein 1
TTAAATGCAG 1 27 273188 Coagulation fector III
CTTGCTCTGT 6 35 263396 Integrin beta 1
GGGTTTGGAG 8 27 274463 Endothelin converting enzyme 1
AATCCAGCCC 11 0 20206 Aquaporin 2
CTTTAGAAAA 0 9 268798 Solute earner organic anion transporter family, member 3a l
TTCATCTGTC 1 16 272675 Solute earner fam ily 20, member 1
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Tag Sequence Tag number XJnigGiiG GenePM SG hCG
TTTCAAGGCA 2 19 46067 Solute carrier fam ily 25 , member 30
A A A A G A A A A T 1 20 276831 Solute earner fam ily 7, member 8
TGATGTGTGA 0 14 260988 Solute earner family 7, member 11
AGAAGGACCT 0 13 21002 Solute earner fam ily 2 member 1
CTCCTGCAGA 3 12 275489 Solute carrier fam ily 7, member 1
TTG CTAAGAA 0 7 272675 Solute carrier fam ily 20, member 1
CACTGTCTTC 0 9 4114 Solute earner fam ily 3, member 2
ATTAATCAGT 11 32 46754 Solute earner fam ily 38, member 2
TCTAGCCAGA 1 10 35253 Solute earner fam ily 12, member 8
TGACATCCAT 0 8 233889 Solute carrier fam ily 39, member 10
TGAACTGTAA 1 9 270647 Solute carrier fam ily 39, member 14
GACTGAATCT 23 33 298 Solute carrier fam ily 25 member 3
GTGGGCGTGT 24 27 5353 Solute carrier fam ily 29 member 3
A CAATAATG A 2 38 658 Solute carrier fam ily 25 member 5
GTGTCCGTAC 1 12 294882 FI 1 receptor
TCACATAAAT 1 10 31752 C D 47 antigen (Rli-related arrtigen, integrin-associated signal transducer)
TGTACAAATG 1 10 15622 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransfeiase, polypeptide 1
ATGCACAGAT 1 9 2551 SEC22 vesicle trafficking protein-like 1 (S. cerevisiae)
AATCACTGTG 0 44 33240 Epithelial V  like antigen
TCCCGGATCA 35 2 18962 Catenin alpha 1
CAGAACAATG 1 15 282084 Adhesion regulating m olecule 1
Cell Metabolism Related Transcripts
GCCTCCAAGG 23 24 5289 G lyceialdeliyde 3-phosphate dehydrogenase
C C A A AT A A A A 38 31 29324 Lactate dehydrogenase 1, A  chain
TGATATGAGC 18 15 9745 Lactate dehydrogenase 2, B chain
GCCCCGGAAT 61 33 196605 H exokinase 1
GCAATCTGAT 25 23 188 Phosphoglycerate kinase 1
CCTACCAATA 16 9 29182 Transaldolase 1
CCTACTAACC 20 25 16763 Aldolase 1 A  rsoform
CAATAGAGAC 1 5 216135 Pyravate kinase, muscle
T AAG G G AAAT 24 12 4222 Triosephosphate isornerase
CTTTGTTAGT 5 12 3879 Hypoxia inducible factor 1, alpha suburrit
ATACTAACGT 99 6 34102 Ornithine decarboxylase
AGGGTGCAGT 2 4 28146 M evalonate (diphospho) decarboxylase
TCCTGTGGGA 21 7 4533 Apolipoprotein A-IV
CTGGAGACGC 0 11 26743 Apolipoprotein A-1
TGCTGCATCA 2 4 168157 Apolipoprotein E
A G CCAAGAGA 5 1 38901 Fatty acid desaturase 2
CAGGCCACAC 46 30 103838 ATP Synthase Mit. FI com plex, beta subunit
G AAAAGTG GA 9 69 15295 E poxide hydrolase 2 cytoplasmic
CCCTTCTTCT 44 10 196110 Hem oglobin alpha, adult chain 1
GGTTATAATA 5 34 28405 Serum /glucocorticoid related kinase
CAACCATCAT 3 26 30071 Lysom som al associated protein transmembrane 4A
TACAATATAC 8 35 31403 TNF alpha induced protein 9
GTTGTTAACA 2 22 143768 F-box only protein 3
TGTATCCAGT 32 8 373561 N ucleosom e assem bly protein 1-like 5
AACCTCGCTG 4 26 30221 Insulin induced gene 1
GTCTATGTTG 7 0 4952 Insulin receptor substrate 1
CTATCCTCTC 7 29 200916 Glutathione peroxidase 3
TTCTCTCCCT 14 1 306954 Carbonic anhydrase 14
TGATGTTAAC 1 12 255848 H exokinase 2
TTCTGTGTCA 0 10 19669 6-phosphofi-ucto-2-kinase/fructose-2,6-biphosphatase 3
C A A A A A T A A A 32 18 70666 Enolase 1, alpha non-neuron
TGTACCCAGG 7 23 3196 Alpha glucosidase 2 alpha neutral subunit
TGTGAAGTAG 16 37 371546 ADP-ribosylation factor 1
G GGGG GAAG A 0 8 27308 ADP-ribosylation factor 6
GTAGCGCTCA 0 8 5121 Peptidylglycine alpha-amidating m onooxygenase
TGTGCTGTTG 0 7 32700 Sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) hom olog (S.
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Tag number Unigene Gene1 kJ LA^^UViiVV; “ PMSG hCG
TGTG AACG AA 4 15 18522
cerevisae)
Carnitine palmitoyltransferase la , liver
GCAGCTCACA 12 3 7236 Dolichyl-di-phosphooligosaccharide-protein glycotransferase
TGAGTTCCCT 2 11 38390 Copine III
TCTGGCAGTC 6 0 221452 RAN binding protein 5
CGTCTGTGGA 7 19 30155 ATPase, H+ transporting, VO subunit C
GTTTAGTGGA 16 6 252255 Proteasome (prosome, macropain) subunit, alpha type 2
CAGTCTTGAG 0 6 22560 Diaphorase 1 (NADH )
AGCAAGATGG 11 40 290578 Am inolevulinic acid synthase 1
ATGAGTGAGC 2 11 27183 Phenylalkylamine Ca2+ antagonist (emopamil) binding protein
CAGATTGTGA 2 11 317701 Thioredoxin dom ain containing 4  (endoplasmic reticulum)
A ACAAATTCT 8 1 35628 Fucosyltransferase 8
CAGGGCTCCG 8 1 193096 StearoyTCoenzym e A  desaturase 2
TCATTCTCCA 1 13 257837 ATPase, class VI, type 11A
AG CAAG AATT 28 226 1061 Feiredoxin 1
TCCCCCCCTT 0 8 4946 Insulin 11
CAGG CAAAAC 25 3 171378 Uncoupling protein 2 mitochondrial
TTG TCAGGTA 20 68 148155 M alic enzyme supernatant
GGGAAGTCTG 5 33 347009 Peroxiredoxin 2
AATTAGTTGT 34 8 353 ATP synthetase H+ transporting, mitochondrial FO com plex, subunit F
ATAATACATA 154 231 200362 Cytochrome b-245 beta polypeptide
GTGATGTTTC 55 26 31018 Cytochrome b-5
CAAGGTGACA 3 20 328846 Phosphodiesterase 6 A, cGM P-specific, rod, alpha
ACCCTGCTTA 10 0 206417 Cystathionine beta-synthase
GGCAATAATG 25 53 9925 Isocitrate dehydrogenase 1 (NADP+), soluble
TCATTCTCCA 1 13 257837 ATPase, class VI, type 11A
AATGGCTAGC 18 5 35389 Cytochrome c, somatic
GAAATATATG 27 11 2966 ATP synthase, H+ transporting, mitochondrial FO com plex, subunit c
GGAGCCATTG 10 1 275780
(subunit 9), isofonn 3
N A D H  dehydrogenase (ubiquinone) 1 alpha subcomplex, 5
AACTGCACAC 0 6 246965 Succinate dehydrogenase com plex, subunit B, iron sulfur (Ip)
CCAATGAACT 7 0 235123 Inner membrane protein, mitochondrial
Oocyte specific genes
TCAGAGTGCT 11 3 9714 G D F 9
AGCTACCTGG 1 0 18213 Transfbnning growth factor, beta 2
GAATACCCCC 2 4 42160 Bone morphogenetic protein 15
AAAATG TCAA 9 1 208554 O ogenesin 1
Protein synthesis and degradation
Ribosom al proteins L32, S17, large P2, SI5a, L3, S3a, L21, S4 (X-linked), L l l ,  L17, L15, S3, L41, S24, L36a, LIO,
L38, L24, S29, PI, S23, L5, L13, SI 1, L36, L40 and mitochondrial ribosomal proteins S21 , S27, L53, L5
AGGCGTGGCT 0 6 30849 Prenylcysteine oxidase 1
TACATTCCAA 1 45 3401 Proprotein convertase subtilisin/kexin type 5
ATCACACACT 0 21 62886 UDP-N-acetyl-alpha-D-galactosam ine polypeptide N -
TGCAATATGG 0 9 260084
acetylgalactosaminyltransferase 7 
Eukaryotic translation initiation factor 4A 2
TGAACACTGA 0 6 330731 Transglutaminase 2, C polypeptide
T AG ACAAAG G 0 9 276815 Adenosine deaminase, RNA-specific, B1
GAAATG TTGT 11 1 22117 Polymerase (R N A ) II (D N A  directed) polypeptide G
T G T ATAAAAA 30 12 87773 Tumor rejection antigen gp96
ATTGCTTAGA 19 4 371574 RN A  binding m otif protein 3
GCTATACAGA 11 0 286830 Leucine aminopeptidase 3
GAGCGTTTTG 57 28 5246 Peptidylprolyl isomerase A
AGCCAAATAC 2 19 261831 Basic leucine zipper and W 2 domains 1
G G CAGCACAA 8 24 9043 Heterogeneous nuclear ribonucleoprotein F
TGTGGATGGC 0 8 30602 Ubiquitin specific protease 22
AATAAACACG 6 20 257629 Protease, serine, 35
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Tag Sequence Tag number U nigene GenePMSG hCG
CAAATGCTGT 10 1 20943 FK506 binding protein 9
TTGATGTACA 3 15 223946 Splicing factor, arginine/serine-rich 11
G G CAGCACAA 8 24 9043 Heterogeneous nuclear ribonucleoprotein L
GCATCCAGCT7 7 0 277091 Poly(A )“binding protein, cytoplasmic pseudogene
AATTGTATTT 7 0 10651 GTP cyclohydrolase 1
CCTGATCTTT 1 10 4071 Laminin receptor 1 (ribosomal protein SA)
CTGAATATCT 0 6 371545 A cidic ribosomal phosphoprotein PO
AGGTGTACAG 0 6 29397 Splicing factor, arginine/serine-rich 15
GCTCACAACC 7 0 272930 Component o f  oligom eric golgi com plex 4
CATTGCGTGG 9 22 27955 W illiam s-Beuren syndrome chromosome region 1 hom olog (human)
ATTATACAGT 3 13 29192 Asparaginyl-tRNA synthetase
ATGCTTCTCA 0 6 248313 R A B 12, member RAS oncogene family
ATTAGGATGT 0 6 22347 Pinin
TGAGGCCTCG 0 13 21671 Eukaiyotic translation initiation factor 3, subunit 9 (eta)
GATGTGGCTG 41 15 2718 Eukaryotic translation elongation factor 1 beta 2
TGGGCAAAGC 23 8 371625 Eukaiyotic translation elongation factor 1 gamma
ATCCGGCGCC 0 8 153758 Transcription elongation factor B (SHI), polypeptide 2
AGGCAGACAG 94 131 335315 Eukaiyotic translation elongation factor 1 alpha 1
A A G A A A AC A T 6 0 218851 Eukaiyotic translation initiation factor 2, subunit 3, structural gene X- 
linked
CCTTTAATTC 14 3 154306 Ubiquitin specific protease 45
TATAGTATGT 8 30 210745 Glutamine synthetase
C G AAAG AACA 0 7 23335 Y M E l-lik e 1 (S. cerevisiae)
AGACAAGCTG 0 7 43331 Splicing factor, arginine/serine-rich 5 (SRp40, HRS)
TAACAGTTGT 18 38 248827 Calnexin
TGTGGATGGC 0 8 30602 Ubiquitin specific protease 22
Cytokines, growth factors and signalling and receptor molecules
TACAGTATAA 89 9 3092 Inhibin beta B
AGGTCCCTAC 39 27 1100 Inhibin alpha
TCTTAATG AA 22 11 4235 Kit ligand
TGCTGTGCAT 14 60 18459 FGF inducible 14
GTTTGTACAA 4 24 182396 TGF beta BP3
ACAGTCGACT 3 2 209571 Bone m oiphogenic protein 3
CAGCATTAGA 2 0 27757 B one m oiphogenic protein 1
TGAGCATCAA 2 0 140965 B one m oiphogenic protein receptor la
ATCACAGGTG 1 4 22248 IGFBP 4
TTTGCACCTT 7 8 1810 C onnective tissue growth factor
TAG CTTTAAA 5 3 233470 IGFBP 7
AAAG CACCAT 7 1 3904 Fibroblast growth factor 15
TAAATGTGCA 45 8 4913 Follistatin
CTTGTATTTA 10 10 4132 Suppressor o f  cytokine signalling 2
GTTTGTACAA 4 24 182396 Latent transfbnning growth factor binding protein 3
TACTTGTGTT 3 18 15125 Stromal cell derived factor receptor 1
ACTCTAAGTT 0 7 347919 B-cell stimulating factor 3
TACCTTGACA 0 45 4791 Epiregulin
TCCCCCCCCC 0 28 35088 Cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal)
CTTAGATGTT 0 19 309193 Ropporin 1-like
A A C A AA A T C T 13 1 3903 RAS, dexamethasone-induced 1
AAGTAATGTG 1 12 10516 Prolactin receptor
TTACCACATA 5 20 28262 Regulator o f  G-protein signaling 2
ACAGCCAGGG 11 1 242413 G protein-coupled receptor, family C, group 5, member C
TCCTTATATT 42 73 290285 RA B39, member RAS oncogene family
ATGTTCGTGG 3 16 1791 Dual specificity phosphatase 6
GTCTTGGGCG 15 36 30156 Protease, serine, 11 (Ig f binding)
TCAGTTTAAT 0 9 275266 Rlio guanine nucleotide exchange factor (GEF) 12
TTCCTATATT 32 59 179011 V av2 oncogene
ATCACTCCAA 1 11 273142 Membrane interacting protein o f  R G S16
GGAGATCTTT 10 1 167625 G protein-coupled receptor 85
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Tag Sequence Tag number ■ U nigene GenePMSG hCG
CGCTCTAACG 6 0 25594 Protein kinase, cAM P dependent regulatoiy, type II beta
AGATCATCTA 0 8 246003 Frizzled hom olog 1 (Drosophila)
GCACAACTTG 27 12 329243 Calmodulin 2
ACAACAGAGG 1 10 24807 Prostaglandin F2 receptor negative regulator
GCCACTTCCT 1 10 371598 Nuclear receptor coactivator 4
A G AAAG G ATA 0 7 296814 Phosphodiesterase 7A
AGTGTGACGT 0 7 43081 M itogen-activated protein kinase 8 interacting protein 3
TGTAACTGGT 4 15 233009 RAS related protein lb
ACTCCTCCCT 1 9 333868 RAS-related protein-la
TA CA A A A TTA 8 1 355306 A DAM  17
GGCTTTTTCG 9 1 27832 V -ial simian leukemia viral oncogene hom olog B (ras related)
TGATG CTAAA 1 9 304976 Down-regulated by Ctnnbl, a
GTCTTTGTGA 6 0 200775 Transfbnning growth factor, beta receptor III
T ACAATAAAC 0 6 40321 Progesterone receptor membrane component 2
TTTGTAATAA 0 30 284855 Endothelin 2
CTCCCACCCA 0 18 249318 Frequenin hom olog (Drosphilia)
ACTCGGAGCC 34 9 285993 Calmodulin 1
AGGTGGCATT 0 6 2442 Calcium binding protein intestinal
ATG ACATAG A 5 28 235182 Calcium/ealmodulin-dependant protein kinase 11 gamma
C AAACAATGT 1 19 277351 G protein coupled receptor 48
AGAGGACTAG 0 15 358930 G protein coupled receptor associated sorting protein 2
TTCTTGTATT 3 22 276405 FK506 binding protein SI
ATGATGGTAG 54 24 353171 EpH receptor A6
CCCCTATATT 14 37 288639 RAB guanine nucleotide exchange factor (GEF) 1
ACAGTTAAGC 0 10 209813 Ephrin-B class 2
TGTTAGCTCC 0 6 21667 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 12
TAAG TGG AAT 12 26 3360 Tyrosine 3-monooxygenase/tryptophan 5-m onooxygenase activation 
protein, zeta polypeptide
GCACAATTG 27 12 35677 Epidennal GF receptor pathway substrate 15
CACCACCACA 11 16 2924 Platelet derived growth factor receptor
AGGGCACTGG 13 6 43760 Nei’ve  GF assoc, receptor protein
TGTAAGGTGT 1 4 254496 FGF receptor
TTGCCATCTC 8 16 1644 LH Receptor
GGGTAGATAT 6 13 142929 Amh type 2  receptor
GCTGTTTTCA 15 11 35009 G protein coupled receptor 27
TGACTCATCT 4 3 57155 FSH receptor
GGATGGGGAG 3 54 204705 Psk 1 transmembrane receptor
TGTCATCTAG 1 67 4071 Laminin receptor 1
GGCCCTCTTT 1 3 197552 TGF beta receptor 1
CTTGCTCTGT 1 35 4712 Integrin beta I (fibronectin receptor beta)
TCCCCCCCCC 28 0 35088 Cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal)
TTCTTGGTTT 4 13 40636 G protein coupled receptor 48
GCACTAGCTG 6 9 9052 Progesterone receptor membrane component 1
TTTAGGGGAG 12 5 22440 Thyroid honnone receptor associated protein 3
TTTGACCCCC 2 0 4839 A ctivin A  receptor type Il-like 1
CAACACCACC 1 3 689 A ctivin A  receptor type 1
ATAGCTGGGC 8 6 248907 M itogen activating protein kinase kinase 1
GAAATG TAAG 19 15 4358 M itogen activating protein kinase kinase kinase 12
C A A A A A A A A A 6 7 44193 M itogen activating protein kinase kinase kinase 7 interacting protein 1
CATTTGAAAA 5 3 196584 M itogen activating protein kinase kinase 2
CCTGCTCTGT 3 4 4437 M itogen activating protein kinase 14
CCAGACATCT 5 1 205152 M itogen activating protein kinase associated protein 1
AACTGTGTGA 2 3 18856 M itogen activating protein kinase 6
GTTTGGAGCT 2 3 18494 M itogen activating protein kinase kinase 3
TCCAATTCCT 3 0 68993 M itogen activating protein kinase 9
TTTTTGATAA 3 32 10504 3-phosphoinositide dependant protein kinase 1
ATGACATAGA 5 28 235182 Calcium/calmodulin-dependant protein kinase II gamma
TTTTCTATTT 23 3 25594 Protein kinase, cAM P dependant regulatory, type II beta
TAGGAGACTG 6 15 2314 Protein kinase C delta
ACCGGGCTGG 9 7 9334 Protein kinase, cAM P dependant regulatory, type 1 beta
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Xfio- Tag number GenePMSG hCG
TTCCATTAAA 3 2 30234 IK cytokine
TGCAGTCAGT 0 4 37204 Suppressor o f  cytokine signalling 5
GAGTCAGCAA 0 4 227274 Protien regulator o f  cytokinesis 1
GTTGTTGTTA 7 4 78106 Serum /glucocoiticoid regulated kinase 3
TTAATTACAG 0 19 28405 Sem m /glucocorticoid regulated kinase
Steroidogenesis and Lipid metabolism related transcripts
GGTCAAGATA 46 4 188939 17P HSD 1
C T A A A A A A A A 9 7 12882 1 7 P H S D 7
CACCACCACC 5 1 8877 17p HSD 2
GTGCATTTCA 13 3 5199 Cytochi'ome P450 19 (aromatase)
GGGCATTTGA 11 108 108678 Cytochrome P450 1 la  (cholesterol side chain cleavage)
GAAGCTGTAT 10 0 5079 l i p  H S D 2
TGTGCCGGCC 1 18 142364 StAR
CAAACTGTAT 6 0 196405 3 p H S D 2
GCTCTGGGAG 152 56 140811 3p HSD 1
ACTG AAG CAA 46 146 4603 Scavenger receptor class B member 1
GGTAACCTAA 1 9 3213 Low density lipoprotein receptor
TGTCCACACA 0 8 196675 LDLR related protein 8
GA A A A TG A G A 133 28 30012 H DL binding protein
AGCAAG AATT 28 226 1061 Ferredoxin
GAGTGGATTC 7 20 277857 Hydroxysteroid (17-beta) dehydrogenase 4
CACATTATCA 0 25 28099 Sterol-O-acyltraiisferase (cholesterol m etabolism )
CTGGAGACGC G 11 26743 Apolipoprotein A-I
GAACTTGCAA 10 24 39472 Farnesy! diphosphate synthetase
TCCTGTGGGA 21 7 4533 Apolipoprotein A-IV precursor
TGGCTCCATC 0 6 316652 3-hydroxy-3-m ethylglutaiyl-Coenzym e A  reductase
AACTGAGGGG 49 306 277498 Prosaposin
TGCAGTGTTA 1 11 249342 7-dehydrocholesterol reductase
TGTTATGTAA 1 10 277376 ATP-binding cassette, sub-family A (A B C l), member 1
GTGTACTTTC 0 10 20615 Peroxisomal biogenesis factor 11a
TTGCTGCCCT 0 8 247764 Peroxisom e biogenesis factor 19
Transcription factors and related genes
GGGAGCGAAA 2 28 34871 Inliibitor o f  D N A  binding 2
GGTGTTCCTT 3 0 31123 Desert hedgehog
GGAGAATTTT 7 1 2543 Indian hedgehog
TAGCCAACTT 0 13 4509 Runt related transcription factor 2
TAGCTTTAGG 0 13 22480 C yclin D  binding m yb-like transcription factor 1
TCTCGTAATG 1 29 42095 Secreted D izzied related sequence protein 4.
A A A G A C AC T A 0 6 360445 Interferon regulatoiy factor 2  binding protein 2
TGCACTGCTG 7 19 44151 Cofactor required for Sp l transcriptional activation, subunit 6
TGAAATGGCC 6 0 28020 Cofactor required for Sp l transcriptional activation, subunit 3
GGTTTTCAAG 7 0 259278 SMT3 suppressor o f  m if two 3 hom olog 1 (yeast)
TCCTTATTGC 2 12 14547 Chromobox hom olog 2 (Drosophila Pc class)
GTTGTTTGTT 1 10 20827 Homeodomain interacting protein kinase 1
AACGTGAGGT 0 8 258773 Zinc finger, M Y ND  domain containing 11
AAGCTCCGAC 0 8 12917 M ultiple endocrine neoplasia 1
GTATGTATGG 2 13 17977 Transcription factor Dp 2
TGCTACTTTA 0 9 153415 E2F transcription factor 5
TATTGTGGCT 0 9 195663 Cyclin-dependent kinase inhibitor lA  (P21)
GAGGAGGAGG 0 10 136604 Nuclear factor, interleukin 3, regulated
GGTATCAGTC 4 19 21281 Ring finger protein 4
GAGTGATTAT 0 12 256422 Zinc finger protein 162
GGATATGTGG 19 42 181959 Early growth response 1
CTAGATGTCG 9 10 34537 CCAAT/enliancer binding protein (C/EBP), alpha
TCTGAACACA 10 2 287795 General transcription factor IIE , polypeptide 1 (alpha subunit)
ACCAAGAGTC 2 12 641 Activating transcription factor 4
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Tag Sequence Tag number PM SG hCG Unigene Gene
Unknown function-significantly differentially expressed named genes
TGGGTTGTCT 156 253 296922 Tumour protein translationally controlled 1
ACCGGGTCAT 1 30 206919 M ale sterility dom ain containing 2
TTG AAATTAC 0 45 362063 Proline rich protein MP5
AG AAG A C A G A 0 15 16769 Testes enhanced gene transcript
CTGCTCTGAC 2 17 153566 B C 019776 Meteorin, glial cell differentiation regulator-like
CCTGTGTATG 0 11 293605 Tumor protein p53 inducible nuclear protein 2
GTTGAGGTTT 13 32 331964 D N A  segm ent, Chr 8 ERATO Doi 531, expressed
GCTCAGCACC 20 3 218957 Gene regulated by oestrogen in breast cancer protein
CTTCCCCGGG 0 10 34903 FSH primary response 1
TACTGCTAAG 0 10 273915 Gene rich cluster, C 3 f gene
AGCAGTGCTT 9 0 274715 C oiled-coil dom ain containing 3
GTTCTGACAG 4 14 261025 Carnitine deficiency-associated gene expressed in ventricle 3
TACCCCACAA 0 6 41849 Brain expressed, associated with Nedd4
TTTGAGGATT 0 6 333893 N on imprinted in Piader-W illi/Angelman syndrome 2  hom olog (human)
CACTGACGAG 10 2 2871 DnaJ (H sp40) hom olog, subfamily C, member 9
ATAAACTGCA 0 6 230654 Testis derived transcript
TTCAGGCACT 1 9 38436 Tetratricopeptide repeat domain 13
GTACTTGTCT 0 7 29658 Chem okine-like factor super fam ily 3
ATCAGTACTA 0 7 46401 Son cell proliferation protein
CCTTTAATGC 7 0 219648 THO com plex 1
TCAACTTGGG 2 12 156727 Hyperparathyroidism 2 hom olog (human)
TGCCGTATGC 1 10 6442 Polycystic kidney disease 2
GTTGAGGTTT 13 32 331964 D N A  segm ent, Clu- 4, W ayne State University 53, expressed
TAACATTGTA 0 9 22225 Zinc finger protein 313
CTAATAAAGC 51 28 329631 Fau Finkel-Biskis-Reilly murine sarcoma virus (FBR-M uSV) 
ubiquitously expressed (fox derived)
GTACTTGTCT 0 7 29658 Chem okine-like factor super family 4
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3.4.4 Genes showing selective expression within granulosa cells
In order to select transcripts which have a direct luteinisaton-related function the 
SAGE libraries were compared to the other 81 murine libraries available on 
SAGEMAP. These included libraries constructed from embryonic stem cells, 
cardiac muscle, neural tissue, spleen, kidney, liver, adipose tissue and testis in a 
variety of physiological and pathological states. It is reasonable to presume that 
transcripts unique to granulosa cells when compared to other libraries may be 
considered more likely to possess a cellular specific function.
Table 3.4 lists the 20 highest expressed genes within the combined libraries 
which show no more than a single tag in any other non-gonadal murine SAGE 
library. Tags found in SAGE libraries sourced from testes tissue have been 
included in this list in order to include genes expressed within the Sertoli cell in 
the male since it has an analogous function to the granulosa cell in the female. 
These genes, while not necessarily unique to granulosa cells, are nonetheless 
showing highly selective expression patterns. Eight of these genes are 
unmatched, have multiple matches or are linked to uncharacterised sequences. 
The possibility that such nan'ow expression across tissue types is linked to a 
luteinisation-specific function is enhanced by the fact that 17 of the 20 genes 
listed show significant differential expression. This is borne out by the presence 
of the steroidogenic gene 17p HSD 1 and the luteinisating hormone receptor 
within this group. Also of interest are leukocyte cell derived chemotaxin 1 and 
mastermind like 1 (Drosophilia) as genes likely to have influence on cell 
proliferation, survival and/or differentiation.
Table 3.5 lists the 20 most abundant tags which are unique to the granulosa cell, 
excluding those tags also found in the testis libraries. Six of these genes are 
unmatched, have multiple matches or are linked to uncharacterised sequences 
and 19 of the 20 genes are significantly differentially expressed. Likely to 
stimulate interest are 4 transcription factors found only within the granulosa cell 
namely transcription factor Dp 2, cyclin D binding myb-like transcription factor 
1, runt related transcription factor 2 and general transcription factor II E, 
polypeptide 1 (alpha subunit), all upregulated by hCG. It should be noted that
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these genes are, of course, expressed in other tissues it is just that they have not 
been detected in SAGE libraries.
Table 3.4 Top 20 most abundant transcripts found specifically in gonadal tissue
Gonadal 
Tag_Sequence PM SG hCG U nigene Gene
CCATCGTCCT 13 66 Unmatched
GTGTTTTGTG 44 25 201455 Secretory carrier membrane protein 1
TACTACATAG 0 54 Unmatched
GG TCA AG ATA 46 4 188939 Hydroxysteroid (17-beta) dehydrogenase 1
TACCTTG ACA 0 45 4791 Epiregulin
TTG AAATTAC 0 45 4491 Proline-rich protein MP5
A C A A T A A T G A 2 38 261182 RIKEN cD N A  2310061B 02 gene
ACAACTCCAC 0 39 Unmatched
C G A A G C A C A A 2 35 264680 Cysteine-rich secretory protein LCCL domain containing 2
TTTTTGATAA 3 32 10504 3-phosphoinositide dependent protein k inase-1
TCCCCCCCCT 0 33 51116 Mastermind like 1 (Drosophila)
TTTG TA ATA A 0 30 1366 Endothelin 2
AATTTC TCA A 24 3 24295 M us musculus transcribed sequences
TATATACTTC 3 22 33062 C D N A  sequence B C 010552
CCAAG AG ACC 20 4 46561 Leukocyte cell derived chem otaxin 1
TTGCCATCTC 8 16 1644 Luteinizing hormone/choriogonadotropin receptor
TTACTGCTAC 0 21 347368 Expressed sequence A I987712
A A C A A A C G C A 0 19 Unmatched
GG GTAGATAT 6 13 142929 Anti-M ullerian hormone type 2 receptor
TTAGATATTG 5 13 1664 Luteinizing hormone/choriogonadotropin receptor
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Table 3.5 Top 20 most abundant transcripts found specifically in granulosa cells
Granulosa
Tag_Sequence PM SG hCG U nigene Gene
TACTACATAG 0 54 Unmatched
TACCTTGACA 0 45 4791 Epiregulin
TTG AAATTAC 0 45 4491 Proline-rich protein MP5
A C A A T A A T G A 2 38 261182 RIKEN cD N A  2310061B 02 gene
C G A AG CA CA A 2 35 264680 Cysteine-rich secretory protein LCCL domain containing 2
TTTTTGATAA 3 32 10504 3-phosphoinositide dependent protein k inase-1
TCCCCCCCCT 0 33 51116 Mastermind like 1 (Drosophila)
TTTG TAATAA 0 30 1366 Endothelin 2
A ATTTC TCA A 24 3 24295 M us musculus transcribed sequences
CCAAG AG ACC 20 4 46561 Leukocyte cell derived chem otaxin 1
CTG GAGACAT 0 18 Unmatched
CAAGTTTCAG 0 17 312623 M embrane-associated ring finger (C3HC4) 3
ATTG TAATAT 2 13 4509 Runt related transcription factor 2
GTATGTATGG 2 13 17977 Transcription factor Dp 2
TGAGGCCTCG 0 14 21671 Eukaryotic translation initiation factor 3, subunit 9 (eta)
A G TTC A TA AG 1 12 284855 Endothelin 2
TAGCTTTAGG 0 13 22480 C yclin D  binding m yb-like transcription factor 1
TATA AC AC TG 1 12 358736 RIKEN cD N A  3830408G 10 gene
TCTG A A CA CA 10 2 287795 General transcription factor IIE , polypeptide 1 (alpha subunit)
CGACCTTTAC 0 12 27154 Vanin 1
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3.4.5 Source and Purity of Granulosa Cell cDNA
In order to confirm the purity of the source mRNA it is necessary to check for 
thecal contamination by searching for highly expressed thecal cell specific 
transcripts that we would not expect to find in granulsoa cell generated cDNA. 
Steroidogenic enzymes such as 17 alpha hydoxylase and signalling molecules 
such as BMP 7 and keratinocyte growth factor are known to be highly expressed 
in thecal cells at this time point and no detection has occurred in either SAGE 
library.
A number of oocyte specific genes are present since no effort was made to 
isolate oocytes fi*om the aspirated follicle contents. GDF 9, BMP 15 and 
oogenesin are oocyte specific transcripts found in the SAGE libraries. GDF 9 
and BMP 15, as paracrine effectors secreted to influence granulosa cell function, 
would be expected to be among the most highly expressed oocyte mRNAs. The 
level of transcript detection is sufficiently low that these transcripts would not be 
expected to skew the SAGE results. If doubt is raised about the source of a 
transcript of interest its expression can easily be localised using in situ 
hybridisation.
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3.5 Investigation and Identification of Unmatched Transcripts
3.5.1 RACE analysis of unknown SAGE tags
One of the inherent problems with SAGE is that many SAGE tags do not match 
to any known gene in the database. This could be because they correspond to 
novel transcripts, or because there is alternative splicing at the 3’ end of the 
gene. The length of a tag does not unfortunately yield sufficient cDNA sequence 
for further analysis. In most cases searching the mouse genome for a particular 
tag sequence will give many matches. In addition, a SAGE tag may match to 
more than one gene in the database, these genes having no homology, functional 
or otherwise, except for this short sequence. In order to address this problem 
Chen et al (2000) developed a technique known as the generation of longer 
cDNA sequences from SAGE tags for gene identification (GLGI). This is a 
technique based on the original SAGE method which helps to validate and better 
characterise the information generated by the SAGE library. Essentially this 
technique uses the SAGE tag as the sense primer and a modified anchored oligo 
d(T) as an anti sense primer, thus converting the lObp SAGE tag into a much 
longer sequence (figure 3.14). These longer 3’ cDNAs provide much higher 
specificity than the SAGE tag for identifying correct genes for SAGE tags with 
multiple matches and for further characterisation of novel genes generated from 
the SAGE tags with no match. A high throughput protocol (Chen et al 2002) has 
improved the efficiency and permits a larger scale analysis of SAGE tags. By 
using this approach it is possible to efficiently generate longer 3’cDNA 
sequences up to a few hundred bases long (256 bases being the theoretical 
maximum for a 4 base recognition site) for multiple SAGE tags.
S ' RACE procedure
The RNA for the generation of longer cDNA fragments for gene identification 
(GLGI) procedure was obtained fi*om multiple combined granulosa cell samples 
sourced from mice treated with PMSG and hCG and cells collected as described 
for the SAGE experiments. Equal aliquots from both PMSG and PMSG/hCG
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treated mice were combined to give one sample. The RNA extraction, reverse 
transcription and 3’cDNA generation was as previously described for SAGE as 
was the annealing of SAGE linker A to the 5’ end of the cDNA fragments 
(figure 3.14), the only difference was that the oligo dT primer had an additional 
sequence at the 5’ end (figure 3.14). Following the 3’cDNA generation an 
additional PCR step is employed to increase the amount of cDNA for large scale 
GLGI analysis. Amplification is carried out using an oligo dT primer (figure
3.14) and a SAGE linker based primer (Primer 1; 5’-
AACTAGGCAATATAGGGA-3’). This amplification was carried out in a 50p,l 
reaction volume with 200nm of primer in each reaction, with other constituents 
as previously stated (Chapter 2). The product of this PCR reaction serves as the 
template for the gene specific amplification.
Oligo dT primer
TTCTAGAATTCAGCGGCCGC(T)30(AGC)(AGCT)
Oligo dT based primer 
TTCTAGAATTCAGCGGCCGC
mRNA extracted  and 
bound to streptavidin 
b ead s
NIa III digest
QTA f
Bind to linker A only 
♦
PCR using linker A and oligo dT(seq) primers
♦
LINKER aKctIt Tag sequence-Amplified 3' end of cDNA-AAAAAAA(SEQ)-
G ene specific primer Oligo dT(seq) primer
Gene specific amplification of 3'cDNA
Figure 3.14 Schematic representation of the large scale GLGI procedure for sequencing 3’ 
cDNAs from SAGE tag transcripts. Annealing a known oligonucleotide linker to the 5’ 
end of a 3’ cDNA fragment allows gene specific amplification using a linker/SAGEtag 
based primer.
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Eleven novel SAGE tags representing unidentifiable transcripts were selected for 
amplification and sequencing on the basis of abundant, differential or selective 
expression patterns within the granulosa cell. The sense primer sequences are 
listed in table 3.6. The tag sequence on which the primer is based is underlined, 
the remainder of the primer is composed of the CATG recognition site and the 
last 7 bases of the SAGE linker sequence giving a total of 21 bases for each 
primer.
The oligo dT antisense primer was based on the oligo dT primer used for reverse 
transcription in the SAGE procedure.
Each PCR reaction was set up in a 50|xl reaction volume containing 200nm of 
the gene specific primer and 200nm of the oligo dT primer. Reaction 
components were described for normal PCR in the basic laboratory methods 
section. Cycling parameters of 95°C for 90 seconds then 30 cycles at 95°C for 20 
seconds, 55°C for 30 seconds and 72°C for 60 seconds were followed.
The subsequent PCR products were run on a 12% polyacrylamide gel (figure
3.15) containing ethidium bromide as described under basic laboratory 
procedures. The gel was visualised under u.v. light and bands excised and 
extracted from the gel using the electroelution and lavage method as described 
for SAGE.
10 bp 
ladder 3'RACE PCR products for each individual reaction
IGbp
ladder
IGObp IGGbp
Figure 3.15 PAGE gel containing 3’RACE reaction products from each of the 
individual reactions using GSPs listed in table 3.6
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The PCR product was cloned into TOPO vector and electroporated using E.coli 
DHIOB cells (both products from Invitrogen, Paisley, U.K.) as previously 
described, cell suspensions were plated out, incubated overnight, colonies 
selected, plasmid inserts amplified and sequenced as previously described for 
SAGE using the plasmid based primers M13R (5’-GGA TAA CAA TTT CAC 
ACA GG-3') and M13F (5’-TGT AAA ACG ACG GCC AGT-3’) (obtained 
from MWG Biotech, UK).
The sequences obtained are listed below (figure 3.16). These sequences were 
then BLAST searched to obtain matching ESTs. The best match for each 
transcript is listed alongside that transcript.
Table 3.6 Gene specific primer sequences for 3’ race
Primer sequence Transcript number
(SAGE tag underlined) PMSG hCG
ATAGGGACATGCCTCCCCTTG 1 98
ATAGGGACATGTCCGCGATCA 58 1
ATAGGGACATGATCAGTGTGC 1 32
ATAGGGACATGACAGTTAATT 0 55
ATAGGGACATGTACTACATAG 0 54
ATAGGGACATGACAACTCCAC 0 39
ATAGGGACATGGGAGCAGACC 0 25
ATAGGGACATGAACAAACGCA 0 19
ATAGGGACATGTCGCTGCCTT 0 15
ATAGGGACATGAAAGCACACA 0 128
ATAGGGACATGCAGTCAATAC 212 30
Figure 3.16 3’ RACE results for unidentified SAGE tags.
T ag-C C T C C C C T T G PM SG 1 hCG 98
C A T G CCTCCCCTTGTAGTCACCAAGGAAAATTACCACTGCTCCCCCTGCCCTTCTGC
ATAAG G G TTATTTCCCCTTTG ATCTTTTTG TATAAAAACTGTAAGTTTTG CTGAATAC
A A C G A G A CC TTG AC AA G A TTC -poly(A)
M atches to 442bp m RNA, A ccession  number A A 791500, GI:2854455, Stratagene m ouse T cell 
937311 M us m usculus cD N A  clone.
T ag~T C C G C G A T C A  PM SG 58 hCG 1
C A T GTCCG CG ATCATCG TTAGAAG CTTGAATTCG AG CAGT-polv(A)
157
M atches to 674 bp m RNA, A ccession  number C X 567486, G I:57594515, M us m usculus cD N A  
clone.
Tag-TACTACATAG PM SG  0  hCG 54
C A T G TA CTA CA TA G C AA TACCTTG TTAT-polv(A)
N o  significant similarity
Tag-ACAACTCCAC PM SG  0 hCG 39
C A T G A C AA CTCC A C TCTG G TG G AG TTCTCTCAAACTATAAG CCAAAATAAACCCTTC
CTTCTT-poly(A)
509 bp m R NA , A ccession  number B G 148701 , GI: 12652123, m ouse N M G B  b cell Mus 
m usculus cD N A  clone.
Tag-GGAGCAGACC PM SG  0 hCG 25
C A T G G G A G C AG AC C A G T A A G G G A C C T TC A A T TT A A A A C A A A A C A A A A C A A A A A A A
C A A TA A A A A G G C TA A T T A A C A G T G G A G -poly(A )
M atches to 273 bp m R N A , A ccession  number B B 421909 , G I:9243264, embryo spinal cord M us 
m usculus cD N A  clone, similar to D 00472 M us m usculus m R NA  for cofilin.
Tag-AACAAACGCA PM SG  0  hCG 19
C A T G A A C A A A C G C A G G A A G -poly(A )
N o significant similarity
Tag-TCGCTGCCTT PM SG  0 hCG 15
C A T GTCGCTGCCTTATTAAATCCTG CCTTCTACATTG T-polv(A)
M atches to 311 bp m RNA, A ccession  number C X 734226, GI:58061062, M us m usculus cD N A  
clone w hole eye.
Tag-AAAGCACACA PM SG  0 hCG 128
C A T G A A A G C A C A C A G AG CTCTGG GG TCG AAACTCATACACCTTTG CACAGG GTAG A
GGAGTCTCG ACGACGACTCAAATTTTTCACAAG CTTTCG-poly(A)
M atches to 66 bp m R NA , A ccession  number B G 370289, GI: 13266826, H om o sapiens cD N A  
clone.
Tag-ATCAGTGTGC PM SG  1 hCG 32
CATG AXQ AG TG TG C-poly(A)
N o  significant similarity 
Tag-ACAGTTAATT PM SG  0 hCG 55
C A T G A C AG TTA ATTCCTTAG ATTAAGTTCAATTGGTATTG TAAATATTTTCAACTG A  
GTTTTTA ATTG A CA ATAA A TA AA ATA CC AC ATTATG CTG -poly(A )
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M atches to 483 bp m R NA , A ccession  number B F453690, GI: 11519859, M us musculus cD N A  
clone
Tag-CAGTCAATAC PM SG 212 hCG 30
C A T GC A G TCA ATA CTTTG TACAG TTAGTAG GCAG TATTCAGCAATG CCCGATAGCTT
C TTTCCGG TTATG TTAAATAAAAAG TCCTG TT-poly(A)
M atches to 457  bp m RNA, A ccession  number B B 821750, GI: 16994379, M us m usculus cD N A  
clone. M atches to U nigene cluster M m  290944.
A number of sequences do not produce a significant match when BLAST 
searched against EST sequences. These sequences do so when the SAGE tag is 
immediately against or in close proximity to the poly (A) tail, leaving little 
additional sequence information to be recovered by 3’ RACE. Further 
information about these can be acquired by sequencing the 5’ end of the gene as 
described in the next chapter. Among those sequences giving clue as to function 
is the EST matching to the SAGEtag GGAGCAGACC which shows similarity 
to the mouse cofilin sequence. The EST match for the SAGEtag 
CAGTCAATAC is also intriguing since it matches to a Unigene cluster (Mm 
290944) showing homology with a highly conserved noncoding human mRNA 
sequence. In addition this tag shows a selective expression pattern for the 
granulosa cell and has been investigated further (Chapter 4).
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3.6 Validation of SAGE results using Real Time PCR
Validation and further investigation of the SAGE results requires the use of 
another method of mRNA quantification - several are available. Hybridisation- 
based methods such as microarrays, northern blot, and in situ hybridisation are 
restricted by their requirement for large volumes of samples, by being labour 
intensive (Bird et al 1998, Duggan et al 1999), and by having a smaller dynamic 
range (Mimics et al 2001). The real time PCR method requires less sample 
volume and has previously been used for validation of larger scale gene 
expression studies and for more precise analysis of selected genes (Chuaqui et al 
2002).
Real time PCR is used to quantify cDNA produced by reverse transcription of 
mRNA. The reverse transcription reaction can be carried out using gene-specific, 
random, or oligo dT primers. Gene specific primers increase specificity and 
decrease background while random hexamers and oligo dT primers maxmise the 
number of mRNA molecules available for analysis (Bustin 2000). The reverse 
transcription step is the source of most variability between different reactions in 
quantative RT-PCR measurements (Freeman et al 1999). In order to minimise 
this variability a reference value can be used to adjust the obtained quantities of 
cDNA, this can be an added RNA standard of known amount added prior to the 
reverse transcription reaction, or the use of reference genes within the RNA 
sample.
Real time PCR measures the PCR product as it accumulates in the exponential 
phase of the reaction. The quantity is characterised by the point at which the 
amplified PCR product climbs above an arbitrary threshold (Ct). The greater the 
quantity of template, the sooner the PCR product level exceeds threshold. This is 
preferable to an endpoint measurement because the end PCR product quantity is 
sensitive to the reaction conditions, whereas during the exponential phase the 
reaction components are not limited; consequently Ct values are reproducible for 
reactions starting with the same copy number.
The PCR product can be detected by amplicon specific probes where 
fluorescence is released by removal of a quencher during the reaction.
160
T,
IAlternatively, DNA intercalating dyes such as ethidium bromide or SYBR green 
can be used. These dyes are not sequence specific and will intercalate in 
unspecific amplification products and in primer dimers, although it is possible to 
study melting curve profiles to detect these artefacts (Bustin 2000).
This study used the Taqman 5’ nuclease assay which utilises a probe, designed |
with a short sequence complementary to the sequence of interest, with both a 
fluorescent (5’) (FAM) and quencher dye (3’) attached (TAMRA). Prior to 
digestion of the probe by the PCR reaction the fluorescence is limited by the 
proximity of the quencher. As the reaction progresses fluorescence is released in 
direct proportion to the accumulation of PCR product. The higher the starting 
copy number of the nucleic acid target, then the sooner a significant increase in 
fluorescence is observed.
3.6.1 Method
The mRNA extractions, DNAase treatments and reverse transcriptions are 
performed as previously described. The reverse transcription in this case 
employed random hexamers to prime the reaction in order to maximise the 
number of mRNA molecules available for analysis (Bustin 2000). Although the 
reverse transcription step is the source of most of the variability inherent in 
quantitative RT-PCR the later use of an internal reference gene negates the need 
to analyse and adjust obtained quantities of cDNA or to include external RNA 
standards in the sample.
To validate differences in gene expression between SAGE libraries real-time 
PCR was used to measure relative mRNA levels of a number of transcripts. In 
eukaryotic cells the use of stably expressed housekeeping genes as standards 
allows for the relative quantification of gene expression (Bustin 2000). In this 
case the ubiquitous housekeeping gene Glyceradehyde-3-phosphate 
dehydrogenase (GAPDH) was used as standard. GAPDH is one of the classical 
normalisation genes and has been shown in microarray studies to be the most 
invariable housekeeping gene (Lee et al 2002). In both SAGE libraries the 
expression levels of GAPDH were similar. The use of mRNA is preferable to the 
more stable ribosomal RNA which constitutes almost 90% of the total cellular
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RNA and is therefore present at a far more abundant level, complicating 
comparison with mRNA which constitutes only 3-5% of cellular RNA (Alberts 
et al 1994). At the time of this study we lacked the equipment necessary to carry 
out multiplex PCR which would have allowed the reference gene to be measured 
in the same reaction as the gene of interest, with the advantage that PCR 
variability would be similar for both ampilcons, but also with the risk of primer 
interference between reactions.
In order to calculate a relative copy number from the Ct values we created 
standard curves fi"om which to the measure amplification efficiency of a diluted ■1series of samples. The DNA concentrations in these samples are relative, not 
absolute, values since an arbitrary quantity is sufficient. In this study a serial 
five-fold dilution was employed. For each standard the concentration was plotted 
against the cycle number at which the fluorescence increased above the threshold 
value (Ct value). An efficiency of one reflects a doubling of the product in each 
PCR cycle.
Each mRNA sample was prepared firom the granulosa cells of 2 normal female 
mice which had undergone superovulation at 20 days of age with either PMSG 
or PMSG/hCG combination and collected at 48 hours or 12 hours post PMSG or ;hCG injection as for SAGE library construction. Each group contained 5’ RNA 
samples. These samples were DNAase treated (Ambion, UK) and checked for 
genomic contamination using the GAPDH primers and probe for real time PCR.
If any amplification was detected then samples were retreated and rechecked. No 
sample had to be treated more than twice in order to remove genomic 
contamination.
The primer and probe sequences used for this analysis are as listed in table 3.7.
These sequences were either as previously published, or if novel, designed using 
Primer Express (Applied Biosystems, Warrington, UK) with sequence 
information obtained from Genbank or in the case of the transcript associated 
with the SAGE tag CAGTCAATAC from RACE analysis of SAGE data.
Real time PCR’s were carried out in a 25 (xl reaction volume in a 96 well plate 
format. The reaction was performed in Ix GeneAmp PCR Gold Buffer and 
6.25mM magnesium chloride solution (both Applied Biosystems), 200{iM
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dNTP’s, 300nM of each primer, 200nM of probe and 0.15 units of enzyme 
(Amplitaq Gold; Applied Biosystems, UK) per 25gl reaction volume. A 
reference dye, Rox, was included in these reactions at a concentration of 
60nmol/L. The thermal profile consisted of an initial 10 minute 95*C 
dénaturation then 40 cycles of 95°C for 15 seconds dénaturation with a 60°C 
extension step. Thermal cycling and flouresence detection was perfonued on a 
Stratagene MX3100P machine and reaction efficiencies were calculated using 
the Stratagene MX3100P software (Stratagene, UK).
3.6.2 Results
Standard dilution series for the gene of interest and GAPDH were produced on 
each reaction plate and the associated standard curves and reaction efficiencies 
are shown in figure 3.16 for each reaction.
Each sample was run in duplicate and 6 samples from each time point (48hrs 
post PMSG injection and 12hrs post hCG injection) were collected, each 
consisting of granulosa cells from 2 normal superovulated mice. The mean 
values from the duplicate reactions, adjusted with reference gene GAPDH, are 
shown in Table 3.8 for each sample. The overall mean value between samples 
was used to calculate relative fold change in expression between the two time 
points.
The expression changes reveal genes both upregulated and downregulated within 
the two sample groups. The steroidogenic enzymes show an expected pattern of 
change, as do the gonadotrophic hormone receptors. These results show that 
there is good correlation between data obtained by real-time PCR and data 
derived from SAGE libraries (figure 3.18).
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Table 3.7 Sequences of real-time PCR primers and probes used in this study.
Gene Primer/Probe Sequence
Aromatase Forward
Reverse
Probe
CCGAAAAAGAATGACCTGTCCTT
TTGTCTGAATTCCTTGGAGAGAAAA
CACCCAAATGAGGACAGGCACCTTGT
Unmatched 
SAGE tag
Forward
Reverse
Probe
TTCTTTAACCAATGTCTGGCTAATG
TCCAACCGTTATCTCTTTAAACATAT
TGAGTGCATTTCAACTATGTCAATGGTTTCTT
Kit ligand Forward
Reverse
Probe
GCCGGCAATGCCATG
AGGTCCCGAGAAAGGGAAA
CTGTCAATTGTAGGCCCGAGTCTTCA
FSH
receptor
Forward
Reverse
Probe
GGCGGCAAACCTCTGAACT
CCAGGCTGAGTCATATCATCAATATC
CATCCAATTTGCAACAAGTCTATTTCAAGGCA
LH receptor Forward
Reverse
Probe
GACCAAAAGCTGAGGCTGAGA
CAATGTGGCCATCAGGGTAGA
TGCCATCCCAATTATGCTCGGAGGA
Wbscr 1 Forward
Reverse
Probe
CTGCAATGTCCACACGAAGTG
TCCCTGAAGGAGGCTCTGACT
CCGGTCACCCAAGAGTGCACCG
Cholesterol 
side chain 
cleavage
Forward
Reverse
Probe
CCAGTGTCCCCATGCTCAAC
TGCATGGTCCTTCCAGGTCT
TGCCTCCAGACTTCTTTCGACTCCTCAGA
GAPDH Forward
Reverse
Probe
TGCCCCCATGTTTGTGATG
TCATGAGCCCTTCCACAA
TTGTCAGCAATGCATCCTGCACCAC
StAR Forward
Reverse
Probe
CCGGAGCAGAGTGGTGTCA
CAGTGGATGAAGCACCATGC
CAGAGCTGAACACGGCCCCACC
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Gene of inteiesl 4  GAPDH
GAPDH and Cholesterol side 
chain cleavage enzyme
30 =
1000
Reaction Eflkâency 
GAPDH 105%
Choleatarol see 105%
GAPDH and Wbscrl
40
35
I  30 
O 25
20
15
10 too 10001
O uB ftty
GAPDH and Non cocfing iranscnpl
5 2S
10001 10 100
O u a m iy
GAPDH and Aromatasa
40
O 25
10 ICO
Q u a r tty
1000
Reaction Efficiency 
GAPDH 82%
W bscrl 101%
Reacton Efficiency 
GAPDH 104%
NO Transcript 102%
Reaction Efüctency 
GAPDH 101%
Aromatase 101%
Figure 3.17 Standard curves and reaction efficiencies for real time PCR reactions
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■ Gene of interest 4  GAPDH 
GAPDH and 3 b e t a  HSD 1
GAPDH and StAR
1000
O uartlY
lOOO
Reaction Efficiency 
GAPOH 91%
3 beta HSD 1 110%
Reaction Efficiency 
GAPDH 95%
StAR 107%
GAPDH and LH Receptor
1000
GAPDH end FSH Receptor
O 2S
100010 1001
Querttv
Reaction Efficiency 
GAPDH 94%
LH Receptor 90%
Reaction Efficiency 
GAPDH 94%
FSH Receptor 09%
Figure 3.17 cont’d. Standard curves and reaction efficiencies for real time PCR 
reactions
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Table 3.8 Real time PCR results for genes of interest relative to GAPDH expression 
PMSG treated granulosa cell samples
S a m p le  1 S a m p le  2 S a m p le  3 S a m p le  4 S a m p le  5 S a m p le  6 M ean S E M
FSH receptor 18.9 19 19.4 35.7 14.4 40 24.6 10.5
LH receptor 64.3 98.6 196.5 416 .4 271.7 332.6 230 136.3
W bscr 1 312.1 185 140.1 387 153 119.5 216.1 108.1
StAR 17.3 6 127.2 10.2 61.6 25.7 41.3 46.5
Cholesterol 
P 450 see 159.8 104.4 158.8 101.9 261.5 104 148.4 61.8
Aromatase 7.9 19.1 30.5 21.7 13.4 27.2 20 8.4
3b-H SD  1 86.1 51.2 79.5 42.5 78 89.2 70.6 19.4
N on-coding
transcript 102.6 530.3 271.7 519.4 356 697.4 412.9 212 .4
PMSG and hCG treated granulosa cell samples
Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 M ean SEM
FSH receptor 8.5 7.6 16.9 7.2 10.1 15.7 11 4.2
LH receptor 277.8 355.8 189.7 306 917 38.7 347.5 300.4
W bscr 1 90.2 111.9 180.5 498.3 729.5 118.8 288.2 264 .4
StAR 219.9 184.2 192.1 308.9 386.9 32.8 220.8 120.7
C holesterol 
P 450 see 611.3 1681.8 979.4 1144.7 491.4 84.5 832.2 559.5
Aromatase 2.2 2.1 1.1 1.4 1.5 3.7 2 0.9
3b-H SD  1 21.2 11.2 25.7 22 25.9 49.8 17.3 12.8
N on-coding
transcript 52.9 315.3 25.2 157.7 49.4 124.1 120.8 107.7
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Figure 3.18 Comparison of SAGE and QRT-PCR expression levels
-10
-15
□ RTPCR ■ SAGE
« 10
transcript Aram 3pHSD 1
wbscrl Cholscc
mRNA sp e c ie s
168
Chapter 4
Investigation of the non coding 
transcript associated with the SAGE tag
CATGCAATAC
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Chapter 4: Investigation of non coding transcript associated with the SAGE 
tag CAGTCAATAC
4.1 Rationale for study
This particular tag warranted further investigation not only because it was the 6* 
highest transcribed sequence in PMSG treated granulosa cells and significantly 
differentially expressed during lutéinisation but also because the 3’race data 
matched this tag to a unigene cluster (Mm.290944) showing 95% homology with 
a highly conserved noncoding human mRNA sequence. In addition this tag is not 
highly expressed in other mouse SAGE libraries, suggesting a selective 
expression within the granulosa cell.
Initially this investigation required the full length sequencing of the cDNA 
transcripts, followed by identification of the genomic location using 
bioinfomatical methods (BLASTn). The analysis of temporal and tissue specific 
expression was carried out using real time PCR and finally cellular localisation 
was achieved by in situ hybridisation.
4.2 Full length sequencing of non coding transcript
The 5’ RACE procedure (figure 4.1) allows the 5’ extension of cDNA fragments 
using a single gene specific primer from the 3’ end of a cDNA sequence. This 
procedure was performed using the SMART RACE cDNA Amplification Kit 
(BD Biosciences, UK).
The 5’ primer utilises a oligonucleotide containing multiple G residues on the 5’ 
end which anneal to multiple C residues left by the reverse transcritpase enzyme 
on the first strand cDNA and serves as an extended template for extension by the 
reverse transcritpase enzyme. This incorporates an extended oligonucleotide 
sequence at the 5’ end which can subsequently be used for PCR amplification in 
conjunction with a 3’ gene specific primer. The only requirement for performing 
this procedure is that enough 3’ sequence information is available to enable the 
design of at least one but preferably two nested gene specific primers.
The SMART RACE reaction kit (Clontech, UK) allows for further amplification 
by providing a nested SMART oligo primer.
The 5’ RACE was carried out using RNA collected from the granulosa cells of 9 
female mice 48 hours after PMSG treatment as previously described for SAGE.
mRNA
I
-P olyA  3'
First strand synthesis with 
terminal addition of dC to 3' end 
of cDNA
5'-cccc- Poly A 3'
Oligo dT 
primer
mRNA discarded
'PolyA 3'
Template switched and new 
cDNA synthesised 
incorporating additional 
oligonucleotide sequence
SMART Oligo 
5'— GGGG- 
CCCC
RTase extension
Generation of template cDNA containing common 5' primer
y GGGG'
I Oligo dT primer
-polyA 3'
SMART oligo pnmer I Gene specific primer
PCR Amplification 
of sequence of interest 
using gene specific primer
Figure 4.1 Schematic illustration of 5’ RACE. Synthetic oligonucleotide 
(SMART) hybridises to the 5’ end of reversed transcribed cDNA by means of a 
short poly(C) tail and is extended in the 3’ direction.
Isolated RNA solution (3|ll), l|ll 5’ CDS primer (12pM), Ipl of the BD SMART 
II oligo (12pM )(sequences listed in table 4.1) were mixed by pipetting and 
collected by pulse spinning, heated to 70°C for 2 minutes to remove secondary 
structure and then cooled on ice for 2 minutes to allow annealing. Added to this
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mixture were 2\i\ 5x first strand buffer (250mM Tris HCl, 375mM KCl, 30mM 
MgCla), l|il DTT (20mM), Ipl dNTP mix (lOmM) and Ipl BD Powerscript 
RTase to give a total reaction volume of lOjiL The reaction was gently mixed, 
pulsed and incubated at 42°C for 90 minutes, 20|xl tricine/EDTA buffer (lOmM 
tricine, ImM EDTA) was then added and the reaction heated to 72°C for 7 
minutes. This provided the PCR template for subsequent amplification using 
gene specific primers.
PCR amplification of gene specific sequence was carried out using 0.5p.l of 
20mM gene specific primer (table 4.1) in a SOpl reaction mix containing 34.5|iil 
rtH20, 5pi BD Advantage 2 PCR Buffer, Ipl dNTP mix (lOmM), 5pi Universal 
Primer Mix (long primer 0.4pM, short 2pM), Ipl BD Advantage 2 Polymerase 
Mix (All BD Biosciences, UK) and 2.5pl cDNA template from the 5’ RACE 
amplification. Negative controls were set up without one of the two primers. 
Cycling parameters were 94°C for 30 seconds followed by 72°C for 3 minutes 
repeated for 5 cycles, then another 5 cycles of 94°C for 30 seconds, 70°C for 30 
seconds, followed by 72°C for 3 minutes, and finally 25 cycles of 94°C for 30 
seconds, 68°C for 30 seconds, followed by 72°C for 3 minutes.
Table 4.1 Primer seauences for 5’ RACE
Primer Sequence (5’ to 3’)
B D  SM ART II 
O ligonucleotide A AG CAGTGG TATCAACGCAG AG TACGCGG G
5 ’ RACE CDS 
Primer (T)25V N  (N = A ,C ,G ,T ;V = A ,G ,C )
U niversal Primer 
M ix
CTAATACG ACTCACTATAGG GCAAGCAG TG GTATCAACG CAGAGT
CTAATACGACTCACTATAGGGC
N ested  UPM CTAATACG ACTCACTATAGG GC
Gene Specific 
Primer for 
C AG TCAATAC
TAACATAAG G CCAAAG AAG CTATCG G G CATTG CTG AATACTG C
N ested  GSP for 
C AG TCAATAC
ATCGGGCATTGCTGAATACTGC
Products were visualised on a 1% agarose gel containing ethidium bromide using
u.v. light. In this particular case the 5’ RACE reaction gave a smear between the 
300bp and 700bp markers.
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The PCR product was diluted in Tricine-EDTA buffer (5pl in 245pl Tricine- 
EDTA) and reamplified using the Nested Universal Primer Mix (Ipl, lOpM) 
(BD Biosciences, UK) and the nested gene specific primer (Ipl, lOmM) (table 
4.1). The reaction mixture was composed of 36pl rtHiO, 5pi BD Advantage 2 
PCR Buffer, Ipl dNTP mix (lOmM), ipl BD Advantage 2 Polymerase Mix (All 
BD Biosciences, UK) and 5pi cDNA template. Cycling parameters of 94°C for 
30 seconds, 68°C for 30 seconds, followed by 72°C for 3 minutes for 20 cycles 
were employed. The product was visualised on 12% polyacrylamide gel to reveal 
a smear of multiple products ranging from 200bp to 600bp in length (figure 4.2). 
The PCR product was TOPO cloned, electroporated into DHIOB E.coli cells 
(Invitrogen, Paisley, UK) and vector insert PCR amplified and sequenced as 
previously described using M13R and M13F primers for amplification and 
M13R for sequencing.
lOObp 5 'RACE
ladder product
BOObp
lOObp
Figure 4.2 12% PAGE gel showing nested 5’RACE reaction products 
alongside 1 OObp ladder
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5 ' RACE Results
The sequenced transcripts were compared and aligned using NCBI BLAST (web 
address). All 81 sequenced transcripts had a constant sequence with variable 5’ 
lengths. The longest sequence is shown in figure 4.3 with the Nla III site and the 
adjacent SAGE tag highlighted in red. The sequence length of the transcript 
varied from 70bp to 682bp, with a mean of 264bp (the distribution is shown in 
figure 4.5). This sequence contains no open reading fi-ame suggesting it may 
function as an untranslated mRNA.
Its genomic sequence is located on chromosome 13 (bases 15480202-15480884) 
approximately 3500 bp downstream of the inhibin j3A subunit (figure 4.3), a 
component of both the inhibin and activin peptide hormones. Comparison of the 
rat, mouse and human genomic sequence is shown in figure 4,6
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5 prime-aaatttaatttgggacatagtgactcttcgataacctccccagtctctattacttacg
t a t c t a c g a c a a g t g t a g a a g t t c t c g t t t t c g t t t a g t g c a c a g a g t c g a t a t a a t a a t a a a t a  
a a a a t a c g t a t t t c a c t t a g t a a a g a a g a c a t a a t t a a a a g t c a c c c c a a a c g g g a g a t a a a t t t  
a c g a a a c t t t t t g t c a c g t a a c t g t t a c c a a c t a t a a a a a g a a a t t t t c t t t t t a t a t t a a t a c t  
t t c g g t t a t a t t a g a c t t t a g a c a a a a c t a g a t t t t g a a a a a t a c a a t a c a c c a a c t a c a a c a a a  
c a a a c a a a a a a t a a a a a t a a a a c a c t c a a g g a a a c g t a t g a t g t a c g t t a a g a a a t t g g t t a c a g  
a c c g a t t a c a t t a a t t t c a a c a a t t a a a t a t a c t c a c g t a a a g t t g a t a c a g t t a c c a a a g a a t t  
a t a a a t a a a a c a t c t t c a c g a c c a t t a a a a a a t a a a t g c t a t a c a a a t t t c t c t a t t g c c a a c c t  
a t a c a a a a g t a c a c a a a t a t c g t c t t c a a t a a a t a a a g a t a a g g t a a g g t c g c c t a t a a g a c t a c  
a a a c g c t c c g t a c g t c a g t t a t g a a a c a t g t c a a t c a t c c g t a c t a a q t c g t t a c q q q c t a t c q a  
a g a a a c c g g a a t a c a a t t t a t t t t t c t g g a c a a a c c c t a - 3  p r i m e
Figure 4.3 682 bp sequence for transcript associated with the SAGEtag 
CAGTCAATAC. The SAGE tag is highlighted in red and the hairpin fold in 
black.
Inhibin PA subunit  NC
G e n e s  ,_ _ _ _   I_ _ _   _L
C hrom osom e 13
s  s
Figure 4.4 Genomic location of noncoding transcribed fragment (NC) in 
relation to inhibin pA subunit
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Figure 4.5 Variation in size of noncoding transcripts
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1 5 0
h u m a n  CATCCCAAAC AGGTCTTTTT ATTTAACATA AGGCCAAAGA AGCTATCAGG
m o u s e  CATCCCAAAC AGGTCTTTTT ATTTAACATA AGGCCAAAGA AGCTATCGGG
r a t  CATCCCAAAC AGGTCTTTTT ATTTAACATA AGGCCAAAGA AGCTATCGGG
5 1
h u m a n  C G T T G C T G A A .......................AC
m o u s e  CATTGCTGAA TACTGCCTAC 
r a t  CATTGCTGAA TACTGTCTAC
101
h u m a n  GCAAACACCA AAATATCCGC 
m o u s e  GCAAACATCA GAATATCCGC 
r a t  GCAAACACCG GAGTATCTGC
TAACTGTACA
TAACTGTACA
TAACTGTACA
TGGAATGCCA
TGGAATGGAA
TGGAATGGAA
100
AAATATTGAC TGCATGCCTC 
AAGTATTGAC TGCATGCCTC 
AAATATTGAÇTGÇATGCCTC
Mouse SAGEtag 1 5 0
TAGAAATAAA TAACTTCTGC 
TAGAAATAAA TAACTTCTGC 
TAGAAATAAA TAACTTCTGC
1 5 1  2 0 0
h u m a n  TATAAACACA TGAAAACATA TCAAACTGTT ATCTCTTTAA ACATATTGTA 
m o u s e  TATAAACACA TGAAAACATA TCCAACCGTT ATCTCTTTAA ACATATCGTA 
r a t  TATAAACACA TGAAAACATA TCCAACCATT ATCTCTTTAA ACATATCGTA
2 0 1  2 5 0
h u m a n  AATAAAAAAA TTACCAGTAC TTCTACACAA TAAATATTAA GAAACCATTG 
m o u s e  AATAAAAAA. TTACCAGCAC TTCTACAAAA TAAATATTAA GAAACCATTG 
r a t  AATAAAAAA. TTACCAGCAC TTCTACAAAA TAAATATTAA GAAACCATTG
2 5 1  3 0 0
h u m a n  ACATAGTTGA AATGCACTCA TATAAATTAA CAACTTTAAT TACATTAGCC 
m o u s e  ACATAGTTGA AATGCACTCA TATAAATTAA CAACTTTAAT TACATTAGCC 
r a t  ACATAGTTGA AATGCACTCA TATAAATTAA CAACTTTAAT TACATTAGCC
3 0 1  3 5 0
h u m a n  AAACAGACAT TGGTTAAAGA ACTGCATGTA GTATGCAAAA CAAAACAAAA
m o u s e  A GACAT TGGTTAAAGA ATTGCATGTA GTATGCAAAG G A A C T C A .. .
r a t  AAACAGACAT CGGTTAAGGA ATTGCATGAA GTATGCAAGG G A A C T C A .. .
3 5 1  4 0 0
h u m a n  CAAAACAAAA AACAAAGTAA AAAACCAACA AAATAGAAAC AAACAAACAA
m o u s e  CAAAATAAAA A .................TAA AAAAC  AAA........................................... CAA
r a t  CAAAATAAAA A T A A .. . .A A  AAAAC  AAA...........................................CAA
4 0 1  4 5 0
h u m a n  ACAACATCAA CCACAGAACA TAAAAAGTTT TAAAATAAAA CAGGCTTCAG 
m o u s e  ACAACATCAA CCACATAACA TAAAAAGTTT TAGATCAAAA CAGATTTCAG 
r a t  ACAACATCAA CCACATAACA TAAAAGGTTT TAGAACAAAA C A G A .TTCAG
h u m a n
m o u s e
r a t
h u m a n
m o u s e
r a t
4 5 1
ATTATCTTGG
ATTATCTTGG
ATTATCTTGG
5 0 1
CCATTGTCAA 
C . ATTGTCAA 
C . ATTGTCAA
CTTTCATAAT
CTTTCATAAT
CTTTCATAAT
TGCACTGTTT
TGCACTGTTT
TGCACTGTTT
5 0 0
TATATTTTTC TTTTAAAGAA AAATATCAAC 
TATATTTTTC TTTTAAAGAA AAATATCAAC 
TATATTTTTC TTTTAAAGAA AAATATCAAC 
Hairpin fold sequence
5 5 0
TTCAAAGCAT TTAAATAGAG GGTAAAACCC 
TTCAAAGCAT TTAAATAGAG GGCAAACCCC 
TTCAAAGCAT TTAAATAGAG GGTAAGACCC
Figure 4.6 Homology between noncoding transcript in mouse, rat and human 
DNA. Identical regions have yellow background.
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5 5 1  6 0 0
h u m a n  TTTGGAAATT AATACAGAAG AAATGATTCA CTTTATGCAT AAAAAÀTAAA
m o u s e  ACTGAAAATT AATACAGAAG AAATGATTCA CTTTATGCAT ÀAAAA.TAAA
r a t  ACTGAAGATT AATACAGA. G AAÀTTATTCA CTTTATGCAT ÂAÀÀA.TAÀA
6 0 1  6 5 0
h u m a n  TAATAATATA GCTGAGACAT GTGGTTTGCT TCTGCTCTTG AAGATGTGAJ!.
m o u s e  TAATAATATA GCTGAGACAC GTGATTTGCT TTTGCTCTTG AAGATGTGAJ.
r a t  T A A T ...A T A  GCTGAGACAT GTGATTTGCT TTTGCTCTTG AAGATGTGAi.
6 5 1  7 0 0
h u m a n  CAGCTTCTAA GCATTCATTT TCTCTGACCC ATACAACAGC TTCTCAGTGA
m o u s e  CAGCATCTAT GCATTCATTA TCTCTGACCC CTCCAATAGC TTCTCAGTGA
r a t  CAGCATCTAT GCATTCATTA TCTCTAACCC ATCCAATAGC TTCTCGGTGA
7 0 1  7 5 0
h u m a n  TACAGGGTTT AATTTAAACA CATACAATGT CCACCCCCAA ACCTTCTGCC
m o u s e  TACAGGGTTT AATTTAAACA CATACAATGT CCATCCCCCA ACCTCCTGCC
r a t  TGTAGAGTTT AATTTAAACA CATACAATGT CCATCCCCAA A C C T C C T G ..
Figure 4.5 cont’d. Homology between noncoding transcript in mouse, rat and 
human DNA. Identical regions have yellow background.
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4.3 Expression study of the non-coding transcript in multiple tissue 
types.
In addition to validation of the SAGE libraries, real time PCR was used to 
examine the expression pattern of the non-coding transcript represented by the 
sage tag CATGCAATAC. A range of tissue samples from male and female mice 
underwent RNA isolation, DNAase treatment and reverse transcription as 
previously described. Real time PCR was performed following the protocols 
listed in chapter 3 and using the primer/probe set already described (table 3.7) 
Two separate samples of each tissue were collected and again each reaction run 
in duplicate. Standard curves were included on the same reaction plate to 
determine amplification efficiency, a typical example of one curve is shown in 
figure 4.7.
The expression of this transcript, relative to GAPDH, is present in a number of 
tissues, the highest expression levels being in the spleen and adult ovary. The 
ovaries used in this experiment were taken from normal adult cycling females 
and had grossly visible follicular development; the expression of this transcript 
in this tissue is therefore expected. The uterus, lung and small intestine also 
recorded a comparatively high degree of expression, with minimal levels in the 
heart, epididymis, brain, liver and bladder (table 4.2 and figure 4.8).
■ Gene of interest ♦GAPDH
Quarttty
Reaction Efficiency 
GAPDH 100%
NC Transcript 114%
Figure 4.7 Standard curve and amplification efficiency for typical QRT PCR 
reaction between GAPDH and noncoding transcript.
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Tissue type Duplicate samples Mean
Testes 0.31 0.21 0.26
Epididymis 3.47 2.99 3.23
Brain 0.62 0.41 0.52
Lung 103.7 12.8 58.2
Heart 0.81 0.68 0.74
Liver 0.69 2.18 2.87
Kidney 0.22 0.1 0.16
Adrenal 0.06 0.21 0.14
Bladder 0.98 0.77 0.88
Small Intestine 13.2 11.8 12.5
Skeletal Muscle 0.18 0.65 0.42
Spleen 76.9 280.3 178.6
Adult ovary 67.2 124.6 95.9
Uterus 13.1 21.6 17.35
Table 4.2 QRT PCR results of expression levels of noncoding transcript
relative to GAPDH
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Figure 4.8 Expression levels of noncoding transcript relative to GAPDH
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4.4 Temporal expression of noncoding transcript within ovarian 
tissue
The expression pattern of this transcript can be assessed at each stage of follicle 
development by using neonatal and juvenile mouse ovaries. The newborn mouse 
ovary contains only primordial follicles. By post-natal day 20 a number of 
follicles have developed to antral follicle stage. Neonatal mouse ovaries 
therefore contain uniform follicle populations of similar sizes as determined by 
the number of days after birth (Sorensen et al 1976; Epigg 1991, Mannan and 
O’Shaughnessy 1991). The gonadotrophin-induced mouse model using PMSG 
and hCG at 20 days old, before the animal has entered its own oestrus cycle, 
simplifies the staging and collection of uniform populations of cells. In order to 
study the expression of this transcript during follicular development we collected 
whole ovaries from day 1, 3, 5, 7, 10, 15 and 20 neonatal mice to give a series of 
ovaries containing follicle populations which mimic primordial to antral follicle 
development (Mannan and O’Shaughnessy 1991). Following on from this day 20 
mice injected with PMSG intraperitoneally were taken at 6, 12, 24, 36 and 48 
hours post injection and whole ovaries harvested. Mice 48 hours after PMSG 
were then administered hCG (following the protocol used for SAGE library 
generation) and ovaries recovered at 2, 4, 8 and 12 hours post injection. Ovaries 
were recovered from 2 animals per sample at each time point, 4 duplicate sample 
series were collected. This produced a collection of samples which follow 
primordial to preovulatory follicle development. Real time PCR was performed 
using the previously stated protocols and primer/probe sets, all reactions were 
run in duplicate.
The results show (table 4.3, figure 4.9) that expression is not detectable in the 
post natal mouse ovary until day 15, rapidly increasing with the development of 
antral follicles by day 20. Following PMSG stimulation there is a gradual 
increase throughout antral follicle development, peaking 48 hours post injection 
and then a rapid decrease during the 12 hours immediately following hCG 
administration as the granulosa cells undergo lutéinisation.
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The lower level of relative expression of the non coding transcript in the sample 
taken 6 hours after PMSG injection compared to the day 20 neonatal mouse can 
perhaps be explained by a likely increase in GAPDH expression levels 
associated with the hormonally induced increasingly follicle mass and cell 
proliferation generated by the exogenous PMSG.
Time 4 Duplicate T issue Sample Sets Mean SEM F ollicle stage
A ge o f  m ouse  
days after birtli dayl 0 0 0 0 0 0 Primordial
day 3 0 0 0 0 0 0
day 5 0 0 0 0 0 0 Primary
day 7 0 0 0 0 0 0
day 10 0 0 0 0 0 0 Secondary
day 15 36.8 18 1.3 22.6 19.7 14.6
day 20 88.1 100 119.1 80.8 97 16.7 Antral
5iu PM SG given  
i/p to d20 m ice PM SG 6h 69.1 59 25.6 81.1 58.7 23.8
PM SG 12h 55.2 75 88.1 133 87.8 33.0 Mature antral
PM SG 24h 60.6 90 52 179.2 95.4 58.2
PM SG 36h 64.5 97 128.1 107.3 99.2 26.5 Pre-ovulatory
PM SG 48h 178 164 131.7 185.6 164.8 23.8
15 iu hCG given  
i/p 48 hours after 
PM SG  injection
hCG 2h 115.4 118 104.4 152.8 122,6 20.9
hCG 4h 69.1 82 67.9 106.9 81.5 18.1
hCG 8h 10.3 14 1.2 30.2 13.9 12.1
hCG 12h 11.7 12 5.6 16.3 11.4 4.4 Luteinising
Table 4.3 Real time PCR results showing expression of the noncoding transcript relative 
to GAPDH in staged whole ovary samples from neonatal mice and following exogenous 
hormone administration.
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200
PMSGt hCG Ovulation ♦  ♦
Hours after PMSGDays after birth Hours after hCG
Figure 4.9 Real time PCR results showing expression of the noncoding transcript 
relative to GAPDH in staged whole ovary samples from neonatal mice and following 
exogenous hormone administration.
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4.5 In situ Hybridisation
Tissue complexity is an additional factor that affects the reliability of RNA 
quantity measurement. In situ hybridisation is a powerful technique allowing the 
localisation of specific nucleic acid sequences in morphologically fixed 
biological samples. The ability to detect the distribution of mRNA within tissues, 
and indeed within cellular compartments, allows evaluation of differential and 
spatial gene expression. In our case it is useful in validating the SAGE and real 
time expression data for the non-coding transcript associated with the SAGE tag 
CAGTCAATAC and confirming localisation of this transcript to the granulosa 
cell.
Our protocol utilised synthetic oligonucleotide probes (MWG Biotech) instead 
of the less stable riboprobes. DEPC (diethylpyrocarbonate) treated water was 
used in preparation of all solutions and standard procedures (baked glassware, 
disposable gloves) were used to avoid RNase contamination.
Method
Tissue and slide production
Normal d20 mice were administered 5IU PMSG intraperitoneally to induce 
superovulation and ovaries removed following euthanasia 48hrs post injection. 
Normal fertile cycling adult mice and normal last third trimester pregnant adult 
female ovaries were also freshly collected following euthanasia. Ovaries were 
immersed in 4% paraformaldehyde for 90 minutes and then transferred to 70% 
alcohol prior to wax embedding.
Embedded tissue was sectioned in slices 7pm thick and mounted by flotation in a 
37°C waterbath onto Superffost Plus microscope slides (BDH Laboratories) and 
stored at 4°C until use. Sections from 4 normal, 6 PMSG treated and 2 pregnant 
mouse ovaries were mounted on each slide.
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Probe preparation
Synthetic oligonucleotide probes corresponding to the sense and antisense 
sequence of the common 3’ end of the cDNAs sequenced by 5’ RACE were 
radioactively labelled with using terminal deoxynucleotide transferase (TdT) 
(Roche, UK).
Sense probe sequence (SAGE tag underlined)
TAACTGTACAAAGTATTGACTGCATGCCTCGCAAACATCA 
Antisense probe sequence
ATTGACATGTTTCATAACTGACGTACGGAGCGTTTGTAGT
4jil oligonucleotide probe (25ng/|il), 5|0,1 TdT Tail Buffer (IM Potassium 
cacodylate, 125 mM Tris-HCl, 1.25 mg/ml BSA) (Roche, UK), 1.5jil C0 CI2 
(25mM), 1.5|il terminal transferase (400U/pL) (Roche, UK) and 2p,l of 
radiolabelled^^S ATP (25qCi/0.925MBq) (PerkinElmer, USA) were combined in 
a reaction volume of 24.5jal, incubated at 37°C for 30 minutes and then placed 
on ice. The oligonucleotide was then separated from the reaction mix using 
Biospin 6 columns (Bio-Rad Laroratories) according to manufacturers 
instructions, recovering approximately 25 pi of probe in each case.
0.5pl of radiolabelled probe was added to 5ml of Ecosinct A scintillation fluid 
(National Diagnostics, UK) and beta radioactivity measured using a 1600TR 
Liquid Scintillation Counter (Packard Bioscience, UK). Counts for the sense 
probe were 317628 and the antisense 259002, corresponding to a total count of 
635256 counts per pi for the sense probe and 518004 counts per pi for the 
antisense probe. Probes were stored at -20°C until use (usually within 48 hours).
Slide Preparation
Slides were warmed to room temperature from 4°C then dewaxed by twice 
immersing in histoclear (National Diagnostics, UK) for 10 minutes. Hydration 
by immersion in decreasing concentrations of ethanol was followed by tissue 
digestion using hydrochloric acid and proteinase K, fixation with
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parafonnaldehyde and then dehydration though an alcohol series as listed in 
table 4.4. Slides were then air dried under a dust cover for 1 hour prior to 
hybridisation.
Table 4.4 Protocol for insitu  hybridisation slide preparation
Step Solution Time
(miimtt
1 Histoclear 10
2 Histoclear 10
3 100% ethanol 5
4 90% ethanol 5
5 80% ethanol 5
6 70% ethanol 5
7 60% ethanol 5
8 30% ethanol 5
9 ddHîO 2
10 ddHîO 2
11 1/46 Hydrochloric acid 15
12 2xSCC 5
13 5ng/ral Proteinase K. in lOOmM Tris pH 7.5 ,50m M  EDTA at 37°C 10
14 Phosphate buffered saline 1
15 Phosphate buffered saline 1
16 4% parafonnaldehyde in PBS 20
17 Phosphate buffered saline 2
18 Acétylation using O.IM Triethanolainine containing 1/400 acetic acid stining continuously 10
19 Phosphate buffered saline 5
20 ddHzO 2
21 30% ethanol 5
22 60% ethanol 5
23 70% ethanol 5
24 80% etlianol 5
25 90% ethanol 5
26 100% ethanol 5
1
Hybridisation o f probe
The hybridisation buffer was prepared by combining 6ml H20, 5ml 20xSCC, 
12.5ml deionised fonnamide, 500pl 5Ox Denhardts solution (Invitrogen, UK) 
and 1ml salmon testes DNA (Invitrogen, UK) before adding 2.5g dextran 
sulphate then mixing thoroughly until dissolved. Probe was added to the 
hybridisation buffer at a ratio of 8pi per ml and 250pl of this solution was
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applied to each slide. This corresponds to just over 4 million counts per slide for 
both probes. Slides were covered with parafilm to prevent drying and incubated 
overnight at 37°C in a humidified container.
Following this the parafilm was removed and excess hybridsation buffer allowed 
to drain off. Slides were then rinsed in Ix SCC and mercapthethanol, H2O and 
ethanol according to the protocol in table 4.5. Slides were then air dried and 
stored at 4°C until émulsification.
Equal number of slides were treated with the sense and antisense control probe.
Table 4.5 Washing protocol for hybridised slides 
Step Solution Time
1 1X SCC with 0.001 % mercapthethanol at room temperature Rinse
2 1X SCC with 0.001 % mercapthethanol at room temperature Rinse
3 1X SCC with 0.001 % mercapthethanol place in 55°C water bath (do not pre wann) 30  minutes
4 Ix SCC with 0.001%  mercapthethanol at 55°C 30 minutes
5 Ix SCC with 0.001%  mercapthethanol at 55°C  30 minutes
6 Ix SCC with 0.001%  mercapthethanol at room tempeiature 60 minutes
7 H2O Rinse
8 70% ethanol with 300mM  ammonium acetate 30 seconds
9 100% ethanol 30 seconds
Emulsification
Emulsification was carried out using Ilford K5 emulsion diluted 1:1 with 2% 
glycerol warmed to 42“C under dark room conditions. Slides were dipped then 
placed on an ice cooled tray, in the presence of silica gel, to dry for 2 hours, then 
boxed and stored at 4°C until development. Developing and fixation was carried 
out using Kodak D19 developer and Kodak Unifix on days 2, 3 ,4 and 6 after 
émulsification. Slides were warmed to room temperature, immersed in D19 
developer for 5 minutes, rinsed in water, then immersed in Unifix solution for a 
further 5 minutes, rinsed once more in water then allowed to dry.
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Staining o f Slides
Staining was performed using haematoxylin and eosin by immersing slides in 
haematoxylin solution for 1 minute, washing in water, dipping once in acid 
alcohol solution followed by a 3 minute immersion in Scott’s tap water 
substitute, rinsed again in water, 20 seconds immersion in eosin stain, rinsed 
again in water then dehydrated in 70%, 80%, 90%, and 100% ethanol by dipping 
in each 10 times consectutively. Mounting covers were applied with DPX 
mounting media.
Results
In the PMSG treated ovaries there is widespread follicle development and high 
levels of expression of the transcript of interest throughout the granulosa cell 
population (figure 4.10). No hybridisation of the antisense probe is visible 
(figure 4.11). Ovaries taken from pregnant mice in the last trimester of gestation 
containing multiple mature corpus lutei do not demonstrate expression of this 
transcript other than in adjacent antral follicles. There is no detectable expression 
in the mature corpus luteum (figure 4.12). No hybridisation of the antisense 
probe is visible in any tissue (figure 4.13). In the nonnal adult ovary with no 
exogenous hormone treatment hybridsation can be seen on granulosa tissue 
within antral follicles (figure 4.14), again no hybridisation is visible with the 
antisense probe (figure 4.15).
Conclusion
The SAGE tag CAGTCAATAC relates to a variable length non eoding transcript 
which shows a tissue and temporal spécifié expression pattern within granulosa 
tissue. Highest levels of expression are found within the gonadotrophin 
stimulated mature antral follicle prior to the LH surge. Exogenous hCG 
administration leads to rapid downregulation of expression.
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Figure 4.10 Light field and dark field views of day 20 PMSG treated mouse 
ovary harvested 48 hours after PMSG administration and hybridised with sense 
probe
Figure 4.11 Light field and dark field views of day 20 PMSG treated mouse 
ovary harvested 48 hours after PMSG administration and hybridised with 
antisense probe.
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Figure 4.12 Normal adult mouse ovary during last trimester of gestation hybridised 
with sense probe.
Figure 4.13 Normal adult mouse ovary during last trimester of gestation hybridised 
with anti sense probe
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Figure 4.14 Adult mouse ovary hybridised with sense probe
Figure 4.15 Adult mouse ovary hybridised with anti sense probe
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Chapter 5
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Chapter 5: General Discussion
The application of SAGE alone and in combination with other methods has been 
proven to provide an accurate and representative method of gene expression 
analysis in a number of in vivo and in vitro systems. The objective of the work 
presented in this thesis has been to apply the technique of serial analysis of gene 
expression to identify the genes associated with the molecular changes of 
lutéinisation. This objective has, largely, been successfully achieved. The use of 
SAGE is effectively an efficient method of producing an EST library from a 
particular tissue. Each SAGE tag represents one polyadenylated RNA molecule 
and contains enough information to uniquely identify that molecule without the 
laborious cloning and sequencing required to generate true EST libraries.
The frequently quoted limitations of SAGE are based on the required labour 
input in comparison to microarray and the sequencing costs to generate libraries 
capable of analysing low expression genes. One intrinsic flaw is the possible 
generation of bias within a library either by preferential amplification of specific 
ditags during the PCR reactions, or loss of some ditag populations through 
melting of the double strand while handling. Ligated ditags serve as template for 
PCR amplification and errors generated by the DNA polymerase early in the 
reaction will be continuously replicated during the subsequent steps. In order to 
minimise this possibility our protocol adopts the use of nested primers for PCR 
amplification. The issue of ditag loss during handling, and in particular gel 
extraction, is addressed by adopting low temperature protocols. The 
electroelution lavage protocol need not be carried out at any higher than room 
temperature, and indeed can be performed at lower temperatures simply by 
adding chilled buffer should the operator consider it necessary.
I would also add one further criticism, that traditional data analysis of SAGE 
libraries, based on the generation of statistically differentially expressed tags (as 
performed here using the Chi squared test), takes no account of actual protein 
product levels, efficacy of gene product action, or gene product role within the 
cell. In the case of the SAGE libraries presented here many of the highly 
abundant or differentially expressed transcripts represent housekeeping or 
protein synthesis related genes (Table 3.1), while important members of the
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signal transduction pathways (discussed later) are found expressed at much 
lower levels. This means that effective analysis of SAGE data still requires using 
manual curation rather than relying on the currently available bioinformatics 
tools if we are not to overlook frequently important transcripts expressed at 
lower levels.
In defence SAGE is the only teclinique available which has the potential to allow 
the simultaneous quantative analysis of the large number of genes studied here 
(40,248 unique transcripts) and has the ability to do so without prior knowledge 
of transcript sequence or expression pattern. The quantification of tag expression 
provides a direct measurement regarding the expression level of the 
corresponding transcript, this measurement is represented by absolute tag counts 
based on random sampling of transeripts, uniquely allowing data comparison 
between different experiments if adjustment is made for the total number of tags
isequenced. SAGE thus has the theoretical ability to characterise the entire 
cellular transcriptome providing sufficient transcripts are sequenced.
5.1 Validation of SAGE method
A number of previous studies have examined the mechanisms of lutéinisation 
(Espey and Richards 2002, Rajapaksha et al 1997, Oksjoki et al 2001, Rodgers et 
al 1986, Hsieh et al 2003 and Park et al 2004) but have been restricted to a 
limited number of genes and have generally studied the expression patterns 
within the whole ovary rather than within spécifié cellular compartments. Where 
comparable, the results from previous studies correlate well with results reported 
here. From previous work and from this study it is clear that there are many 
genes involved in the functional regulation of granulosa cell differentiation. It is 
also clear that some of the genes expressed may only contribute in a temporal 
fashion and expression may only be required for a short, but crucial time point.
In this study the application of SAGE was restricted to time points before and 
after the induction of ovulation with hCG. While SAGE is unrivalled in its 
ability to detect unexpected and novel transcripts, even at low levels of 
expression, it is time-consuming and relatively expensive. This imposes a
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practical limitation on its use but nonetheless the data produced has yielded a 
comprehensive list of genes undergoing regulation during lutéinisation. This data 
will, serve as a baseline measurement for further studies into granulosa cell 
differentiation. For example, and as demonstrated in this thesis, a more complete 
analysis of transcripts likely to be of interest can easily be performed by studying 
their expression throughout the entire time course of follicle development and 
lutéinisation using real time PCR.
This study has characterised the expression of genes novel to lutéinisation, but 
also confirmed the expression pattern of many transcripts already known to be 
associated with this process. This in itself helps to validate the SAGE process. 
Table 5.1 lists a number of genes classically associated with either the granulosa 
or luteal phenotype whose changes in expression seen in the SAGE data match 
with previous work. Other studies (Espey and Richards 2002, Rajapaksha et al 
1997, Oksjoki et al 2001, Rodgers et al 1986, Hsieh et al 2003 and Park et al
2004) examining the molecular changes during lutéinisation have revealed a 
number of genes which are now known to be differentially expressed during this 
process. For example, several membrane binding and communication related 
components such as clusterin, annexin A2, and the gap junction membrane 
channel proteins (connexins) are known to show fluctuations in expression levels 
during granulosa cell development and lutéinisation. The overwhelming level of 
Cx 43 expression in the PMSG SAGE library supports current thinking that this 
is the primary means of intercellular communication between granulosa cells and 
reinforces the hypothesis of a functional granulosa cell syncitium throughout 
folliculogenesis (Ackert et al 2001). Expression of Cx 43 decreases markedly 
after induction of luteinisaton, as shown previously (Itahana et al 1996), 
although it may continue to be expressed in the developing corpus luteum 
(Khan-Dawood et al 1998). In addition the steroidogenic enzymes such as 
aromatase, StAR, and cholesterol side chain cleavage (Espey and Richards 2002, 
Rajapaksha et al 1997, Rodgers et al 1986, Pescador et al 1996), genes involved 
in extracellular remodelling including ADAMTS-1, cathepsin L (Espey and 
Richards 2002, Oksjoki et al 2001), and a variety of signalling molecules 
including epiregulin and secreted frizzled related protein 4 (Hsieh et al 2003,
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Park et al 2004) all display good correlation between SAGE and previously 
published data, confirming the reliability and accuracy of the SAGE method.
In approaching this I intend to break down this discussion into four main themes, 
focusing mainly on novel transcripts and pathways. First, approaching those 
genes involved in signalling and communication, secondly those responsible for 4granulosa cell survival, growth and regulation of proliferation, thirdly genes 
implicated in controlling cellular differentiation and finally I will consider some 
novel transcripts which may be involved in the remodelling of cellular and 
follicular structure.
j:Other areas of granulosa cell function will be mentioned only briefly, if at all, 
purely because the SAGE data largely supports current thinking without 
introducing a substantial quantity of new information. For example the 
steroidogenic functions of the granulosa cell are well documented and expression 
data presented here matches well to that previously presented elsewhere and 
consequently will not feature in this discussion.
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Table 5.1 Comparison of SAGE transcripts with known expression profiles
Gene
Change in gene expression 
level during lutéinisation 
according to SAGE data
References
Steroidogenesis
Aromatase
Cholesterol side chain
cleavage
StAR
Scavenger receptor class B
member 1
11PHSD2
Ferredoxin
17p HSDl
Low Density Lipoprotein
Receptor
17P HSD4
Signaling
LH receptor
GDF9
Epiregulin 
Connexin 43
Progesterone receptor 
Early growth response 1
Serum glucocorticoid 
regulated kinase
Remodelling
ADAMTS 1 
ADAMTS4 
Cathepsin L 
VEGF
Collagen type IV 
Integrins 
Syndecan 1
Others
Frizzled 1
Secreted frizzled related 
protein 4
CAAT enliancer binding 
protein beta (C/EBPP) 
Cell cycle inhibitor P21
Decrease
Increase
Increase
Increase
Decrease
Increase
Decrease
Increase
Increase
Increase
Decrease
Increase
Decrease
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Ronen-Fuhrmann et al 1995, Richards 
1994, O’Shaughnessy et al 1990, Snadhoff 
and Maclean 1996, Ronen-Fuhrmann et al 
1998, Rodgers et al 1986.
Li et al 1998
Tetsuka et al 1997 
Rodgers et al 1986 
Rodgers et al 1986
Golos et al 1986, Golos and Strauss 1987 
Brown 2004
Zeleznik et al 1974
Elvin et al 1999, Hayashi et al 1999, Vitt 
and Hseuh 2002 
Park et al 2004
Acket et al 2001, Itahana et al 1996 
Natraj and Richards 1993
Espey et al 2000
Alliston 2000, Gonzalez-Robayna 1999
Robker et al 2000, Espey et al 2000
Abbaszade et al 1999
Robker et al 2000
Schams et al 2001
Yamada et al 1999
Yamada et al 1999
Ishiguro et al 1999
Richards et al 2002 
Hsieh et al 2003
Sirois and Richards 1993 
Robker and Richards 1998
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5.2 Cell signalling- novel components expressed during lutéinisation
The established endocrine role of the granulosa cell has already been described 
in chapter 1. The essential role of steroid and peptide hormones in regulating 
pituitary function is supported by the expression changes of the inhibin PB and a 
subunits, fbllistatin, and the decreased oestrogen and increased progesterone 
production caused by change in the aromatase and cholesterol side chain 
cleavage enzymes. The gonadotrophin receptors are expressed in both libraries, 
with LH showing a two-fold upregulation in response to hCG administration. 
Numerous paracrine factors are expressed at relatively lower levels than the 
endocrine components, for example, kit ligand, responsible for oocyte growth 
and maturation, antrum formation and thecal proliferation (Driancourt et al 
2000), is expressed in the PMSG-treated library and downregulated by hCG. 
Equally, components of the IGF (IGFBP 4), TGF (TGFBP 3, TGFPR I and III), 
BMP (BMP 3, BMP 15, BMPRIA) and FGF (FGF 15, FGFR) systems, GDF 9, 
CTGF, EGFR, AmhR type II and early response factors such as epiregulin have 
established functions within the follicle, as outlined in chapter 1, and show 
expression within one or both libraries.
Novel transcripts, never previously associated with granulosa cell function, 
include several components of G protein coupled receptor signalling. 
Specifically G protein coupled receptor family C group 5, member C (GPRC5c), 
G protein coupled receptor 85 (GPR 85) and G protein coupled receptor 27 
(GPR 27) are down regulated by hCG with G protein coupled receptor 48 (GPR 
48), regulator of G protein signalling 2 and G protein coupled receptor 
associated sorting protein 2 showing significant upregulation by hCG. The 
functions of the G protein receptors listed above are unknown. GPRC5C is 
expressed in neurological tissue and postulated to mediate the cellular effects of 
retinoic acid. (Robbins et al 2000). GPR 85 is highly conserved across 
mammalian species, expressed in brain, spleen and placenta in man (Hellebrand 
et al 2001) but has only been identified in the brain of the mouse. GPR 48 is 
expressed in the kidney, placenta, brain and heart, and has been detected as early 
as 7d post coitus in mouse (Loh et al 2001). GPR 27 is highly conserved
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between mammalian species and abundantly expressed in neural tissue 
(Matsumoto et al 2000).
Apart from a common expression pattern in neural tissue the paucity of 
information about these particular transcripts limits our ability to hypothesise a 
function in the granulosa cell. However the expression patterns would suggest a 
capacity for functional significance. GPR 48, for example, undergoes 6-fold 
upregulation in response to hCG and GPR 85 a 10 fold downregulation.
GPR5C5 undergoes an 11 fold reduction in expression level following hCG 
administration. In vitro transfection experiments have shown than GPRC5C is 
expressed at the cell surface and is inducible by retinoic acid (Robbins et al
2000). The ovary is known to express retinoic acid receptors (Zhuang et al 1994) 
and retinoic acid is known to be required for normal reproductive function, 
affecting diverse functions of ovarian tissue such as follicular development 
(Scgweigert and Zucker 1988), steroidogenesis (Graves-Hogaland et al 1988) 
and oocyte maturation (Ikeda et al, 2005) as well as exerting influence on 
embryo development (Liu et al 1993) and the intrauterine environment 
(MacKenzie et al 1997). The molecular mechanisms involved in retinoic acid- 
mediated gene expression in the granulosa cell have not however been fully 
elucidated. The SAGE libraries have revealed a number of genes associated with 
retinoic acid metabolism not previously identified in the granulosa cell. In 
addition to GPR5C5, transglutaminase 2, C polypeptide and MAPK8 interacting 
protein 3, essential for early embryonic neurogenesis (Xu et al 2003) are both 
genes inducible by retinoic acid and upregulated by lutéinisation while nuclear 
receptor coactivator 4, an enhancer of retinoic acid mediated transcription 
(Heinlein and Chang 2003), eukaryotic translation initiation factor 4 gamma 2, a 
mediator of retinoic acid induced differentiation (Yamanaka et al 2000) and 
chromobox homolog 2, thought to have a role in controlling access to retinoic 
acid response elements of several genes (Core et al 1997), are also all 
significantly upregulated.
GPR 27 and GPR 85 are members of the super-conserved receptor expressed in 
brain (SREB) family, SREBl and SREB2 respectively (Matsumoto et al 2005). 
SREB2 is the most conserved receptor throughout vertebrate evolution
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(Matsumoto et al 2000) indicating an essential function within the vertebrate 
group. SREB members have been identified in both the neural systems and |
genitalia and SREB2 is known to be temporally and spatially expressed during :
embryonic development and in adult brain (Hellebrand et al 2001). This suggests 
a specific functional role in neural development, which has been tentatively 
suggested to be in the maintainence of neural plasticity (Matsumoto et al 2005).
Although no progress has been made towards identifying the ligands for GPR27 
and GPR 85 their expression during lutéinisation warrants further investigation.
In addition there are cytokine related transcripts, B-cell stimulating factor 3 and 
stromal cell derived factor receptor 1, upregulated by hCG supporting the notion 
liking ovulation to an inflammatory reaction, and regulatory proteins such as 
suppressor of cytokine signalling 2 and 5, and protein regulator of cytokinesis 1.
5.3 Intracellular metabolic adaptations to follicular lutéinisation
Follicular cell multiplication and differentiation are cellular events requiring 
energy. The granulosa cells of preantral follicles are known to utilise both the 
glycolytic pathway and Krebs cycle when under the influence of gonadotrophins 
(Roy and Terada 1999). When oxygen is limited cells switch from oxidative 
phosphorylation to anaerobic glycolysis. The hypoxic response at the cellular 
level is manifest by the increased expression of genes coding for glycolytic 
enzymes. The oocyte is known to require the expression of glycolytic enzymes 
in adjacent cumulus cells to supply pyruvate, obligatory for resumption of 
meiosis and oocyte maturation (Downs and Hudson 2000, Rose-Hellekant et al
1998). Energy production in the antral follicle, prior to the LH surge, is regulated 
by the oocyte in a developmentally coordinated manner (Sugiura et al 2005).
Following the LH surge, during the period of oocyte maturation, cumulus cells 
are unresponsive to oocyte secreted factors (Sutton et al 2003, Sugiura et al 
2005). FSH and LH have been reported to activate glycolysis in cumulus cells 
while EGF, IGF-I and TGF|3 have been hypothesised to do so on the basis of 
activity in other tissues (Roy and Terada 1999). This work is, however, based on 
preantral follicles using in vitro culture systems and the influence of
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gonadotrophins on the glycolytic pathway varies with the maturation status of 
the follicle. The mechanisms responsible for the maintainence of the glycolytic 
state, post oocyte maturation, have not yet been identified.
Figure 5.1 Glycolytic pathway in granulosa cells during lutéinisation 
Glucose
Hexokinase 2 ^  ^ Hex old n as e 1
Fruct ose-6 -ph osph at e
^ Phosphofructokinase Pfkp precursor
Fruct ose-1,6-biphosphate U
^ Aldolase PFKFB3
1,3 bi ph o sph ogl y c erat e
^ Ph osph ogl yc erat e kinase
2-ph osph ogly c erat e
Enolase 
Phosphoenol pyruv ate
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The red arrows indicate enzymes upregulated by lutéinisation. PFKFB3 is a potent 
activator of glycolysis, controlling expression of the rate limiting enzyme 
(phosphofiuctokinase) in this pathway. Hexokinase 2 upregulation couples 
glycolysis and oxidative phosphorylation
In both SAGE libraries high levels of the transcripts for hexokinase 1, GAPDH, 
aldolase, tirosephosphate isomerase, enolase, phosphoglycerate kinase, and 
lactate dehygrogenase (isoforms 1 and 2) can be found (table 5.2 figure 5.1). The 
rate-limiting enzyme in the glycolytic pathway is fiuctose-2,6-biphosphate (Fru- 
2,6-P2), a potent activator of glycolysis which is capable of exerting control over 
the rate of glucose utilisation (Kawaguchi et al 2001, Hue and Rosseau 1993, 
Okar and Lange 1999, Pilkis et al 1995). The enzyme 6-phosphoffucto-2- 
kinase/ffuctose-2,6-biphosphatase (PFKFB) controls the synthesis and
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degradation of Fru-2,6-P2, Among the PFKFB mammalian isoforms PFKFB3 
has the highest activity and is found highly expressed in transformed cells 
(Chesney et al 1999, Sakakibara et al 1997) implicating it as having some 
responsibility for the high glycolytic rate found in neoplastic cells. This 
particular isoform undergoes significant up-regulation following hCG 
administration, indeed while expression has not been detected by the PMSG 
SAGE library, 10 transcripts have been sequenced in the hCG library.
The induction of PFKFB3 has been shown to occur in response to a hypoxic 
cellular state, compatible with an adaptive cellular response to enhance 
glycolysis during periods of oxygen deficiency (Minchenko et al 2002), but also 
in response to certain mitogens, growth factors and cytokines (Hue and Rousseau 
et al 1993). PFKFB3 has been found to be highly induced by hypoxia in various 
cell lines and in vivo (Minchenko et al 2003) and regulation of the PFKFB 
family is controlled by hypoxia inducible factor 1 (HIF-1) (Minchenko et al 
2003).
Table 5.2. SAGE expression of glycolytic enzymes
Gene Unigene Tag countPMSG hCG
Hexokinase 1 196605 61 33
Hexokinase 2 255848 1 12
Phosphofiuctokinase 1166 149 70
Fructose-2,6-biphosphatase (PFKFB) 19669 0 10
Aldolase 16763 20 25
Phosphoglycerate kinase 188 25 23
Enolase 70666 32 18
Pyruvate kinase 216135 1 5
Lactate dehydrogenase 1 A chain 29324 38 31
Lactate dehydrogenase 2 B chain 9745 18 15
Glyceraldehyde 3-phosphate dehydrogenase 5289 23 24
Triosephosphate isomerase 4222 24 12
The establishment of a rarefied oxygen gradient across the follicle from the 
peripheral to central granulosa cells during follicular expansion (Tsafriri et al 
1976) generates the hypoxic requirement for HIF-1 induction. HIF-1 consists of 
a  and p subunits, the p subunit is constitutively expressed, but a  subunit 
stabilisation is hypoxia dependant (Semenza GL 1999). HIF-1 a  is expressed in
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both SAGE libaries and upregulated by hCG administration (2.4 fold). Although 
hypoxia plays a major role in the activation and stabilisation of HIF-1 the 
amplitude of this response can be modulated by a number of growth factors 
including EGF, IGF-1, FSH, androgens, TNFa, and TGFP acting tlirough the 
Ras/Raf/MAPK and PI3/PKB signalling cascades (Bardos and Ashcroft 2005). 
These observations suggest that microenviromental hypoxia and 
paracrine/endocrine signals both contribute to the high rates of granulosa cell 
glycolysis.
Another aspect of glycolysis is the multifunctional roles served by some of the 
glycolytic enzymes. Hexokinase irreversibly catalyses the phosphorylation of 
glucose, the first step of glycolysis. Hexokinase 1 (HKl) is highly expressed in 
both libraries, but hexokinase 2 (HK2) is only represented by a single tag in the 
PMSG library, and is significantly upregulated (12 transcripts) in the hCG 
library. Mammalian HK2 localises to the mitochondria and uses mitochondrial 
ATP to phosphorylate glucose, coupling the glycolytic pathway with oxidative 
phosphorylation (Golshani-Hebroni and Bessman 1997). HK2 has been 
implicated in having involvement in the transcriptional regulation coordinating 
glycolysis and in the enhanced glycolysis found in malignant and immortalised 
cells under aerobic conditions (Arora et al 1990). The upregulation of HK2 may 
therefore represent a hypoxia independent method of maintaining the glycolytic 
pathway in the granulosa cell following the LH surge and a means of linking the 
glycolytic pathway to mitochondrial oxidative phosphorylation. In addition 
mitochondrial HK activity has been shown to be required for growth factor 
induced cell survival (Kim and Dang 2005), suggesting a role for HK2 in the 
apoptotic pathway.
The induction of HIF-1 in response to FSH occurs via the PI 3-kinase pathway 
and is known to be required for the up regulation of LHR and inhibin a  (Alam et 
al 2004). The importance of HIF-1 for follicular and luteal development is 
further demonstrated by the subfertile phenotypes of HIF-lp knockouts (Le 
Provost et al 2002) and by the major role the HIF family are known to play in the 
regulation of genes required for angiogenesis (Wang et al 1995, Zhang et al 
2003) and, in hypoxic conditions, in the suppression of proliferation and
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promotion of anti-apoptotic mechanisms (Leek et al 2005). The activation of 
HIF-1 is a critical response in neoplastic cells undergoing hypoxic and 
nutritional stress allowing adaptation to a suboptimal microenviroment. In the 
granulosa cell these adaptations are likely to include PFKFB 3 to enhance cell 
survival by allowing metabolic adaptation to the hypoxic conditions created by 
the rapid follicular expansion and the avascular nature of the granulosa 
compartment. (Wenger and Gassmann 1999, Semenza 2000).
Another transcription factor known to be upregulated by hypoxic conditions and 
significantly up regulated in the hCG SAGE library is early growth response 1 
(Egr-1). This is a zinc finger transcription factor involved in a number of early 
responses to numerous stimuli (Cummins and Taylor 2005). Hypoxia induced 
Egr-1 activity is mediated through a PKC pathway and has been shown to be an 
important event in contributing to vascular remodelling (Semenza GL 2000, Yan f
et al 1999). The induction of Egr-1 by gonadotrophins is well documented 
(Espey et al 2000) and its essential role in female fertility has been extensively 
discussed elsewhere (Espey et al 2000, Russell et al 2003). The activation of 
such transcription factors is a critical response in granulosa cells ensuring the 
enhanced transcription of a number of genes that increase oxygen and nutrient 
supply.
Serum/glucocorticoid related kinase (sgk) is a serine/threonine kinase and 
another key component of the cellular stress response. It is known to exhibit a 
biphasic expression pattern under gonadotrophin stimulation correlating with 
granulosa cell proliferation and differentiation (Alliston et al 1997) with highest 
levels seen in differentiated non-proliferative mural granulosa cells. This 
confirms the expression pattern in the SAGE libraries, which show a 6.8 fold 
induction of sgk following lutéinisation. Sgk plays a critical role in maintaining 
cell survival, is up regulated by multiple different stress stimuli (Leong et al 
2003), and mediates survival signals via the phosphorylation and negative 
regulation of the pro-apoptotic forkhead transcription factor FKHRLl (Brunet et 
al 2001). In addition, stimulation of sgk by glucocorticoids has been shown to 
cause cell cycle arrest, the opposite of the effect of serum induction which leads 
to cellular proliferation. These opposing effects indicate a dichotomy of function
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for sgk depending on its localisation within the cell with cytoplasmic 
compartmentalisation in cells undergoing glucocorticoid stimulated growth
. 'i:arrest and nuclear localisation necessary for cell proliferation. Forced retention 
of sgk within the cytoplasmic compartment is sufficient to suppress cell growth 
(Buse et al 1999). The granulosa cell is known to modulate intracellular 
glucocorticoid levels, generating increased glucocorticoid levels around 
ovulation. The downregulation of 11 (3HSD2, which catalyzes the conversion of 
cortisol to the inactive metabolite cortisone will increase exposure to cortisone 
and under this influence the up-regulation of sgk may represent a mechanism 
contributing to the cessation of granulosa cell proliferation in the preovulatory 
follicle.
Glutathione transferases (GSTs) are induced by and participate in cellular 
defences against the oxidative damage during periods of cell stress (Hayes et al
2005). Murine GST alpha 4 is induced in vivo by tumor necrosis factor alpha 
(TNFalpha), interleukin-6 (IL-6), and epidermal growth factor (EGF) (Desmots 
et al 2002), and is significantly downregulated by lutéinisation. These factors 
play crucial roles in cell survival and proliferation during cellular regeneration 
and GSTa4 may be considered as part of the cell survival mechanism during 
follicle growth. GSTa4 serves to regulate 4-hydroxynonenal (HNE) intracellular 
levels (reviewed in Awasthi et al 2004), a toxic end product of lipid 
perioxidation, which affects signal transduction pathways controlling apoptosis 
(Kruman et al 1997), cell differentiation (Barrera et al 1991), and can modulate 
cell proliferation (Zarkovic et al 1993). In vitro GSToc4 transfection results in 
lower levels of HNE and increases proliferation while inhibiting differentiation 
and apoptosis (Awasthi et al 2004). These observations suggest a previously 
unrecognised mechanism in the granulosa cell for maintaining the 
undifferentiated phenotype during follicular expansion, with the observed 9-fold 
down-regulation of GSTa4 by hCG contributing to the cessation of cell 
proliferation and encouraging development of the differentiated phenotype via 
increased intracellular levels of HNE.
In summary we are witnessing a dynamic balance of hormonally and 
environmentally regulated peptide factors and metabolic changes, co-ordinately
205
5.4 Cell survival: Apoptotic/survival signalling pathways
' I
regulating an intricate network of intracellular processes that stringently control 
granulosa cell metabolism and survival during lutéinisation.
The balance between cell growth and proliferation, cell senescence, and cell 
death within the follicle is delicately controlled by many different pro-survival or 
pro-apoptotic factors. The LH surge acts to promote cell survival but local 
paracrine mediators are also essential for continued follicle health (discussed in 
section 1.8.3.6).
Transcriptional regulators of the cell cycle include the E2F transcription factor 
family, whose role in transcriptional control of cell proliferation has been well 
documented (Zhu et al 2005, Nevins 1998). Previous work has shown that 
overexpression of various E2F proteins will induce cell cycle progression, while 
dominant negative mutants inhibit cell growth (Johnson et al 1993, Dobrowolski 
et al 1994). E2F factor 5 (E2F-5) shows significant upregulation in the hCG 
library. Initially this expression appears anomalous in a cell population exiting 
from mitotic activity. E2F has been considered primarily as a family that 
promotes cell proliferation. However high E2F levels have been recorded in post 
mitotic cells which have exited the cell cycle and are undergoing differentiation 
in Drosphilia (Brook et al 1996) suggesting E2F has functions separable from its 
role in cell proliferation. Further studies suggest that the E2F family might 
actually serve to limit proliferation by repressing the transcription of growth 
promoting genes (He et al 2000, Zhang et al 1999) and Gaubatz et al 2000 
showed that E2F5 is specifically required for G1 arrest of cycling cells. It has 
been suggested on the basis of expression patterns in murine epithelium that 
E2F2 and E2F4 participate in maintaining an undifferentiated proliferative 
phenotype while E2F5 is important in maintaining a terminally differentiated 
state (Dagnino et al 1997). It is now understood that activator and repressor E2Fs 
function in an opposing manner and that E2F5 functions by recruiting the pocket 
protein p i30 to E2F regulated promoters thereby suppressing transcriptional 
activity and allowing cell cycle exit (Dimova and Dyson 2005). More intriguing
206
yet is the finding that mice deficient for E2F4/5 exhibit defective differentiation 
of numerous cell lineages in a mamier which appears context specific and differs 
between individual cell types (Dimova and Dyson 2005).
Table 5.3 SAGE expression of components of the E2F system for cell 
cycle regulation
Gene Unigene Tag countPMSG hCG
E2F transcription factor 5 153415 0 9
Transcription factor Dp2 17977 2 13
Retinoblastoma binding protein 7 270186 7 24
Cyclin dependant kinase 4 6839 0 6
Cyclin dependant kinase 8 219645 2 10
Cyclin 1 250419 9 11
Cyclin D binding myb-Hke 22480 0 13transcription factor 1
Cyclin dependant kinase inhibitor 195663 0 91A(P21)
B Cell translocation gene 2 239605 0 12
Also significantly upregulated is transcription factor DP2, a dimérisation partner 
of E2F (Zhang and Chellappan 1995). Numerous alternatively spliced forms of 
DP2 exist with either cytoplasmic or nuclear location, suggesting that DP 
binding may control E2F localisation. (Dyson 1998). Binding of DP2 to E2F can 
directly enhance heterodimer DNA affinity and transcriptional activity (Hitchens 
and Robbins 2003), however binding of DP/E2F complexes to members of the 
retinoblastoma (Rb) family of proteins can yield a complex which actively 
suppresses transcriptional activity (Dyson 1998). The concomitant 3.4 fold 
upregulation of retinoblastoma binding protein 7 in the SAGE libraries is likely 
to be related to this E2F/DP2 system and requires further investigation. Known 
to be a core component of two co-repressor complexes it has been shown to 
inhibit cell growth in vitro and in vivo (Yang et al 2002). It thus provides a link 
between gonadotrophin stimulation and cell cycle control having previously 
been shown to increase expression in the ovaries of FSHp null mice (Bums et al
2003). The precise mechanisms utilised to carry out this role in vivo have not yet 
been identified.
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Figure 5.2 Proposed action of E2F5 and associated genes in regulating cell cycle 
exit in the granulosa cell
Inhibition of cdk 
activation bv BTG2 (  g jg2
cdk activated by 
cyclin D
Phos
cdk mediated release of Rb 
Cell cycle progression
Suppression of transcription 
Cell cycle exit
E2F5 dimerises with DP2 and retinoblastoma protein 7 to suppress transcription and induce 
cell cycle exit. Phosphorylation o f Rb7 by cdk would allow release of E2F and result in cell 
proliferation. Inhibition o f cdk activation by BTG2 may be an early response inhibiting cdk 
action and inducing cell cycle exit. All components shown here, except cyclin D, demonstrate 
significant upregulation in the SAGE libraries in response to hCG administration.
The expression levels of cyclin dependant kinase 4 (cdk4), cyclin dependant 
kinase 8 (cdk8), and cyclin G associated kinase (Cgak) are all up-regulated by 
hCG. Cdk4 is responsible for phosphorylation of retinoblastoma protein (pRb). 
This is a process thought to result in the release of E2F and the expression of 
genes allowing S phase entry and cell proliferation (Cobrinik 2005), increased 
expression in a quiescent non proliferative cell cannot easily be explained using 
the current models. We also have a significant increase in expression of cyclin- 
dependant kinase inhibitor lA  (P21), perhaps serving to counteract the activity 
of the cdk’s. B cell translocation gene 2 (BTG2) negatively regulates cell growth
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and promotes differentiation (Guehenneux et al 1997) and can do so through its 
effects on pRb activity. Cyclin D1 is a target of, and negatively influenced by, 
BTG2 (Guardavaccaro et al 2000). D type cyclins bind and activate the cyclin 
dependant kinases that phosphorylate pRb (Matsushime et al 1992). Inhibition of 
this phosphorylation will prevent the release of E2F and discourage progression 
of the cell cycle. Inhibition of cyclin D function by BTG2 may therefore be an 
early response inhibiting Rb phosphorylation and cell cycle progression. This 
gene is also significantly up regulated by hCG.
Although this is the first report implicating the E2F system in granulosa cell 
lutéinisation E2F5 has previously been shown to influence FSH-R expression 
with ectopic expression increasing FSH-R promoter activity (Putowski et al
2001). This may function as a feedback mechanism with increasing FSH 
sensitivity via increased FSHR expression negating the effects of E2F5 to 
maintain a proliferating phenotype during rapid follicle growth. Further work is 
required to elucidate fully the roles played by different components of the E2F 
mechanism during follicular expansion and lutéinisation, and in particular the 
reasons behind the apparently anomalous increase in cdk expression.
A number of other transcripts implicated in the control of cell proliferation 
and/or senescence are also included among those tags significantly upregulated. 
Growth arrest specific 1 (Gasl) (no expression in PMSG library, 14 transcripts 
in hCG library) is a membrane protein up-regulated during cell quiescence and 
whose ectopic expression exerts a growth suppressing effect (Del Sal et al 1992). 
It has also shown induction in response to endothelial cadherin and VEGF and to 
inhibit endothelial cell apoptosis (Spagnuolo et al 2004). Two members of the 
mortality factor 4 (MORF 4) family (MORF 4 like 1 and MORF 4 like 2) are 
significantly upregulated in response to lutéinisation (no expression in PMSG 
library, 9 and 11 transcripts respectively following lutéinisation). MORF 4 has 
been shown to induce replicative senescence in immortalised cells. Due to its 
nuclear location, and leucine zipper motif allowing DNA binding it is postulated 
to acts as, or interact with, a transcription factor influencing genes regulating cell 
cycle progression (Bertram et al 1999). Salvador is a gene influencing both cell 
cycle control and apoptosis in Drosophilia and in human cell lines. Loss of
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::Salvador leads to increased cyclin E levels and delayed cell cycle exit. (Tapon et 
al 2002). The SAGE tag corresponding to Salvador homolog 1 (Drosophila) 
undergoes 40 fold upregulation in the granulosa cell in response to hCG 
administration.
This multilevel regulation permits several layers of control that can 
simultaneously or individually converge on the same cellular component in 
response to appropriate extracellular signals to regulate cell survival,
5.5 Cell Differentiation and Transcription factors
A relatively small group of essential molecular signals are repeatedly used to 
regulate cellular development. Wingless, Hedgehog, TGF|3, Receptor tyrosine 
kinase/phosphatase (RTK/P) and Notch pathways are the central molecular 
pathways acting individually and cooperatively to coordinate the transcriptive 
cellular response (Gerhart 1999). Within the granulosa cell the Wnt, TGFp, and 
RTK/P signaling pathways have been recorded but the influence of the Notch 
and Hedgehog pathways on luteal development is as yet unknown. Both Indian 
and Desert Hedgehog are expressed in the PMSG treated library (7 and 3 
transcripts respectively) and both are down regulated by hCG (1 and 0 transcripts 
respectively). Both are highly conserved and known to influence gonadal 
development and function, regulating thecal cell gene expression during 
folliculogenesis (Wijgerde et al 2005). The downregulation following hCG 
suggests they do not have an active role in lutéinisation.
Mastermind like 1 (Drosophila) (Mamll) undergoes considerable up-regulation 
under hCG influence, no tags are recorded in the PMSG library yet 33 transcripts 
are present following lutéinisation. Mamll acts as a regulator of Notch signalling 
(Wu et al 2004). Noteh receptors modulate the development of a broad spectrum 
of tissues and it has been firmly established that developing embryos use Notch 
signalling to amplify and consolidate molecular differences between adjacent 
cells. Notch is involved in the regulation of cellular differentiation, proliferation 
and specification, (Iso et al 2003, Hoyne 2003, Kojika and Griffin 2001).
Binding of membrane Notch receptors by ligand initiates proteolytic cleavage
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and release of the Intracellular Domain of Notch (ICN or Ncid) which 
translocates to the nucleus and activates the DNA binding transcription factor 
CSL by displacement of co-repressors and recruitment of co-activators (Figure 
5.3). These in turn regulate expression of tissue specific transcription factors that 
influence lineage commitment, apoptosis and proliferation (Wu et al 2002, 
Artavanis-Tsakonas et al 1999, Mumm and Kopan 2000). Johnson et al (2001) 
has previously demonstrated the presence of components of the Notch signalling 
pathway during folliculogenesis but recent transcript profiling has also revealed
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Notch expression in primordial follicles (Serafica et al 2005) while the essential
role of Notch signalling in female fertility has been proven by the infertility, I
abberant folliculogenesis and failure of oocyte meiosis in lunatic fnnge-null 
female mice (Hahn et al 2005). This is however the first report of differential 
expression of components of the Notch pathway during lutéinisation. 'Mamll is a highly conserved critical component in the transcriptional activation 
induced by Notch signalling and is dynamically expressed at different 
developmental stages suggesting tight regulation and a role in the modulation of 
cell fate determination (Wu et al 2000 and 2004). The effects of Notch signalling 
have been shown to extend beyond differentiation, influencing both growth 
potential (Weng et al 2003) and apoptosis (Artavanis-Tsakonas et al 1999).
Mamll inhibition has been shown to result in growth inliibition and death of 
Notch 1-induced human and murine cell lines, indicating that signals transduced 
by nuclear Notch 1 via Mamll are required for growth and survival. In addition 
to the induction of Mamll, A Disintegrin and Metalloproteinase domain 10 and 
17 (AdamlO, Adam 17) are also differentially expressed, both are involved in the 
proteolytic degradation of the Notch receptor. Adam 10 undergoes 2.2 fold 
upregulation and Adam 17 significant downregulation in response to hCG.
Intracellular cleavage is mediated by presenilin 1 or 2, expressed at a much 
lower levels. A large number of other components of Notch signalling are also 
expressed in one or both libraries (table 5.4).
These findings expose the lutéinisation process of mammalian granulosa cells as 
a novel site of active Notch signalling. Given that both Notch and its ligands are 
transmembrane proteins and that signalling only occurs between closely apposed
cells it is logical to conclude that Notch must be acting in either an autocrine 
manner, influencing adjacent granulosa cells, or paracrine manner, influencing 
thecal and/or oocyte development. The Notch signalling pathway has been 
repeatedly demonstrated to play a crucial developmental role in tissues where it 
is expressed and consequently the proposition that it is involved in modulating 
final follicular maturation is reasonable. One problem with an intrafbllicular role f
is presented by the rapid follicular expansion induced by hCG, loss of cell-cell 
and cell-oocyte contact is an inevitable prequel to ovulation, as demonstrated by 
the changes in Cx43 and cell adhesion proteins. Equally the separation of the
. ,Vthecal and granulosa compartments by the follicular basement membrane would 
surely hinder thecal/granulosa interaction by this method. The role of a 
signalling system dependant on contact with adjacent cells to operate in rapidly 
disintegrating tissue structure seems incongruous. Is induction of Mamll in 
granulosa cells perhaps a final effort on the part of the oocyte to maintain cell 
survival during ovulation? Or is Notch responsible for the differentiation within 
the granulosa compartment of mural and cumulus cells?
In order to understand the potential role of Notch signalling in the granulosa cell 
we have to glance further afield and consider the synergistic manner in which 
signalling pathways interact to exert transcription control. Notch interacts with 
both TGFp and Wnt signalling to regulate the implementation of particular 
developmental programs (Jacobsen 2005, Klüppel and Wrana 2005). To 
understand the potential interactions we have to draw comparisons with 
functions in other tissue types. Notch 1 is essential for early embryonic 
development of haematopoietic stem cells (HSC) but dispensable for later 
differentiation (Radtke et al 2004). Notch signalling is active in phenotypically 
defined HSCs but absent following differentiation (Duncan et al 2005).
Prevention of Notch cleavage, CSL transcription factor binding and Mamll 
activation all resulted in enhanced lineage differentiation. In the same system it
was found that Wnt stimulation upregulated expression of Notch target genes
1and the ability of Wnt signalling via Wnt3a to inhibit differentiation is dependant a
on Notch signalling (Duncan et al 2005) demonstrating that HSCs undergo 
continuous self renewal in vivo with involvement of both Notch and Wnt
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-1signalling pathways. These interactions between signalling pathways also 
incorporate the TGFp superfamily. Recent work has revealed the interactions 
between TGFp and Notch (Dahlqvist et al 2003, Blokzijl et al 2003, Itoh et al
2004) in the transcriptional regulation of Notch target genes and the inhibition of 
cellular differentiation and migration. TGFp signalling induces the expression of 
Hes-1, a known Notch target gene via a CSL/Nicd pathway mediated by Smad 2 
and/or Smad3 (Bolkzijl et al 2003). It is now known that Samd and Ncid proteins 
can interact directly and that this interaction is enhanced by TGFp (Bolkzijl et al 
2003, Klüppel and Wrana 2005). This raises the prospect of TGFp and Notch 
signals combining through recruitment of Smad 3 to activate Notch target 
sequences. During myogenesis this integration of signals leads to inhibition of 
myogenic regulatory factors and thus inhibition of myogenesis (Bolkzijl et al 
2003). This work is supported by the interaction of the BMP family with Notch 
regulating myogenic differentiation and endothelial migration (Dahlqvist et al 
2003, Itoh et al 2004).
Consequently, it becomes apparent that a major biological function of Notch is 
the suppression of cellular differentiation and the maintainence of a self 
renewing cell population. It also appears to be the case that, in some tissues at 
least, this function is mediated by exposure to members of the TGFp 
superfamily. As discussed earlier (Introduction) the oocyte produces members of |
this signalling family (GDF9, BMP 15) during follicular development and 
through them regulates the differentiation of granulosa cells in a paracrine 
manner leading to a differentiative phenotypic gradient within the follicle. It 
would appear possible that oocyte-produced paracrine members of the TGFp 
family could interact with Notch signalling pathways to maintain the 
undifferentiated proliferative granulosa phenotype most apparent in cumulus 
cells, and that terminal lutéinisation is allowed to proceed via a ehange in the 
transcriptional activity of the Notch pathway following reduced exposure to 
TGFp ligands created by a combination of follicular matrix expansion, 
downregulated connexin expression by the granulosa cell and reduced ligand 
expression by the oocyte.
Table 5.4 Genes present in SAGE libraries known to be involved in or regulated 
by Notch signalling.
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This suggestion leaves us with unresolved questions as to the mechanisms by 
which Notch exerts its influence during the regulation of granulosa cell 
differentiation. Intrafbllicular localisation of ligand/receptor pairs, particularly 
looking for oocyte expression of Notch ligands, and functional disruption of this 
pathway will be required to provide further insights into its role.
Gene Unigene Tag countPMSG hCG
Adam 10 3037 5 11
Adam 17 27681 23 1
Presenilin 1 998 4 3
Presenilin-like protein 4 246376 14 7
Mastermind like-1 (Drosophila) 51116 0 33
Strawberry noteh homolog 1 (Drosophilia) 104898 5 0
Notch gene homolog 1 (Drosophila) 31255 4 3
Delta/notch-like EGF-related receptor 39067 1 0
Notch gene homolog 3 (Drosophila) 4945 0 1
Notch regulated ankyrin repeat protein 46539 0 1
Adaptor related protein complex 3, delta subunit 28463 10 7
Jagged 2 186146 2 0
Jagged 1 22398 1 0
Hairy and enhancer of split 5 (Drosophila) 137268 0 1
Hairy/enhancer-of-split related with YRPW motif 2 103573 6 3
Numb gene homolog (Drosophila) 4390 3 2
Recombining binding protein suppressor of hairless 180561 7 3(Drosophila)
SKI interacting protein
X \ J \ J  VX A
27094 6 7
A pending anterior pharynx defective 1A homolog 268053 14 1
1
(C, elegans)
Cir-pending CBFl interacting corepressor 268053 0
Deltex 2 homolog (Drosophila) 29343 0 2
Dishevelled, dsh homolog 1 (Drosophila) 3400 0 2
Dishevelled associated activator of morphogenesis 
1
Protein O-fucosyltransferase 1
87417 0 2
216045 0 1
«
Figure 5.3 Suggested Notch signalling pathway in the granulosa cell before 
and during lutéinisation 
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5.6 Cellular and follicular remodelling: Angiogenic and cytoskeletal 
remodelling
Angiogenesis
The high vascularity required by the corpus luteum necessitates the rapid 
development of a vascular system generated by the invasion of thecal 
micro vessels and extensive angiogenesis. The angiogenic response is associated 
with changes in cellular adhesive interactions exemplified by the well 
documented changes in integrin p expression, the secretion of proteolytic 
enzymes and the remodelling of the adjacent ECM as previously discussed 
(section 1.8.3.7). Endothelial cell migration througli the follicular basement 
membrane requires the local production of angiogenic factors, endothelial cell 
proliferation, orientation, differentiation, establishment of the basement 
membrane and lumen formation all of which eventually leads to the formation of 
intact micro vessels.
Recent studies suggest that angiogenesis is mediated by 3 important 
ligand/receptor systems, namely VEGFA^EGFR, angiopoietins/Tie receptors and 
ephrins/Eph receptors (Yancopoulos et al 2000). The VEGF system has been 
well documented in luteinising granulosa cells, the angiopoietin and ephrin 
mediated systems less so. Components of all 3 mechanisms are found within the 
SAGE libraries with angiopoietin like 4 (Angptl4) and ephrin B class 2 both 
significantly upregulated by hCG administration. Ephrin B2 is an endothelial 
marker suggested to be involved in the formation of the arterial muscular wall in 
adults (Yancopoulos et al 2000). It serves to distinguish arteries ixom veins 
before any structural, physiologic, or functional distinctions can be made (Umess 
et al 2000). Upregulation prior to ovulation suggests a role marking the early 
development of the nascent corpra luteal arteriolar system.
Angiopoietins are major players in the formation and stabilisation of new blood 
vessels (Yancopoulos et al 2000). Angptl4 has recently been implicated as an 
angiogenic mediator in pathologic processes, to exert anti-apoptotic effects 
specifically on endothelial cells, and to function as a secreted protein likely to 
have paracrine effects (Hermann et al 2005). The expression pattern of Angptl4
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is limited to specific tissue types (inflamed synovium, kidney, liver and adipose 
tissue) and induction of its expression has been recorded primarily in neoplastic 
and inflammatory tissue (Hermann et al 2005), expression in the granulosa cell 
not previously having been recognised. Expression and secretion of Angptl4 
from luteinising granulosa cells could therefore provide a paracrine angiogenic 
signal to promote and stabilise blood vessel formation within the developing CL. 
In addition to the ephrin/angiopoietin/VEGF mechanisms we have identified 
other genes significantly differentially expressed within the SAGE libraries with 
known functions related to angiogenesis and endothelial remodelling.
Blood vessel epicardial substance (bves) is significantly upregulated following 
lutéinisation, not showing expression in the PMSG treated library. It is a 
transmembrane protein thought to have involvement in cellular adhesion. 
Expressed during embryogenesis and in specific regions of developing 
epithelium (Osier and Bader 2004) it has never previously been detected in 
ovarian tissue. It is one of the first adhesion proteins to traffic to points of cell­
cell contact in fonning epithelium (Wada et al 2001) and consequently is 
postulated to have a role in cell development and orientation tlirough its function 
in morphogenesis. Its expression was first recorded during coronary blood vessel 
development in mesenchymal cells recruited to the blood vessel wall (Reese et al
1999), a unique occurrence in the developing embryo since the endothelial cells 
are usually derived from the endothelial sheet connected to the endocardium 
rather than local mesenchyme (Coffin and Poole 1988). This raises the intriguing 
possibility that it may be involved in the morphogenetic organisation of 
developing capillary structures within the new CL through the recruitment of 
mesenchymal cells to the vessel walls.
Fibroblast inducible growth factor 14 (Fn 14), undergoes a 4.3 fold upregulation 
after hCG and functions as a TNF-related weak inducer of apoptosis (TWEAK) 
receptor. TWEAK promotes angiogenesis and endothelial migration 
(Jakubowski et al 2002, Wiley et al 2001) and has been shown to stimulate 
vascular formation in vivo (Lynch et al 1999). Interestingly TWEAK retains a 
functional ambiguity, promoting endothelial cell survival and regulating 
endothelial cell proliferation, migration, and morphogenesis by modulating the
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response to bFGF and VEGF. In conjunction with bFGF TWEAK demonstrates 
pro-angiogenic behaviour but inhibits the endothelial cell morphogenesis 
induced by VEGF suggesting that its role regulating angiogenesis is dependant 
on the local microenviroment (Jakubowski et al 2002).
Cytoskeletal elements
Several cytoskeletal associated transcripts are differentially regulated during 
lutéinisation including actin, vinculin, cofilin, tubilin and tropomyosin. It is 
known that gonadotrophins regulate structural gene expression in granulosa cells 
(Sasson et al 2004, Grieshaber et al 2003) and cytoskeletal remodelling during 
lutéinisation is likely to be an essential part of the movement and morphological 
development of the cells. One transcript does show an unexpected upregulation. 
Vimentin is a cytoplasmic intermediate filament expressed in a variety of 
mesenchymal cell types during development (Evans 1998). Vimentin undergoes 
a dramatic 48-fold upregulation following hCG administration, yet appears to 
have little effect on the organisation of cytoplasmic structures other than 
filament associated proteins (Evans 1998). The explanation for such marked 
upregulation is found instead in the role of vimentin in lipid metabolism, 
vimentin filaments form structures around nascent lipid droplets (Franke et al 
1987) and have been suggested to have involvement in the transport of 
cholesterol required for steroidogenesis (Almahbobi et al 1992). In cell culture 
there is a striking correlation between the presence of a vimentin If network and 
the ability of the cell to utilise lysosomal cholesterol. (Sarria et al 1992). 
However vimentin null mice appear phenotypically normal and can reproduce 
without obvious deficiencies suggesting that even this function has considerable 
redundancy (Colucci-Guyon et al 1994).
5.7 Genes with a poorly defined role in lutéinisation
In addition to confirming changes in gene expression previously reported or 
predicted, the SAGE data set reported here also identifies a number of genes of 
interest that have not previously been linked to the process of early lutéinisation.
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This list is made up of genes with unknown function and genes with known 
function but with no previous association to granulosa lutéinisation. Genes with 
known function and differentially regulated during lutéinisation include 
syndecan-1, secreted phosphoprotein 1 (Sppl), secreted acidic cysteine-rich 
glycoprotein (SPARC), prosaposin, and vanin 1.
Syndecan-1 is a heparin sulphate-rich integral membrane proteoglycan, and it is 
expressed in a developmental and cell type-specific pattern (Beilin et al 2002), 
but it has not previously been indentified as having a role in folliculogenesis or 
lutéinisation. Syndecans have major roles as matrix and cell surface receptors, 
coreceptors for growth factor signalling, internalisation receptors and soluble 
paracrine effectors (Beilin et al 2002). In addition, syndecan-1 appears to be 
capable of independent signalling and may play a role in regulation of Wnt 
signalling (Beilin et al 2002). Syndecan-1 is not expressed in the PMSG treated 
library but shows a high level of transcript expression after hCG administration. 
Syndecans have well-established involvement in the regulation of cytoskeletal 
organisation (Beilin et al 2002) and a likely function of syndecan-1 in the 
luteinising follicle is in the regulation of cytoskeleton assembly.
Sppl (also known as osteopontin or Eta-1) is among the most highly up­
regulated tags after hCG administration. It is a multifunctional protein expressed 
in various cell types and involved in a number of physiological and pathological 
processes including biomineralisation, inflammation, leukocyte recruitment, cell 
survival, tissue repair, cell proliferation and proliferation of vascular smooth 
muscle cells (Mazzali et al 2002). It is possible therefore that Sppl has multiple 
functions during lutéinisation. For example, it may act as a survival factor 
preventing onset of apoptosis during the critical phase of ovulation and 
lutéinisation. Equally the effects on vascular smooth muscle suggest a possible 
role in the angiogenic process that accompanies formation of the corpus luteum. 
Prosaposin is expressed at a medium level in the antral follicle but shows a 6- 
fold upregulation after hCG administration. The protein is either secreted or acts 
as a precursor of smaller saposins, and it has been shown to have diverse 
functions including involvement in the MAPK and Akt signalling pathways and 
maintainence of cell growth, differentiation and survival (Morales et al 2000).
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The likely role of prosaposin in development of the corpus luteum is uncertain 
but may, again, relate to overall function as a survival factor.
Vanin 1 is a glycosylphosphatidylinositol-anchored cell surface molecule 
involved in thymic and gonadal development (Bowles et al 2000, Aurrand-Lions 
et al 1996). As with Sppl, it is also highly up regulated in granulosa cells after 
hCG administration. Vanin 1 is expressed specifically in the Sertoli cells of the 
developing foetal gonad, and it has been suggested that it may be involved in the 
migration of mesenchymal cells from the mesonepliros into the developing 
gonad (Bowles et al 2000). The likely function of vanin 1 in the developing 
corpus luteum is unclear but, by analogy with developing thymic and gonadal 
tissue, it is possible that it may be involved in the cell migration that occurs early 
in corpus luteum formation to integrate both thecal and endothelial cells into the 
developing tissue.
Secreted acidic cysteine-rich glycoprotein (SPARC, osteonectin, basement 
membrane protein 40) is a highly expressed transcript which undergoes a 7-fold 
up regulation during lutéinisation. SPARC is expressed in vivo where cells are 
undergoing proliferative or reorganisational activity (Lane and Sage 1994) and it 
has previously been identified in follicular granulosa cells after the LH surge 
(Bagavandoss et al 1998). It is possible that SPARC may play an essential role in 
the development of the corpus luteum because specific peptide fragments of the 
protein are strongly angiogenic (Reed et al 1993). In the follicle, SPARC is 
found in both granulosa cells and oocytes, although expression in the oocyte may 
derive from adjacent granulosa cells (Bagavandoss et al 1998). Calmodulin, a 
protein with strong functional and structural similarities to SPARC, has been 
implicated in the resumption of meiosis in the starfish oocyte (Santella and 
Kyozuka 1997), and it is possible that up-regulation of SPARC after hCG may 
play a role in allowing resumption of meiosis in the oocyte.
For those genes already discussed in this thesis it is possible to hypothesise a 
putative function in ovulation and corpus luteum development based on their 
known properties and functions in other tissues. The SAGE libraries described 
here also contain many other highly expressed or differentially expressed 
transcripts for which this is not currently possible. Included among this latter
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group are proline rich protein MP-5, tumour protein translationally controlled 1, 
testes enhanced gene transcript and polycystic kidney disease 2. In addition the 
list of tags differentially regulated after hCG contains a considerable number that 
are unmatched in the SAGEmap database or are matched only to EST clusters or 
uncharacterised transcripts. The challenge now will be to identify those genes 
from this list that are fundamentally involved in the process of lutéinisation and 
those genes that have a more downstream role in the development of the corpus 
luteum.
5.8 Non coding transcript
A final consideration has to be given to the role of non-coding transcripts in the 
regulation of lutéinisation. Chapter 4 details the further investigations we have 
taken into the characterisation and expression of the RNA transcript represented 
by the SAGE tag CAGTCAATAC. We have demonstrated the expression, 
within the granulosa cell and other tissue types, of a variable length RNA 
without translation initiation sites that we propose acts as an RNA. Increasingly, 
evidence is mounting that the role of cellular RNA extends far beyond that of an 
intermediary in protein synthesis. The high conservation of the genomic 
sequence for this transcript across the mammalian genomes and the specific 
temporal and spatial expression pattern suggest a significant cellular function. 
The abundant and differential expression exhibited in response to gonadotrophin 
stimulation suggests that this function may be associated with folliculogenesis.
A growing number of RNAs lacking open reading frames have been identified as 
transcriptional or protein function regulators (Szmanski et al 2003) and 
accumulating evidence suggests critical roles for noncoding RNAs in a variety of 
cellular processes, including developmental decisions relating to gene dosage, 
silencing or genome imprinting (Erdmann et al 2001). Among the groups are 
naturally occurring antisense RNAs (Brandi 2002), small interfering RNAs 
(siRNA) and small temporary RNAs (stRNA) which mediate down-regulation of 
gene expression either through interference and degradation of perfectly 
complementary mRNA (siRNA) or translational inhibition while retaining
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stability of imperfectly complementary mRNA (stRNA) (Hutvagner and Zamore 
2002). A further model suggests that ncRNAs function to define the domains of 
open chromatin necessary to facilitate transcriptional activation (Morey and 
Avner 2004). The essential nature of RNA metabolism to development and 
survival is demonstrated by the early developmental arrest of Dicer enzyme null 
mice (Bernstein et al 2003). The discovery that ncRNAs are implicated in a 
disparate variety of regulatory systems, and likely to be integral to the overall 
molecular architecture of organisms, suggests that they are part of a cellular 
efficiency drive utilising signalling molecules which can be produced and 
destroyed at a lower metabolic cost than protein molecules. Comparison of 
mouse, human and other mammalian genomes shows a considerable degree of 
homology out-with protein coding regions (Mayor et al 2000, Mattick 2001).
We have demonstrated that the expression of this non-coding RNA is strongly 
induced by PMSG in granulosa cells, but not by hCG. The expression was first 
detected in early antral follicles and peaked 48hrs after PMSG administration 
before rapidly declining to basal levels 8 hrs following hCG administration. |
Sequencing analysis of the cDNA revealed a polyadenylated transcript with no 
extensive open reading frames. In addition several unexpected features are 
associated with this transcript, these include a 23 nucleotide hairpin fold centred 
on base 233 and several small 5-6 base complementary sequences located either 
side of the hairpin fold (Figure 4.2b) which may be involved in secondary 
folding of the RNA. While a high degree of homology is maintained by this 
transcript throughout mammalian, and even avain genomes, indicating an 
evolutionary conservation, no significant antisense match can be found to any 
known gene suggesting that an RNAi related function is unlikely.
The genomic location raises the possibility that this transcript may be part of the 
3’ UTR of the inhibin pA subunit. 3’ RACE carried out using primers for inhibin 
PA failed to produce a band greater than 600bp long (personal communication.
Prof. PJ O’Shaughnessy) (Figure 5.4, provided courtesy of Prof PJ 
O’Shaughnessy) Southern blot showed that only the 350bp band was derived 
from the inhibin pA subunit. This band yielded matching sequence (data 
provided courtesy of Prof PJ O’Shaughnessy) to the 3’ genomic region of
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inhibin pA. It is highly unlikely therefore, that the non-coding RNA is part of the 
inhibin PA 3’ UTR.
Figure 5.4 Agarose gel showing product of 3’ RACE reaction and southern 
blot on inhibin pA subunit
lOObp 3’ RACE Southern 
ladder product Blot
Band
and only
350bp
Bands of 350bp and 600bp produced from 3’ RACE are of insufficient size 
to demonstrate continuity between the inhibin subunit and the noncoding 
transcript
A  though the biological functions of this transcript remain unknown the 
observation that induction occurs during PMSG stimulated folliculogenesis and 
downregulation proceeds hCG stimulated luteal differentiation suggests a 
possible role in granulosa cell proliferation or differentiation. The induction of a 
non-coding RNA transcript in cells undergoing TGFP driven differentiation has 
previously been recognised. The bone morphogenic proteins (BMP) and 
osteogenic proteins (OP), members of the TGFp superfamily and responsible for 
the induction of bone formation in vivo, have been shown to induce expression 
of a non-coding transcript. Two proteins BMP-2 and OP-1, specifically induce 
transcription of the 3Kb non coding BORG RNA (BMP/OP-responsive gene), 
which has been suggested to play a key role in osteoblast differentiation (Takeda 
et al 1998) although its precise function is unknown.
The potential for hairpin folding in the secondary structure of our transcript 
draws comparison with the E.coli thi-box structure. These are conserved RNA 
structures that co-regulate the expression of genes involved in thiamine
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metabolism (Miranda-Rios et al 2001, Lesnik et al 2005) and are utilised for 
small molecule-mRNA interactions involved in translation regulation in 
prokaryotes (Stormo and Ji 2001). Riboswitches consist of RNA that forms a 
selective binding site for a target metabolite, binding creates an allosteric 
structural changes that leads to transcriptional change. Such riboswitches are 
common in prokaryotes and archaea and there is some evidence for them in 
eukaryotes. A motif similar to the thiamine riboswitch has been found in 
eukaryotic genes involved in thiamine biosynthesis (Sudarsan et al 2003). In the 
eukaryotic examples the proposed riboswitches are contained within 3’ UTR or 
intronic sequences of the genes in question.
Regardless of the mechanism of action the obvious question arises regarding the 
genes and/or cellular functions that may be affected by the expression of this 
transcript. The obvious candidate is the adjacent inhibin pA subunit which serves 
as a component of inhibin A (PA:PB) and activin A (pA:pA), TGpp family 
members regulating follicle development. The expression profiles of these 
during follicle development and ovulation have been studied elsewhere (Newton 
et al 2002). In summary as follicles develop under FSH stimulation inhibin A 
production begins to predominate over inhibin B. Following the LH surge there 
is a dramatic fall in inhibin A and B with a concomitant increase in activin A 
expression. The action of activin A on the oocyte is critical for matur ation (Aak 
et al 1998) and has been suggested to mediate the LH surge in this regard 
(Newton et al 2002). In the rat the transcription of the pA subunit is reported to 
increase progressively within the follicle following recruitment from the 
primordial follicle pool (Meunier et al 1998, Aral et al 2002), following a pattern 
identical to that of the non-coding transcipt. This raises the question as to 
whether the non-coding transcript may act to control transcription and/or 
translation of the inhibin pA subunit, or to affect the post-translational 
availability of the inhibin pA subunit.
An additional clue to the possible function of this transcript is its global 
expression profile throughout the mammalian tissue range. Highest levels of 
expression are found in the spleen and ovary with lower levels in intestine, lung 
and uterus (figure 4.6). These tissues have in common the presence of a
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proliferating and differentiating cell population, in ovary the granulosa cell, in 
spleen the haematopoietic cell lines, and in intestine, lung and uterus the constant 
turnover of epithelial tissue necessitates the continual regeneration and 
proliferation of cellular stock. The inhibin pA subunit has been heavily 
implicated in cellular differentiation and especially in haematopoietic and 
epithelial differentiation (Shav-Tal and Zipori 2002, Zhang et al 2004, Ball and 
Risbridger 2001), in particular negative regulation of activins during pancreatic 
epithelial development has been shown to induce cellular proliferation and 
inhibit terminal differentiation. Whether the non coding transcript identified here 
has a role in this modulation of activin signaling requires investigation.
Much of this is highly speculative and further work is required to disclose the 
precise functional role of this transcript and its target and mechanisms of action 
in granulosa cell development. An analysis of expression patterns of both the 
noncoding transcript and the inhibin pA subunit in a variety of tissues and 
development situations where one or both is known to be expressed in 
conjunction with up/down regulation of the non coding transcript in cell or 
follicle culture is required. At the time of writing siRNA knockdown of this 
transcript in granulosa cell culture is being carried out and this study should 
provide some insight into the functional significance of the expressed RNA.
5.9 Conclusion
A large number of differentially expressed transcripts have been successfully 
identified using SAGE as well as many more genes abundantly, if not 
differentially, expressed. A body of literature has already characterised the 
individual cellular events activated by either steroid hormones, peptide hormones 
and growth factors which trigger the principle signal transduction pathways 
employed by the granulosa cell to respond to external stimuli. We have isolated a 
large number of candidate genes related to the cellular differentiation processes 
occurring within the granulosa cell during lutéinisation. In particular the finding 
of a number of novel transcription factors and signalling receptors with altered 
expression profiles in response to hCG requires further investigation. Equally we
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have demonstrated that there are a variety of potential mechanisms of cross talk 
and interaction between different signalling and/or metabolic pathways 
controlling the development of the terminal luteal phenotype. The data generated 
and presented here constitutes a new base for the testing of hypotheses in the 
field of follicle development and lutéinisation.
!
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Appendix 1: Identified significantly differentially
expressed transcripts with annontations briefiy
describing gene function.
Tag sequence hCG PM SG p-value U nigene Gene
TTGTTGCTAC 387 8  395 1 .2 9x10”  268000 Vim entin
A  member o f  a w ell characterised class o f  cytoskeletal elements. Class III intemediate filament specific for mesenchymal tissue, 
undergoes significant reorganisation during cell division.
TTGCTACTTT 367 6  373 1.23x10'^'^ 27961 Leprecan 1
Extracellular matrix protein located in plasma membrane w hose human hom olog G rosl has been shown to have growth
suppressor activity
CCTTTAATCC 61 397 458 1.5x10-^* 347445 Hyaluronidase 1
A  lysosom al hyaluronidase intracellularly degrades hyaluronan, one o f  the major compoments o f  the extracellular matrix.
C A A AC AC CG T 278 2  280 2 .0 2 x 1 0 '^ "^ 288474 Secreted phosphoprotein 1
Forms part o f  the cell-ECM  interaction and can also act as a cytokine, enhancing interferon and interleukin production
AACTG AG G G G  306 49  355 6.38x10-^“ 277498 Prosaposin
Glycoprotein which is a precursor for 4  saposins involved in the lysosom al degradation o f  sphingolipids
TAA TG TAG AC  2  4 3 x 1 0 '^ ® 370184 Gap junction membrane cham iel
protein alpha 1
A  member o f  the com iexin gene family and a component o f  gap jmictions.
A G C A A G A A T T  226 28 254 1.95x10^^ 1061 Ferredoxin 1
An iron-sulftir protein found in steroidogenic tissues, transféra electrons from N ADPH  through ferredoxin reductase to a tenninal 
cytochrome P450.
A G G C A A T A A A  143 3 146 1.95x10"^^ 27154 Vanin 1
This is a member o f  a family that includes secreted and membrane-associated proteins. This protein is a GPI-anchored cell surface 
m olecule.
T A A C T G A C A A  140 11 151 2.62x10-^“ 147226 M etallothionein 2
M etallothioneins are sm all cysteine-rich proteins w ith highly specific roles in fundamental zinc-regulated cellular processes.
G G TTA AA TG T 206 56 262 6 . 4 l x l 0 ‘® 930 Cathepsin L
A  component o f  the lysosom al proteolytic system believed to participate in intracellular degradation and turnover o f  proteins.
A TA CTA AC G T ^ 1 .7 3 x 1 0 -"* 34102 Ornithine decarboxylase,
structural 1
The rate-limiting enzym e o f  the polyam ine biosynthesis pathway. An increase in the activity level o f  this enzyme is often seen in  
réponse to growth promoting stimuli.
T A C A G T A T A A  9 98 107 2.62x10''® 3092 Inhibin beta-B
In combination with the inliibin alpha subunit forms a pituitary FSH seeretion inhibitor also shown to regulate gonadal stromal 
cell proliferation negatively. A lso fonns a homodimer, activin B, which in combination with the beta A  subunit forms activin 
which stimulates FSH secretion. Both compounds are involved in regulating a number o f  functions including hormone secretion  
(hypothalamic, pituitaiy, gonadal) and germ cell maturation.
G G GCATTTGA 108 11 119 9.31x10'® 302865 Cytochrome P 450 H a l
Cytochrome P450 cholesterol side chain cleavage, catalyzes the conversion o f  cholesterol to pregnenolone, the rate-limiting step 
in  the synthesis o f  the steroid honnones
C A A A C TC TC A  , 3 2  4 .9 8 x 1 0 "  291442 Secreted acidic cysteine rich
glycoprotein
A lso called osteonectin. This is a matrix-associated protein inhibits eell-cycle progression and influences the synthesis o f  
extracellular matrix (Bradshaw et a l ,  2003)
G ATACTTG G A 73 3 76 9.97x10 '^  297 Actin, beta, cytoplasm ic
Major cytoskeleton component and mediator o f  internal cell motility
A A A A C A G TG G  16 91 107 1 .6 8 x 1 0 '^  21529 Ribosom al protein L37a
Structural component o f  ribosomes
GCTCTGGGAG 208 5.48x10"  140811 Hydroxysteroid dehydrogenase- 1
delta<5>-3-P
The 3beta-HSD enzym e plays a crucial role in the biosynthesis o f  all steroid honnones
A C T G A A G C A A  , 4 ^ 4 ;  6 .5 6 x 1 0 "  282242 Scavenger receptor class B .
member 1
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Tag sequence hCG PMSG p-value Unigene Gene
Facilitates the cellular uptake o f  cholesterol from high density lipoprotein
GACTCAGGGC 47 0 47  4.98x10-" 2580 Syndecan 1
Mediates cell-matrix and cell-cell adhesion and inhibits cell invasion,
G A A A A G T G G A  69  9 78 7.91x10 " 15295 Epoxide hydrolase 2, cytoplasm ic
This protein binds to specific epoxides and converts them to the corresponding dihydrodiols. Mutations in this gene have been  
associated with familial hypercholesterolemia.
GGATQQGGAG ,4 3 57 5.79410" 283926 Seizure related 6 homolog
(m ouse)-like 2
An extracellular protein previously shown to have a role in CNS development, most abundant duiing/after neuronal differentiation 
and during cell specification or axogenesis.
T A C C T T G A C A  45 0 45 1.33x10'° 4791 Epiregulin
Growth factor acting as a paracrine mediator o f  the LH signal throughout the follicle.
TTGAAATTAC 45 0 45 1.33x10-'” 362063 Proliue-rich protein MP 5
Unknown function
AATCACTG TG  44 o  4 4  2.17x10-'“ 33240 Epithelial V -like antigen 1
A  cell membrane protein expressed during early thym ic em bryogenesis, mediates homophilic cell-cell adhesion  
TGGCTCGGTC 53 4 57 5.46x10 '” 300639 Actin, gamma, cytoplasm ic 1
Major cytoskeleton component and mediator o f  internal cell motility
TACATTCCAA 4, , 46 5.54x10“ 3401 P™protein convertase
subtihsin/kexm  type 5
This encoded protein mediates post-translational endoproteolytic processing for several integrin alpha subunits.
TAC TTTA TA A  A  disintegrin-like and
3 9  0  39 2.54x10-”” 1421 metalloprotease (reprolysin type)
with thfom bospondin type 1 
m otif, 1
A ctive metalloprotease, cleaves proteoglycans, aggrecan, vereican and brevican. Has angiogenic inhibitor activity. They have 
been associated with various roles in coim ective tissue organization, coagulation, inflammation, arthritis, angiogenesis and cell 
migration as w ell as follicular mpture.
GGTCAAGATA 4 4^  2.74x10* 188939 Hydroxysteroid (17-beta)
dehydrogenase 1
In ovarian granulosa cells the activity o f  17HSD1 is essential for gonadal estradiol biosynthesis and is also involved in the 
modulation o f  steroid hormone action.
T TA G A A G TG A  40  i 41 6.44x10 ”” 373563 Salvador hom olog 1 (Drosophila)
Involved in regulating both cell proliferation and cell death, hi Drosphila Salvador is a gene that promotes both cell cycle  exit and 
cell death and rautatons in the maimnalian hom olog have been implicated in three cancer cell lines.
GATTG TCAGA 42  2 44  9.18x10-”” 25613 Immediate early response 3
This gene functions in the protection o f  cells from Fas- or tumor necrosis iàctor type alpha-induced apoptosis. Alternative splicing  
o f  this gene results in two transcript variants.
ACTTCCTTTC 3^  „ 3g i.ux io*  282242 Scavenger receptor class B,
member 1
Facilitates the cellular uptake o f  cholesterol from high density lipoprotein
GCTGCCCTCC 409  566 975 1.45x10-”® 104368 Ribosom al protein L32
Structural component o f  ribosome
GTGGCGCACG 10 54 64 2 .9 8 x 1 0 ”® 214645 Hyaluronidase 3
A  lysosom al hyaluronidase intracellularly degrades hyaluronan, one o f  the major compoments o f  the extracellular matrix 
TCCACCAG AT 41 3 44  5.22x10"”® 279361 VincuHn
Vinculin is a highly conserved F-actin anchoring cytoskeletal protein associated with cell-cell and cell-matrix junctions. 
AGACACTTCC 48  6 54 5.62x10'”® 238343 Annexin A 2
M embers o f  this family o f  membrane proteins have a role in the regulation o f  cellular growth and signal transduction. This protein  
functions as an calcium  binding autocrine factor known to enliance osteoclast formation and bone resorption.
TCCCG GATCA 2 35 37 7.12x10 “® 18962 Catenin alpha i
Cadherin associated actin binding cell adliesion protein found at cell-cell and cell-matrix boundaries 
A A T T TC A A A A  5 41 46  1.14x10 ”'' 371577 R ibosom al protein S I 7
Structural component o f  ribosome
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Tag sequence hCG PMSG Total p-value Unigene Gene
TATG A A TG CT  ^ 158x10 ”” 158700 Chondroitin sulfate proteoglycan
Secreted hyaluronic acid binding extracellular matrix protein w hich may play a role in intercellular signaling  
GGGGGAGCAT 6 42  48 2.03x10"”” 275973 Sialyltransferase 4C
Catalyses conversion o f  glycoproteins and glycolipids. Highly expressed in adult placenta, ovary and testes 
TTTG TA A TA A  30 0  30 2.18x10"”” 284855 Endothelin 2
Peptide hormone involved in signal transduction and cell communication
ATCAGTGTGC 32 1 33 3.29x10"”” 275555 Calponin 3, acidic
Cytoskeletal binding protein assocaited with cell growth and maintainence. Capable o f  binding to actin, calmodulin, troponin and
tropomyosin
T A A A T G T G C A  8 45 53 3.44x10"”” 4913 Follistatiu
Follistatin is a gonadal protein that specifically inhibits FSH release. Binds directly to activin and functions as an activin  
antagonist.
A A G A T C A A G A  44 6 50 3.6x10"””
Major cytoskeleton component and mediator o f  internal cell motility
TGCTGTGCAT
360115 A ctin, alpha, cardiac
14 Fibroblast growth factor inducible 14
Fibroblast growth factor-inducible 14 mediates multiple pathways o f  induced cell death, proliferation and angiogenesis through its 
function as a TW EAK (a TNF fam ily member ) receptor.
CTCTGAATAC ^ 5.71x10"”” 2442 Calcium binding protein,
intestinal
Belongs to a fam ily o f  calcium-binding proteins that includes calmodulin, parvalbumin, troponin C, and SI 00 protein. Its exact 
function is unknown. In the intestine its expression correlates with calcium transport activity.
TC C C C C C C C e 0 28 5.88, 10*  35088 receptor, nicotinio,
beta polypeptide 2 (neuronal)
After binding acetylcholine responds by opening an ion-conducting channel across the plasma membrane, hivolved in synaptic 
transmission, signal transduction and ion transport. Picciotto et al. (1995) disropted the CHRNB2 m ouse hom olog in embryonic 
stem (ES) cells to generate 'knockout* m ice deficient in this subunit. H om ozygous m ice were viable and had no physical deficits.
60 74 4.26x10"' 289662
30 1 31 8.83x10"*
31
ACCGGGTCAT
Unknown function
ATTTGACTGG 30 1
Stiuctural component o f  cytoskeleton.
TTG TCAGG TA 68 20
M alate dehydrogenase (oxaloacetate-decarboxylating) (NADP4-) activity
TCTCGTAATG
8.83x10"'
1.44x10"'
206919 M ale sterility domain containing 2 
29677 M yosin heavy chain IX
148155 M alic enzym e, supernatant
29 1 30 1.45x10"' 42095 Secreted frizzled-related sequence protein 4
A cts as a soluble modulator o f  Wnt signaling. In ventricular myocardim expression o f  SFRP4 correlates with apoptosis related 
gene expression. In the m ouse ovary expression has previously been shown to be up-regulated in granulosa cells o f  large antral 
follicles after hCG administration.
C AC A TT  ATC A  25 0 25 2.62x10"”” 28099 Stcrol 0-acyltransferase 1
A n endoplasm ic reticulum integral membrane protein. Catalyzes the fonnation o f  cholesterol esters from long-chain fatty acyl 
C oA  and cholesterol
CCCTTCTTCT 10 44  54 3.41x10"“”
Involved in oxygen transport to the various peripheral tissues.
GGATTTGGCT 51
Structural component o f  ribosome 
A A G A G G C A A G  37 
Stiuctural component o f  ribosome 
TTA A ATG C AG  27
107
87
1
158
124
28
3.5x10'
3.6x10"'
196110 H em oglobin alpha, adult chain 1
341719 Ribosom al protein, large P2
288212 Ribosom al protein S 15a
273188 Coagulation factor III3.89x10"””
Cell surface glycoprotein, enables cells to initiate the coagulation cascades and functions as a high-affinity receptor for the 
coagulation factor VII.
TAT A G T G T A A  g  3 91x10"”” 158700 Chondroitin sulfate proteoglycan
Secreted hyaluronic acid binding extracellular matrix protein w hich may play a role in intercellular signaling 
GGCTTTGGTC 60 119 179 3.92x10'”” 3158 R ibosom al protein, large, PI
Structural com ponent o f  ribosome
230
. V :  !
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TTTTTG ATAA 3 2  3 35  3 97x10-”” 42095 Secreted frizzled-related sequence
protein 4
Acts as a soluble modulator o f  Wnt signaling. In ventricular myocardium expression o f  SFRP4 coiTelates with apoptosis related 
gene expression. In the m ouse ovary expression has previously been shown to be up-regulated in granulosa cells o f  large antral 
follicles after hCG administration.
G G G A G C G A A A  28 2 30  8.46x10 ”” 34871 Inhibitor o f  D N A  binding 2
T his gene encodes a helix-loop-helix (HLH) protein that can form heterodimers with members o f  the basic HLH fam ily o f  
transcription factors and therefore can inhibit the D N A  binding and transcriptional activation ability o f  proteins with which it 
interacts. This protein may play a role in cell growth, senescence, and differentiation.
G G TTA TAA TA  ^ 1 3 2 x 1 0  ”” 28405 Serum /glucocorticoid regulated
kinase
This kinase has been shown to be important in activating certain potassium, sodium, and chloride channels. Expression o f  is 
stimulated by TGF-beta. Plays an important role in  cellular stress response, mediates cell suivival signals, phosphoiylates and 
negatively regulates pro-apoptotic foxo3a
TGGGTTGTCT ,  4 3 x 1 0 *  296922 Tumor protein, translationally-
controlled 1
M olecular function unknown. Found in several healthy and tumoral cells including erythrocytes, hepatocytes, macrophages, 
platelets, kératinocytes, erytluoleukemia cells, gliom as, m elanom as, hepatoblastomas, and lymphomas.
GAAAG CCTCT ^4 i 25 1 .7 2 x 1 0 *  8245 Tisstie inhibitor o f
metalloproteinase 1
The proteins encoded by this gene fam ily com plex with metalloproteinases (such as collagenases, a group o f  peptidases involved  
in degradation o f  the extracellular matrix) and irreversibly inactivate them. TIM Pl is highly inducible at the transcriptional level 
in response to many cytokines and hormones and is also known to suppress angiogenesis 
A TC AC AC A CT U DP-N -acetyl-alpha-D-
21 0 21 1.94x10"”” 62886 galactosamine: polypeptide N-
acetylgalactosaminyltransferase 7 
This gene catalyzes the initial reaction in o-linked oligosaccharide biosynthesis controlling the initiation step o f  m ucin-type O- 
linked protein glycosylation and transfer o f  N-acetylgalactosam ine to serine and Üireonine amino acid residues. 
G GGAAGTCTG 33 5 38 2.09x10"”” 347009 Peroxiredoxin 2
This gene is involved in redox regulation o f  the cell. M ay play an antioxidant protective role in cells by reducing peroxides. 
Speculated to participate in the signaling cascades o f  growth factors and tumor necrosis factor-alpha by regulating the intracellular 
concentrations o f  hydrogen peroxide.
CTTGCTCTGT 3 5  ^ 4 ,  2 .2 1 x 1 0 *  263396 Integrin beta 1 (fibronectin
receptor beta)
Integrin fam ily members are membrane receptors involved in cell adhesion and recognition in a variety o f  processes including 
em bryogenesis, hemostasis, tissue repair, immune response and metatastatic diffusion o f  tumor cells. Integrin-beta(l) has also 
been shown to be necessary for inducing angiogenesis by regulating cell survival and differentiation after implantation into 
ischem ic tissue
24 2.83x10"””GATATGGTCT 23
Involved in protein glycosylation
TTATCAAG TG
1
28
2863 Integral membrane protein 1
32 2.86x10"* 358946
Similar to developm ent- and 
differentiation-enliancing factor 2; 
PYK 2 C term inus-associated  
protein
PYK2 C is a GTPase activator activity, signal transduction and cell communication
AAC AG G TTCA  19
Structural component o f  ribosome
CACGGCTTTC 2
Structural component o f  ribosome
TCTTTAATCC
54
23
73 3.21x10"' 292027 Ribosom al protein S25
25 4.05x10"”” 306548 Ribosom al protein L26
23 25 4.05x10"”” 196638 CDC23 (cell d ivision cycle 23, yeast, hom olog)
Part o f  the APC com plex that functions as a protein ubiquitin ligase arrd governs exit fi’orn mitosis.
C A G G C A A A A C  ,  2 5  28 4 .52x10 “  171378 U ncoupling protein 2,
mitochondrial
Facilitates the transfer o f  anions from the irurer to the outer mitochondrial membrarre and the return trarrsfer o f  protons from the 
outer to the iimer mitochondrial membrane.
GATTCCGTGA 36 78 114 4 .8 4 x 1 0 ”” 10474 Ribosom al protein L37
Structural component o f  ribosome
CTTAGATGTT 19 0 19 5 .3 2 x 1 0 ”” 309193 Roppcrin 1-like
I
231
Tag sequence hCG PMSG TotalJSSl p-value Unigene Gene
Interacts w ith both A-kinase anchoring protein and the Rho signalling pathway, present on sperm and thought to be sperm  
specific.
TTA A TTA CA G  ^ 5  32x10-”” 28405 Seram /glucocorticoid regulated
kinase
This kinase has been shown to be important in activating certain potassium, sodium, and chloride channels. Expression o f  is  
stimulated by TGF-beta. Plays an important role in cellular stress response, mediates cell su m v a l signals, phosphorylates and 
negatively regulates pro-apoptotic foxoSa
AATTAG TTGT
8  34  42  6.53x10-“” 353
ATP synthase, H + transporting, 
mitochondrial FO com plex, 
subunit F
Catalyzes ATP synthesis during oxidative phosphorylation
CAACCATCAT 26 29 7.02x10'05 30071 L ysosom al-associated protein  transmembrane 4A
Suggested to have a role in the transport o f  small m olecules across endosomal and lysosom al membranes.
G A TAA TG C AC  N A D H -ubiquinone
6  30 36 7.54x10'”” 253142 oxidoreductase 18  kDa subunit,
mitochondrial precursor
Nuclear gene coding for the 18 kD  (IP, AQ DQ ) subunit o f  respiratory com plex I. Known to have a critical role in the 
differentiation and fimctional activity o f  brain cells
TGCACCACCT 30 5 35 8.27x10'”” 182470 Ribonuclease H2, large subunit
O f the multiple RNases H in mammals, shows increased activity during D N A  replication,
C TCCCACCCA 18 0  18 8.83x10'”” 249318 Frequenin hom olog (Drosophila)
This gene regulates G protein-coupled receptor phosphorylation in a calcium-dependent manner and can substitute for calmodulin.
G A TG A CA CC A  39 80 119 9.84x10''
Stiuctural component o f  ribosome
C CTAC CA A G A  I7 48 65 O.OOOl
Structural component o f  ribosome
A A A A G A A A A T
20 1 21 0.0001
High-affinity transport o f  large neutral amino acids.
TTTTCTATTT
371603 Ribosom al protein S28  
R ibosom al protein S20328529
276831
Solute carrier fam ily 7 (cationic 
amino acid transporter, y+  
system ), mem ber 8
3 23 26 0.0001 25594 Protein kinase, cAM P dependent regulatory, type II beta
cAM P-dependent protein kinase (AM PK) transduces signals through phosphorylation o f  different target proteins. Four different 
regulatory subunits and tliree catalytic subunits o f  AM PK have been identified in humans. The protein encoded by this gene is one 
o f  the regulatory subunits. This subunit has been shown to interact with and suppress tlie transcriptional activity o f  the cAM P  
responsive element binding protein 1 (C R E B l) in activated T  cells.
TA C A A TA TA C 35 43 0.0001 31403 Tumor necrosis factor, alpha- induced protein 9
Located on plasma membrane and involved in electron transport
CCTGGCCAAG 29 5 34 O.OOOl 28099 Sterol O-acyltransferase 1
A n endoplasm ic reticulum integral membrane protein. Catalyzes the formation o f  cholesterol esters fr om  long-chain fatty acyl 
C oA  and cholesterol
A AC AA TTTG G  42 83 125 0 .0 0 0 1  300271 Ribosom al protein L9
Structural component o f  ribosome
ACTCG GAGCC 9 3 4  43 0 .0 0 0 1  285993 Calmodulin 1
Calcium binding protein involved in cell signal transduction and communication
G TTGTTAACA 22 2 24  0.00015 143768 F-box only protein 3
Constitutes one o f  the four subunits o f  the ubiquitin protein ligase com plex w hose function is phosphorylation-dependent
ubiquitination. Involved in ubiquitin protein ligase activity
A G C A A G A TG G  40  11 51 0.00016 290578 A m inolevulinic acid synthase 1
5-Am inolevulinate synthase (A L A S) catalyzes the first step o f  the hem e biosynthetic pathway in mammalian cells
TGTATCCAGT ,  3 ;  40 0 .00016 373S61 N u d eosom e assem bly p r o fe in l-
like 5
N ucleosom e assembly
AACCTCGCTG 26 4  30 0.00019 30221 Insulin induced gene 1
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Regulated by peroxisom e proliferator- activated receptor gamma (PPAR gamma) w hich regulates lipid m etabolism and glucose  
hom estasis, providing a link between insulin sensitization/glucose hom eostasis and lipid hom eostasis. A lso a key regulator in  the 
processing o f  the sterol regulatory elem ent-binding proteins (SREBPs)
GTGCTGTTGT 26 4  30 0.00019 196189 A ngiopoietin-like 4
This gene ia a transcriptional target o f  PPAR alpha and gaimna and is a proangiogenic factor produced during ischem ia having
been demonstrated to induce a strong angiogenic response even in the absence o f  VEGF
A TG A C A T A G A  5  33 0 0 0 0 2  235182 Calcium /calm odulin-dependent
protein kinase II gamma
The influx o f  Ca^* has been shown to activate multiple intracellular protein kinases pathways, such as PKA, PKC, PKG, nitric 
oxide synthase, as w ell as CaM kinase II. CaM kinase II plays a regulatory role in the maintenance o f  phosphoiylation o f  CREB  
protein.
C A A A C A A T G T  19 1 2 0  0 .0 0 0 2  277351 G protein-coupled receptor 48
G-protein-coupled receptor involved in signal transduction. A lso expressed in human pancreas, placenta, kidney, brain, and heart. 
Additionally expressed as early as 7 days post coitus in the mouse, suggesting som e potential involvem ent in development.
G A A C A TTG C A   ^ ^o 0 .0 0 0 2  291442 Secreted acidic cysteine rich
glycoprotein
A lso called osteonectin. This is a matrix-associated protein inhibits cell-cycle progression and influences the synthesis o f  
extracellular matrix
GTGGCTCTCA „ 0.00022 355306 A  disintegrin and
m etalloproteinase domain 17 
A  member o f  the A D A M  protein fam ily im plicated in a variety o f  biologic processes involving cell-cell and cell-matrix 
interactions also functions as a tumor necrosis factor-alpha converting enzyme cleaving the membrane-bound precursor o f  tnf- 
alpha to its mature soluble form and is responsible for the proteolytic release o f  several other cell-surface proteins.
TCCAACTCCT  ^ 0 00022 371616 M itochondrial ribosom al protein
Mitochondrial ribosomal structural protein
T G G AA CA ATG  18 I 19 0 ,00034 338790 Proteoglycan 1, secretory granule
This gene encodes a protein best known as a hematopoietic cell granule proteoglycan.
TGTGCCGGCC  ^ 0 .00034 293314 Steroidogenic acute regulatory
protein
K ey function in the regulation o f  steroid hormone synthesis by enhancing the conversion o f  cholesterol into pregnenolone through 
mediation o f  cholesterol transport across the mitochondrial membrane.
A G A A G A C A G A  15 0  15 0.00041 16769 Testis enlianced gene transcript
A  novel, conserved gene o f  the rat that is  developm entally regulated in the testis. Analysis o f  rat R NA from different stages o f  
sperm atogenesis indicated that accumulation o f  the short transcript occurred mainly postmeiotically. Function unknown.
A G A G G A C TA G  0.00041 358930 G protein-coupled receptor
associated sorting protein 2
G protein associated cell signalling m olecule
TAA AG AG G C C  51 91 142 0.00043 261679 R ibosom al protein S26
Stiuctural component o f  ribosome
TTCTTGTATT 2 2  3 25 0.00047 276405 FK 506 binding protein 51
Expression o f  FKBP5 is strongly enhanced by glucocorticoids, progestins, and androgens. It has diverae biochem ical functions. 
B est studied is its role as a component o f  steroid hormone receptors. It has been suggested that increased expression o f  FKBP5 
through progestin stimulation may attenuate progestin responsiveness in hormone-conditioned cells 
GATGTGGCTG 0  00047 2718 Eukaryotic translation elongation
factor 1 p 2
This gene encodes a translation elongation factor, acts as a guanine nucleotide exchange factor involved in the transfer o f  
aminoacylated tRNAs to the ribosome.
G TTTG TAC AA  ^  4 2; 0.0005 182396 Latent trausfonning growth factor
beta binding protem 3
An extracellular matrix fonn o f  TGF-p binding protein, which requires com plexing with Cys33 o f  the TGF-beta propeptide for 
secretion after coexpression with TGF-p. N ull m ice show growth retardation, splenic and thymic involution, multiple skeletal 
abnormalities and high falatity levels 3-4 weeks afterbirth.
A G G A TCA ATG  28 6  34 0 .0005 205601 Cortactin
Cytoskeleton binding cytoplasmic protein regulating interactions between adherens junctions and cytoskeletal organisation.
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28 34 0.0005 1421
T A A A T G A T A A  A  disintegrin-like and
metalloprotease (reprolysin type) 
with thrombospondin type 1 
m otif, 1
Known to be honnonally regulated in the ovary by LH and the progesterone receptor (PR). Protease involved in regulation o f  the 
ECM. Expression pattern related to that o f  verscian and hyaluronan.
A TA A T A C A T A  231 154 385 0.00051 200362 Cytochrome b-245, beta
polypeptide
Cytochrome b is comprised o f  a light chain (alpha) and a heavy chain (beta).
A TG ATG G TAG  24 54 78 0 .00052 353171 Eph receptor A 6
Eph receptore and their ligands, the eplirins, represent a class o f  cell-cell communication m olecules with organ-site-specific
expression patterns with proven roles in regulation o f  tissue deveopment
GCTCAGCACC  ^ 23 0 .00059 218957 Gene regulated by estrogen in
breast cancer protein
The expression pattern o f  this gene has been shown to corr elate with that o f  oestrogen receptor, no fiinction has been determined. 
A G G AATCCAC 14 0 14 0.00067 22701 Growth arrest specific 1
Growth arrest protein which blocks entry to s phase preventing mitotic cycling o f  normal and transfonned cells.
TGAGGCCTCG ^ 0 00067 21671 Eukaryotic translation initiation
factor 3, subunit 9 (eta)
EIF3 binds to 40S ribosomal subunits and stimulates recruitment o f  M et-tRNAiM et and m RNA to the pre-initiation complex. 
TGATG TGTGA
14
Membrane bound solute transport
A G C CA AA TA C  
Regulation o f  translational initiation
TTTCAAG G CA
Membrane bound solute transport 
CTATCCTCTC 29
0 14
21
21
36
0.00067
0.00067
0.00067
260988
261831
46067
Solute carrier fam ily 7 (cationic 
amino acid transporter, y+  
system ), mem ber 11
B asic leucine zipper and W 2  
domains 1
Solute carrier fam ily 25 , member 
30
2 0 0 916 Glutathione peroxidase 30.00073
Glutathione peroxidase catalyzes the reduction o f  hydrogen peroxide arrd lipid peroxides and protects cells against oxidative 
damage.
TTTCATTGCC ^5 5 30 0.00078 308452 Transfonmng, acidic coiled-coil
contam mg protein 1
The function o f  this gene has not yet been determined, it is expressed at high level during early embryogenesis arrd is 
known to interact with microtubules and tubulin and to be involved oncogenic transformation.
TTCATCTGTC  ^ 0  00092 272675 Solute carrier fam ily 20, member
Membrane bound solute transport
GTGATGTTTC 26 55 81 0.00097 31018 Cytochrome b-5
Membrane bound hemoprotein w hich functions as an electron carrier for several membrane bound oxygenases. 
G A G G A G A A G A  15 39 54 0.001 290899 R ibosom al protein L3
Structural component o f  ribosome
TATAG TATG T 30 8 38 0.001 210745 Glutamine synthetase
Cytoplarnsic enzyme, central role in  cellular nitrogen metabolism, conerts glutamate to glutamine
GGGAAGGCGG 22
Structural component o f  ribosome
A G A AG G A CC T
Membrane bound solute transport 
A T G A G A A C A G  13
49 71
13
13
0.0011
0.0011
0.0011
331113 Ribosom al protein S3a
21002 Solute carrier fam ily 2 (facilitated  glucose transporter), member 1
236123 Splicing factor 3b, subunit 3
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Forms pari o f  a small nuclear ribonucleoproteins com plex (U 2 snRNP). These com plexes may function in clu'oinatin m odification, 
transcription, splicing, and D N A  repair.
T A A T A A A A TT
13
Membrane bound solute transport 
TAG CC AA CTT 13 0
Solute carrier fam ily 7 (cationic 
13 0.00 H  276831 amino acid transporter, y +
system ), mem ber 8
Runt related transcription factor 213 0.0011 4509
Transcription factor involved in osteoblastic and skeletal differentiation and m oiphogenesis. Runx2 overexpression upregulates 
several genes in osteoblasts, including collagen type I and osteocalcin.
TAG CTTTAGG 13 0 13 0.0011 22480 C yclin D  binding m yb-like transcription factor 1
D N A  dependant regulation o f  transcription
GA A AC TG AA C 12
C AA G G TG AC A 20
12
23
0.0011
0.0012
42196
328846
Ubiquitin-like, containing PH D  
and RING finger domains, 1 
Interacts with topoisom erase Il-alpha w hich introduces transient double-stranded breaks in DN A , required during the cell cycle. 
(Hopfiier et al., 2000).
Phosphodiesterase 6A, cGM P- 
specific, rod, alpha 
Hydrolase activity. M etabolism and energy pathways.
TCGCTGCTGC 20 3 23 0 .0012 276647 C yclin G associated kinase
Governs the cell cycle, expression oscillates slightly during the cell cycle, peaking at g l .  Cyclin G is a transcriptional target of, 
and functions downstream of, p53. A lso regulates epidennal growth factor receptor signaling.
CCCTCACCCA 22 4 26 0 .0012 371591 Tubulin, alpha 1
Major constituent o f  microtubules.
GAGCGTTTTG 28 57 85 0.0012 5246 Peptidylprolyl isom erase A
Encodes a member o f  the cyclophilin family. They have been proposed to act either as catalysts or as molecular chaperones in 
protein-folding events tlnough catalyzation o f  cis-trans isomerization o f  peptidylprolyl im ide bonds in oligopeptides..
A G G A A G A TC A  nnnia an7s A ntigen identified by  m onoclonal
antibody K i 67
Cell surface protein used as cellular marker o f  apoptosis
TTCTCTCCCT l  14 15 0 .0014 306954 Carbonic anhydrase 14
Carbonic anhydrases (CAs) are a large fam ily o f  zinc metalloeuzym es that catalyze the reversible hydration o f  carbon dioxide.
They participate in a variety o f  biological processes.
0 .0015C A G A A C A A T G  15 l 16
Plasma membrane protein promoting cell adhesion. 
G C C TA ATG TA  36 67 103
Structural component o f  ribosome
CCAAG AG ACC
0.0015
282084 Adhesion regulating m olecule 1 
3 71575 R ibosom al protein L 21
20 24 0.0015 46561 Leukocyte cell derived  chem otaxin 1
Bifunctional glycoprotein that stimulates the growth o f  chondrocytes and inhibits the tube formation o f  endothelial cells. Serves as 
a growth regulator that stimulates the growth o f  cultured chondrocytes in  the presence o f  basic fibroblast growth factor (fgf) but 
inhibits the growth o f  cultured vascular endothelial cells.
TGACCCCGGG 72
Structural component o f  ribosome
CTGCTCTGAC
112 184
19
0.0015
0.0017
297372 R ibosom al protein L40
153566 B C 019776 M eteorin, glial cell differentiation regulator-like
Unknown function
T A G A A T C C TA  12 33 45 0.0018
Cytokine-inducible negative regulator o f  cytokine signaling.
CGACCTTTAC
4132 Suppressor o f  cytokine signaling 2
Integrin beta 1 (fibronectin  
receptor beta)
Critical cell adhesion m olecule for inducing therapeutic angiogenesis. Has been shown to regulate cell survival and differentiation 
in ischem ic tissue
C TTAAATCTT B -cell translocation gene 2, anti­
p r o l i f e r a t iv e ^ __________________
12
12
0
0
12
12
0.0019
0.0019
263396
239605
" I
.
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Tag sequence hCG PM SG p-value U nigene Gene
A  member o f  the BTG/Tob family. This fam ily has structurally related proteins that appear to have antiproliferative properties.
This encoded protein is involved in the regulation o f  the G l/S  transition o f  the cell cycle. M odulates transcription regulation
mediated by esr l. %
GAGTG ATT AT 12 0 12 0.0019 256422 Zinc finger protein 162
A lso known as splicing factor 1, belongs to a new and growing fam ily o f  genes dubbed STAR (signal transduction and activator ' }
o f  RNA) proteins. Thought to play a downstream role in cell signaling and RNA binding.
G G AA TTTA G A  12 0 12 0.0019 332793 B lood  vesse l epicardial substance
This gene is expressed in cardiac and skeletal m uscle and is involved in the regeneration o f  adult skeletal m uscle and may act as a ; É
cell adhesion m olecule in coronary vasculogenesis. Bves is an early marker o f  developing vascular sm ooth m uscle cells ;
TGCAG GAGCT  ^ 0 0019 333388 Chromodomain helicase D N A
binding protein 4
Part o f  die nucleosom e rem odelling and histone deacetylation (nurd) complex. Expression increases in vascular endothelium in f;:
response to TNF alpha secretion
G T G A A A C T A A  9 28 37 0.002 66 Ribosom al protein S4, X -linked f
Structural component o f  ribosome.
A A A A T G T A C T  0 11 11 0.002 3752 R A N  binding protein 1
Interacts with GTP meatabolism and consequently m ay act in an intracellular signaling pathway with possible involvem ent in U
progression thiougli the cell cycle  by regulating the transport o f  protein and nucleic acids across the nuclear membrane.
AATCCAG CCC 0 11 11 0.002 20206 Aquaporin 2
This gene encodes a water channel protein located in the kidney collecting tubule. Forms a water-specific channel that increases |
plasma membranes permeability to water, thereby permitting water to m ove in the direction o f  an osm otic gradient. a
G C TATA CA G A  0 11 11 0.002 286830 Leucine aminopeptidase 3 ?
Catalyzes the removal o f  unsubstituted n-tenninal amino acids from various peptides
A TTG CTTAG A 4 19 23 0.0025 371574 R N A  binding m otif protein 3
RN A  binding and processing U
A A C A A A A T C T  1 13 14 0.0025 3903 R A S, dexam ethasone-induced 1
This gene encodes a novel GTP-binding protein (G protein) that is stimulated by glucocorticoids. Thought to function as an 
inhibitor o f  tlie ERK mitogen activated protein kinase cascade. It may play a role in dexamethasone-induced alterations in cell 
m orphology, growth and cell-extracellular matrix interactions.
CGCTGGTTCC 21 45 66 0.0026 371622 R ibosom al protein LI 1
Structural component o f  ribosome
GCCCG GGAAT 33 61 94 0.0028 322491 Ribosom al protein LI 7
236
Structural component o f  ribosome
TACTTGTGTT 3 0 003 15125 Stromal ce ll derived factor
receptor 1
Small cytokine that belongs to the intercrine family, members o f  w hich activate leukocytes and are often induced by . s
proinflammatory stimuli such as lipopolysaccharide, TNF, or I L l. Chemoattractant active on lym phocytes and m onocytes, but not iÿ
neutrophils.
ACTCCTTAGT II 0 11 0.0032 336400 SyntTophiu, gamma 1
Syntrophins are cytoplasmic peripheral membrane proteins. Involved in actin and protein binding
CCTGTGTATG „  g „  0,0032 293605 Tumor protein p53 inducible
nuclear protein 2
Function unknown
CTGGAGACGC 11 0 11 0.0032 26743 A polipoprotein A-1
Apolipoprotein A-1 (apoA-1) is the major protein in liigh density lipoprotein (HDL).
GCTTGCCTCC 11 0  11 0 .0032 232293 Ubiquitin specific protease 36
Ubiquitin-mediated proteasomal degradation comprises a major proteolytic pathway in eukaryotes. U sp36 has growth-suppressing 
activity and induces airest in g l  phase upon controlled expression.
TAA ATTCA G G  Serna domain, im m unoglobulin
domain (Ig), transmembrane 
11 0 11 0.0032 275909 domain (TM ) and short
cytoplasm ic domain, (semaphorin)
4B
Semaphorins have been implicated in neuronal growth and differentiation. Sema4b is expressed differentially in the olfactory 
pathway both during development and regeneration
TTAG AACG TG  11 0 11 0 .0032 27218 M ortality factor 4  like 2
Involved in growth regulation and replicative senescence. The human hom olog MRGX can repress or activate the B-myb  
promoter depending on the cell type studied, suggesting that there may be tissue-specific functions o f  this protein.
Ï
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CCCCTATATT non-m R A B  guanine nucleotide exchange
factor (GEF) 1
R egulatoiy protein RabGEFl binds to Ras and negatively regulates Ras activation. RabGEFl null m ice develop skin 
inflammation in vivo.
GGGTTTGGAG 27 8 35 0.0034 274463 E ndothelin  converting  enzym e 1
Converts big endothelin-1 to endothelin-1 type ii membrane protein. M ice null for Ece 1 have numerous craniofacial and cardiac 
abnonnalities.
ATTA ATCA G T ^  43 q0035 46754 Solute carrier fam ily 38, mem ber
Membrane bound solute transport
ACCCTGCTTA 0 10 10 0.0035 206417 Cystathionine beta-synthase
This enzym e has an important role o f  this enzym e in glutathione-dependent redox homestasis
GAAGCTGTAT „ 0,0035 5079 Hydroxysteroid 11-beta
dehydrogenase 2
Catalyzes the conversion o f  cortisol to the inactive m etabolite cortisone.
GTCTGCTTGT 0 10 10 0.0035 4375 Fatso
Thought to be involved in the processes o f  programmed cell death, craniofacial development, and establishment o f  left-right 
asymmetry during embryonic development.
TGCCACCACT
GTTCACTTTC
Energy metabolism
G G CA A TA ATG
10
20
10
25
0.0035
0.0036
327037
20841
Similar to Phosphatidylinositol-4- 
phosphate 3-kinase C2 domain- 
containing beta polypeptide 
(Phosphoinositide 3-K inase-C2- 
beta) (PtdIns-3-kinase 0 2  beta) 
(PI3K-C2beta) (C2-PI3K)
ATP synthase, H+ transporting, 
mitochondrial F I com plex, 
epsilon subunit
53 25 78 0.004 9925 Isocitrate dehydrogenase 1 (N A D P+), soluble
The protein encoded by this gene is the NADP(-i-)-dependent isocitrate dehydrogenase w hich serves a significant role in 
cytoplasm ic NA D PH  production.
G G A G T A A G A A  4 18 22 0.0041 371563 H3 histone, fam ily 3B
Histones are basic nuclear proteins that are responsible for the nucleosom e structure o f  the chromosomal fiber. Histone li3, along
with histone h4, plays a central role in nucleosom e fonnation.
G TG TTAACCA 13 1 14 0.0041 2050 R ibosom al p ro te in  L I 5
Structural component o f  ribosome
TCATTCTCCA 13 1 14 0.0041 257837 ATPase, class VI, type 11A
Integral membrane ATPase. The encoded protein is probably phosphoiylated in its intermediate state and likely drives the 
transport o f  ions such as calcium  across membranes
G TG GTGCACA 2 14 16 0.0046 28779 Ubiquitin specific protease 54
Member o f  the ubiquitln-specific protease (U SP) fam ily functions in the extremely com plex and diverse U SP proteolytic system. 
TG AAG TACTG  15 2 17 0.0047 17519 Z fy259 Zinc finger protein 259
Interacts with the survival motor neurons (srnn) gene in m ice, essential for embryonic viability. Required for the localization o f  
SM N in nuclear bodies.
GGGTTTTTAT o.oo47 258204 Nuclease sensitive dement
b ind ing  p ro te in  1
A lso called M SY  1. Regulates expression o f  tire rnuiine growth hormone receptor gene.
GGTATCAGTC 19 4 23 0.0047 21281 R ng finger protein 4
Transcription regulator, interacts with, and inliibits the activity of, T R PS1, a transcription suppressor o f  GATA-rnedfated 
transcription. Studies in the m ouse suggest a role for this protein in spermatogenesis, also highly expressed in human testes. 
Enhances steroid receptor-mediated transcriptional activation as w ell as activatiirg basal transcription.
A CA G TTAA G C  10 0 10 0.0054 209813 Ephrin-B class 2
The ephrins and EPH-related receptora comprise the largest subfamily o f  receptor protein-tyrosine kinases and have been 
im plicated in mediating developmental events, especially in the nervous system  and in erythropoiesis. The ephrin-B (EFNB) class 
are transmembrane proteins implicated in a control system  integrating blood vessel and tissue morphogenesis. 
A C G A A A A C C A  10 0 10 0.0054 4509 Runt related transcription factor 2
1
3'4:
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Transcription factor involved in osteoblastic and skeletal differentiation and m oiphogenesis. Runx2 overexpression upregulates 
several genes in osteoblasts, including collagen type I and osteocalcin.
C CACTG TACA 10 0 10 0.0054
N ucleic acid binding
CTTCCCCGGG 10 0  10 0.0054
Function as yet unknown. M ay function as a transcriptional regulator.
GAG G AG G AG G
267473 PHD finger protein 20-like 1
34903 FSH primary response 1
10 0 10 0.0054 136604 N uclear factor, interleukin 3, regulated
The NF1L3 (E 4B P4) transcription factor has been identified as a key regulation protein affecting murine interleukin-3 (lL -3)- 
dependent cell survival. Expression o f  NF1L3 is regulated by oncogenic Ras mutants through botli the Raf-m itogen-activated 
protein kinase and phosphatidylinositol 3-kinase pathways. NFIL3 inliibits apoptosis without affecting B cl-xL  expression. E4BP4  
m ay play a role in the glucocorticoid repression o f  genes.
GCGAAGGCTG ^ 0  0054 2718 Eukaryotic translation elongation
factor 1 beta 2
Translation elongation is the process o f  adding amino acylated tRNAs to the growing polypeptide chain. Translation elongation  
factor 1 A, eE F lA , transfers aminoacylated tRNAs to the A  site o f  the ribosome. This is a GTP-dependent process catalyzed by  
cE F lB , a guanine nucleotide exchange factor.
GTGTACTTTC 10 0 10 0 .0054 20615 Peroxisom al biogenesis factor 11a
A  PPAR alpha target gene PE X l 1 proteins play a direct role in peroxisom e division and that their loss inhibits peroxisom e  
m etabolism  indirectly, perhaps due to altered membrane structure or dynamics.
TACTG CTAAG  10 0 10 0.0054 273915 Gene rich cluster, C 3 f gene
Unknown function
TGG ACATTTG L ow  density  lipopro te in  recep to r- 
10 0 10 0.0054 276656 re la ted  p ro te in  8 , apo lipopro te in  e
recep to r
Apolipoprotein E is a component o f  lipoproteins such as chylomicron remnants, ve iy  low  density lipoprotein (VLDL), and high 
density lipoprotein (HDL). Binds lipoprotein and transports it into cells by endocytosis.
TTCTGTGTCA 6-phosphofructo-2-
10 0 10 0.0054 19669 kinase/fructose-2,6-biphosphatase
3
Hypoxia inducible factor-1 inducible gene. A  key regulator o f  glycolytic flux. Up regulated in response to hypoxia by HlF-1 to 
provide glycolytic metabolism.
AATG C TTG AT 24 7 31 0 .0057 270186 Retinoblastom a binding protein 7
Together with metastasis-associated protein-2, it deacetylates p53 and modulates its effect on cell growth and apoptosis and 
functions in the regulation o f  cell proliferation and differentiation. High levels o f  RbAp46 expression inhibit the transformation o f  
tumor cells tlmough interfering with normal cell cycle  and/or enhancing apoptotic cell death.
T G T A T A A A A A  12 30 42  0 .0058 87773 Tumor rejection antigen gp96
M olecular chaperone that functions in the processing and transport o f  secreted proteins.
CCCCAGCCAG 35 61 96 0.0058
Structural component o f  ribosome
A G A G C G A AG T 44 72 116 0.0063
Structural component o f  ribosome
AATATG G A TG
236868 Ribosom al protein S3
290786 Ribosom al protein L41
0 0.0063 30012 High density lipoprotein (H DL) binding protein
High density lipoprotein (HDL) plays a key role in the transportation o f  cholesterol to extraliepatic tissues including steroidogenic 
tissues and in the reverse transportation o f  cholesterol from extrahepatic tissues to the liver. Previously show n to be present in the 
rodent ovary and regulated by gonadotrophins
9 0.0063AGCAG TG CTT
Unknown function
CCTTGACACC
0
0
274715 C oiled-coil domain containing 3
0.0063 1262 Cytochrome P 450, fam ily 17, subfam ily a, polypeptide 1
Cholesterol side chain cleavage enzyme, progesterone synthesis 
G C A G A A A G C A  0 9 9 0.0063
GTPase activating protein involved in reorganisation o f  the actin cytoskeleton. 
TG A A A C A C TG  0  9 9 0.0063 1605
Thought to play a role in apoptosis but the specific role has not yet been determined 
AAG TA ATG TG  12 1 13 0 .0069 10516
268397 Cdc42 GTPase-activating protein
Programmed cell death 4
Prolactin receptor
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Prolactin has been implicated in physiological functions such as immunoregulation and ovarian steroid production. Prlr has been  
show n to be present in luteinized granulosa cells
A G TTC A TA AG  12 1 13 0 .0069 359654 Similar to airway trypsin-like 3
GTGTCCGTAC 12 l 13 0 .0069 294882 FI 1 receptor
Regulator o f  tight junction assembly in epithelia. Can also act as a receptor for reovirus, a ligand for tire integrin L FA l and a 
platelet receptor,
TGATG TTAAC 12 l 13 0 .0069 255848 H exokinase 2
Hexokinases phosphorylate glucose to produce gIucose-6-phosphate, thus committing glucose to the glycolytic pathway. 
Expression o f  this gene is  insulin-responsive, and studies in rats suggest that it is involved in the increased rate o f  g lycolysis seen  
in rapidly growing cancer cells.
TGTTGGTTGA 12 l 13 0.0069 246990 Reticulon 3
Retinal expressed protein implicated in axon development, precise function unknown
TTA C CA CA TA  20 5 25 0.0069 28262 Regulator o f  G-protein signaling 2
K nown to regulate membrane signaling pathways, expressed in ovarian follicles in response to an ovulatory dose o f  gonadotropin. 
TCTCCAGGCG 31 55 86 0.0075 200608 Clusterin
An anti-apoptotic factor regulated by lGF-lR/Src/M APK/Egr-1 signaling
A CAG CCAG G G  , 242413 G protein-coupled receptor,
fam ily C, group 5, mem ber C 
M ember o f  the type 3 G protein-coupled receptor family. The specific function o f  this protein is unknown 
A TA G T AAG CT Fascin hom olog 1, actin bundling
1 11 12 0.0075 289707 protein (Strongylocentrotus)
purpuratus)
Crosslinks F-actin into highly ordered bundles within dynamic cell extensions, acts as an actin bundling protein.
G A A ATG TTG T , „  0.0075 22.17 Polym erase (R N A ) II (D N A
directed) polypeptide G
Subunit o f  the polym erase responsible for synthesizing m essenger RNA in eukaryotes.
G CCTTTATGA 16 35 51 0.0076 16775 R ibosom al protein S24
Structural component o f  ribosome
A TA AG G G ATT 14 2 16 0.0076 4593 U D F-galactose translocator 2
GTCAACG TAC 25 8 33 0.0076 179189 R ibosom al protein L36a-like
Structural component o f  ribosome
A TA C A C C A G A
16 3 19 0.0077 27286
Protein tyrosine phosphatase-like 
(proline instead o f  catalytic
A TGTTCGTGG 16 3 19 0.0077 1791
arginine), mem ber b
Dual specificity  phosphatase 6
A lso known as M itogen-activated protein kinase phosphatase 3. Inactivates target kinases by dephosphorylating both the 
phosphoserine/threonine and phosphotyrosine residues. This gene product inactivates ERK2 and mediates the response to 
fibroblast growth factor signalling.
C TA ATA AA G C
Function unknown
GG ATATG TGG
28
42
51
19
79 0.0078 329631
Finkel-B iskis-R eilly  murine 
sarcoma virus (FBR-M uSV) 
ubiquitously expressed (fox  
derived)
Early growth response 161 0.0078 181959
Functions as a transcriptional regulator. Activates target genes required for differentitation and m itogenesis.
GTCTTGGGCG 36 15 51 0 .0079 30156 Protease, serine, 11 (Ig f binding)
Proposed to regulate the availability o f  insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been  
suggested to be a regulator o f  cell growth. Binds to various TGF-beta proteins and inhibits the signaling o f  BM P-4, -2 and TGF- 
beta 1
TGACTGG GAG 36 15 51 0 .0079 333849 Nur77 downstream gene 2
(N ur77=N G FlB) N ovel gene o f  unknown function w hose expression is regualted by Nur77, a nuclear orphan steroid receptor that 
has been implicated in negative selection.
TGG GCAAAG C „ Eukaryotic translation elongation
factor 1 gamma23 31 0.0085 371625
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Translation elongation factor-1 (EF-1), a ubiquitously expressed protein that regulates the efficiency and fidelity o f  m RNA  
translation in eukaryotic cells, EF-1 binds aininoacyl-tRNAs and then transfers them to 80 S ribosomes, w hile binding and 
hydrolyzing GTP.
TGTACCCAGG 23
Structural gene for lysosom al enzym es 
A A G G A A A TG G  26 48
Stmctural component o f  ribosome
A C A C T C T T T G  9 0
30
74
0.0086
0.0087
3196 Alpha glucosidase 2 alpha neutral subunit
2 8 5 0 21 R ibosom al protein L 3 1
309193 Ropporin 1-like9 0.0091
Interacts with both A-kinase anchoring protein and the Rho signalling pathway, present on  sperm and thought to be spenn  
specific.
CAAACACCG G 0
Structural component o f  mitochondrial ribosome. 
CACTGTCTTC
9 0 9
0.0091
0.0091
30208
4114
Membrane bound solute transport 
CTGTAGAGTG 9 0
M itochondrial ribosomal protein  
S27
Solute carrier fam ily 3 (activators 
o f  dibasic and neutral amino acid  
transport), member 2
M ortality factor 4 like 19 0.0091 196508
Component o f  the nua4 Instone acetyltransferase (hat) com plex w hich is involved in transcriptional activation o f  select genes. 
T his may both alter nucleosom e - dna interactions and promote interaction o f  the m odified histones with other proteins w hich  
p ositively regulate transcription. M ay be required for the activation o f  transcriptional programs associated with oncogene and 
proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and 
dna repair. Interestingly, M RG15 is m ost highly expressed in adult testis and S p l is a testis-enriched protein, suggesting a 
potential role for M R G l 5 in m eiosis and/or germ cell differentiation.
C T T T A G A A A A  9 o 9 0.0091 268798 Solute carrier organic anion transporter fam ily, mem ber 3 a l
Membrane bound solute transport
GCTGGATGTG 9 0 9 0.0091
M ediates cell-matrix and cell-cell adhesion and inhibits cell invasion.
G G AA A TG AC T
2580 Syndecan 1
Ras hom olog gene fam ily, 
member E
Members o f  the Rho family o f  Ras-related GTPases, such as ARHE, regulate the organization o f  the actin cytoskeleton in 
response to extracellular growth factore. Rlio fam ily member's appear to cycle between an inactive GDP-bound form and an active 
GTP-bound form.
GGGGCAATCC  ^  ^ g  0 00^ ^  296202 ^^°^^^ol polyphosphate-5-
phosphatase B
Involved in sertoli cell vacuolization and germ cell adhesion in m ouse testes
GG GG GAGG GA 9 0 9 0.0091 273915 Gene rich cluster, C 3 f gene
A PPARalpha regulated gene involved in lipid metabolism and known to be upregulated in cells with peroxisom e proliferation.
0 0.0091 46497
GTGCTGCCTT 0 0.0091 295565 Echinoderm microtubule associated protein like 4
738
22225
Procollagen, type IV, alpha 1 
Zinc finger protein 313
Cytoskeletal component
G T G T C T G A T A  9 0 9 0.0091
Major type IV alpha collagen chain o f  basement membranes.
TA A C A T TG T A  9 0 9 0.0091
Unknown fiinction
TAA CC G A G A C  9 0 9 0.0091
Involved in connections o f  major cytoskeletal structures to the plasma membrane. It plays a key role in cell surface structure 
adhesion, migration, and organization.
T A G AC AA AG G
277812 V illin  2
0 0.0091 276815 A denosine deaminase, R N A - specific, B 1
Responsible for pre-mRNA editing o f  the glutamate receptor subunit B 
TATTGTGGCT 0 0.0091 195663 Cyclin-dependent kinase inhibitor 1A (P 21)
Transcription factor/regulator responsive to activin A  signalling and previously shown to regulate sertoli cell proliferation
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TCAGTTTAAT 0 0,0091 275266 Rho guanine nucleotide exchange  factor (GEF) 12
Rlro GTPases mediate cellular processes that are initiated by extracellular stimuli through G protein coupled receptors. This 
particular transcript is highly expressed in haematopoietic stem cell fractions and has been shown to demonstrate colocalization  
with tire insulin-like growth factor-1 (lG F-1) receptor, suggesting a potential physiologic as an activator o f  RhoA in response to 
lGF-1
TG C AA TATG G  9 0 9 0 0091 260084 Eukaryotic translation initiation
factor 4A 2
Subunit o f  a protein com plex involved in cap recognition and is required as a single polypeptide drain for m R N A  binding to 
ribosome.
TG CTACTTTA 9 0 9 0.0091 153415 E2F transcription factor 5
The E2F fam ily plays a crucial role in the control o f  cell cycle. This is an transcriptional activator o f  marry genes w hose products 
are involved in cell proliferation. E2F5 is dispensable for cell cycle  progression but necessary for G l arrest o f  cyclirrg cells and 
w hile other members o f  the E2F fam ily participate in mairrtahring a proliferative unifferentatied phenotype, E2F5 serves to 
maintain the differentiated state.
9 0.0091 248337TGGATTTGCT
Unknown firirction
TTG AG G TA G A
0 Slit-like 2 (Drosophila)
0.0091 1421
A  disintegrin-like and 
m etalloprotease (reprolysin type) 
w ith thrombospondin type 1 
m otif, 1
A ctive metalloprotease, cleaves proteoglycans, aggrecan, versican aird brevican. Has arrgiogenic inhibitor activity. T hey have  
been associated with various roles in connective tissue orgarrization, coagulation, inflanunation, arthritis, angiogenesis arrd cell 
migration as w ell as follicular rupture.
GTTGCTGAGA 30 53 83 0 .0092 100113 Ribosom al protein 10
Structural component o f  ribosome
AATGG CTAGC 5 18 23 0 .0092 35389 Cytochrome c, somatic
Component o f  the electron transport chain in mitochondria. Cytochrome c is also involved in initiation o f  apoptosis, 
TGTG AAG TAG  37 16 53 0.0093 371546 ADP-ribosylation factor 1
The A R F l protein is localized to the Golgi apparatus and has a central role in intra-Golgi transport.
TCCTTATATT 73 42 115 0.0099 290285 R A B 39, mem ber R AS oncogene  fam ily
Rab39 is  a novel Golgi-associated Rab GTPase involved in cellular endocytosis. 
G A A TTA A C A T
21 28 0.01 234700
Tyrosine 3-
m onooxygenase/tryptophan 5- 
m onooxygenase activation  
protein, epsilon  polypeptide 
One o f  a fanrily o f  ubiquitous phosphoserine/threonine-binding proteins. M ice deficient in Y whae have defects in brain 
developm ent and neuronal migration. There is a cracial role for 14-3-3epsilon in rreuronal development through sunstance o f  the 
effects o f  CDK5 phosphorylation
0.01TCCTGTGGGA 7 21 28
Apolipoprotein A -IV  precursor.
G A A ATATA TG
11 27 38
Energy metabolism.
C CTCG G A AA A  9 24 33
Structural comporrent o f  ribosome.
A G A G A G A G A G
19 5
4533 Apolipoprotein A -IV  precursor
ATP synthase, H+ transporting, 
0.01 2966 mitochondrial FO com plex,
subunit c (subunit 9), isoform  3
0.01 371629 R ibosom al p ro te in  L38
Phospholipase A 2, group VII 
(platelet-activating factor 
acetylhydrolase, plasma)
The secretory PLA2 (sPLA2) fam ily, in w hich 10 isozym es have been identified, consists o f  low-m olecular w eight, Ca2+- 
requiiing secretory enzym es that have been im plicated in a number o f  biological processes, such as m odification o f  eicosanoid  
generation, inflarmnation, and host defense.
OTGCTTTCAA  ^ o.oi 289645 G H .2 , imprinted maternally
expressed untranslated m R N A  
The m ouse Gtl2 gene is differentially expressed during embryonic development, encodes m ultiple alternatively spliced transcripts, 
and may act as an RNA.____________________________________________ __________________________________________________________
24 0.01 9277
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GTTGAGGTTT 13 45 o.Ol 331964 D N A  segm ent, Chr 4, W ayne
State U niversity 53, expressed
Unknown function
G G C A G C A C A A  ^4 g 32 o o l l  9043 Heterogeneous nuclear
ribonucleoprotein L
Plays a major role in the formation, packaging, processing, and function o f  mRNA.
A AG G TCTTTA   ^ g  g  298893 Casein kinase II, alpha 1
po lypeptide
Casein kinase 11 is a serine/threonine protein kinase that phosphorylates acidic proteins such as casein.
CGTGGTGGCC  ^ g g Cartilage oligom eric matrix
pro te in
Cartilage oligom eric matrix protein is a noncollagenous extracellular matrix protein previously thought to have a relatively 
cartilage-specific expression pattern.
TA A A G G A TA C  ^  g  g  ^213 M annan-bindinglectin serine
protease 1
A lso known as the Ra-reactive factor (RARF), this is a complement-dependent bactericidal factor that binds to the Ra and R2 
polysaccharides expressed by certain enterobacteria. This gene is involved in the mannan-binding lectin (M BL) pathway o f  
com plem ent activation.
TTCCTATATT 59 32  91 0.011 179011 V av2 oncogene
V A V 2 is the second member o f  the V A V  oncogene fam ily universally expressed in most tissues. Acts as a guanine nucleotide 
exchange factor for the rho fiunily o f  ras-related gtpases. Vav-2 has a role in  B cell antigen receptor calcium  signaling and is 
critical to B cell developm ent and fiinction
A TC A C T C C A A  Membrane interacting protein o f
R G S16
A  mammalian glycerophosphoinositol phosphodiesterase regulated by stimulation o f  G protein-coupled receptom. MIR16 
provides a link between phosphoinositide m etabolism and G protein signal transduction.
GTGCTACTCC 11 l 12 0.011 738 Procollagen, type IV, alpha 1
Cytoskeletal component
TGCAG TG TTA 11 1 12 0 .0 1 1 249342 7-dehydrocholesterol reductase
Catalyzes the reduction o f  7-dehydrocholesterol (DH C), the terminal reaction in cholesterol biosynthesis.
TTGTTACTGC 11 l 12 0 .0 1 1 280231 A nnexin A7
Calcium/phospholipid-binding protein w hich promotes membrane fusion and is involved in exocytosis. Suggested to have a 
function in electromechanical coupling, probably through C a(2+) hom oeostasis.
CCTTTAATTC 3 14 17 0 .012 154306 Ubiquitin S p e c if i c  p r o t e a s e  45
Has a role in the negative regulation o f  gluconeogenesis. Required for proteosome-dependent catabolite degradation o f  finctose- 
1,6-bisphosphatase (fbpase). Accelerates proteosomal breakdown o f  ubiquitinated proteins as it disassem bles free ubiquitin chains 
that would com pete with ubiquitinated proteins to bind to the proteosome.
AGGGGCCGGT 15 3 18 0.012 232930 Neuritin 1
N euiitin  is an immediate-early gene induced by C a(2+) influx through N M DA  receptors and U-type voltage-sensitive calcium  
chamiels. Expression is mediated through the CaM Idnase and M AP kinase pathways and is inducal by  camp. In neuronal tissue  
this is an effector gene targeted by signal transduction pathways mediating synaptic plasticity. It has also been shown to undergo 
androgenic regulation
TTG ATG TA CA   ^ ^^^2 223946 Splicing factor, arginine/serine-
rich 11
The function o f  this protein is not yet known but structure and immmioiocalization data suggest that it may play a role in pre- 
inRNA processing.
A TT GT A A T  AT 13 2 15 0 .012 4509 Runt related transcription factor 2
A  member o f  the Core Binding Factor gene fam ily (Runx 1, Runx 2 and Runx 3) o f  transcription factors with distinct tissue  
specific gene expression patterns which operate to regulate developm ent in different cellular lineages. Runx genes have been  
identified as potential oncogenes.
G G G G G A G G G A  13 2 15 0.012 204670 T h io redox in  dom ain  con tain ing  1
M odifies m olecules with its oxidoreductase activity and be involved in the redox regulation in the endoplasmic reticulum.
GTATGTATGG 13 2 15 0.012 17977 Transcription factor Dp 2
Can stimulate e2f-dependent transcription by binding D N A  cooperatively with e 2 f  transcription factor fam ily members. The  
dp 2/e2f com plex functions in the control o f  cell-cycle  progression from G l to S phase and appeara to mediate both cell 
proliferation and apoptosis.
TCCCGATATC 13 2 1 5 0 .012 263414 Poliovirus receptor-related 4
Expressed on differentiating rreuronal cells during neurogenesis, may play a role in early neuronal differentiation and axon  
outgrowth.
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15 0.012 249555 Procollagen, type III, alpha 1TGTTCATCTT 13 2
Component o f  cytoskeleton
C AAATG CTG T 1 10 11 0.013 20943 FK 506 binding protein 9
A lso known as Peptidyl-piolyl cis-trans isomerase, accelerates the folding o f  proteins during protein synthesis 
GGAGATCTTT 1 10 11 0.013 167625 G protein-coupled receptor 85
G-protein coupled receptor with identical protein sequence in man and mouse, previously believed to be confined to the biain in  
the m ouse
GG AG CCATTG 1 10 11 0.013
Energy metabolism
A A T A A A C A C G  20 6 26 0.014
Chym otiypsin and tiypsin  activity, proteolysis and peptidolysis
AACGTGAGG T
N A D H  dehydrogenase 
275780 (ubiquinone) 1 alpha subcom plex, 
5
257629 Protease, serine, 35
0 0.015 258773 Zinc finger, M Y N D  domain  containing 11
M ultiple endocrine neoplasia 1
Functions as a transcriptional repressor, inhibits the transcriptional activity o f  c-Myb.
AAG CTCCGAC 8 0 8 0 .015 12917
M en l encodes menin, a nuclear protein, hiteracts w ith several transcription factors and inhibits their activities and is essential for 
repression o f  the endogenous lGFBP-2, a gene that can regulate cell proliferation.
A G A A TA TTTT 8 0 8 0 .015 253564 Actinin, alpha 1
Alpha actinin is an f-actin cross-linking protein witli multiple roles in different cell types. In nonm uscle cells, the cytoskeletal 
isoform is found along microfilament bundles and adherens-type junctions, where it is  involved in binding actin to the membrane. 
A G A TC ATC TA  8 0 8 0.015 246003 Frizzled hom olog 1 (Drosophila)
Membera o f  the 'frizzled' gene fam ily are receptors for Wnt signaling proteins. The F Z D l protein contains a signal peptide and 
belongs to the g-protein coupled receptor fe/sm o family.
ATCCGGCGCC icn co  Transcription elongation factor B
(SHI), polypeptide 2
Encodes tire protein elongin B, which is a regulatory subunit o f  the transcription factor B (S ill)  com plex. This com plex activates 
elongation by RNA polym erase 11.
ATGTTTGGGG 8 0  8 0.015
CCCTCTGGAT
17461
8 0 8 0.015
Implicated in the regulation o f  cell growth and proliferation.
CTC AG ATA AC
100144
Serine/threonine kinase 16 
S I 00 calcium  binding protein A 6 
(calcyclin)
0 0.015 34399 Zinc metalloproteinase, STE24  hom olog (S. cerevisiae)
A  multispanning membrane protein w idely distributed in maimnalian tissues. Disruption caused severe growth retardation and 
premature death in hom ozygous-null m ice. Zmpste24-null m ice are defective in the proteolytic processing o f  prelamin A. 
G G G G G G AA G A  8 0 8 0.015 27308 ADP-ribosylation factor 6
A  small guanine nucleotide-binding protein that plays a role in vesicular trafficking and as an activator o f  phospholipase D. 
GTAGCGCTCA  ^  ^  ^ Peptidylglycine alpha-amidating
m onooxygenase
The protein encoded by this gene localizes to perinuclear endosom es and associates with peptidylglycine alpha-amidating 
m onooxygenase, and may be involved with the trafficking o f  this enzym e tln ough secretory or endosom al pathways. 
TCCCCCCCTT 8 0 8 0.015 4946 Ins2 Insulin II
Insulin upregulated gene
TCTCTCAGTC 8 0 8 0.015 1620 Annexin A5
The protein encoded by this gene belongs to the annexin fam ily o f  calcium-dependent phospholipid binding proteins som e o f  
w hich have been implicated in membrane-related events along exocytotic and endocytotic pathways. Amrexin 5 is a 
phospholipase A 2 and protein kinase C inhibitory protein w ith calcium  chamiel activity and a potential role in  cellular signal 
transduction, inflammation, growth and differentiation.
TGACATCCAT 0
M embrane bound solute transport
TGTCCACACA
0.015
0.015
233889
276656
Solute carrier fam ily 39 (zinc  
transporter), mem ber 10
L ow  density lipoprotein receptor- 
related protein 8 , apolipoprotein e 
r e c e p t o r _______________________
' 3
243
Tag sequence hCG PM SG p-value U nigene Gene
This gene encodes an apolipoprotein E receptor, a member o f  the low  density lipoprotein receptor (LDLR) fam ily, Apolipoprotein  
E is a small lipophilic plasma protein and a component o f  lipoproteins such as chylomicron remnants, very low  density lipoprotein 
(VLDL), and high density lipoprotein (HDL). The apolipoprotein E receptor is involved in cellular recognition and internalization 
o f  these lipoproteins. Alternative splicing generates three transcript variants for this gene; additional variants have been described, 
but their foil length nature has not been deteim ined. :■
TGTGGATGGC 8 0 8 0.015 30602 Ubiquitin specific protease 22
Belongs to the peptidase c l  9 family. Invovled in the synthesis and degradation o f  proteins.
T T G C T G C C C T  8 0 8 0.015 247764 Peroxisom e biogenesis factor 19
PEX genes encode the machinery required to assem ble the peroxisom e. Membrane assembly and maintenance requires three o f  
th e s e (P E X 3 ,16, and 19)
T T C A T T C T A G  ;  23 0.016 122366 H eterogeneous n uc lea r
R N A  binding protein com plexes with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in ; I
the nucleus and appear to influence pre-mRNA processing and other aspects o f  m RNA metabolism  and transport.
ribonucleoprotein F 
r  
TATCCCACGC ^ 3  g 3 1  0 0 1 6  280038 SI 00 calcium  binding protein A l l
(calizzarin) ^
Proinflammatory cytokine and a chemoattractant for m onocytes and granulocytes. Strongly expressed at sites o f  apoptosis in the 
m ouse embryo and in tumor necrosis factor alpha (TNF)-treated murine cells. High level expression correlates predominantly with  
hypoxic and apoptotic cells. It is also an anti-angiogenic protein which inhibits fetal lung neovascularization and leads to the ‘
arrest o f  lung airway epithelial morphogenesis and apoptosis
TAA CA G TTG T 38 18 56 0 .017 248827 Calnexin
Calcium-binding protein that interacts with newly synthesized glycoproteins in the endoplasmic reticulum. It may act in assisting  
protein assem bly and/or in the retention within the ER o f  unassem bled protein submiits. Seems to play a major role in the quality 
control apparatus o f  the ER by the retention o f  incorrectly folded proteins
G CACAACTTG 1 2  27 39 0 .017 329243 Calmodulin 2
Calmodulin is the principal mediator o f  the intracellular calcium  signa and is therefore involved in regulation o f  numerous 
processes.
A A G C A G A A G G  ^ q 0 1 7  1 S 100 calcium  binding protein A lO
(calpactin)
The protein encoded by this gene is a member o f  the S 100 fam ily o f  proteins and is involved in the regulation o f  a number o f  
cellular processes such as cell cycle progression and differentiation. M ay fonction in exocytosis and endocytosis.
CTG AACATCT ^ q 0 1 7  5286 A cidic ribosom al phosphoprotein
Stmctural component o f  ribosome
TCCATATATT ,  2 3  0 .018 259667 R N A  binding m otif, single
Stranded interacting protein 1 
This gene encodes a member o f  a sm all fam ily o f  proteins w hich bind single stranded D N A /R N A . This protein interacts with the 
region upstream o f  the c-m yc gene and may have a role in D N A  replication. Has been shown to suppres hypoxia inducible factor 
1 and VEOF expression blocking angiogenesis
A AG GGTG CTG 1 0  l 11 0 .019 265347 A nnexin A 6
A nnexin VI belongs to a fam ily o f  calcium-dependent membrane and phospholipid binding proteins. Although their functions are 
still not clearly defined, several members o f  the annexin fam ily have been implicated in membrane-related events along exocytotic  
and endocytotic pathways. Annexin VI has been im plicated in mediating the endosom e aggregation and vesic le  fusion in secreting |
epithelia during exocytosis
A C A A C A G A G G   ^ ^  2 4 3 0 7  Prostaglandin F2 receptor
negative regulator
Induces a decrease in receptor number, suggesting a non-com petitive means o f  inliibition o f  prostaglandin receptora 
A TA G A G A A G G  1 0  l 11 0 .019 250419 C yclin I
Controls cell-cycle progression by regulating the activity o f  cyclin-dependent kinases.
CCTCTAGCTG  ^ 2 9 3 4 5  Guanosiiie monophosphate
reductase 2
A  guanosine monophosphate reductase, can promote the monocytic differentiation o f  H D 6 0  leukemia cells.
CCTGATCTTT  ^ Laminin receptor 1 (ribosomal
protein SA )
Structural constitutent o f  ribosome
GCCACTTCCT 1 0  I 11 0 .019 371598 N uclear receptor coactivator 4
AR A 70 enhances androgen receptor transactivation through the increase o f  receptor expression, protein stability, and nuclear 
translocation. A lso regulates induction and repression o f  PPAR alpha transcription.
GTTGTTTGTT  ^ 2 0 3 2 7  H om eodom ain interacting protein
kinase 1
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The protein encoded by this gene belongs to the Ser/Thr fam ily o f  protein kinases. Also modulates localization, phosphorylation, 
and transcriptional activity o f  Daxx, a transcriptional regulator important for transducing growth regulatory signals.
T C AC A T  A A  AT C D 47 antigen (Rh-related antigen,
10 1 11 0.019 31752 integrin-associated signal
transducer)
This gene encodes a membrane protein involved in the increase in intracellular calcium concentration that occurs upon cell 
adhesion to extracellular matrix.
0.019 172TCATTTGGTG 10 1 11
Initiates the crosslinking o f  collagens and elastin.
TCTAGCCAGA
10 1 11
L ysyi oxidase
0.019 35253
Solute carrier fam ily 12 
(potassium /chloride transporters), 
m em ber 8
M ediates sodium and chloride reabsorption, plays a role in the regulation o f  ionic balance and cell volum e  
TGCCGTATGC 10 l 11 0 .019 6442 P olycystic kidney disease 2
PKD2 encodes a protein o f  unknown function, mutated in 15% o f  autosomal dominant polycystic kidney disease fam ilies.
TG TAC A AA TG  U DP-G al:betaG lcNAc beta 1,4-
10 1 11 0 .019 15622 galactosyltransferase, polypeptide1
Binds to specific glycoside residues on multiple extracellular ligands, mediates cell-cell and cell-matrix interactions in a variety o f  
cells. A lso acts as a sperm surface receptor binding to the zona pellucida glycoprotein during fertilisation.
TGTTATG TAA ATP-binding cassette, sub-fam ily
A  (A B C l), member 1
A BC proteins transport various m olecules across extra- and intracellular m em brane. Functions as a cholesteral efflux pump in the 
cellular lipid removal pathway. Essential for high density lipoprotein (HDL) fonnation and considered rate-controlling for reverse 
cholesterol transport.
CTG AG GAAG T 14 3 17 0 .019 29027 SPARC-like 1 (mast9, hevin)
A n extracellular calcium-modulated protein that binds collagen 1. Similar to SPARC (secreted protein acidic and rich in cysteine), 
a matricellular protein that regulates cell adhesion, cell cycle, and matrix assembly and remodeling.
C A A A A T A C A T  8  21 29 0.019 27578 M elanom a antigen, fam ily D , 1
M ediates p75 neurotrophin receptor-dependent apoptosis binding in neuronal cells. Inhibits cell cycle  progression, and facilitates 
p75ntr-mediated apoptosis. C losely related to the magphinin proteins known to be present in the m ale and fem ale germ cells 
during gam etogenesis.
GTGTTTTGTG 25 44 69 0.019 201455
Functions as a carrier to the cell surface in post-golgi recycling pathways. 
AAG G TCG AG C 3 13 16 0 .019 282814
Structural component o f  ribosome 
CCCTGATTTT
Secretory carrier membrane 
protein 1
Ribosom al protein L24
13 16 0.019 185453 Eukaryotic translation initiation  factor 4, gamma 2
A  novel translational repressor mRNA. This translation initiation factor hom olog for eIF4G controls specific gene expression  
pathways required for cellular differentiation. Null cells exhibit an impaired ability to differentiate.
G TG CATTTCA  ^ 13  1 5  o o i 9  5199 Cytochrome P 450 , fam ily 19,
subfam ily a, polypeptide 1
Cytochrome P450 aromatase catalyzes the last steps o f  estrogen biosynthesis.
GTGCTATTCA 1 2  2  14 0.019 1639 M yeloid ce ll leukem ia sequence 1
B elongs to the B cl-2 family. Alternative splicing occurs and two distinct isofonns have been identified. The longer gene product 
(isofonn 1 ) enhances cell survival by inhibiting apoptosis w hile the alternatively spliced shorter gene product (isofonn 2 ) 
promotes apoptosis and is death-inducing. Acts via the M APK pathway and can prolong cell viability under a variety o f  cytotoxic 
conditions.
T A C A T T A A T A  12  2  14 0 .019 225505 Choline kinase alpha
Implicated in hematopoietic development but null m ice develop normally suggesting action is compensated by activity o f  a
c losely  related protein tyrosine kinase Csk.
TCAACTTG GG
Unknown function
TCCTTATTGC
12
12
14
14
0.019
0.019
156727
14547
Hyperparathyroidism 2 hom olog  
(human)
Chromobox hom olog 2 
(Drosophila Pc class)
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Transcriptional repressor. H om ozygous null m ice show greatly retarded growth, hom eotic transformations o f  the axial skeleton, 
sternal and limb malformations and a failure to expand in vitro o f  several cell types including lymphocytes and fibroblasts. 
A A C TT T T A A A   ^  ^  ^ ^^2  354643 Heterochromatin protein 1,
binding protein 3
N ecessary for the condensation o f  nucleosom e chains into higher order structures. This product appears during m eiosis in  
spermatogenesis, expressed in pachytene spermatocytes during meiotic prophase 1 .
A ATTGTATTT
Am ino acid synthesis 
C CAATG AACT
0
0
Stiuctuial component o f  mitochondrial membrane 
CCTTTAATGC 0 7 7
Unknown function
GCATCCAGCT  ^  ^ 7
0.02
0.02
0.02
0.02
10651 GTP cyclohydrolase 1
235123 Inner membrane protein, mitochondrial
219648 THO com plex 1
277091
Binds to the poly(A ) tail present at the 3-prime ends o f  m ost eukaryotic mRNAs.
GCTCACAACC 0
Component o f  Golgi apparatus
GGTTTTCAAG
0.02 272930
Poly(A )-binding protein, 
cytoplasm ic pseudogene
Component o f  oligom eric golgi 
com plex 4
0.02 259278 SMT3 suppressor o f  m if  two 3 hom olog 1 (yeast)
Has a key role in the modification o f  many transcription factora including PPAR gamma.
GTCTATGTTG 0  7 7 0 .0 2  4952 Insulin receptor substrate 1
The principal substrate for the insulin and insulin-like growth factor-1 (lG F-1) receptors. Disruption o f  IRSl results in  insulin
resistance, but not DM , because o f  compensatory hyperinsulinemia.
A A A A T G T C A A  l  9 1 0  0 .0 2 2  208554 Oogenesin 1
M ouse protein expressed in oocytes during follicle developm ent and in early cleavage-stage embryos specific function unknown.
GGCTTTTTCG  ^ V-ral simian leukem ia viral
 ^  ^ 10 0. 2 2  27832 oncogene hom olog B (ras related)
This gene encodes a GTP-binding protein that belongs to the small GTPase superfamily and Ras fam ily o f  proteins. GTP-binding 
proteins mediate the transmembrane signaling initiated by the occupancy o f  certain cell surface receptors.
T A T GC A G  A T G 1 9 1 0  0 .0 2 2  2662 Glutathione S-trans (erase, alpha 4
In m ice GST A 4 has been shown to be induced by TNFalpha, lL - 6  and EGF, factor's that play crucial roles in cell survival and 
proliferation suggesting an antiapoptotic role.
0.025CTAGTCTTTG 68
Structural component o f  ribosome
A A A TG C A C T A
94
0
162 154915 Ribosom al protein S29
0.026 57734 LIM and senescent cell antigen­like domains 1
347919 B -cell stimulating factor 3 
Phosphodiesterase 7A
Involved in the regulation o f  iirtegrin-mediated cell adhesion 
A CTCTA AG TT 7 0  7 0 .026
Recently indentified cytokine acts as a novel myelom a growth and survival factor 
A G A A A G G A T A  7 0  7 0.026 296814
Plays a role in signal transduction by regulating the intracellular concentration o f  cyclic nucleotides, particularly cAM P
A G A CA AG CTG  .  Splicing factor, arginine/serine-
rich 5 (SR p40, HRS)
Plays a role in constitutive splicing arrd can modulate the selection o f  alternative splice sites.
A GA TG TA C TG  7 0  7 0 .026 21767 Cadherin 5
Interacts with filarneirtous actin forming a functional com plex controlling endothelial tube formation.
A G C C A A A C A A   ^ ^  ^ 172897 M itogen activated protein kinase
kinase kinase 12
Protein serine/threonine kirrase w hich plays an active part in cellular processes related to terminal differentiation. With cell-type- 
specifio expression in the sem iniferous tubules o f  mature testes, and other tissues.
AGTGTGACG T  ^  ^  ^ ^^26  43081 M itogen-activated protein kinase
8 interacting protein 3
Encodes a scaffold protein for c-Jun N-terminal kinase cascades.
:1
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0 0.026 4 6 4 0 1 S on cell proliferation proteinA TC A G TA C TA  7
Unknown fonction
C G A A A G A A C A  7 0  7  0 .026 23335 YM E 1-like 1 (S. cerevisiae)
The protein encoded by this gene is the m ouse ortholog o f  yeast mitochondrial A A A  metalloprotease, Y m elp . It is proposed that 
this gene plays a role in mitochondrial protein metabolism.
CTGTAGAGTG 7 0  7 0 .026 3158
Structural component o f  ribosome
GCTGACTCCG 7 0  7 0 .026 34374
Inactive precureor o f  alpha-chymotrypsin, one o f  a fam ily o f  serine proteases 
GTACTTGTCT 0 0.026 29658
R ibosom al protein, large, PI
C hym otrypsinogen B1
C hem okine-like factor super 
fam ily 4
Function unknown
T A A A T A A G A T Chondroitin sulfate proteoglycan  
2
M ay play a role in intercellular signaling and in connecting cells with the extracellular matrix. Binds hyaluronic acid.
TATC TA TAC A  ^ q 7  0  026 258475 finger and B TB  domain
containing 24
Regulator o f  Bax-mediated signaling pathways for apoptosis. Bax is a proapoptotlc member o f  the B cl-2  protein fam ily that 
com m its the cell to undergo programmed cell death in respoirse to apoptotic stimuli.
TG C CA ATA AT
0 0.026 158700
0 0.026 23156
A  disintegrin-like and 
m etalloprotease (reprolysin type) 
with thrombospondin type 1 
m otif, 4
M ember o f  the ADAM TS protein family. Responsible for the degradation o f  aggrecan, a major proteoglycan o f  cartilage, and 
brevican, a brain-specific extracellular matrix protein,
TGCCTGTCTG 7 0  7 0.026 3064 properdin
A  positive regulator o f  the alternate pathway o f  complement. Binds to and stabilizes the c3- and c5-corrvertase errzyrne com plexes, 
The stmctural locus for murine tissue inlribitor o f  rnetallothionine proteases (Timp) and properdin are located together.
TGGTCGCTGA 0
Probable ATP-dependent RNA helicase D D X 27  
TGTGCTGTTG
7 0
Fatty acid biosynthesis and sterol metabolism  
TTG CTA AG AA   ^ ^
0.026
0.026
0.026
295031
32700
272675
D EA D  (A sp-G lu-A la-A sp) box  
polypeptide 27
Sterol-C5-desaturase (fungal 
ERG3, delta-5-desaturase) 
hom olog (S. cerevisae)
Solute carrier fam ily 20 , member 
1
Sodiurn-phosphate syrnporter. A ctive in early gruwth phase.
TTGGCTGGAT 7 0  7 0 .026 3815 Syndecan 4
M ember o f  the syndecan gene family o f  heparan sulfate proteoglycans with the ability to bind and activate protein kinase C-alpha. 
Production stimulated by TNF alpha in ischaem ic environments and it is an important cell-surface receptor in wound healing and 
angiogenesis
TGTAACTG GT 15 4  19 0 .027 233009 R AS related protein lb
B elongs to a superfamily o f  RA S-like small GTP-binding proteins involved in cell signalling. Promotes integrin-dependent cell
adhesion and can modulate integrin alpha(Ilb)beta(3) interactiorrs w ith the actin cytoskeleton,
T G TG A A C G A A   ^ ^^27 18522 Carnitine palmitoyltransferase la ,
liver
R esponsible for the initiation o f  the mitochondrial oxidation o f  long-chain fatty acids.
GAGTGGATTC 7 27 0.027 277857 Hydroxysteroid (17-beta)
dehydrogenase 4
Biforrctional errzyrne acting on the peroxisom al beta- oxidation pathway for fatty acids. Catalyzes the formation o f  3- ketoacyl-coa  
intermediates from both straight-chain arrd 2 -metlryl- branched-chain fatty acids.
TTC A TTA TA A  6  17 23 0 .028 19187 Prothymosin alpha
Nuclear protein thought to play a critical role in cellular proliferation. Transcription activated by the proto-oncogene c-m yc. 
During m ouse foetal development the temporal, spatial and tissue-specific expression patterns o f  both myc proto-oncogenes 
coincide with the pattern o f  prothymosin alpha.
CTG TAGG TGA 36 56 92 0 .029 295618 R ibosom al protein S23
247
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Structural component o f  ribosome.
AAC TG CTTCA   ^ 30010 A ctin related protein 2/3 com plex,
subunit IB
Part o f  a com plex implicated in the control o f  actin polym erization in cells
A TA CG G A G C A   ^ 333183 M itochondrial ribosom al protein
L53
Structural component o f  ribosome
A TC TCA AA CC   ^ 248163 M itochondrial ribosomal protein
Structural component o f  ribosome
A T T A T A C A G T  13 3 16 0.03 29192 Asparaginyl-tRNA synthetase
Protein synthesis
CTCTGGGGTT 13 3 16 0.03 271711 Transgelin 2
The protein encoded by this gene is a hom olog o f  the protein transgelin, which is one o f  the earliest markers o f  differentiated 
sm ooth muscle. It is an actin-associated protein with a unique cell lineage-restricted pattern o f  expression.
TGAATTCCCT  ^ 373569 Chem okine-like factor super
fam ily 3
Unknown function
CTGCTATCCG 20 36 56 0.03 4419 Ribosom al protein L5
Structural component o f  ribosome.
A C C A C TG A TA   ^  ^ 50424 T ax i (human T -cell leukem ia
virus type I) binding protein 1 
Cellular m yosin, appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping.
A lso im plicated in Rlro signalling pathways.
ACTCCTCCCT 9 1 10 0.031 333868 R A S -re lated  p ro te in - la
R A P l A  belongs to a superfamily o f  RAS -like small GTP-binding proteins involved in cell signaling. Involved in interactions 
with beta 1 and beta 2  integrins
A T  A C T G AAGC 9 l 10 0.031 319719 R ibosom al protein LI 3
Stmctural component o f  ribosome
A TC AA AG TTC   ^  ^ ^^^99 Col5a2 Procollagen, type V , alpha
Alpha chain for one o f  the low  abundance fibrillar collagens.
A TG CA CA G A T  ^  ^ 2 5 5 1  SEC22 vesic le  trafficking protein­
like 1 (S. cerevisiae)
Cytoplasm ically oriented integral membrane protein involved in vesicle docking/fusion fidelity between the endoplasm ic 
reticulum and Golgi.
A t t t c c C G A G  g j QQ21 288974 A ctin related protein 2/3 com plex,
subunit 5
This gene encodes a subunit o f  the human A ip2/3 protein com plex which has been implicated in the control o f  actin 
polym erization in cells and is highly conserved across species.
CCCGTAGCCC 9 l 10 0.031 121878 Tropom yosin 1, alpha
Ubiquitous protein associated with the actin filaments o f  myofibrils and stress fibers. In nonm uscle cells is im plicated in
stabilizing cytoskeleton actin filaments.
G G TAA CC TAA  9 i 10 0.031 3213 L ow  density lipoprotein receptor
Cell surface protein involved in receptor-mediated endocytosis. Low density lipoprotein (LDL) is normally bound at the cell 
membrane and taken into the cell. Providing the substrate for cholesterol synthesis.
TG A AC TG TAA   ^  ^ 270647 Solute carrier fam ily 39 (zinc
transporter), mem ber 14
N o literature infonnation available
TG A TG CTA AA  9 1 10 0.031 304976 Down-regulated by C tnnbl, a
D R C T N N B 1A  has been shown to be involved in the beta-catenin-TcfrLef signaling pathway.
TTCAGGCACT  ^  ^ Tetratricopeptide repeat domain
N o literature information available
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GCAG C TC AC A  D olichyl-di-
3 12 15 0.031 7236 phosphoo ligosaccliaride-p ro tein
glycotransferase
Essential subunit o f  n-oligosaccharyl transferase enzym e w hich catalyzes the transfer o f  a high mannose oligosaccharide. 
TCTGTGCACC 3 1 2  15 0.031 196538 R ibosom al protein S 11
Structural component o f  ribosome.
ATG AG TG AG C Phenylalkylam ine Ca2+
11 2 13 0.031 27183 an tagonist (em opam il) b ind ing
pro te in
Emopamil-binding protein (EBP) is an integral membrane protein o f  the endoplasmic reticulum. It is similar to sigm a receptors 
and may b e a member o f  a superfamily o f  high affinity drug-binding proteins in the endoplasmic reticulum o f  different tissues.
EBP shares structural features with bacterial and eukaryontic drag transporting proteins.
C AG AC CTCA A  ^ 13 q031 250605 S e ll (suppressor o f  lin -12) 1
hom olog (C. elegans)
Impacts on the expression o f  genes involved in regulation o f  cellular growth, possibly through the TGF-beta signaling pathway. 
Expression has been associated with a reduction in both proliferative activity in vitro and in vivo neoplastic aggressiveness
C AG ATTG TG A ^ 13  q 0 3 1  317701 Thioredoxin domain containing 4
(endoplasm ic reticulum)
M ay be involved in the control o f  oxidative protein folding.
G G G A AC A AC T  ^ 13 o03l 8687 CAP, adenylate cyclase-associated
protein 1 (yeast)
H ighly conserved actin monomer binding protein present in all eukaryotes, promotes rapid actin filament depolym erization and is 
impoitant for cell m orphology, migration, and endocytosis. CAP promotes rapid actin dynamics in conjunction with A D F/cofilin  
and is required for several central cellular processes in mammals.
TGAGTTCCCT 11 2 13 0.031 38390 Copine III
Ubiquitously expressed, intrinsic kinase activity. Represents a novel unconventional kinase family.
G A A CTTG C AA  24 10 34 0 .034 39472 Fam esyl diphosphate synthetase
Catalyzes the sequential condensation o f  isopentenyl pyrophosphate with the allylic pyrophosphates, dim ethylallyl pyrophosphate, 
and then with the resultant geranylpyrophosphate to the ultimate product fam esyl pyrophosphate 
Involved in cholesterol biosynthesis.
A TG TC TCA AA  30 48  78 0 .035 324696 TubuIin, alpha 2
Cytoskeletal component
A G G C A G A CA G  ^25 0 036 335315 Eukaryotic translation elongation
factor 1 alpha 1
Tissue-specific isofonn o f  peptide elongation factor-1A  (eE F lA -1); its m RNA is expressed only in, tissues dominated by 
tenninally differentiated, long-lived cells such as brain, heart, and skeletal muscle. Has been shown to be a specific translational 
target o f  TrkA signalling w ith eE F lA -1 m RNA translation stimulated by the NGF-signaling pathway 
A A T G T T T C T G  2 10 12 0.036 7141 P ro liferating  ce ll nuclear an tigen
This protein is an auxiliary protein o f  D N A  polym erase involved in the control o f  eukaryotic dna replication.
CACTG ACGAG DnaJ (H sp40) hom olog, subfam ily
" C ,m e m b ^ 9
N ovel member o f  the DnaJ family, is expressed in tire germinal zone o f  the rat brain, liver lung and kidney.
A A G A A A A C A T  Eukaryotic translation initiation
0 6 6 0.036 218851 factor 2, subunit 3, structural gene
X -linked
elF-2 is com posed o f  three subunits, [alpha], [beta] and [gamma], which, in the presence o f  GTP, form a ternary com plex w ith  
M et-tRNA, recruiting it to the 40S ribosomal com plex
A A G A G A A A A G   ^  ^  ^ ^ 240066 Proteasom e (prosom e, macropain)
activator subunit 4
Nuclear proteasorne activator involved in D N A  repair.
C AA AC TG TAT Hydroxysteroid dehydrogenase-2,
 ^ 6 ddta<5C3_beta
Bifunctional errzyrne, catalyzes the oxidative conversion o f  delta(5)-ene-3-beta-hydroxy steroid, and the oxidative conversion o f  
ketosteroids. Plays a cracial role in the biosynthesis o f  all classes o f  hormonal steroids.
CGCTCTAACG Protein kinase, cAM P dependent
 ^  ^  ^ regulatory, type 11 beta
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cAM P-dependent protein kinase (AM PK) transduces signals through phosphorylation o f  different target proteins. Four different 
regulatory subunits and three catalytic subunits o f  AM PK have been identified in humans. T he protein encoded by this gene is one  
o f  the regulatory subunits. This subunit has been shown to interact with and suppress the transcriptional activity o f  the cAM P  
responsive elem ent binding protein 1 (C R E B 1 ) in activated T  cells.
GTCTTTGTGA  ^  ^  ^ 200775 Traitsforming growth factor, b eta
receptor III
Transfonning growth factor beta (TGF-beta) signaling is mediated by the cell surface TGF-beta type I (ALK 5), type 11, and the 
accessory type 111 receptors endoglin and betaglycan. The type 111 receptor may regulate the ligand-binding ability or surface 
expression o f  the type 11 receptor
TCTGGCAGTC 0  6  6 0 .036 221452 R A N  binding protein 5
Involved in nucleocytoplasm ic transport. The protein encoded by this gene is a member o f  the importin beta family. 
T GAAATGGCC Cofactor required for S p l
0 6 6 0.036 28020 transcrip tional activation , subun it
3
Sp 1 transcriptional factor cofactor implicated in  metastasis suppression in neoplastic cells.
A A C A A A T T C T  1 8 9 0.039 35628 Fucosyltransferase 8
The product o f  this gene catalyzes the transfer o f  focose from GDP-fucose to N-linked type com plex glycopeptides. The
expression o f  this gene may contribute to the malignancy o f  cancer cells and to their invasive and metastatic capabilities.
CAGGGCTCCG j  g  ^  193096 Stearoyl-Coenzym e A  desaturase
Integral membrane protein, belongs to the fatty acid desaturase family. Tenninal component o f  the microsom al stearyl-coa 
desaturase system , that utilizes o(2) and electrons from reduced cytochrome b5 to catalyze the insertion o f  a double bond into a 
spectrum o f  fatty acyl-coa substrates.
T A C A A A A T T A  A  disintegrin and
8 0.039 355306 n^etalloproteinase dom ain  17
This gene encodes a disintegrin and metalloprotease (A D A M ) domain 17, which is a member o f  the A DAM  protein family. 
M embers o f  this fam ily are membrane-anchored proteins implicated in a variety o f  biologic processes involving cell-cell and cell- 
matrix interactions, including fertilization, m uscle development, and neurogenesis. The member encoded by tliis gene functions as 
a tumor necrosis factor-alpha converting enzyme; binds mitotic arrest deficient 2  protein; and also plays a prominent role in the 
activation o f  the N otch signaling pathway. A lso identified as the major convertase o f  epiregulin, TGF alpha, amphireguUn and 
EGF-like growth factor.
TTTACTGTGT I 8  9 0 .039 28897 Pyrophosphatase
Regulates constituency o f  extracellular matrix
CGTCTGTGGA  ^ ^6 0 04 30155 ATPase, H +transporting, VO
subunit C
Encodes a component o f  vacuolar ATPase (V-ATPase), an enzym e that mediates acidification o f  organelles, necessary for 
processes such as protein sorting, zym ogen activation, endocytosis, and synaptic vesicle proton gradient generation.
TGC ACTGCTG Cofactor required for Sp I
19 7 26 0.04 44151 transcrip tional activation , subun it
6
Nuclear receptor cofactor for Sp 1
CATTGCGTGG W  illiam s-B euren syndrome
22 9 31 0.041 27955 chrom osom e region 1 hom olog
(human)
Translation initiation factor, functions to stimulate the initiation o f  protein synthesis at the level o f  m R N A  utilization.
GTTCTGACAG  ^ 261025 Carnitine deficiency-associated
gene expressed in ventricle 3 
Localized mainly in cytoplasm, phosphorylated preferentially by Abl. Phosphorylation o f  tyrosine 120 in tins protein leads to an 
apparent m obility shift in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, suggesting confonnational change in the 
phosphorylated protein. Thus, appears to be a novel substrate o f  Abl tyrosine kinase. Function unknown.
GTTTAGTGGA ^ ^ 2  0  043 252255 Proteasom e (prosome, macropain)
subunit, alpha type 2
Part o f  a multicatalytic proteinase com plex that plays a role in  the generation o f  peptides for presentation by major 
histocompatibility com plex class 1 m olecules.
A A A G A C A C T A   ^  ^  ^ g 3 ^ ^ 4 4 5  Interferon regulatory factor 2
binding protein 2
Interacts specifically with Interferon Regulatory Factor-2 (lR F-2). Nuclear protein with the properties o f  lRF-2-dependent 
transcriptional co-repressors that can inhibit both enhancer-activated and basal transcription
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A A C T  GC AC AC Succinate dehydrogenase
6 0 6 0.046 246965 com plex, subun it B , iron  su lfu r
(Ip)
Com plex 11 o f  the respiratoiy chain, w hich is specifically involved in tire oxidation o f  succinate, carries electrons flrom FADH to 
CoQ.
AGGCGTGGCT 6 0 6 0.046 30849 Prenylcysteine oxidase 1
Involved in the degradation o f  prenylated proteins to yield free cysteine and the aldehyde o f  the isoprenoid lipid, expressed at high  
levels in m ouse liver, kidney, heart, and brain. H om ozygous null m ice are both healthy and fertile.
AGGTG GCATT 6  0  6  0 .046 2442 Calcium  binding protein,
intestinal
Belongs to a fam ily o f  calcium-binding proteins that includes calmodulin, paivalbumin, troponin C, and S I 00 protein. Its exact 
function is unknown. In the intestine its expression correlates with calcium transport activity
AG G TG TACAG   ^  ^  ^  ^ 29397 Splicing factor, arginine/serine-
rich 15
Acts to physically and functionally link transcription and pre-rmna processing (by similarity).
A TA A A C T G C A  6  0  6  0.046 230654 Testis derived transcript
Unknown function
ATC AG TG TG A  6  0  6  0 .046 275555 Calponin 3, acidic
ATG CTTCTCA 0 0.046 248313 RAB 12, mem ber RAS oncogenefam ily
Localized to the Golgi com plex w ith a role in the specification o f  the apicolateral junctional com plex sites and the formation and 
segregation o f  apical tight junctions
ATTA G G A TG T 6  0  6  0 .046 22347 Pinin
Involved in translation initiation by promoting the binding o f  the fonnylm ethionine-tRNA to ribosomes.
C A A G A A T T A A  6  0  6  0 .046 294083 A nnexin A 1 1
Calcium-dependent phospholipid-binding protein. Distinctive properties include calcyclin binding, autoantigenicity, organelle 
transport, nuclear localization, extracellular targeting, and tyrosine phosphorylation.
C AG AA CTTTG  6  0  6  0 .046 4352 Procollagen, type X V lll, alpha 1
Alpha chain o f  type X V llI collagen, one o f  tire multiplexins, an extracellular matrix proteins that contains multiple triple-helix  
dom ains interrupted by non-collageiious domains. Potently inhibits endothelial cell proliferation and angiogenesis. M ay inliibit 
angiogenesis by binding to the heparan sulfate proteoglycans involved in growth factor signalling such as FGF-2. 
C A G C A A T A A A  6  0  6  0 .046 291326 M ahogunin, ring finger 1
C 3HC4 RlNG-containing protein with E3 ubiquitin ligase activity.
CAGTCTTGAG 6  0  6  0 .046 22560 Diaphorase 1 (N A D H )
Oxidoreductase participating in N O  production from vasorelaxants. Can convert selected N O  donors, glycerol trinitrate (GTN) 
and formaldoxime (FAL) to nitrites and nitrates with NO  as an intennediate.
C TCTCCAG AA 6  0  6  0 .046 274810 H RAS like suppressor 3
Growth inhibitoiy RAS target gene, target o f  interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in 
human ovarian carcinoma cells.
CTG AATATCT 0 0.046
60S acidic ribosomal protein PO, structural component o f  ribosomes.
CTG AG AATGC 6  0  6  0.046
GAGTCTCTTC 0 0.046
371545
184021
Regulates tire tyrosine phosphorylation that controls cell activities and proliferation. 
GTAATCACGT 6  0  6  0 .046 2654
The encoded protein may help induce the disassem bly o f  actin filaments.
TA C A A T A A A C 0
Steroid binding integral membrane protein
TAC CC CA C AA 6 0
N o literature available 
TACTATAG TC 6 0
0.046
0 .046
0.046
40321
41849
A cidic ribosom al phosphoprotein  
PO
Unmatched tag
Protein tyrosine phosphatase,
receptor type, D
W D repeat domain 1
Progesterone receptor membrane 
com ponent 2
Brain expressed, associated w ith  
N edd4
123211 Po lym erase  (D N A  directed), be ta
D N A  polym erase beta is involved in D N A  base excision  repair. m RNA most abundant in spermatocytes at early pachytene may 
be involved in the repair-type D N A  synthesis associated with the recombination process.
I
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Tag sequence hCG PMSG p-value Unigene Gene
TGAACACTGA  ^ ^ 0.046 330731 Tr^sglutaminase 2 , C
po lypeptide
Catalyzes tlie cross-linking o f  proteins and the conjugation o f  polyainines to proteins 
T G A A T G A A T G  6 0 6 0 .046 U nm atched  tag
T G A A T G A G C G   ^ ^ ^ C hem okine (C -X -C  m otif)
recep to r 4
Chem okine receptor specific for stromal cell-derived factor-1. Involved in neoplastic metastasis and in endothelial cell survival
T G G A G C G T T G  6 0 6 0 .046 6839 C yclin -dependent k inase 4
M ember o f  the Ser/Tlu’ protein kinase family, catalytic subunit o f  the protein kinase complex that is important for cell cycle  G l 
phase progression. T he activity o f  this kinase is restricted to the G l-S  phase. Regulates cell proliferation and hypertrophy and the 
activity o f  the c-M yb transcription factor
T G G C T C C A T C  3-hydroxy-3-m ethy lg lu tary l-
'   ^ C oL y n ^ A red u ct^ e
3-hydroxy-3-rnethylglutaryl-coenzyme A  (HM G-CoA) reductase catalyses the rate-limiting step for cholesterol synthesis. 
HM G-CoA reductase inliibitors have been shown to upregulate the cyclin-dependent kinase inhibitor p27K ipl and to block cell 
proliferation through cholesterol-independent patlrways. Growth hormone significarrtly increases both the LDL-r and HM G-CoA  
reductase trarrscript levels
T G T G T C C C G C  6 0 6 0 .046 287810 Im portin  13
Importin beta-related receptors mediate translocation through rruclear pore complexes. Co-operation with the RanGTPase system  
allow s them  to bind and subsequently release their substrates on opposite sides o f  the nuclear envelope, w hich in turn ensures a 
directed nucleocytoplasmic transport. Imp 13 also shows export activity towards the translation initiation factor e lF lA  and is  thus 
a case where a single importin beta-like receptor transports different substrates in opposite directions.
T G T T A G C T C C  P ro teasom e (prosom e, m acropain )
^ ^  ^ 26 S subunit, non-A T Pase, 12
Receptor protein, mediates TNF alpha membrane transport
T T T G A G G A T T  N on  im prin ted  in  Prader-6 0 6 0.046 333893 W illi/A ngelm an  syndrom e 2
hom olog  (hum an)
N ovel gene, ubiquitously expressed, highly conserved with predicted function as receptor or transporter protein 
A G G A A G G C G G  48 68 116 0 .046 11376 R ibosom al p ro te in  L 3 6
Structural com ponent o f  ribosome
C T C C T G C A G A  Solute carrier fam ily  7 (cation ic
12 3 15 0 .046 275489 am ino acid  transporter, y+
system ), m em ber 1
High-affrnity, low  capacity pennease involved in the transport o f  tire cationic amino acids (arginine, lysine and ornithine) in non- 
hepatic tissues.
T C T T C A T C A A  SW I/SN F re la ted , m atrix
12 3 15 0 046 229151 associated , ac tin  dependen t
regu lator o f  ch rom atin , sub fam ily  
a, m em ber 1
Members o f  the Imitation Switch (ISW l) fam ily o f  chromatin remodeliirg proteins. Predominantly expressed in tenninally  
differentiated neurons after birth and in adult animals and in terminally differentiated cells within ovaries and testes o f  adult mice. 
Suggested to have distinct firnctions associated with cell maturation or differentiation.
T G C C T A C A G T  12 3 15 0 .046 1815 C ytid ine 5 -triphosphate  syn thase
The catalytic conversion o f  UTP to CTP, important in the biosynthesis o f  phospholipids and nucleic acids, key role in cell growth, 
developm ent, and tumorigenesis.
C A A A A A T A A A  18 32 50 0.047 70666 E nolase 1, a lpha non-neuron
Glycolytic enzym e under the inducible control o f  hypoxia inducible factor 1
T A A G T G G A A T  T yrosine 3-
26 12 3 8 0,047 3360 monooxygenase/tryptophan 5-
m onooxygenase ac tiva tion  
pro te in , ze ta  po lypeptide
This highly conserved gene product belongs to a fam ily o f  proteins w hich mediate signal transduction by binding to 
phosphoserine-containirig proteins. Found in botli plants and mammals, this protein is  99% identical in the mouse, rat and sheep. 
Involved in initiating the embryonic cellular cormmmication system
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Appendix 2: List of abbreviations
ADAM A disintegrin and metalloproteinase
ADAMTS A disintegrin and metalloproteinase with thrombospondin motifs
AhR Aryl hydrocarbon receptor
Amh Antimullerian hormone
Apaf-1 Apoptotic protease activating factor 1
Ar Amphiregulin
AR Androgen receptor
ARC Apoptotic repressor
ATP Adenosine triphosphate
Bad Bcl-2 antagonist of cell death
BAG 1 BAG family molecular chaperone regulator-1
Bax Bcl-2 associated X protein
Bcl-2 B cell leukaemia/lymphoma 2
BDNF Brain derived neurotrophic factor
bFGF Basic fibroblast growth factor
BMP Bone morphogenic protein
Bok Bcl-2 related ovarian killer protein
Boo Apoptosis regulator Bcl-B
BORG BMP/OP-responsive gene
BSA Bovine serum albumin
B+W Binding and washing buffer
BTC Betacellulin
BTG2 B cell transclocation gene 2
C/EBP (3 CAAT enhancer binding protein (3
CAM Cell adhesion molecule
cAMP Cyclic adenosine monophosphate
cdk Cyclin dependant kinase
C-fos Proto-oncogene protein c-fos
Cgak Cyclin G associated kinase
c-jun Transcription factor AP-1
c-kit Kit ligand receptor
CL Corpus luteum
C-myc Myc proto-oncogene protein
CGC Cumulus oocyte complex
COX-2 Prostaglandin endoperoxidase synthetase 2
CTGF Connective tissue growth factor
Cx Connexin
CYP 51 Lanosterol 14a-demethylase
C ypllal Cytochrome P450 side chain cleavage enzyme
Cypl9 Cytochrome P450 aromatase enzyme
Dax-1 Nuclear receptor OB 1
DES Diethylstilbestrol
DHT Dihydrotestosterone
DNA Deoxyribonucleic acid
dNTPs DNA nucleotides
DTT Dithiothreitol
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E2 Oestrogen
eCG Equine chorionic gonadotrophin
ECM Extracellular matrix
EDTA Ethylenediaminetetracetic acid
EGF Epidermal growth factor
Egr-1 Early growth regulatory factor
EMBL European Molecular Biology Laboratory
EPI Epiregulin
ER Oestrogen receptor
ERK Extracellular regulated kinase
EST Expressed sequence tag
FABP Fatty acid binding protein
FIGa Factor in the germline alpha
Fru-2,6-P2 Fructose-2,6-biphosphate
FS Follistatin
FSH Follicle stimulating hormone
FSHR Follicle stimulating hormone
Fz Frizzled
GAPDH Glyceraldehyde-3 -phosphate dehydrogenase
RACE Rapid amplification of complementary ends
G-CSF Granulocyte colony-stimulating factor
G-CSFR Granulocyte colony-stimulating factor receptor
GDF-9 Growth and differentiation factor 9
GnRH Gonadotrophin releasing hormone
GnSAF Gonadotrophin surge attenuating factor
GPR G protein coupled receptor.
SREB Super-conserved receptor expressed in brain
GSTs Glutathione S transferases
GVBD Germinal vesicle breakdown
hCG Human chorionic gonadotrophin
HDL High density lipoprotein
HIF-1 Hypoxia inducible factor 1
HK Hexokinase
HNE 4-hydroxynonenal
HSC Haematopoietic stem cell
HSD Hydroxysteroid dehydrogenase
ICN Intracellular domain of notch
IGF Insulin-like growth factor
IGFBP Insulin-like growth factor binding protein
IGF-R Insulin-like growth factor receptor
IHOP Information hyperlinked over proteins
GLGI Generation of longer gene fi'agments for gene identification
11 Interleukin
IL-1 -ra Interleukin 1 receptor antagonist
INSL3 Insulin like 3
JNK c-Jun N-terminal kinases
Jun D Jun proto-oncogene related gene dl
KGF Keratinocyte growth factor
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KL Kit ligand
LB Lnria bertani
LDL Low density lipoprotein
LDLR Low density lipoprotein receptor
LGR8 Leucine-rich repeat-containing G protein-coupled receptor 8
LH Luteinising hormone
LHR Luteinising hormone
Mamll Mammalian homolog 1 (Drosphilia)
MAPK Mitogen activated protein kinase
MAS Meiosis activating sterol
MCAM Melanoma cell adhesion molecule
MGF Mast cell growth factor
MMP Matrix metalloproteinase
MORF4 Mortality factor 4
MPF Maturation promoting factor
mRNA Messenger RNA
NADPH Nicotinamide adenine dinucleotide phosphate
NGF Nerve growth factor
NGFI-B Nerve growth factor induced
p21 CIP/KIP Cyclin dependant kinase inhibitors
P4 Progesterone
P450scc Cytochrome P450 side chain cleavage enzyme
PACAP Pituitary cyclase-activating polypeptide
PAGE Polyacrylamide gel electrophoresis
PAPP-A Pregnancy associated plasma protein A
PCR Polymerase chain reaction
PDE4D cAMP specific phosphodiesterase 4D
PFKFB 6-phosphofimcto-2-kinase/fmctose-2,6-biphosphatase
PGS-2 Prostaglandin endoperoxide synthase-2
PI Phosphatidyllinositol
PI3 Phosphatidyllinositol-3 -kinase
PKA Protein kinase A
PKB Protein kinase B
PKC Protein kinase C
PMSG Pregnant mare serum gonadotrophin
PPAR Peroxisome proliferator-activated receptor
PR Progesterone receptor
pRb Retinoblastoma protein
PRL Prolactin
QRT-PCR Quantative reverse transcription polymerase chain reaction
RIP 140 Nuclear receptor interacting protein 1
RNA ribonucleic acid
RTK/P Receptor tyrosine kinase/phosphatase
RT-PCR Reverse transcription polymerase chain reaction
SAGE Serial analysis of gene expression
SF-1 Steroidogenic factor 1
SFRP-4 Secreted frizzled related protein 4
Sgk Serum/glucocorticoid regulated kinase
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Smad Mothers against decapentaplegic homolog 2
Snk Serum induced kinase
SPARC Secreted acidic cysteine-rich glycoprotein
Sppl Secreted phosphoprotein 1
SR-Bl Scavenger receptor B1
StAR Steroidogenic acute regulatory protein
STC Stanniocalcin
TAB Tris acetate EDTA
TEMED T etra-methylethylene-diamine
TGFa Transfonning growth factor alpha
TGF(3 Transforming growth factor beta
TIMP Tissue inhibitor of matrix metalloproteinase
TNF-a Tumour necrosis factor alpha
TWEAK TNF-related weak inducer of apoptosis
TZPs Transzonal projections
UTR Untranslated region
VEGF Vascular endothelial growth factor
VEGFR Vascular endothelial growth factor receptor
Angptl4 Angiopoietin like 4
Zp Zona pellucida protein
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